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Molecular Controls over Developmental Acquisition of Diverse  
Callosal Projection Neuron Subtype Identities 
 
Abstract 
 
The mammalian neocortex is an exquisite, highly organized brain structure composed of hundreds of 
subpopulations of neurons and glia, precisely connected to enable motor control, sensory perception, 
information integration, and planning.  Unique molecular, structural, and anatomical neuronal properties 
underlie diverse functionality, endowing much of the neocortex’s complex processing power.  Neocortical 
size correlates with information processing capacity, suggesting that increased neuronal number and 
diversity begets increased sophistication.  One excitatory projection neuron type, callosal projection 
neurons (CPN), has disproportionately expanded with cortical size increase.   
CPN directly connect homotypic regions of the two neocortical hemispheres by sending axons via the 
largest white matter fiber tract in the brain, the corpus callosum (CC), allowing quick relay, integration, 
and comparison of information.  In humans, the CC contains over 300,000 axons, CPN have been 
centrally implicated in autism spectrum disorders, and absence or surgical disruption of CPN connectivity 
in humans is associated with defects in abstract reasoning, problem solving, and generalization.  
Therefore, CPN are critical to complex brain functions, and their diversity likely contributes to these 
roles.   
Work presented in this dissertation addresses molecular controls over CPN development, specifically 
genes that are expressed by, and function in, particular subpopulations of CPN. While much progress has 
been made in identifying molecular controls over neocortical arealization, lamination, and broad subtype 
specification, CPN diversity has remained largely unaddressed.  Therefore, this work begins by 
	  iv 
identifying genes more highly expressed in CPN than other closely related projection neuron populations, 
and uncovers molecular diversity within CPN.  From this molecular diversity, functional analysis of three 
candidate molecular controls over CPN subtype diversity follows.  Cited2 acts broadly in neocortical 
progenitor development and postnatally in refining somatosensory CPN identity.  Caveolin1 identifies a 
population of CPN with dual axonal projections.  Tmtc4 is mutated in human CC disease and can function 
in CPN axonal development.  These analyses of CPN molecular diversity in mouse then expand to an 
investigation of which molecular subpopulations are conserved, expanded, or uncommon between rodent 
and primate, allowing both for comparative evolutionary theories of CPN function, and indicating which 
CPN populations critical for human brain function can be best studied in rodent models. 
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1.1 Overview 
 
The human cerebral cortex is the region of the brain responsible for cognitive function, sensory 
perception, voluntary motor control, spatial reasoning, language, and consciousness. It contains over 
two-thirds of the neuronal mass of the whole nervous system, and three-quarters of all synaptic 
connections(Rakic, 1988).  About 90% of the cerebral cortex is contained in a structure unique to 
mammals that has undergone dramatic expansion and elaboration throughout evolution, the 
neocortex(Finlay and Darlington, 1995). The mammalian neocortical capacity for high-order processing 
emerges from its complex, yet highly organized, six-layered structure and the unique connections 
between its hundreds of different neuronal subtypes, and their association with diverse glial populations 
that support and enable appropriate neuronal function and communication (Peters and Jones, 1984; 
Ramón y Cajal, 1995). Neocortical expansion in primates has occurred both radially and longitudinally 
throughout evolution, transitioning to a thicker cellular layer, more white matter, as well as to more 
surface area from lissensephalic (smooth brain) to gyrencephalic (wrinked brain).  As this neocortical 
expansion proceeded, the diverse population of interhemispheric connecting callosal projection neurons 
(CPN) has expanded disproportionately more than other populations of long-distance neocortical 
projection neurons, likely representative of their functional contribution to increased neocortical 
processing capability(Smart et al., 2002b). 
Two broad classes of neurons make up the neocortex: interneurons, GABAergic inhibitory non-
pyramidal neurons that make local connections; and projection neurons, glutamatergic excitatory 
pyramidal neurons that extend axons to distant intracortical, subcortical, and subcerebral targets to 
transmit information from the neocortex to other neocortical areas, or to other regions of the central 
nervous system (Molyneaux et al., 2007). During development, these two broad classes of neurons are 
generated from different progenitor zones; interneurons are generated primarily from progenitors in the 
ventral (subpallial) telencephalon, and migrate tangentially over long distances to their final locations 
within the neocortex (Wonders and Anderson, 2006), while projection neurons are generated from 
progenitors of the neocortical germinal zone located in the dorsolateral (pallial) wall of the 
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telencephalon, and migrate radially to their final neocortical position (Rakic, 1972; Tan et al., 1998; 
Ware et al., 1999; Anderson et al., 2002; Gorski et al., 2002a; Molyneaux et al., 2007; Leone et al., 
2008).  
Different subpopulations of projection neurons are born in overlapping temporal waves, with newly 
born projection neurons migrating past the earlier born neurons to form more superficial layers of 
neurons, thus progressively establishing the six layered structure of the mature neocortex in an “inside-
out” manner, with layers VI and V generated first, followed by layers IV, III, and II (Angevine and 
Sidman, 1961; Molyneaux et al., 2007; Leone et al., 2008) (See Figure 1.1). Within the mature 
neocortex, distinct populations of projection neurons are located in different cortical layers and areas 
(with many subtypes intermingled in each layer and area), have unique morphological features, express 
and are controlled by different complements of transcription factors, and ultimately serve different 
functions. The complexity and diversity of projection neuron subtypes makes any classification scheme 
difficult, but the most accurate system likely extends beyond the most commonly used system of 
hodology (anatomical projections) to include a combination of hodology, morphology, 
electrophysiological properties, and combinatorial patterns of gene expression that most likely represent 
yet-unrecognized functional differences (Peters and Jones, 1984; Migliore and Shepherd, 2005; 
Molyneaux et al., 2007).  
Establishing this complex neocortical circuitry requires tightly regulated spatial and temporal 
developmental programs that not only generate the requisite cellular diversity, but also appropriately 
integrate the components into functioning networks. In order to understand the development of the 
neocortex, it is essential to understand molecular controls that guide these developmental programs, and 
precisely regulate neuronal fate specification, differentiation, maturation, and connectivity.  
Here, in this introduction, I review the development of the rodent neocortex in the context of recent 
data revealing roles of individual and combinatorial sets of genes in controlling specification and 
development of distinct projection neuron subtypes.  In this dissertation, I focus on molecular controls 
over development of subtypes of one diverse population of neocortical projection neurons, the callosal 
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projection neurons (CPN), which are critical for long-distance bilateral transfer and integration of 
cortical information, and have been centrally implicated in autism spectrum disorders (ASD).  
First, I describe the diversity of progenitors that give rise to the projection neurons of the neocortex. 
Next, I discuss current knowledge on molecular programs that instruct early steps of progenitor 
specification, and extensively review molecular controls over neuronal subtype and layer specific 
identity. Finally, I focus on the distinct projection neuron population that is the focus of this 
dissertation, CPN, and one comparative population, subcerebral projection neurons, and describe recent 
advances in understanding the interplay of combinatorial molecular controls over the generation of 
precision and diversity of these developmentally and clinically important neuronal subtypes, and, by 
extension, neocortical diversity more broadly. 
 
1.2 Neocortical Progenitors 
 
During early mammalian brain development, the cerebral cortex arises from the dorsal aspect of the 
rostral forebrain (telencephalon), a brain structure formed by evagination of the two cerebral 
hemispheres at the rostral end of the neural tube surrounding the lateral ventricles. The six-layered 
neocortex (“new cortex”, as opposed to evolutionarily older and perhaps less refined cortical areas like 
“archicortex”), which makes up the majority of the cerebral cortex, is initially composed of a thin 
neuroepithelium lining the dorsal wall of the lateral ventricles, called the ventricular zone (VZ; Figure 
1.1). As neurogenesis proceeds, an additional proliferative layer known as the subventricular zone 
(SVZ) forms superficial to the VZ (Bayer and Altman, 1991). Progenitors residing in the VZ and SVZ 
produce projection neurons of the different neocortical layers in a tightly controlled temporal order 
from approximately E10.5 to E17.5 in mouse (Angevine and Sidman, 1961; Rakic, 1974; Caviness and 
Takahashi, 1995). Post-mitotic neurons then position themselves in the developing neocortex via 
defined modes of radial and tangential migration (Rakic, 1972; Noctor et al., 2001; Rakic, 2003; 
Britanova et al., 2006). The earliest born neurons appear around E10.5 in the mouse, and form a layered 
structure called the preplate (PP), which is later split into the more superficial marginal zone, and the 
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deeply located subplate (SP). The cortical plate, which will give rise to the multilayered neocortex, 
develops in between these two layers (Bayer and Altman, 1991), such that later born neurons arriving at 
the cortical plate migrate past earlier born neurons, progressively establishing the six layered structure 
of the mature cortex in an “inside-out” manner (Angevine and Sidman, 1961; Rakic, 1974). 
 
1.2 a. Neocortical Progenitor Types 
Three broad classes of progenitors give rise to cortical projection neurons, characterized by 
different competency states and proliferative properties: neuroepithelial cells, radial glia, and 
intermediate progenitors (Gotz and Huttner, 2005) (Figure 1.2). Neuroepithelial progenitors are 
multipotent, (i.e. able to generate neurons, astroglia, and oligodendroglia) (Williams and Price, 1995), 
and have epithelial morphological features with a clear apical-basal polarity. They primarily undergo 
symmetric divisions, producing two neuroepithelial progenitors, thereby expanding the progenitor pool 
whose progeny will ultimately populate the neocortex. In addition, a minority undergoes asymmetric 
division, generating two different daughter cells, a neuroepithelial progenitor and a neuron of the deep 
layers of the neocortex (Smart, 1973; Chenn and McConnell, 1995; Gotz and Huttner, 2005).  
 As neurogenesis progresses, these neuroepithelial progenitors differentiate into radial glial 
cells, maintaining some neuroepithelial properties, such as expression of the intermediate filament 
protein nestin (Hartfuss et al., 2001), and an apical-basal cell polarity, but also acquiring astroglial 
properties, including expression of astrocytic molecular markers such as glial fibrillary acidic protein 
(GFAP), the calcium-binding protein S100β, and the glutamate transporter GLAST (Hartfuss et al., 
2001; Noctor et al., 2002; Kriegstein and Parnavelas, 2003). Radial glial cells reside on the apical 
surface of the VZ, and extend a long process to the pia; this process has a well-characterized role in 
guiding migrating neurons from their site of production in the VZ to their final laminar destination, by 
serving as a migratory scaffolding (Rakic, 1972; Rakic, 2003). More recently, radial glial cells have 
been shown to have properties of neuronal progenitors, and, depending on the stage of development, 
divide either symmetrically to produce two radial glia, or asymmetrically to generate another radial glia  
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Figure 1.1:  Progenitors residing in the VZ and SVZ produce projection neurons in an “inside-
out” fashion 
(A-C) From approximately E10 to E12, pallial ventricular zone (VZ) progenitors divide asymmetrically 
and generate neurons that migrate radially and form the preplate (PP). At approximately E12.5, a 
second wave of postmitotic neurons migrates radially and intercalates into the preplate, splitting it into 
the superficial marginal zone (MZ) and a deep subplate (SP), forming the cortical plate (CP), which will 
expand over the next several days and the first week postnatal week into the mature, six-layered 
neocortex. The subventricular zone (SVZ) develops superficial to the primary VZ, providing a 
secondary germinal zone composed of intermediate progenitor cells (IPCs). Over the next 
approximately five days, diverse cortical projection neuron subtypes are born in sequential and 
overlapping waves. At approximately E12.5, cortical projection neurons destined for layer VI are born, 
including corticothalamic projection neurons and a subset of callosal projection neurons (CPN). At 
approximately E13.5, an additional subpopulation of CPN and subcerebral projection neurons (SCPN), 
including corticospinal motor neurons (CSMN), destined for layer V are generated. At approximately 
E14.5, layer IV pyramidal neurons are born. Finally, between approximately E15.5 and E17.5, 
heterogeneous subpopulations of CPN and other intracortical projection neurons destined for layers 
II/III are generated. WM, white matter. Adapted from (Molyneaux et al., 2007). 
 
  
	  7 
  
Figure	  1.1	  (Continued)	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Figure 1.2: Cortical projection neuron progenitors 
Neuroepithelial cells (green) in early cortical development largely divide symmetrically (dark green; 
circular arrow) to generate more neuroepithelial cells, while some neuroepithelial cells increasingly 
over time likely divide asymmetrically (lighter green; thin arrow) to generate immature neurons (pink) 
that will differentiate into early, deep layer projection neurons (brown). As the developing cortical 
epithelium thickens, neuroepithelial cells elongate and differentiate into radial glial progenitors (blue). 
Radial glial progenitors either 1) self-renew (dark blue; circular arrow), 2) divide asymmetrically 
(medium blue) to directly generate immature neurons (pink) that migrate along the maintained pial 
process, then mature into deep layer projection neuron subtypes (brown), or 3) divide asymmetrically to 
generate intermediate progenitors (yellow; also “basal progenitors”), which divide symmetrically to 
produce two immature neurons that migrate radially along the radial glial progenitor and mature into 
superficial layer projection neurons (red).  A distinct population of cortical progenitors has been 
described, short neural precursors (dark purple), which generally produce neurons directly from the VZ 
rather than producing intermediate progenitor cells, generating progeny that predominantly reside in 
layer IV. 
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and either a postmitotic neuron or an intermediate progenitor cell (Malatesta et al., 2000; Hartfuss et al., 
2001; Noctor et al., 2001; Heins et al., 2002; Noctor et al., 2002; Malatesta et al., 2003; Anthony et al., 
2004; Miyata et al., 2004; Noctor et al., 2004; Mo et al., 2007; Noctor et al., 2008). During neurogenic 
divisions, the radial glial cell maintains its pial process, and the newly born neuron migrates along the 
parent glial scaffold to its destination layer (Noctor et al., 2001; Noctor et al., 2004). 
In addition to the typical radial glia, other neuron-producing progenitors have been described within 
the VZ (Hinds and Ruffett, 1971; Gotz and Huttner, 2005; Gal et al., 2006; Mo et al., 2007). Recently, a 
subpopulation of progenitors that can be distinguished from radial glia cells by absence of a full-length 
pial process, and by the ability to drive the Tα1 α-tubulin promoter has been identified (Gal et al., 2006; 
Stancik et al., 2010). These short neural precursors, or SNPs, have a longer cell cycle length than radial 
glial cells, and they generally produce neurons directly from the VZ rather than producing intermediate 
progenitor cells (Stancik et al.). Further, SNPs and radial glial cells fate-mapped at E14.5 generate 
neurons in distinct lamina of the cortex, with SNP progeny residing predominantly in layer IV, and 
radial glial progeny in layer II/III (Stancik et al.). Although further study is needed to clarify the extent 
of progenitor diversity, and the relationships between currently identified and likely further to-be-
identified subtypes of progenitors within the VZ, there is growing evidence to indicate that progenitor 
heterogeneity might be critical in generation of the full and rich diversity of cortical projection neuron 
subtypes. 
In addition, intermediate progenitors (also called basal progenitors because they divide without 
touching the apical surface) are the other major type of neuron-producing progenitor.  Intermediate 
progenitors are located throughout the proliferative zones (the basal VZ early in corticogenesis and 
SVZ later in corticogenesis) (Haubensak et al., 2004; Pontious et al., 2008; Kowalczyk et al., 2009), 
and are the primary component of the SVZ. Intermediate progenitors of the VZ, which contribute to 
early-born, deep layer projection neuron subtypes, and intermediate progenitors of the SVZ, which give 
rise to later-born, superficial layer projection neuron subtypes, are molecularly distinct, although both 
have been shown to express Tbr2/ Eomes during G1 (Kawaguchi et al., 2008). The SVZ begins to form 
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as a distinct region at approximately E13.5 in mouse, and expands significantly during late 
corticogenesis (Smart and McSherry, 1982; Bayer and Altman, 1991). Smart and McSherry (1982) 
proposed that the SVZ might be a site of neurogenesis for superficial layer neurons (Smart and 
McSherry, 1982), but solid evidence supporting this hypothesis was lacking. Instead, cell divisions in 
the SVZ were thought to primarily contribute to gliogenesis, not neurogenesis (Takahashi et al., 1995). 
More recently, however, elegant studies in slice culture have shown that radial glia frequently undergo 
an asymmetric division to generate an intermediate progenitor, which then can migrate into the SVZ 
before pausing and undergoing a symmetric cell division to produce two more intermediate progenitors 
or two neurons (Miyata et al., 2004; Noctor et al., 2004). The SVZ might not be the sole source of 
superficial layer neurons, as low-level radial glia progenitor neurogenic divisions have also been 
observed throughout corticogenesis (Kowalczyk et al., 2009). By observing neurogenesis in Tis21-
green fluorescent protein (GFP) knock-in mice that only express nuclear-GFP in cells undergoing a 
neuron-producing division, Haubensak et al. (2004) identified intermediate progenitors dividing at the 
basal side of the VZ (the developing SVZ) that undergo symmetric cell divisions to give rise to two 
post-mitotic neurons (Haubensak et al., 2004), confirming and extending the slice culture results in 
vivo.  
Circumstantial evidence that this observed neurogenesis in the SVZ contributes to generation of 
superficial layer neurons came from identification of several genes that are expressed in the SVZ during 
superficial layer neurogenesis, and are also expressed by superficial layer post-mitotic neurons. For 
example, the genes Svet1 and Cux2 are expressed by a subset of dividing cells in the SVZ during 
generation of superficial layer neurons, and postnatally in some neurons of layers II-IV, suggesting that 
Svet1 and Cux2 might be markers for superficial layer progenitors within the SVZ (Tarabykin et al., 
2001; Nieto et al., 2004; Zimmer et al., 2004; Franco et al., 2012). Interestingly, Cux2 expression is 
detected in the basal VZ starting at E11.5, suggesting that progenitors committed to the generation of 
superficial layer neurons might be present early in cortical neurogenesis, before formation of the SVZ, 
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and several days before the production of superficial layer neurons (Nieto et al., 2004; Zimmer et al., 
2004), though more definitive fate mapping experiments are needed to explore this possibility.  
A separate set of in vivo fate mapping experiments used the promoter regions of the Nex gene to 
obtain Cre recombinase expression in progenitors of the SVZ, combined with a floxed reporter 
delivered by adenovirus at E14, to label progenitors during generation of superficial layer neurons. GFP 
reporter expression was mapped to neurons residing in the superficial layers, providing more definitive 
support for the SVZ origin of superficial layer neurons (Wu et al., 2005). Studies of the evolution of 
mammalian cortex suggest that superficial layer neurons are a recent evolutionary addition, while layer 
V and VI projection neurons might be related to pyramidal neurons of a primitive cortex(Reiner, 1991; 
Marín-Padilla, 1992; Aboitiz and Montiel, 2003; Aboitiz et al., 2003). Thus, expansion of the SVZ 
might represent an evolutionary mechanism to increase the number of neurons within the neocortex, 
especially during generation of neurons of superficial layers (Smart et al., 2002a; Kriegstein et al., 
2006).  
The SVZ has further expanded in primates (and some gyrencephalic non-primate mammals) to 
include two progenitor regions - an inner and an outer SVZ, the progenitors of which are distinct (Smart 
et al., 2002a; Fietz et al.; Hansen et al.). The progenitors of the inner SVZ (ISVZ) more closely 
resemble rodent SVZ intermediate progenitors; they express Tbr2, but down-regulate Pax6 (Fietz et al., 
2010). The progenitors of the primate outer SVZ (OSVZ), on the other hand, are more similar to radial 
glial cells, both in morphology and molecular identity (Smart et al., 2002a; Fietz et al.; Hansen et al.). 
Further, the radial glial-like progenitors of the OSVZ can undergo both symmetric, self-renewing 
divisions, as well as asymmetric, neurogenic and self-renewing divisions (Fietz et al., 2010; Hansen et 
al.). This capacity of OSVZ progenitors to undergo self-renewing asymmetric divisions to also generate 
progenitors that can further proliferate greatly enhances neuronal output, and may have been an 
important evolutionary step in the expansion of the neocortex. 
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1.2 b. Neocortical Progenitor Cell Fate Plasticity 
   
The precise relationships among progenitors, and the identities of distinct progenitor populations 
that give rise to broad classes and restricted sets of projection neuron subtypes, are still largely 
unknown, though recent results are beginning to clarify progenitor heterogeneity. Lineage tracing of 
clonally related populations indicates that, at the earliest stages of cortical neurogenesis (approximately 
E11.5 in mouse), individual progenitors are able to give rise to pyramidal neurons across layers II-VI 
(Tan et al., 1998; Reid and Walsh, 2002). As development progresses, progenitors become 
progressively restricted in their competence states(Azim et al., 2009b). Some early cortical progenitors 
at the time of generation of deep layer neurons are still multipotent and can generate later-born neurons 
of superficial layers when transplanted into the niche of late progenitors (McConnell and Kaznowski, 
1991); progenitors of the superficial layers possess less plasticity (Frantz and McConnell, 1996; 
Mizutani and Saito, 2005), but appear to retain some ability to generate earlier fates under the 
appropriate conditions (Molyneaux et al., 2005; Fukumitsu et al., 2006).  
A delicate balance of cell intrinsic and extrinsic factors act in concert on cortical progenitors to 
determine, and progressively restrict, fate of their neuronal progeny. Elegant transplantation 
experiments in the 1990s demonstrated that progenitors are partially responsive to environmental 
factors in determining laminar fate of their progeny, in a cell-cycle dependent manner. Prior to 
completion of S-phase of the cell cycle, transplanted progenitors can generate progeny more appropriate 
to the age of the host, but upon cell-cycle exit, they are more committed to their normal fate 
(McConnell and Kaznowski, 1991). The progressive increase in the length of cell cycle, and in G1 
phase in particular, throughout cortical neurogenesis (Takahashi et al., 1994; Caviness and Takahashi, 
1995; Takahashi et al., 1995), is strongly correlated with a shift to differentiative rather than 
proliferative division of progenitors (Lukaszewicz et al., 2002; Calegari et al., 2005), and long G1 
length might provide an extended plastic period of sensitivity to the influence of extrinsic and intrinsic 
cell-fate determining signals (Dehay and Kennedy, 2007).  
In agreement with findings demonstrating extrinsic control over early cortical progenitor plasticity, 
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recent experiments have revealed that manipulation of extracellular signals can also alter fate of 
neurons born late in cortical neurogenesis. BDNF delivered to progenitors during birth of later born 
neurons shifts them to laminar fate with some characteristics of earlier born neurons if progenitors are 
exposed to BDNF before the S phase of the cell cycle (Fukumitsu et al., 2006). Some extrinsic signals 
regulating progenitor development and fate may come in the form of feedback regulation by postmitotic 
neurons of the cortical plate (Morrow et al., 2001; Barnabe-Heider et al., 2005; Seuntjens et al., 2009). 
For example, newly born cortical neurons produce the neurotrophic cytokine cardiotrophin-1, which 
instructs cortical progenitors to produce astrocytes rather than neurons, thereby ensuring that 
gliogenesis does not occur until neurogenesis is largely complete (Barnabe-Heider et al., 2005). Further, 
conditional deletion of the transcription factor Sip1 from postmitotic cortical projection neurons results 
in over-expression of neurotrophin-3 at E14.5, resulting in precocious generation of superficial layer 
projection neurons at the expense of deep layer projection neurons, while at E16.5 there is an over-
expression of Fgf9, leading to precocious gliogenesis (Seuntjens et al., 2009). Thus, Sip1 might repress 
the expression of signaling factors in postmitotic neurons that regulate sequential fate decisions of 
progenitors to ensure the generation of appropriate numbers of neurons and glia throughout 
corticogenesis (Seuntjens et al., 2009). 
Throughout corticogenesis, neocortical progenitors also undergo intrinsic, progressive restriction in 
their competence state. As mentioned previously, heterochronic transplantation experiments from 
McConnell and colleagues demonstrated that progenitors of early-born, deep-layer neurons have the 
potential to give rise to superficial layer neurons when transplanted into the germinal zone of an older 
host, but progenitors of later-born neurons are restricted to generating superficial layers, even when 
transplanted into the germinal zone of a younger host at the time of deep layer neuron birth (Frantz and 
McConnell, 1996; Desai and McConnell, 2000), suggesting an intrinsic restriction of potential. Further, 
in vitro analysis of single cortical progenitor clones using time-lapse microscopy combined with 
molecular analysis, suggests that the temporal sequence of generating broad neuronal classes is, to a 
significant extent, intrinsically programmed in the progenitors, and this level of determination is not 
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easily malleable by cell-extrinsic factors outside the immediate environment of the progenitor clone 
(Shen et al., 2006). These single cortical progenitor clones exhibit a similar timeline of progressive 
restriction in potential as seen in vivo, in that neurons that express at least the broadest laminar markers 
are produced after the same number of cell divisions in vitro as their in vivo counterparts. However, 
now that much more is known about projection neuron subtype development and combinatorial 
molecular markers of distinct subtypes, it remains to be seen whether individual clones generate 
multiple lineages or only distinct subtypes within a layer in an in vitro environment. Additional 
experiments are necessary to investigate the clonal relationships among neuronal subtypes of different 
layers, and to determine whether single progenitors can progress through generation of different 
subtypes of pyramidal neurons with full cortical phenotypes in vitro (Hack et al., 2004).  
Transplantation studies support the principle of environmental influence on defining neurogenic 
and non-neurogenic regions in adult cortex, and provide evidence for a critical role of the 
microenvironment in influencing potential of neural progenitors. When adult neural progenitors are 
transplanted into distinct neurogenic regions, they can differentiate into neurons in a manner somewhat 
appropriate to the region of transplantation (Gage et al., 1995; Suhonen et al., 1996; Takahashi et al., 
1998; Shihabuddin et al., 2000). Some SVZ progenitors generate what appear morphologically to be 
dentate gyrus neurons when transplanted into the dentate gyrus, and, reciprocally, some dentate gyrus 
subgranular zone progenitors generate what appear morphologically to be olfactory bulb interneurons 
after transplantation into the rostral migratory stream (RMS) (Suhonen et al., 1996). When implanted 
outside these constitutively neurogenic regions, both types of progenitors generate only glia, 
highlighting the importance of the microenvironment, and suggesting that at least some progenitors 
might be able to be directed to differentiate into specific fates other than their normal fate during 
development. 
Glia and neurons share a common lineage in corticogenesis, yet, unlike neurons, glia are 
continuously produced throughout adulthood, suggesting glial progenitors as another source of plastic 
cortical progenitors potentially capable of producing neurons. Thus, neocortical progenitors might be 
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manipulated much later in development, or even during adulthood, to produce specific, diverse types of 
neurons. In support of this idea, previous experiments have shown that with the appropriate stimuli, 
progenitors in the adult mouse neocortex can be induced to generate new projection neurons (Magavi et 
al., 2000; Chen et al., 2004; Brill et al., 2009), demonstrating the existence of at least some manipulable 
progenitors within the adult neocortex. 
 
1.3 Specification of Neocortical Projection Neuron Progenitor Domains 
Upon induction of the telencephalon by gradients of extracellular signaling molecules such as sonic 
hedgehog, fibroblast growth factors, and bone morphogenetic proteins (Rallu et al., 2002), a number of 
repressive transcription factor interactions, of which key examples are discussed here, establish a 
dorsal, or pallial, neocortical progenitor identity as distinct from ventral, or subpallial progenitor 
identity (Figure 1.3). These transcription factors include Lhx2, FoxG1, Emx2, Pax6, and Sox6, each of 
which has crucial roles in specifying the progenitors that give rise to projection neurons of the 
neocortex. Together, these five transcriptional regulators establish the neocortical progenitor domain by 
repressing dorsal midline (Lhx2 and FoxG1) and subpallial fates (Emx2, Pax6, and Sox6), a critical first 
step in the initial specification of neocortical projection neuron identity. 
Lhx2 functions as an essential intrinsic determinant of cortical identity, acting cell-autonomously to 
specify cortical identity and suppress alternative fates in a spatially dependent manner, during an early 
critical period when progenitors comprise the cortical neuroepithelium (Mangale et al., 2008). In the 
absence of Lhx2, the majority of the neocortical VZ is absent (Vyas et al., 2003), and Lhx2 null cells 
adopt “antihem” identity laterally (at the lateral cortical boarder). Medially they become cortical “hem” 
cells (at the border with the hippocampus), which can induce and organize ectopic hippocampal fields 
(Bulchand et al., 2001; Monuki et al., 2001; Mangale et al., 2008). Additionally, Lhx2 functions at a 
critical period, before neuroepithelial cells are converted to telencephalic progenitors, to determine their 
region-specific differentiation into neocortical rather than olfactory progenitors (Chou et al., 2009). 
Similarly, in the absence of FoxG1, neocortical progenitors are not specified, while progenitors of the 
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archicortex (which give rise to the hippocampus and other evolutionarily older cortical regions) and the 
cortical hem (one major source of Cajal-Retzius cells) are expanded (Dou et al., 1999; Muzio and 
Mallamaci, 2005). Remarkably, FoxG1 removal as late as E13.5 from progenitors that already possess a 
neocortical identity results in the production of cells with characteristics of Cajal-Retzius cells 
(Hanashima et al., 2004; Shen et al., 2006), indicating that persistent expression of FoxG1 throughout 
neurogenesis is required for maintenance of neocortical progenitor identity. This suggests that 
progenitors, though seemingly progressively fate-restricted, retain a tremendous degree of plasticity.  
Emx2 and Pax6, key determinants of the proper development of cortical areas, are expressed in 
opposite and overlapping gradients in the dorsal telencephalon (reviewed in (Mallamaci and Stoykova, 
2006)), and are also required for establishing the identity of pallial progenitors (Muzio et al., 2002). In 
the absence of both genes, the cortex does not form, and subpallial progenitor domains expand across 
the entire dorsal telencephalon (Muzio et al., 2002; Schuurmans and Guillemot, 2002). The absence of 
Pax6 alone results in the expression of markers of subpallial progenitors, such as Mash1, Gsh2, and 
Dlx2, in the pallium, and abnormalities in the production of projection neurons most pronounced in 
rostral cortex (Stoykova et al., 2000; Toresson et al., 2000; Yun et al., 2001; Muzio et al., 2002; 
Schuurmans et al., 2004). This is not due to migration of subpallial cells into cortical territory (Kroll 
and O'Leary, 2005), but, rather, to a cell autonomous failure to repress subpallial genes in the absence 
of Pax6 expression (Quinn et al., 2007). Cross-repression between Pax6, expressed in the pallial VZ, 
and Gsh2, expressed in the subpallial VZ, helps establish the pallial-subpallial boundary (PSB) (Yun et 
al., 2001). Pax6 also activates expression of the basic helix-loop-helix (bHLH) transcription factor 
Ngn2, which, in coordination with Ngn1, establishes the PSB, largely by repressing subpallial 
expression of the bHLH transcription factor Mash1 (Ma et al., 1996; Fode et al., 2000; Monuki et al., 
2001; Schuurmans and Guillemot, 2002).  
The SRY-type HMG box (SOX)-containing transcription factors Sox5 and Sox6 also play a critical 
cross-repressive role in parcellation of the proliferative neuroepithelium at the PSB(Azim et al., 2009a). 
Sox6 and Sox5 are complementarily expressed in pallial and subpallial progenitors, respectively, and 
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Figure 1.3: Establishment of the pallial progenitor domain 
(A) During neocortical development, shown here at ~E11, the telencephalon is parcellated into pallial 
(dorsal; red) and subpallial (ventral; blue) domains. The pallium gives rise to excitatory projection 
neurons of the cortex, with the dorsal midline region (green), including the archicortex and cortical 
hem, giving rise to neurons of the hippocampus and choroid plexus, and Cajal-Retzius cells. The 
subpallium, subdivided into the medial, lateral, and caudal ganglionic eminences (MGE, LGE, and 
CGE), gives rise to the basal ganglia and associated limbic regions, as well as the inhibitory 
interneurons that migrate tangentially to populate the neocortex. This spatial segregation of proliferative 
domains (dark red and dark blue) enables distinct molecular programs to generate diverse populations 
of excitatory and inhibitory cortical neuron subtypes via cross-repressive actions of combinatorial 
molecular controls. (B) A number of the key transcriptional regulators that establish the pallial 
progenitor domain through repression of dorsal midline and subpallial molecular programs have now 
been elucidated. PSB, pallial-subpallial boundary; LGE/MGE, lateral/medial ganglionic eminence. 
Portion of figure adapted from(Schuurmans and Guillemot, 2002; Azim et al., 2009a). 
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Sox6 controls the segregation of pallial from subpallial progenitors by repressing the expression of 
Mash1 and downstream subpallium-specific programs in pallial progenitors(Azim et al., 2009a). 
Interestingly, despite the partial ventralization of Sox6 null pallial progenitors, Pax6 and Ngn2 are 
expressed normally in the Sox6 null pallium, and projection neuron laminar distribution and subtype- 
and layer-specific molecular expression are largely normal. Thus, Sox6 critically maintains pallial 
progenitor identity by repressing subpallial programs of gene expression, but redundant and/or 
compensatory controls (for example, Ngn2 and Ngn1) persist that are sufficient to ensure largely 
appropriate pallial corticogenesis, indicating that Sox6 likely acts cooperatively with Ngn2 to control 
the segregation of telencephalic progenitor domains during development(Azim et al., 2009a). 
During corticogenesis, Pax6, along with Nr2e1 (previously called Tlx), also controls the 
proliferation of VZ progenitors during the establishment and expansion of the SVZ. In both Pax6 
mutants and Nr2e1 mutants, deep layer neurons are generated normally, while the superficial cortical 
layers are decreased in thickness (Caric et al., 1997; Tarabykin et al., 2001; Land and Monaghan, 2003; 
Nieto et al., 2004; Schuurmans et al., 2004; Zimmer et al., 2004). There is a global decrease in 
superficial layer neurons in both the Pax6 and Nr2e1 single mutants, including a reduction in the 
number of Cux1, Cux2, and Svet1 expressing neurons in the Pax6 mutants (Tarabykin et al., 2001; 
Nieto et al., 2004), with an even more severe phenotype in the double mutants (Schuurmans et al., 
2004).  
Investigations into the mechanisms underlying the decrease in superficial layer neuron number in 
the Pax6 and Nr2e1 mutants indicates that these genes control the kinetics of cell division of VZ 
progenitors, and the decision of a progenitor to divide symmetrically or asymmetrically. Therefore, they 
appear to regulate the expansion of the SVZ, and the number of pyramidal neurons in the superficial 
layers. In Nr2e1 mutants, the SVZ is decreased in size, progenitors proliferate less, and they undergo 
premature differentiation, producing the most superficial layers of the neocortex one to two days early 
(Land and Monaghan, 2003; Roy et al., 2004). Similarly, in Pax6 mutants, there is an increase in the 
proportion of progenitors undergoing asymmetrical cell division between E12.5 and E15.5 (Estivill-
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Torrus et al., 2002), with a premature decrease in the number of Cux2 expressing cells in the SVZ of 
Pax6 mutants (Nieto et al., 2004), despite an apparent expansion of the SVZ in the mutants due to the 
defective migration of late born cells (Caric et al., 1997).  
Recent work has begun to offer some insight into the temporal sequence of molecular controls that 
regulate these decisions. For example, Pax6 is expressed at high levels in progenitors dividing at the 
ventricular surface, while it is largely excluded from intermediate progenitors in the SVZ. The 
progressive loss of Pax6 as cells migrate into the SVZ is associated with the initiation of Tbr2 
expression, identifying the transition to intermediate progenitor cells (Englund et al., 2005). This 
observation, combined with the recent finding that there is a reduction in the number of Tbr2 
intermediate progenitors in the absence of Pax6 (Englund et al., 2005; Quinn et al., 2007), suggests that 
Pax6 regulates the formation and expansion of the SVZ. In further support of this transcription factor 
regulating the development of the superficial layers, conditional disruption of Pax6 at the onset of 
neurogenesis leads to premature cell cycle exit, increased production of deep layer neurons, and a near 
complete loss of superficial layer neurons (Tuoc et al., 2009). Interestingly, loss of Pax6 after 
generation of the deep layer neurons does not affect specification or numbers of superficial layer 
neurons, suggesting that the severe reduction in superficial layer neurons in the Pax6 null neocortex 
results from a depletion of the progenitor pool available for late neurogenesis (Tuoc et al., 2009).  
 
 
1.4 Molecular Controls Over Neocortical Projection Neuron Subtype Specification and 
Development 
Within the broad class of neocortical projection neurons, many subtypes of projection neurons exist 
with distinct connectivity, soma laminar location, and gene expression. Three broad classes of 
projection neurons exist, based on anatomical classification: (1) corticofugal projection neurons, which 
are located exclusively in deep layers, and extend their axons away from the cortex to subcortical (e.g. 
striatum, thalamus) and subcerebral targets (e.g. brainstem and spinal cord); (2) callosal projection 
neurons (CPN), which are located in layers II/III, V and VI, and extend an axon to the contralateral 
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hemisphere; and (3) associative projection neurons, which extend their axon within a single cortical 
hemisphere (Figure 1.4) (Molyneaux et al., 2007; Fame et al., 2011). 
The corticofugal projection neurons include subplate neurons, which form the deepest cortical layer 
and send pioneering axons to the thalamus (McConnell et al., 1989; McConnell et al., 1994); 
corticothalamic projection neurons (CThPN), located primarily in layer VI, which project to different 
nuclei of the thalamus; and subcerebral projection neurons, which reside in deep layer V (Vb) and 
extend their primary axon to targets in the midbrain, hindbrain, and spinal cord. Although all 
subcerebral projection neurons have a common laminar position, and are born within the same 
developmental time frame, they are themselves quite diverse and include several unique subtypes. 
Corticospinal motor neurons (CSMN) are large pyramidal neurons that reside in sensory and motor 
areas and extend their primary axon to the spinal cord, with some extending secondary collaterals to the 
striatum, red nucleus, caudal pons and medulla, whereas corticopontine and corticobulbar projection 
neurons extend a primary axon to brainstem targets in the pons and medulla, respectively. Corticotectal 
projection neurons reside in layer V of visual cortex, and extend their primary axon to the superior 
colliculus in the midbrain (Arlotta et al., 2005; Molyneaux et al., 2007). 
CPN are heterogeneous with respect to their birth dates and their final laminar destinations, and 
include several subtypes with distinct projection patterns. CPN with a single contralateral axonal 
projection reside in layer II/III (~80%), V (~20%) and VI (a small %), while CPN with an additional 
ipsilateral frontal projection reside primarily in layer Va (Mitchell and Macklis, 2005; Molyneaux et al., 
2007; Molyneaux et al., 2009). Other subtypes of CPN with distinct dual projections are now being 
identified anatomically and molecularly (Fame et al., 2011). Another subtype, a subtype of 
corticostriatal projection neurons (CStrPN) called intratelencephalic corticostriatal projection neurons 
(CStrPNi), which also reside primarily in layer Va, have axonal projections with shared characteristics 
of both CPN and subcerebral projection neurons: their axons project across the midline to the 
contralateral hemisphere, but extend collaterals subcortically to the ipsilateral or contralateral striatum 
and may display hybrid molecular properties(Wilson, 1987; Molyneaux et al., 2007; Azim et al., 2009b; 
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Reiner et al., 2010). Approximately 60% of all corticostriatal inputs are CStrPNi, whereas the other 
40% arise from striatal collaterals of CSMN (Jinnai and Matsuda, 1979; Reiner et al.). It has been 
suggested that as a population, CStrPN express Etv1, but no molecular distinction has yet been 
identified between the two distinct populations of CStrPN (Gong et al., 2007), although 
electrophysiological and physical dichotomy exists (Reiner et al., 2010). 
The molecular mechanisms that direct neocortical progenitors toward this remarkable diversity of 
projection neuron phenotypes are only recently becoming elucidated. Despite the discovery of genes 
that identify neocortical progenitors as global populations (e.g. Pax6, Tbr2, and Sox6), as of yet, there 
are only a few markers to distinguish among progenitors generating different projection neuron 
subtypes (e.g. Fezf2 and Svet1). Therefore, much less is known about genes that control the progressive 
commitment of progenitors to give rise to distinct subtypes of post-mitotic projection neurons. A 
number of neuronal subtype specific genes are expressed in what appear to be subpopulations in the VZ 
and SVZ, where they might label progenitors or early post-mitotic neurons of that same neuronal 
subtype, suggestive of a role in their fate determination. FEZ family zinc finger 2 (Fezf2) is a 
transcription factor expressed both by a subpopulation of VZ progenitors during generation of deep 
layers (presumed to be the progenitors for all corticofugal neuron subtypes), and selectively by 
postmitotic subcerebral projection neurons at high level, and by corticothalamic and other corticofugal 
projection neurons at lower level (Chen et al., 2005a; Chen et al., 2005b; Molyneaux et al., 2005).  
Fezf2 controls specification of subcerebral projection neurons, and, in its absence, this entire broad 
neuronal population is not specified during development (Chen et al., 2005a; Molyneaux et al., 2005; 
Chen et al., 2008a). The transcription factors Cux2 and Tbr2, as well as the non-coding RNA Svet1, 
located in an intronic sequence of the Unc5d gene (Sasaki et al., 2008), are specifically expressed in the 
SVZ and by superficial layer neurons, suggesting a role in SVZ intermediate progenitor cell 
neurogenesis, and development of superficial layer neurons (Tarabykin et al., 2001; Nieto et al., 2004; 
Englund et al., 2005).  
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Figure 1.4: Major subtypes of projection neurons within the neocortex 
Classified by hodology, there are three basic classes of cortical projection neurons: associative, 
commissural, and corticofugal. Some principal subtypes are:  
(A) Callosal Projection Neurons (commissural) 
Callosal projection neurons are projection neurons of small to medium pyramidal size that are primarily 
located in layers II/III (~80%), V (~20%) and VI (a small %) and extend an axon across the corpus 
callosum. At least four major types of callosal neurons can be classified that maintain (1) single 
projections to the contralateral cortex (red); (2) dual projections to the contralateral cortex and 
ipsilateral frontal cortex (blue); (3) dual projections to the contralateral cortex and ipsilateral caudal 
cortex (pink); (4) dual projections to the contralateral cortex and ipsilateral or contralateral striatum 
(green). These are not thought to project axons to targets outside of the telencephalon. 
(B) Corticofugal (projections away from the cerebral cortex) 
Corticothalamic projection neurons: projection neurons primarily located in cortical layer VI, with 
a smaller population in layer V, that project subcortically to different nuclei of the thalamus 
(purple). 
Subcerebral Projection Neurons: (also referred to as Type I layer V projection neurons) include 
pyramidal neurons of the largest size, which are located in deep layer V and extend projections to 
the brainstem and spinal cord. They can be even further subdivided into several distinct projection 
neuron subtypes. Among them (1) corticospinal motor neurons (light blue) are located in the 
sensorimotor area of cortex and maintain primary projections to the spinal cord, with some 
extending secondary collaterals to the striatum, red nucleus, caudal pons and medulla; 
corticopontine projection neurons (orange) maintain primary projections to the pons; corticotectal 
projection neurons (teal) are located in the visual area of cortex and maintain primary projections to 
the superior colliculus, with secondary collateral projections to the rostral pons. Many other 
subtypes of subcerebral projection neurons exist that send axons to different areas of the brainstem 
or with different combinations of collaterals, but are not depicted here for simplicity.  Adapted from 
(Molyneaux et al., 2007). 	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However, it is important not to directly infer that a gene plays a role in specification of subtypes at 
the progenitor level based on restricted expression that is later observed in that particular neuronal 
subtype; it is entirely possible that the gene has two independent functions during development 
(Alvarez-Bolado et al., 1995). This is best illustrated by considering Lhx2, which is expressed in the VZ 
and SVZ prior to and during the generation of superficial layers, and is also expressed by postmitotic 
neurons of the superficial layers. The finding that loss of Lhx2 results in absence of neurons of all layers 
(Bulchand et al., 2001; Monuki et al., 2001) suggests that Lhx2 likely has two functions during 
development: in the VZ, it is required to establish neocortical identity of progenitors of all layers, while 
later in development it might control more specific aspects of superficial layer differentiation. 
Furthermore, genes expressed by neocortical progenitors at the time a subpopulation is born may not 
directly regulate their specification, as is the case with Otx1. Otx1 is a transcription factor that is 
expressed by VZ progenitors and postmitotic subcerebral projection neurons, but controls a later stage 
of differentiation - the pruning of exuberant axonal projections (Frantz et al., 1994b; Weimann et al., 
1999). On the other hand, as discussed above, there is better evidence that genes like Cux2 and Svet1 
might be identifiers of SVZ progenitors destined to give rise to a superficial layer pyramidal neuron. 
For each of these genes, further study is required to define the relationship between progenitors and 
post-mitotic neurons expressing the same genes, and fate-mapping experiments combined with 
molecular analysis will be an important step in linking molecular identity of distinct progenitors to 
direct fate determination of specific neuronal lineages.  
A critical step for understanding developmental processes that govern projection neuron 
specification and differentiation is the delineation of the postmitotic gene expression profiles of distinct 
projection neuron subtypes, and characterization of the functions of these genes in the pathways from 
progenitors to differentiation of the multitude of mature neuronal phenotypes. Recently, tremendous 
advances have been made in identification of laminar- and subtype-specific markers through multiple 
approaches: large scale in situ hybridization projects (Gray et al., 2004; Visel et al., 2004; Magdaleno et 
al., 2006; Lein et al., 2007); the creation of transgenic mouse lines expressing GFP under the control of 
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promoters of lineage or layer restricted genes (Gong et al., 2003); gene expression studies comparing 
microdissected regions of neocortex (Liu et al., 2000; Zhong et al., 2004; Bedogni et al., 2010); and 
comparison of purified neuronal subtypes by microarray analysis (Arlotta et al., 2005; Sugino et al., 
2006; Molyneaux et al., 2009). The Brain Gene Expression Map (BGEM) (Magdaleno et al., 2006), the 
Allen Brain Atlas (ABA) (Lein et al., 2007), and Genepaint (Visel et al., 2004) are three notable 
databases providing comprehensive digital atlases of gene expression in the developing and adult 
central nervous system via in situ hybridization of thousands of transcripts, facilitating identification of 
spatio-temporal expression of lamina and region-specific genes, as well as genes that are coordinately 
expressed in specific regions. These data have been leveraged by the GENSAT project (Heintz, 2004) 
to generate bacterial artificial chromosome (BAC) transgenic reporter lines, in which the gene coding 
region has been replaced with an enhanced GFP driven by the endogenous regulatory promoter regions, 
for all genes expressed in the nervous system. The select mouse lines that recapitulate in vivo 
expression (not all do) provide a powerful tool for analysis of axonal projections from neurons 
expressing the gene of interest, as well as fate-mapping of these subpopulations of neurons in mutant 
mice.  
Until recently, molecular classification of projection neurons in the neocortex largely consisted of 
lamina-specific genes, such as Er81, which is expressed throughout layer V in both CPN and 
subcerebral projection neurons (Yoneshima et al., 2006), and Cux2, which is expressed by SVZ 
progenitors, as well as in superficial layers (Nieto et al., 2004; Zimmer et al., 2004). However, this 
broad parcellation does not reflect the complexity of neocortical circuitry, where neurons born at the 
same time, and that share final laminar location and partial overlap of gene expression, differ 
significantly with respect to axonal projections, areal location in neocortex, and expression of subtype-
specific genes that control specification and differentiation of that particular neuron subtype. This is 
particularly striking in layer V, where neurons with a shared birthdate project to such diverse targets as 
contralateral hemisphere and spinal cord. 
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A substantial advance in identifying genes that are unique to, and potentially control development 
and function of, diverse projection neuron subtypes in the neocortex came from recent work 
demonstrating that combinatorial programs of gene expression unique to each projection neuron 
subtype control specificity and precision of differentiation and connectivity of distinct subtypes of 
projection neurons in the neocortex(Arlotta et al., 2005; Molyneaux et al., 2005; Ozdinler and Macklis, 
2006; Molyneaux et al., 2007; Arlotta et al., 2008; Joshi et al., 2008b; Lai et al., 2008; Azim et al., 
2009a; Azim et al., 2009b; Molyneaux et al., 2009; Tomassy et al., 2010; MacDonald et al., in press). 
These specific cell-intrinsic programs were identified by selective purification of projection neuron 
subtypes during development of neocortex, using retrograde labeling followed by fluorescence-
activated cell sorting (FACS), and microarray comparisons of gene expression for distinct subtypes of 
projection neurons at critical stages of differentiation (embryonic day [E] 18, postnatal day [P] 3, P6, 
and P14) (Arlotta et al., 2005) (Figure 1.5). This approach has been extremely successful at identifying 
many critical molecular controls over specification and development of distinct projection neuron 
subtypes; these include Fezf2 (Chen et al., 2005a; Chen et al., 2005b; Molyneaux et al., 2005; Chen et 
al., 2008a), Ctip2 (Arlotta et al., 2005; Arlotta et al., 2008), Sox5 (Lai et al., 2008), Bhlhb5 (Joshi et al., 
2008b), Lmo4 (Azim et al., 2009b), Clim1 (Azim et al., 2009b), Sox6(Azim et al., 2009a), among others 
(Molyneaux et al., 2009; Tomassy et al., 2010). The remarkably fine resolution of this approach is 
demonstrated by the identification of unique molecular controls over CSMN development, even as 
compared to the closely-related subcerebral projection neurons, CTPN, which reside in layer V, and 
extend an early projection to the spinal cord that is later pruned (O'Leary, 1992; O'Leary and Koester, 
1993). 
In addition to cell type-specific molecular controls over cortical specification, layer-specific genes 
give insight into development and specification of restricted populations of cortical neurons. Examples 
of layer-specific genes include, among many others: Cux1, Cux2, and Lhx2, markers of layers II/III to 
IV (Nakagawa et al., 1999; Bulchand et al., 2003; Nieto et al., 2004; Zimmer et al., 2004); Brn2, a 
marker of layer II/III and V(McEvilly et al., 2002; Sugitani et al., 2002); RORβ, a marker of layer IV 
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(Schaeren-Wiemers et al., 1997; Jabaudon et al., 2012); 6430573F11Rik and Encephalopsin, markers of 
layer V (Arlotta et al., 2005; Magdaleno et al., 2006); and Foxp2, a marker of layer VI (Ferland et al., 
2003). Among these genes, some have been described as being expressed by one specific neuronal type 
within a layer or across layers, including a large number of genes that exhibit varying degrees of 
restricted expression to CSMN (Arlotta et al., 2005) and others with restricted expression by all CPN or 
a series of progressively more precise CPN subpopulations (Molyneaux et al., 2009); discussed further 
below. Genes with expression known to be restricted to individual subtypes include: Ctip2 and Fezf2, 
which are both expressed at high levels by subcerebral neurons of layer V, and at much lower levels by 
corticothalamic neurons of layer VI (Arlotta et al., 2005; Molyneaux et al., 2005); Scip, which is 
primarily expressed by subcerebral projection neurons of layer V, in addition to lower levels of 
expression by neurons of layers II-III (Frantz et al., 1994a); Otx1, which is expressed by 40-50% of 
subcerebral neurons, as well as a number of cells in layer VI (Weimann et al., 1999); Er81, which is 
expressed by cortico-cortical as well as subcerebral projection neurons of layer V (Hevner et al., 2003); 
Nfh, which is expressed by subcerebral projection neurons of layer V (Voelker et al., 2004); Lmo4, 
which is expressed by callosal neurons of layers II/III, V, and VI, and is excluded from CSMN 
(Bulchand et al., 2003; Arlotta et al., 2005); Sox5, which is expressed at high levels in developing 
CFuPN, and is excluded from CPN (Lai et al., 2008); and Lpl, Hspb3, Nectin3, Plxnd1, and Dkk3, 
expressed by distinct subpopulations of CPN and excluded from CSMN (Molyneaux et al., 2009). The 
subplate neurons also exhibit molecular diversity: some genes, including Ctgf and Cplx3, are 
specifically expressed by subplate neurons (Heuer et al., 2003; Hoerder-Suabedissen et al., 2008), while 
Tmem163 and MoxD1 are expressed by both subplate neurons and by a subpopulation of layer V 
neurons (Hoerder-Suabedissen et al., 2009).  
Investigations into functions of layer and subtype-restricted genes are starting to provide insight 
into how neuronal subtypes are specified in the neocortex. Brn1 and Brn2, which are expressed 
primarily by neurons of layers II-V (McEvilly et al., 2002; Sugitani et al., 2002; Hevner et al., 2003), 
are involved in directing differentiation and migration of neurons within these layers. Brn1/Brn2 double  
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Figure 1.5: Schematic representation of an experimental approach used to identify projection 
neuron-specific genes. CPN (red), corticothalamic projection neurons (purple), corticospinal motor 
neurons (green), and corticotectal projection neurons (blue) were retrogradely labeled at distinct stages 
of development from the contralateral hemisphere, the thalamus, the spinal cord, and the superior 
colliculus, respectively. Labeled neurons were dissociated, purified using fluorescence activated cell 
sorting (FACS), and followed by comparative microarray genetic expression analysis(Catapano et al., 
2001; Catapano et al., 2004; Arlotta et al., 2005; Ozdinler and Macklis, 2006; Molyneaux et al., 2007; 
Molyneaux et al., 2009). Adapted with permission from Ref.. (Molyneaux et al., 2009).	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knockouts possess decreased numbers of neurons of layers II-V, and those that are born exhibit 
abnormalities in migration, arresting in the VZ/SVZ (McEvilly et al., 2002; Sugitani et al., 2002). 
Additionally, some markers of superficial layer neurons are expressed in these mutants, while others 
(e.g. mSorLa) are absent, suggesting subtype specific abnormalities in differentiation of different 
populations of superficial neurons. In contrast, Tle4 and Tbr1 expressing neurons of layer VI appear to 
form and migrate normally into the cortical plate in the absence of Brn1 and Brn2 (McEvilly et al., 
2002; Sugitani et al., 2002). Further analysis of Brn1/Brn2 mutants with recently identified markers is 
needed to illuminate precisely which subtypes of neurons are affected in the absence of Brn1 and Brn2. 
While it has been proposed that Ngn1 and Ngn2 play key roles in regulating deep layer 
neurogenesis (Schuurmans et al., 2004; Guillemot et al., 2006), the majority of Er81 positive and Tbr1 
positive neurons of layers V and VI are clearly generated in their absence (Fode et al., 2000; 
Schuurmans et al., 2004). Ngn1 and Ngn2 likely function, therefore, to maintain dorsal glutamatergic 
fate within deep layer neurons (Schuurmans et al., 2004), rather than playing a primary role in 
specifying laminar or projection neuron subtype fate. Mdga1, a recently identified cell adhesion 
molecule, is required for layer II/III projection neurons to migrate to their appropriate position in the 
neocortex (Takeuchi and O'Leary, 2006).  Knockdown of Mdga1 by RNAi results in migrational arrest 
in the intermediate zone and deep layers of the neocortex (Takeuchi and O'Leary, 2006). 
Interestingly, many genes are expressed across multiple projection neuron subtypes, and are likely 
to cooperate with distinct partners expressed in a more restricted pattern to exert a subtype-specific 
function. For example, Tbr1 is expressed at high levels by subplate and layer VI, but in rostral cortex is 
also expressed in layers II/III (Bulfone et al., 1995), and it accordingly has multiple described functions 
across different subtypes and cortical layers; this includes regulating preplate splitting, development of 
corticothalamic projections, and guidance of developing CPN axons across the midline to form the 
corpus callosum (Hevner et al., 2001; Bedogni et al.). Id2 codes for a helix-loop-helix transcription 
factor that is expressed in layer V in intermediate and caudal regions of neocortex, with an abrupt 
boundary in the rostral region, yet in layer II/III it exhibits a complementary pattern of high rostral 
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expression and low expression levels in intermediate and caudal areas. Bhlhb5 is expressed in an area-
restricted pattern across layers II-V, but exerts specific developmental control over CSMN in layer V 
(Joshi et al., 2008b). Clim1 and Lmo4 are both expressed broadly, but progressively delineate CSMN 
from CPN in layer V (Azim et al., 2009b). Such examples illustrate that combinatorial programs of 
gene expression across layers and subtypes of projection neurons delineate a molecular complexity that 
parallels the known anatomical and functional complexity of neocortical projection neurons (Koester 
and O'Leary, 1992; O'Leary and Koester, 1993; Arlotta et al., 2005; Mitchell and Macklis, 2005; 
Molyneaux et al., 2007). Similar investigations for each of the other subtype-specific genes are needed 
in order to delineate programs of gene expression that direct subtype-specific differentiation. As more 
evidence accumulates regarding functional roles played by the many subtype-specific genes that are 
being discovered, we will likely witness rapid progress in understanding programs of molecular 
controls that direct neuronal subtype differentiation in the neocortex. 
 
1.4 a.  Callosal Projection Neuron Specification, Development, and Diversity 
In contrast to subcerebral projection neurons (discussed in more detail in the following section), 
callosal projection neurons (CPN) are heterogeneous with respect to their birthdate and laminar postion. 
CPN are the largest class of commissural neurons in placental mammals (Aboitiz et al., 2003), 
connecting homotopic regions of the two cerebral hemispheres via the corpus callosum, the principal 
white matter fiber tract in the brain that, in human, is composed of over 300,000 fibers (Swenson, 
2006). CPN are critical for bilateral transfer and integration of cortical information, and they have been 
centrally implicated in autism spectrum disorders (ASD). One of only a few anatomically identified 
pathologies of ASD is a reduced corpus callosum relative to overall brain volume (Egaas et al., 1995; 
Vidal et al., 2006; Herbert and Kenet, 2007; Minshew and Williams, 2007; Freitag et al., 2009; 
Mcalonan et al., 2009). Absence, or surgical disruption, of CPN connectivity in humans is also 
associated with defects in abstract reasoning, problem solving, and generalization (Paul et al., 2007).  
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Early Development and Axon Guidance 
CPN maturation follows a set of discrete sequential steps as CPN establish correct circuitry and 
synaptic connections with their targets in the contralateral hemisphere. CPN are born throughout 
corticogenesis at the same times in development as other neurons with cell bodies residing in their same 
cortical layers: in the mouse, layer VI CPN are born at approximately embryonic day 12.5 (E12.5) 
along with corticothalamic projection neurons (CThPN); layer V CPN are born around E13.5 along 
with corticospinal motor neurons (CSMN); and superficial layer CPN are born from approximately 
E15.5 to E17.5(Angevine and Sidman, 1961; Molyneaux et al., 2007).  As CPN are born, the two 
telencephalic hemispheres begin fusing, aided in part by two populations of glia - midline zipper glia 
and indusium griseum glia(Silver et al., 1982; Shu et al., 2003b; Richards et al., 2004; Lindwall et al., 
2007) (Figure 1.6A).   While cellular and molecular mechanisms of midline fusion have not been 
completely identified, it is clear that, if the midline is not fully fused, callosal axons have no substrate 
and cannot cross to the contralateral hemisphere.  Many midline fusion and glial defects cause partial or 
complete agenesis of the corpus callosum, independent from abnormalities of CPN themselves (see Ref. 
(Donahoo and Richards, 2009) for review).	   
As the hemispheres continue to fuse, populations of glia and local neurons form the transient 
bridge-like subcallosal sling across the midline (Silver et al., 1982; Shu et al., 2003a; Niquille et al., 
2009).  CPN send axons ventrally toward the intermediate zone guided, in part, by signals from 
indusium griseum glia dorsally at the midline, and glial wedge and subcallosal sling populations 
ventrally(Shu et al., 2003a; Richards et al., 2004; Niquille et al., 2009). Upon reaching the intermediate 
zone, callosal axons turn toward the midline to cross at the corticoseptal boundary, rather than 
projecting laterally as CFuPN do. Upon encountering the contralateral glial wedge, CPN axons turn 
dorsally and extend into the neocortex toward homotopic targets. Mechanisms of precise CPN targeting 
to contralateral homotopic regions are still largely unknown, but callosal axons have been shown to 
follow the trajectory of radial glia in the contralateral hemisphere as they extend their axons to 
appropriate targets(Norris and Kalil, 1991). During development (at E17 in mouse), axons from neurons 
	  35 
of the cingulate cortex begin the process of midline crossing(Silver et al., 1982; Koester and O'Leary, 
1994; Ozaki and Wahlsten, 1998; Rash and Richards, 2001) and might act as pioneers for neocortical 
CPN(Piper et al., 2009) (Figure 1.6A), which begin to cross one day later(Silver et al., 1982). First-
born, deep-layer cingulate pioneers and neocortical CPN are the first of each respective population to 
cross the midline and, therefore, reach final targets before superficial layer CPN. 
Processes of midline crossing and targeting are mediated by a large number of long-range and 
short-range signals that, while highly studied, are not completely known.  Key molecular regulators 
controlling midline crossing and targeting are best studied for deep layer, early-crossing CPN; it is not 
evident whether or not superficial layer, later-born CPN employ the same mechanisms. These processes 
have been extensively reviewed elsewhere(Rash and Richards, 2001; Richards et al., 2004; Lindwall et 
al., 2007; Niquille et al., 2009) and I will only briefly summarize that body of work here. Studies over 
the past decade have uncovered some midline crossing and targeting controls that operate at several 
different levels of CPN function. At the level of growth cone dynamics in callosal axons themselves, 
Mammalian Enabled (Mena) plays a role in actin cytoskeletal dynamics in neurons of neocortical layers 
II/III and V, and is required for proper formation of the corpus callosum as well as the hippocampal 
commissure(Lanier et al., 1999).  Long-range guidance molecules, such as members of the Slit/ Robo, 
Wnt, and Netrin families also play active roles in axon guidance across the corpus callosum.  Slits, 
including Slit2, are enriched along the midline, surrounding the area through which CPN axons pass; 
these axons express the Slit receptor Robo1 (Bagri et al., 2002; Shu et al., 2003c; Sundaresan et al., 
2004; Andrews et al., 2006; Lindwall et al., 2007; López-Bendito et al., 2007). Wnts, particularly 
Wnt5a, are necessary for formation of all forebrain commissures, both through canonical, Frizzled3-
mediated(Wang et al., 2006), and non-canonical, related to tyrosine kynase (Ryk)-mediated(Keeble et 
al., 2006; Li et al., 2009), receptor transduction pathways(Lindwall et al., 2007).  In addition to Slits 
and Wnts, Netrin1 and its receptor, deleted in colorectal cancer (DCC), are also required for all 
forebrain commissure formation(Serafini et al., 1996; Fazeli et al., 1997; Lindwall et al., 2007; Ren et 
al., 2007); however, although CPN express DCC, there is no evidence that DCC-mediated mechanisms 
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Figure 1.6: CPN development and diversity (A) During development, callosal axons (red) turn 
toward the midline. Multiple glial populations (blue) and mixed neuronal/glial populations (purple) play 
critical roles in CPN axon guidance and midline crossing. Pioneering axons (brown) from neurons of 
the cingulate cortex begin the process of midline crossing.  This schematic represents processes that 
occur across multiple embryonic times during mouse CPN development. Abbreviations: CP, cortical 
plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular zone; IGG, indusium griseum 
glia; GW, glial wedge; SCS, subcallosal sling; MZG, midline zipper glia. (B) At least four major types 
of adult CPN can be classified based on projection patterns.  These include: single projections to the 
contralateral cortex (red); dual projections to the contralateral cortex and ipsilateral or contralateral 
striatum (green); dual projections to the contralateral cortex and ipsilateral premotor cortex (blue); or 
dual projections to the contralateral cortex and ipsilateral sensorimotor cortex (purple).   
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of guidance are the same in the corpus callosum as they are for Netrin1 in commissure formation of the 
spinal cord(Serafini et al., 1996; Shu et al., 2000).   At least some guidance roles of the subcallosal sling 
are mediated by Semaphorin-3C (Sema3C) attraction through the Neuropilin1 receptor on CPN(Gu et 
al., 2003; Niquille et al., 2009).  In addition to long-range signals, short-range, local interactors – in 
particular ephrins and their receptors (EphA5, EphB1, and EphrinB3)– are essential for corpus callosum 
formation(Hu et al., 2003; Mendes et al., 2006; Lindwall et al., 2007). Notably, it appears rare for 
guidance defects in corpus callosum formation to be callosum-specific; rather, they typically affect 
broader populations of commissures. 
As a broad population, CPN extend exuberant projections throughout development, with the 
maximal number of CPN with dual projections occurring at approximately postnatal day 8 (P8) in 
mice(Innocenti and Price, 2005; Mitchell and Macklis, 2005).  Dual projections are progressively 
refined until approximately P21, when the adult projection pattern for  CPN is established; this process 
is thought to occur largely through activity-dependant, Hebbian mechanisms(Innocenti and Price, 2005; 
Mizuno et al., 2007; Wang et al., 2007; Mizuno et al., 2010).  Interestingly, laterally located CPN that 
are furthest from the midline and the many signaling molecules present there, extend a bifurcated axon 
early in development that projects toward both the midline and the internal capsule. Only later 
(approximately P11 in mice) do lateral developing CPN retract axonal segments projecting to the 
internal capsule(Garcez et al., 2007). 
Anatomical Diversity 
While CPN have long been regarded as a single, relatively uniform population, substantial diversity 
within this broad population is being increasingly revealed, and molecular controls underlying 
development of CPN and these distinct subpopulations are beginning to be elucidated (Molyneaux et 
al., 2009; Fame et al., 2011). All CPN extend an axon to the homotopic region of the contralateral 
neocortex; thus, the locations and laminar positions of CPN within the neocortex define the targets of 
their callosal axons. The corpus callosum is often broadly categorized in six regions from rostral to 
caudal, named for homotopic regions these axons connect: frontal, motor, somatosensory, auditory, 
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temporoparietal, and visual.  Callosal fibers vary in density and diameter across these regions, both in 
rodents and humans(Aboitiz and Montiel, 2003).   
In addition to homotopic, interhemispheric projections extended by all CPN, subpopulations of 
CPN can be defined by the variety of long-range dual axonal projections they extend.  Subpopulations 
of CPN send dual projections to contra- or ipsilateral striatum (here, referred to as CStrPNi)(Wilson, 
1987), caudally to contra- and/or ipsilateral primary somatosensory cortex (here, referred to as 
BPN)(Cauller et al., 1998; Mitchell and Macklis, 2005), or rostrally to contra- or ipsilateral frontal areas 
(here, referred to as FPN)(Mitchell and Macklis, 2005) (Figure 1.6B).   CPN with dual projections 
reside preferentially in the deep layers of the neocortex.  For example, in adult mice, only about 4% of 
layer II/III CPN extend dual axonal projections to the frontal premotor cortex, while approximately 
40% of layer V CPN do(Mitchell and Macklis, 2005).  CStrPNi reside almost exclusively in layer 
Va(Wilson, 1987), which supports the hypothesis that CPN with dual projections reside in 
evolutionarily-older deep layers, and, therefore, are more likely to have been evolutionarily co-opted 
from existing CFuPN. Additionally, deep layer CPN (layers V and VI) provide about 80% of the 
collaterals connecting primary motor cortex to primary somatosensory cortex, and some deep layer 
CPN have also been shown to project to secondary somatosensory cortex and the claustrum, in addition 
to the striatum(Veinante and Deschenes, 2003).  In patients with partial agenesis of the corpus 
callosum, diffusion tensor imaging detects heterotopic axonal projections that are not detectable in 
healthy subjects(Wahl et al., 2008).  It is possible that, in healthy subjects, these heterotopic projections 
are still present, but undetectable over overwhelming signal from intact, homotopic axons.  If this is the 
case, there might be much more diversity of connectivity within the human corpus callosum than 
investigators have been able to detect with current technology.  However, recent data using diffusion 
spectrum magnetic resonance imaging (DSI) provides compelling evidence that axons in the corpus 
callosum tract run exclusively longitudinally or perpendicular to those longitudinal fibers, with no other 
orientations(Wedeen et al., 2012). 
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While many deep layer CPN have long-distance dual projecting axons, superficial layer CPN 
participate in local column circuitry. Layer II/III CPN send collaterals to pyramidal neurons within 
layer II/III, more strongly to layer V, and to pyramidal and stellate neurons in layer VI, in both 
ipsilateral and contralateral hemispheres (Petreanu et al., 2007). Thus, in addition to their role in 
connecting two homotopic regions of the neocortical hemispheres, CPN are responsible for functional 
association and integration among different neuronal types in ipsilateral and contralateral cortical 
hemispheres. 
This laminar, anatomical, and connectivity diversity within the broad population of CPN 
demonstrates that it is not a homogenous population of projection neurons. Rather, CPN are a strikingly 
diverse set of subpopulations requiring precise control of their neuronal diversity by a complex and 
interactive set of molecular controls. 
Molecular Controls over CPN Development and Diversity 
Although, as discussed earlier, much progress has been made in beginning to understand the 
anatomical trajectory of developing CPN axons and cellular and molecular controls over midline 
crossing(Silver et al., 1982; Norris and Kalil, 1991; Lanier et al., 1999; Shu et al., 2000; Rash and 
Richards, 2001; Richards et al., 2004; Sundaresan et al., 2004; Andrews et al., 2006; Smith et al., 2006; 
Tole et al., 2006; Lindwall et al., 2007; López-Bendito et al., 2007; Plachez et al., 2008; Niquille et al., 
2009), considerably less is known about molecular controls that specify CPN subtype identity and 
control this precise development.  Because the majority of CPN reside in superficial layers, the first 
identified molecular controls over CPN generation and development were identified as laminar-specific 
genes such as Brn1, Brn2, Cux1, and Cux2, as discussed above (Table 1.1).  In 2008, the first critical 
molecular regulator of broad CPN specification, special AT-rich sequence-binding protein 2 (SATB2), 
was identified and characterized as a DNA-binding transcription factor expressed by CPN.  SATB2 is 
necessary for specification of CPN through repression of COUP-TF interacting protein 2 
(CTIP2)(Alcamo et al., 2008; Britanova et al., 2008), a transcription factor critical for CSMN axon 
outgrowth and fasciculation(Arlotta et al., 2005; Chen et al., 2005a; Chen et al., 2005b; Molyneaux et 
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al., 2005; Molyneaux et al., 2007).  In the absence of SATB2 function, neurons that would have 
extended axons across the corpus callosum instead project subcortically through the internal capsule 
and take on some molecular and electrophysiological characteristics of CFuPN(Chen et al., 2008a).  
Identification of SATB2 as a molecular regulator of CPN identity across all layers, especially axonal 
connectivity through inhibition of CTIP2, significantly advanced the characterization of CPN at a 
molecular level.  However, many interesting questions about instructive molecular signals responsible 
for midline crossing and precise homo- and heterotopic connections remain to be answered.  
Importantly, mechanisms by which this and other still-uncharacterized signals govern general CPN 
development are still largely unknown. 
 Recently, molecular controls that act specifically in subclasses of CPN have begun to be identified.  
The transcription factor activator enhancing binding protein 2 gamma (AP2γ)  acts specifically in a 
subset of radial glia cortical progenitors to specify SVZ intermediate progenitors and enable the switch 
from proliferative to neurogenic division, and to generate a specific subpopulation of superficial layer 
CPN in visual cortex (Pinto et al., 2009). Interestingly, while the action of AP2γ  is highly area specific, 
the expression of AP2γ is not, suggesting an areally-restricted partner or compensatory activity. In 
addition, Cux1 and Cux2, previously discussed as layer-specific identifiers, regulate dendrite branching, 
spine development, and synapse formation specifically in layer II/III CPN (Cubelos et al., 2010). These 
subtype-specific controls are important for understanding the diversity that exists within and is integral 
to the broad CPN population. 
Multiple approaches have been used successfully to identify molecular controls over temporal 
and/or laminar stages of neocortical projection neuron development.  Investigators have screened gene 
expression databases for transcriptional regulators expressed in relevant laminae or progenitor zones of 
the neocortex, or have investigated functions of guidance molecules known to play critical roles in 
guiding neuronal populations in other regions of the nervous system.  However, in order to identify 
molecular controls over development of specific, individual populations of neocortical projection 
neurons in a more direct and unbiased manner, approaches to isolate and purify individual neuronal 
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populations have provided substantial power and sensitivity.  As discussed above, one approach that has 
proven useful for isolating distinct populations of cortical projection neurons has been to first 
retrogradely label them from their developmental axonal trajectories and final axonal targets, and then 
to purify them using fluorescence activated cell sorting (FACS) (Figure 1.5). For a variety of reasons 
discussed in more detail in Chapter 2 (Arlotta et al., 2005; Molyneaux et al., 2005; Molyneaux et al., 
2007), this approach was first used to label and isolate CPN (Catapano et al., 2001; Catapano et al., 
2004; Arlotta et al., 2005; Molyneaux et al., 2009), CSMN (Arlotta et al., 2005; Molyneaux et al., 2005; 
Ozdinler and Macklis, 2006), corticotectal projection neurons (CTPN(Arlotta et al., 2005)), CThPN, 
CStrPN, and segmentally specific cervical or lumbar CSMN.   These purified neurons were submitted 
to comparative microarray analysis to identify genes differentially expressed by each population at four 
key embryonic and postnatal developmental stages (E18.5, P3, P6, P14).  Other purification methods 
have also proven fruitful for isolating distinct populations of cortical projection neurons (Barres et al., 
1988; Dugas et al., 2008).   
Purification of specific neuronal populations, followed by comparative gene expression analyses 
has not only led to the identification of genes expressed by each population at distinct stages in 
development, but has also enriched for critical subtype-specific molecular controls by comparing gene 
expression between very closely related cortical projection neuron populations.  This work has already 
identified a set of genes that, in combination, define a progressively restricting program of molecular 
controls (or a “molecular-logic”) over development of important populations of cortical projection 
neurons including CPN (Arlotta et al., 2005; Molyneaux et al., 2005; Arlotta et al., 2008; Joshi et al., 
2008b; Lai et al., 2008; Molyneaux et al., 2009; Tomassy et al., 2010).   These data were collected 
symmetrically with regard to development of the neocortical projection neuron populations compared, 
and provides equivalent (but not yet functionally investigated) information regarding molecular controls 
over CPN development both as a broad population and in specific subpopulations(Molyneaux et al., 
2009) (Figure 1.7, Table 1.1). 
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CPN genes identified in this way have been analyzed based on their laminar- and sublaminar-
specific distributions across different stages of maturation (Molyneaux et al., 2009)  (Figure 1.7, Table 
1.1).  Temporal information from these analyses identifies distinct molecular stages of CPN 
development that likely reflect known processes occurring during CPN maturation.  Molecular controls 
expressed most highly early in CPN development (i.e.. at or before E18.5 in the mouse, such as Inhba, 
Btg1, Frmd4b, Epha3, and Ptn) likely act during neuronal subtype specification, refinement of 
differentiation, migration, or initial axonal extension.  Genes whose expression sharply rises and falls 
(i.e.. are specifically expressed only during the mid-stages of CPN development, such as Cpne4, Tmtc4, 
Nnmt, Cav1, Nectin-3, and Chn2) might be hypothesized to function when CPN have already crossed 
the midline and are extending toward their specific targets.  Genes expressed specifically late in CPN 
development (e.g. Plexin-D1, Gfra2, TcrB, and Dkk3) might more likely function in final CPN 
maturation and refinement of adult connectivity. 
In addition to temporal gene expression data, this work identifies differential subtype-specific 
laminar gene expression.  A subset of the identified CPN genes appear specific to CPN in all layers in 
which CPN reside (i.e. layers II/III and V-VI), while others discriminate between CPN of deep layers 
and those of superficial layers (Figure 1.7).  Further, several genes finely subdivide CPN within 
individual layers, and appear to label discrete CPN subpopulations that have not been previously 
described using anatomical or morphological criteria(Mitchell and Macklis, 2005; Molyneaux et al., 
2009).  Interestingly, while a number of the genes expressed specifically in superficial layer CPN are 
expressed throughout the entirety of layers II/III, some genes are restricted to only the most superficial 
portion of layers II/III, while other genes are restricted to the deeper portion of superficial layers 
(Figure 1.7).  
In isolation, differences in laminar expression might merely reflect birthdate differences.  However, 
in light of being specific to CPN versus other neocortical projection neurons, and considering the 
existence of diverse hodological CPN subpopulations already identified, these differentially expressed 
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Figure 1.7: Spatially-restricted genes identify novel CPN subpopulations. 
 
Schematic representation of neocortical layers depicting laminar-specific expression of 20 selected, 
representative genes expressed by early postnatal CPN within the neocortex (Molyneaux et al., 2009).  
Dark and light blue bands indicate high and low levels of expression, respectively.  Grey oblique stripes 
demarcate layers in which CPN reside.  Most of these genes have dynamic patterns of expression 
through development; therefore, developmental stage must be considered when using these genes to 
identify specific populations of CPN.  Representative genes are depicted with multiple patterns of 
laminar expression: most cortical layers; and deep cortical layers only (top row); superficial cortical 
layers only (middle row); and subdivisions of superficial layers (bottom row).  See text and table S1 for 
more detailed expression and references. Abbreviations: roman numerals indicate neocortical layers (I-
VI); SP, subplate.  
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Figure	  1.7	  (Continued)	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Table 1.1 Genes expressed by callosal projection neurons (CPN) and their progenitors 
 
 
Abbreviations:  VZ, ventricular zone; SVZ, subventricular zone; IPC, intermediate progenitor cell; E, 
embryonic day; P, postnatal day; S1, primary somatosensory cortex; roman numerals (I-VI) label 
neocortical layers. 
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   Gene	  
	  
Expression	   Developmental	  
Stage	  
Published	  
Function	  in	  
CPN/progenitors	  	  
References	  
CPN	  Progenitors	   Ap2γ	   VZ	  progenitors	   embryonic	   regulates	  basal	  progenitor	  fate,	  and	  formation	  of	  layer	  II/III	  CPN	  in	  the	  occipital	  cortex	  
(Pinto	  et	  al.,	  2009)	  
Brn1	   SVZ	  IPCs	  and	  migrating	  neuroblasts	  
embryonic	   together	  with	  
Brn2,	  regulates	  generation	  and	  migration	  of	  layers	  II-­‐IV	  	  
(McEvilly	  et	  al.,	  2002;	  Sugitani	  et	  al.,	  2002)	  
Brn2	   SVZ	  IPCs	  and	  migrating	  neuroblasts	  
embryonic	   together	  with	  
Brn1,	  regulates	  generation	  and	  migration	  of	  layers	  II-­‐IV	  	  
(McEvilly	  et	  al.,	  2002;	  Sugitani	  et	  al.,	  2002)	  
Cux1	   mitotic	  SVZ	  IPCs	   embryonic	   unknown	   (Nieto	  et	  al.,	  2004)	  
Cux2	   mitotic	  SVZ	  IPCs	   embryonic	   regulates	  SVZ	  progenitor	  proliferation	  and	  generation	  of	  superficial	  layers	  
(Nieto	  et	  al.,	  2004;	  Zimmer	  et	  al.,	  2004;	  Cubelos	  et	  al.,	  2007)	  
Lhx2	   VZ	  and	  SVZ	  progenitors	   embryonic	   regulates	  cortical	  hem	  formation	   (Bulchand	  et	  al.,	  2001;	  Bulchand	  et	  al.,	  2003)	  
Svet1	   SVZ	  IPCs	   embryonic	   unknown	   (Tarabykin	  et	  al.,	  2001)	  
Tbr2	   SVZ	  IPCs	   embryonic	   regulates	  IPC	  specification,	  and	  expansion	  of	  all	  cortical	  layers.	  
(Englund	  et	  al.,	  2005;	  Sessa	  et	  al.,	  2008;	  Chou	  et	  al.,	  2009)	  
Tlx	   VZ	  and	  SVZ	  progenitors	   embryonic	   Regulates	  generation	  of	  layers	  II/III	  and	  size	  of	  corpus	  callosum	  
(Land	  and	  Monaghan,	  2003;	  Roy	  et	  al.,	  2004)	  
Unc5d	   SVZ	  IPCs	   embryonic	   unknown	   (Zhong	  et	  al.,	  2004)	  Post-­‐mitotic	  CPN	  	   Brn1	   layers	  II/III	  and	  IV	   maintained	  through	  early	  postnatal	  development	  
unknown	   (McEvilly	  et	  al.,	  2002;	  Sugitani	  et	  al.,	  2002)	  
Brn2	   layers	  II/III	  and	  IV	   maintained	  through	  early	  postnatal	  development	  
unknown	   (McEvilly	  et	  al.,	  2002;	  Sugitani	  et	  al.,	  2002)	  
Btg1	   CPN	  in	  layers	  II/III	   high	  at	  E18,	  decreasing	  postnatally	   unknown	   (Molyneaux	  et	  al.,	  2009)	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Cav1	   CPN	  in	  deep	  sublamina	  of	  II/III,	  and	  Va	  
high	  at	  P3,	  and	  decreased	  by	  P14	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Chn2	   CPN	  in	  deep	  sublamina	  of	  II/III	   high	  at	  P6,	  with	  expression	  maintained	  at	  P14	  
unknown	   (Molyneaux	  et	  al.,	  2009)	  
Cited2	   CPN	  in	  layers	  II/III,	  V,	  and	  VI	   high	  at	  E18,	  decreasing	  postnatally	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Cux1	   layers	  II/III	  and	  IV	   from	  embryonic	  development	  through	  adulthood	  
regulates	  dendritic	  branching,	  and	  synapse	  formation	  of	  layer	  II/III	  CPN	  
(Nieto	  et	  al.,	  2004;	  Cubelos	  et	  al.,	  2010)	  
Cux2	   layers	  II/III	  and	  IV	   from	  embryonic	  development	  through	  adulthood	  
regulates	  dendritic	  branching,	  and	  synapse	  formation	  of	  layer	  II/III	  CPN	  
(Nieto	  et	  al.,	  2004;	  Zimmer	  et	  al.,	  2004;	  Cubelos	  et	  al.,	  2010)	  
Dkk3	   CPN	  in	  layer	  VI	   increasing	  expression	  postnatally	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Dtx4	   cortical	  plate	  and	  superficial	  sublamina	  of	  II/II,	  layer	  IV	  
early	  post-­‐mitotic	  until	  early	  postnatal	  (decreased	  by	  P14)	  
unknown	   (Zhong	  et	  al.,	  2004)	  
EphA3	   CPN	  in	  superficial	  sublamina	  of	  II/III	  
high	  at	  E18,	  decreasing	  postnatally	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Frmd4b	   CPN	  in	  superficial	  sublamina	  of	  II/III	  
high	  at	  E18,	  decreasing	  postnatally	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Gfra2	   CPN	  in	  Layers	  V	  and	  VI	   increasing	  expression	  postnatally	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Gpr6	   layers	  II/III,	  highest	  occipital	   expressed	  from	  P3-­‐P15,	  with	  highest	  expression	  at	  P6.	  	  	  
unknown	   (Chenn	  et	  al.,	  2001)	  
Hspb3	   CPN	  in	  layers	  II/III,	  V,	  and	  VI	   high	  at	  P3,	  with	  expression	  maintained	  at	  P14	  
unknown	   (Molyneaux	  et	  al.,	  2009)	  
Inhba	   CPN	  in	  layers	  II/III	   high	  at	  P3,	  and	  decreased	  by	  P14	   unknown	   (Molyneaux	  et	  al.,	  2009)	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Kitl	   layers	  II/III,	  IV,	  and	  early	  VI	   early	  post-­‐mitotic	  until	  early	  postnatal	  (decreased	  by	  P14)	  
unknown	   (Zhong	  et	  al.,	  2004)	  
Limch1	   CPN	  in	  layers	  II/III	   high	  at	  E18,	  decreasing	  postnatally	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Lhx2	   layers	  II-­‐IV	   high	  embryonic	  and	  early	  postnatal	  expression,	  decreasing	  by	  adulthood	  
necessary	  to	  specify	  neocortex	   (Bulchand	  et	  al.,	  2003;	  Chou	  et	  al.,	  2009)	  
Lmo4	   CPN	  in	  layers	  II/III	  and	  V	   Increases	  in	  CPN	  throughout	  postnatal	  development,	  with	  hightest	  expression	  medially	  
regulates	  area	  identities	  and	  connectivity	  of	  somatosensory	  cortex	  
(Arlotta	  et	  al.,	  2005;	  Kashani	  et	  al.,	  2006;	  Azim	  et	  al.,	  2009b;	  Huang	  et	  al.,	  2009)	  	  
Lpl	   CPN	  in	  layers	  II/III,	  V,	  and	  VI	   high	  at	  P3,	  and	  decreased	  by	  P14	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Mdga1	   preplate,	  IZ,	  and	  cortical	  plate.	  	  Layers	  II/III,	  and	  layers	  IV	  and	  VIa	  in	  S1	  
high	  preplate	  expression	  at	  E13.5	  and	  high	  cortical	  expression	  by	  P7	  
controls	  correct	  migration	  of	  layer	  II/III	  neurons	   (Takeuchi	  and	  O'Leary,	  2006)	  
Mef2c	   cortical	  plate	  and	  layers	  II/III,	  IV	  
early	  post-­‐mitotic	  until	  early	  postnatal	  (decreased	  by	  P14)	  
critical	  for	  differentiation	  of	  neocortical	  neurons	  
(Zhong	  et	  al.,	  2004;	  Vlamings	  et	  al.,	  2008)	  
Mena	   layers	  II/III,	  and	  V	   from	  embryonic	  development	  through	  adulthood	  
plays	  a	  role	  in	  actin	  cytoskeletal	  dynamics,	  and	  is	  necessary	  for	  formation	  of	  the	  corpus	  callosum	  
(Lanier	  et	  al.,	  1999)	  
miR-­‐189	   layers	  II-­‐IV	   high	  broad	  neocortical	  expression	  at	  P9	  becoming	  restricted	  to	  layers	  II-­‐IV	  by	  P14	  
binds	  to	  Slitrk1,	  whose	  overexpression	  increases	  dendrite	  length	  
(Abelson	  et	  al.,	  2005)	  
Nectin-­‐3	   CPN	  in	  the	  middle	  sublamina	  of	  II/III	  
high	  at	  P6,	  and	  decreased	  by	  P14	   unknown	   (Molyneaux	  et	  al.,	  2009)	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Nnmt	   CPN	  in	  the	  superficial	  sublamina	  of	  II/III	  
high	  at	  P3	  and	  P6,	  and	  decreased	  by	  P14	  
unknown	   (Molyneaux	  et	  al.,	  2009)	  
PlexinD1	   CPN	  in	  Va,	  and	  the	  superficial	  sublamina	  of	  II/III	  
high	  at	  P3,	  with	  expression	  maintained	  at	  P14	  
unknown	   (Molyneaux	  et	  al.,	  2009)	  
Ptn	   CPN	  in	  deep	  sublamina	  of	  II/III	   high	  E18-­‐P6,	  and	  decreased	  by	  P14	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Satb2	   layers	  II-­‐IV,	  V,	  and	  VI	   early	  post-­‐mitotic	  until	  early	  postnatal	  (decreased	  by	  P7)	  
represses	  Ctip2	  to	  regulate	  CPN	  identity	  and	  axonal	  midline	  crossing	  
(Britanova	  et	  al.,	  2005;	  Alcamo	  et	  al.,	  2008;	  Britanova	  et	  al.,	  2008)	  
Svet1	   layers	  II-­‐IV	   maintained	  from	  progenitors	  into	  adulthood	  (not	  observed	  after	  P60)	  
unknown	   (Tarabykin	  et	  al.,	  2001)	  
Tcrβ	   CPN	  in	  layers	  Vb	  and	  VI	   increasing	  expression	  postnatally	   unknown	   (Molyneaux	  et	  al.,	  2009)	  
Unc5d	   cortical	  plate	  and	  layers	  II/III,	  IV	  
early	  post-­‐mitotic	  until	  early	  postnatal	  (decreased	  by	  P14)	  
unknown	  	   (Zhong	  et	  al.,	  2004)	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genes might be hypothesized to be molecular controls and/or functional hallmarks of these previously 
identified subpopulations, as well as of novel, as-of-yet unidentified subpopulations of CPN.  Molecular 
controls expressed by all CPN are more likely to control top-level, unifying properties of CPN, such as 
midline crossing and avoidance of corticofugal fate and connectivity. Alternatively, these broadly 
expressed genes might have more restricted action due to combinatorial intersection with areally 
restricted binding partners and/or co-factors (such precedents exist with Bhlhb5 (Joshi et al., 2008b), 
Clim1 and Lmo4 (Azim et al., 2009b), and AP2γ (Pinto et al., 2009)). Since superficial layers have 
undergone substantial evolutionary expansion in comparison to deep layers, as discussed in more detail 
below, genes with expression restricted to deep layers might reflect transcriptional changes that allowed 
CPN to arise from evolutionarily older corticofugal projection neuron populations (Molnár et al., 2006; 
Lai et al., 2008; Azim et al., 2009b). The deep layers also contain the overwhelming majority of CPN 
with dual-projecting axons (Wilson, 1987; Mitchell and Macklis, 2005), and, as such, genes expressed 
by subpopulations of deep layer CPN might identify and control development of these dual-projecting 
populations. In contrast, genes restricted to superficial layer CPN might serve as controls over 
development of columnar collaterals, or subpopulations of CPN that evolved later and are born later in 
cortical development than deep layer CPN. Additionally, different combinations of these genes identify 
even more sublaminae than are observed by examining single genes in isolation. Thus, it is evident that 
there is striking molecular, and likely hodological and functional, diversity within the broad population 
of CPN. Investigation of functions of these combinatorial molecular controls will allow for better 
characterization and understanding of functions and clinical relevance of each of these and other unique 
subpopulations of CPN. 
Evolution  
CPN and their associated axonal pathway in the corpus callosum arose relatively recently in 
evolution; observed first in placental mammals(Aboitiz and Montiel, 2003).  The corpus callosum is not 
unique in its ability to connect the two neocortical hemispheres, but is the only fiber tract devoted solely 
to integration of information from the two cortical hemispheres. In non-placental mammals, such as 
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marsupials, the dominant interhemispheric fiber tract in the brain is the much smaller anterior 
commissure (AC), consisting of interhemispheric fibers from the amygdala, olfactory tract, and 
temporal lobes, as well as long-distance connections from the neocortex that take a convoluted route to 
project to the contralateral neocortex(Aboitiz and Montiel, 2003).  The hippocampal commissure also 
plays a role, albeit much smaller than the anterior commissure, in enabling interhemispheric 
communication in animals lacking a corpus callosum (Aboitiz and Montiel, 2003; Mihrshahi, 2006).   
Pre-existence of these other commissural tracts might have more readily allowed for evolution and 
establishment of cortical commissural projection neurons that became CPN.  For example, hippocampal 
commissure axons, in addition to cingulate axons, might pioneer the path that neocortical CPN later 
follow across the corpus callosum, suggesting that these hippocampal commissural neurons might have 
fasciculated with emerging early CPN to enable their crossing of the midline barrier to first project 
across the region that is now the corpus callosum (Rash and Richards, 2001; Mihrshahi, 2006; Donahoo 
and Richards, 2009). 
The broad laminar distribution of CPN speaks not only to a broad time window of CPN generation 
during development from diverse progenitor populations, but also suggests preferential evolutionary 
expansion of this neuronal population as the cortex expanded throughout evolution.  The telencephalon 
of sauropsids (e.g. reptiles and birds) is a three-layered structure that is evolutionarily related to layers I, 
V, and VI in the mammalian neocortex, but is devoid of CPN (Molnár et al., 2006; Charvet et al., 
2009).  The evolutionarily novel cortical layers II/III, which are present in rodents, are greatly expanded 
in primates (Smart et al., 2002a; Molnár et al., 2006) (Figure 1.8), as is the volume of white matter in 
the corpus callosum(Schoenemann et al., 2005), with over 190 million axons in the human (Tomasch, 
1954).  These mammalian neocortical superficial layers arise primarily from progenitors of the SVZ 
(Tarabykin et al., 2001), which is a distinct progenitor zone present in mammals and some sauropsids 
(including birds and crocodilians, but not turtles), but not in amphibians(Charvet et al., 2009).  The 
SVZ itself has greatly expanded and diversified in primates to include two distinct regions, the inner 
and the outer SVZ, which generate the expanded cortical diversity, particularly in superficial layers, 
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found in primates(Smart et al., 2002a; Fietz et al., 2010; Hansen et al., 2010) (Figure 1.8).  The outer 
SVZ contains unique self-renewing, proliferative, radial glia-like progenitors that are distinct from 
those in the inner SVZ(Fietz et al., 2010; Hansen et al.).  A number of molecular controls over SVZ 
populations have been identified as discussed above, including T-box brain gene 2 (Tbr2, also known as 
Eomes)(Baala et al., 2007; Arnold et al., 2008; Sessa et al., 2008), and subventricular-expressed 
transcript 1 (Svet1)(Tarabykin et al., 2001).  Given that the majority of CPN reside in the evolutionarily 
expanded superficial layers generated from this progressively expanded population of intermediate 
progenitors, it is logical to hypothesize that CPN have undergone extensive expansion throughout 
evolution of the cerebral cortex.  Thus, compared to deep layer-restricted CFuPN, CPN might be 
predicted to serve especially important roles in primate cognitive function. 
Expansion of superficial neocortical layers in primate evolution far exceeds expansion of deep layers 
(Molnár et al., 2006). A large portion of CPN with known heterotopic long-range dual-projecting axons 
reside in deep neocortical layers, suggesting that deep layer CPN might have been evolutionarily co-
opted from existing populations of CFuPN to project not only to subcortical targets, but also across the 
midline to connect and integrate the two hemispheres of the neocortex.  Once the early, deep 
population(s) of CPN were established, their presence might have favored expansion of the neocortex, 
and addition of more subtypes of CPN to augment the functionally advantageous rapid and precise 
integration of neocortical hemispheres, perhaps first in primary visual cortex(Aboitiz and Montiel, 
2003) or newly evolving motor cortex(Mihrshahi, 2006). Interestingly, there is a large group of CPN-
enriched genes expressed in sublaminae within superficial neocortical layers in mouse(Molyneaux et 
al., 2009) (Figure 1.9).  In the mouse, neocortical layers II and III are not typically distinguished as 
distinct, but they are expanded and obviously distinct in primates.  While developmental expression of 
these sublaminar CPN genes in primate cortex is not currently known, some (e.g. Cux2, Nectin-3, and 
Plxnd1) display similar expression in adult human cortex as in mouse cortex (Arion et al., 2007; Allen-
Institute-for-Brain-Science, ©2009b). It is interesting to speculate that sublaminarly-distributed genes  
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Figure 1.8: Comparison of developing and adult mammalian neocortex of mouse, macaque, and 
human shows correlations between SVZ expansion, superficial neocortical layer expansion, and 
white matter expansion. 
Schematic comparison of histological sections of (A) developing and adult mouse, (B) developing and 
adult rhesus macaque monkey, and (C) adult human neocortex.  Adult cross-sections are from visual 
cortex. The thicknesses are represented relative to a common scale. Callosal projection neurons (red) 
reside mostly in layers II/III (~80%), V (~20%), and VI (few %) in the adult neocotex.  There is a 
strong correlation between the expansion of the SVZ and the expansion of the superficial layer 
thickness and neocortical white matter. Abbreviations: E, embryonic; PP, preplate; VZ, ventricular 
zone; MZ, marginal zone; CP, cortical plate; SP, subplate; SVZ, subventricular zone; OSVZ, outer 
SVZ; ISVZ, inner SVZ; OFL, outer fibrous layer; IFL, inner fibrous layer; WM, white matter; Roman 
numerals denote neocortical layers (I-VI). Adapted and expanded with permission from (Smart et al., 
2002a) (macaque) with data from  (Allen-Institute-for-Brain-Science, ©2009a) (mouse), and 
(Schoenemann et al., 2005; Allen-Institute-for-Brain-Science, ©2009b) (human). 
  
	  55 
  
Figure	  1.8	  (Continued)	  
	  56 
Figure 1.9 : Evolutionary expansion of callosal projection neuron populations 
(A) Schematic comparison of histological sections of adult sauropsid (in particular, turtle, reptile) 
cortex, and mouse, monkey, and human neocortex (visual cortex), with thicknesses represented relative 
to a common scale. Sauropsids have a three-layered cortex, with no callosal projection neurons (CPN). 
In mammals, CPN (red) reside in layers II/III, V, and VI. The majority (~80%) of CPN reside in the 
superficial layers II/III, where they are the predominant projection neuron population. Approximately 
20% (in mouse) of CPN reside in layer V, co-mingled with subcerebral projection neurons (green), with 
a small population of CPN found among the corticothalamic neurons (grey) in layer VI. There is a 
dramatic expansion of the layer II/III CPN population between mouse and primates (with layers II and 
III becoming distinct lamina), while the overall thickness of layers V and VI remains relatively 
constant. Adapted and expanded from (Smart et al., 2002a) (Macaque), with data from (Allen-Institute-
for-Brain-Science, ©2009a) (mouse), and (Schoenemann et al., 2005) and (Allen-Institute-for-Brain-
Science, ©2009b) (human). (B) Schematic of genes expressed specifically by CPN in early postnatal 
mouse neocortex layers, depicting the substantial molecular heterogeneity of CPN subpopulations. 
Some genes are expressed only in CPN of layers V and VI (potentially evolutionarily older CPN 
derived from CFuPN), others are expressed by CPN of all layers, while others distinguish between CPN 
of the superficial layers II/III and the deep layers V and VI. Interestingly, other CPN genes finely 
subdivide the canonical cortical layers, revealing new sublayers. For example, Frmd4b, Nnmt, and 
Epha3 are expressed in superficial layer II/III, while Nectin-3, Chn2, and Ptn are expressed in deep 
layer II/III, perhaps reflecting a molecular subdivision of layers II and III in the mouse, serving as 
evolutionarily early molecular identifiers of the further expansion and specialization of superficial 
layers in primates. 
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might serve as evolutionarily early molecular identifiers of the further expansion and specialization of 
superficial layers in primates. 
Recent evidence supports a growing understanding and new appreciation of the striking 
diversity within the broad population of CPN.  CPN as a population are defined by their homotopically 
projecting axons across the corpus callosum, but, as mentioned above, some subpopulations of CPN 
have dual-projecting axons to long distance ipsilateral and contralateral targets, while other 
subpopulations participate in local column circuitry, both ipsilaterally and contralaterally.  The 
progressive evolutionary emergence of complexity and increased diversity of connectivity in the 
cerebral cortex also suggests diversity in the origin of CPN. Deep-layer CPN might have arisen from 
evolutionarily older CFuPN(Lai et al., 2008; Azim et al., 2009b), while superficial-layer CPN expanded 
greatly with the expansion of the SVZ in the progression from lower mammals to primates and humans.   
Currently, molecular controls over CPN as a broad population, as well as over specific 
subpopulations of CPN, are being discovered and functionally investigated. This work elucidating the 
connectivity, guidance, and molecular characteristics of CPN, both as a broad population, and as 
distinct hodological and functional subpopulations of CPN, will greatly contribute to the understanding 
of CPN and complex associative functions in which they play critical roles. More in-depth 
understanding of distinct, critical functions of specific CPN subpopulations will enable more 
sophisticated understanding of cortical function, and insight into neurological abnormalities involving 
CPN and the corpus callosum, including agenesis of the corpus callosum, autism spectrum disorders, 
and likely other syndromes of high-level dysfunction of associative connectivity. 
 
1.4 b. Molecular Controls Over Subcerebral Projection Neuron Specification and Differentiation 
Among the different types of cortical projection neurons, subcerebral projection neurons have been 
a good model population for studying subtype specification in the neocortex. They are a readily 
identifiable, prototypical projection neuron population, located within layer Vb of the neocortex (Figure 
1.4). They are defined by axons that project caudal to the cerebrum to targets in spinal cord or 
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brainstem, including tectum, red nucleus, and pons(Wise and Jones, 1977; Killackey et al., 1989; Legg 
et al., 1989; O'Leary and Koester, 1993; Arlotta et al., 2005; Molnár et al., 2006). All subcerebral 
projection neurons extend a primary axon through the internal capsule, cerebral peduncle, and 
pyramidal tract toward the spinal cord. Inappropriate connections are later eliminated, such that 
subcerebral projection neurons in sensorimotor cortex project to caudal pons and spinal cord, while 
those in visual cortex maintain projections to rostral pons and superior colliculus (O'Leary and 
Terashima, 1988; Schreyer and Jones, 1988; O'Leary and Koester, 1993). Given this common pattern of 
initial development, many of the molecular controls regulating early specification and differentiation 
are likely to be shared among different subtypes of subcerebral projection neurons (Arlotta et al., 2005; 
Molyneaux et al., 2007; Joshi et al., 2008b).  
The most well studied subtype of subcerebral projection neuron is corticospinal motor neurons 
(CSMN), a developmentally and clinically important population. CSMN are of great interest since they 
control precise voluntary movement in humans, they degenerate in motor neuron degenerative diseases 
including amyotrophic lateral sclerosis (ALS), and their injury contributes centrally to the loss of motor 
function following spinal cord injury. The precise point in development at which CSMN begin to differ 
molecularly from other subcerebral projection neurons, and mechanisms that initiate this difference, 
have only recently begun to be elucidated (e.g. (Arlotta et al., 2005; Joshi et al., 2008b)). Recently, 
identification of a large number of subcerebral and CSMN specific genes has enabled an expanding 
effort to decipher programs controlling CSMN development (Molyneaux et al., 2007). The expression 
patterns of these genes indicate that fate specification and differentiation of subcerebral projection 
neurons in general, and CSMN in particular, is directed by a combinatorial integration of transcription 
factors and other molecular controls. These molecular controls are expressed in patterns that together 
uniquely identify CSMN. For example, a small number of CSMN genes appear restricted to 
sensorimotor cortex (e.g. Diap3, Igfbp4, and Crim1), distinguishing CSMN from other subcerebral 
projection neurons of layer V (Arlotta et al., 2005). Other genes are expressed by subcerebral projection 
neurons across the full extent of layer V (e.g. Ctip2, Encephalopsin, Fezf2, Clim1, Pcp4, and S100a10), 
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indicating restriction to all or most subcerebral projection neurons (Arlotta et al., 2005). Thus far, 
functions of only a minority of these genes have been reported, but these studies are already revealing 
key roles for these genes in subcerebral specification and differentiation (Weimann et al., 1999; Arlotta 
et al., 2005; Chen et al., 2005a; Chen et al., 2005b; Molyneaux et al., 2005; Ozdinler and Macklis, 
2006; Molyneaux et al., 2007; Chen et al., 2008a; Joshi et al., 2008b; Lai et al., 2008; Azim et al., 
2009b; Tomassy et al., 2010). 
Fezf2, a transcription factor expressed by all subcerebral projection neurons from early stages of 
development through adulthood (Inoue et al., 2004; Arlotta et al., 2005), is required for specification of 
all subcerebral projection neurons (Chen et al., 2005a; Chen et al., 2005b; Molyneaux et al., 2005). In 
the absence of Fezf2 function in null mutant mice, the entire population of subcerebral projection 
neurons is absent, and there are no projections from the cerebral cortex to either spinal cord or 
brainstem (Chen et al., 2005a; Molyneaux et al., 2005). Importantly, without Fezf2, neocortical 
progenitors still produce similar numbers of layer V neurons (Chen et al., 2005b; Molyneaux et al., 
2005); however, lineage tracing of the normally Fezf2 positive neurons and axons using a Fezf2 mutant 
with a human placental alkaline phosphatase (hPLAP) insertion at the Fezf2 locus demonstrates that 
these neurons adopt CPN-like properties, including axonal extension across the midline via the anterior 
commissure, and expression of the CPN-specific molecular marker Satb2 (Chen et al., 2008a), a critical 
transcriptional regulator of CPN identity (Alcamo et al., 2008; Britanova et al., 2008). In contrast, 
superficial layer pyramidal neurons are born correctly and appear normal (Chen et al., 2005a; 
Molyneaux et al., 2005). Thus, Fezf2 does not affect ability of progenitors to generate glutamatergic 
neurons that position themselves in layer V; it likely acts to direct the next step in the program of 
specification, defining characteristics of a subcerebral projection neuron. As additional support for 
Fezf2 in directing subcerebral projection neuron specification, over-expression of Fezf2 is sufficient to 
induce birth of entirely new deep layer projection neurons that express Ctip2 and Tbr1, and extend 
axons through the internal capsule (Chen et al., 2005b; Molyneaux et al., 2005). Interestingly, layer VI 
neurons and subplate neurons, which express Fezf2 at lower levels than subcerebral projection neurons, 
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exhibit disorganization and abnormalities in gene expression in Fezf2 null mutant mice, but are much 
less seriously affected (Hirata et al., 2004; Chen et al., 2005a; Molyneaux et al., 2005), suggesting that 
the level of Fezf2 protein is directly linked to its function, and it exerts different functions in distinct 
neuronal populations in a dose-dependent manner. 
A second set of molecular controls has been identified that control later aspects of subcerebral 
projection neuron development, including axon fasciculation and extension to the spinal cord. One 
important member of this set is Ctip2, which likely acts downstream of Fezf2, as Ctip2 is not expressed 
in Fezf2 null mutant mice (Molyneaux et al., 2005; Chen et al., 2008a). In the absence of Ctip2, 
subcerebral projection neuron axons exhibit defects in fasciculation, outgrowth, and pathfinding, with 
most axons misrouted in the forebrain, and only very few axons even reaching the brainstem; none 
reach the spinal cord (Arlotta et al., 2005). In addition, reduced Ctip2 expression in Ctip2 heterozygous 
mice results in a defect in pruning of transient projections to the spinal cord from subcerebral projection 
neurons residing in somatosensory cortex, further demonstrating different functions for these 
transcription factors at different levels of expression (Arlotta et al., 2005).  Interestingly, Ctip2 also 
controls proper differentiation of striatal medium spiny neurons (MSN), including their patch-matrix 
organization through which CSMN axons traverse, and the expression by MSN of a set of axon and 
migrational guidance and repulsive signals; these results implicate Ctip2 as potentially having 
additional non cell-autonomous function in CSMN axon growth and fasciculation (Arlotta et al., 2008; 
Woodworth and Macklis, 2009). These experiments identified Ctip2 as a critical regulator of 
subcerebral axon extension and refinement of collaterals as these neurons mature. 
Another central transcriptional regulator known to function in target choice of subcerebral 
projection neurons is Otx1. This protein is expressed by putative deep layer progenitors in the VZ, 
exhibiting decreasing levels of expression in the VZ during generation of superficial layer neurons 
(Weimann et al., 1999; Inoue et al., 2004). As deep layer projection neurons mature, localization of 
OTX1 shifts from cytoplasm to nucleus, indicating a fine regulation of the activity of this protein 
(Frantz et al., 1994b; Weimann et al., 1999). Postnatally within layer V, Otx1 is expressed by 40-50% 
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of subcerebral projection neurons, primarily those within visual cortex, while it is not expressed by 
callosal projection neurons (Weimann et al., 1999). Mice lacking the gene for Otx1 have defects in 
development of corticotectal projection neurons. Without Otx1, corticotectal projection neurons 
maintain an axon to the spinal cord and caudal pontine nuclei, collaterals that are only appropriate for 
CSMN and are normally eliminated by corticotectal projection neurons (Weimann et al., 1999). These 
results indicate that Otx1 might function later in subcerebral projection neuron development than Fezf2 
and Ctip2, controlling refinement and pruning of axonal collaterals. Additional axon outgrowth and 
guidance molecules, such as IGF-I and RYK, have been described to function in extension and 
guidance of subcerebral projection neuron axons to targets in the brainstem and spinal cord (Liu et al., 
2005; Harel and Strittmatter, 2006; Ozdinler and Macklis, 2006).  
Sox5 controls another critical element in proper differentiation of CSMN and all other corticofugal 
projection neuron subtypes: post-mitotic regulation of their sequential generation from subplate neurons 
(earliest born corticofugal projection neurons), through corticothalamic neurons to corticospinal motor 
neurons and corticostriatal projection neurons. Sox5 controls this sequential generation of corticofugal 
projection neuron subtypes by progressively reducing its repression (via Sox5 down-regulation) of 
genes required for differentiation of later generated subtypes, ultimately CSMN, preventing premature 
emergence of normally later-born neurons during early stages of corticogenesis (Lai et al., 2008). Sox5 
loss-of-function causes striking overlap of the identities of the three principal sequentially born 
corticofugal neuron subtypes (subplate, corticothalamic, corticospinal); in the Sox5 null cortex, subplate 
neurons aberrantly develop molecular hallmarks and connectivity of subcerebral projection neurons, 
CThPN are imprecisely differentiated, while differentiation of subcerebral projection neurons is 
accelerated (Lai et al., 2008). Sox5 over-expression at late stages of corticogenesis causes re-emergence 
of neurons with corticofugal features, reinforcing the critical role of Sox5 in controlling the sequential 
generation of corticofugal neurons. Thus, Sox5 functions in immature post-mitotic neurons to control 
coordinate regulation of subtype-specific genes, and timing of critical fate decisions in different 
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subtypes of corticofugal projection neurons, thereby enabling these closely related neuronal populations 
to differentiate into distinct neuronal subtypes. 
Studies of motor neuron development in Drosophila melanogaster provide insight into how cortical 
progenitors might progressively generate distinct classes of pyramidal neurons over time (e.g. 
corticofugal projection neurons as a class, with multiple subtypes determined postmitotically). In this 
system, progenitors express a sequential series of transcription factors during neurogenesis, including 
hunchback, krüppel, pdm1, and castor, followed by maintained expression of these same transcription 
factors in post-mitotic progeny that were born during the window of expression of each gene by the 
progenitors (Isshiki et al., 2001). Similarly, it is conceivable that, in mammalian neocortex, radial glia 
progenitors might express a sequential series of transcription factors that are maintained in intermediate 
progenitors and post-mitotic neurons, imparting class identity. Thus, during generation of corticofugal 
projection neurons from Sox6+/Fezf2+ progenitors, genes such as Otx1, Ctip2, Sox5, Clim1/Lmo4, 
Bhlhb5 might act on partially specified progenitors to determine further aspects of laminar and 
projection identity as individual subtypes of corticofugal and other pyramidal neurons are generated 
(Figure 1.10). Fezf2, with these other regulators, specifies the precise subcerebral projection neuron 
lineage within a layer (e.g. layer V), enabling development of the molecular, morphological, and 
anatomical projection properties of subcerebral projection neurons and other subtypes. Later, once this 
cascade is initiated, the regulated and level-dependent expression of genes such as Ctip2 and Otx1, 
which govern subcerebral axonal outgrowth, fasciculation, pruning, and, ultimately, connectivity, 
function to establish precise connectivity and later morphological features of subcerebral and other 
projection neurons. The direct relationships between these transcriptional regulators and the many not-
yet-functionally characterized genes that act in cascades of subcerebral and other projection neuron 
development remains to be determined. Together, the transcriptional regulators above comprise first 
elements of the molecular program that controls subcerebral projection neuron development modeled 
and described anatomically almost two decades ago by O’Leary and colleagues (O'Leary and Koester, 
1993).  
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Figure 1.10: Molecular controls over layer V cortical projection neuron subtype development 
The sequential actions of a combinatorial set of molecular controls regulate the generation of distinct 
layer V subcerebral projection neuron (SCPN) and callosal projection neuron (CPN) subtypes. As layer 
V projection neurons are generated from the VZ, Pax6, Ngn2, and Sox6 maintains the dorsal identity of 
pallial progenitors. Fezf2 is expressed by a subpopulation of VZ progenitors and in postmitotic 
subcerebral PN, specifying subcerebral PN fate over CPN fate. Simultaneously, Sox5 acts 
postmitotically to regulate the sequential acquisition of distinct corticofugal projection neurons subtype 
fates. Downstream of Fezf2, Ctip2 postmitotically controls SCPN differentiation, regulating axonal 
extension and fasciculation, potentially in coordination with Otx1. Bhlhb5 functions postmitotically in 
acquisition of the caudal motor areal identity of CSMN, as well as the areal identity of neurons in 
somatosensory cortex. In neighboring CPN, Satb2 postmitotically controls CPN differentiation over 
subcerebral PN fate, at least in part by directly repressing Ctip2 expression. Yellow neurons at E15.5 
represent the gradual refinement of molecular identity between SCPN and CPN during postmitotic 
differentiation. VZ, ventricular zone; CP, cortical plate. The outline on the whole brain inset on the top 
right illustrates the cortical region described in the figure. Figure adapted from (Azim, 2009, 
Dissertation). 
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1.5 Areal Diversity of Neocortical Projection Neurons 
The complexity of neocortical circuitry is further magnified by neuronal diversity across areas 
along tangential axes of the neocortex. Each area is characterized by distinct cytoarchitecture, 
connectivity, gene expression, and laminar composition and, as such, imparts a unique functional 
capacity to the neocortex. The neocortex has four primary areas (three sensory and one motor): 
somatosensory cortex (S1), which processes sensory information from the body; visual cortex (V1), 
which processes visual information relayed from the retina; auditory cortex (A1), which receives input 
from the ears; and primary motor cortex (M1), which controls voluntary movement (Figure 1.11). Each 
area is innervated by thalamocortical afferents from distinct thalamic nuclei, which convey modality-
specific sensory information from the periphery, a reciprocal area-specific/nucleus-specific relationship 
that is critical for both development of cortical areas, as well as their adult function (O'Leary and 
Nakagawa, 2002). 
Arealization of the neocortex is controlled by the interplay of intrinsic and extrinsic factors, 
working in combination to regulate specification and development of neocortical areas.  During	  early	  stages,	  prior	  to	  innervation	  from	  thalamocortical	  afferents,	  area	  identity	  is	  broadly	  the	  tangential	  axes	  at	  later	  stages	  of	  area-­‐specific	  neuronal	  differentiation. 
Morphogens, such as fibroblast growth factors (FGFs) and Wnts secreted from the commissural 
plate, and bone morphogenic proteins (BMPs) secreted from the cortical hem, initiate graded 
transcription factor expression tangentially across the telencephalon, influencing identity and size of 
cortical areas (Rash and Grove, 2006). Emx2 displays low rostro-lateral to high caudo-medial 
expression, and Pax6 shows a complementary high rostro-lateral to low caudo-medial expression 
profile. These opposing gradients influence downstream molecular patterning that confers areal identity 
to regions of neuroepithelium, regulating subsequent establishment of projections, and, therefore, 
function of cortical areas (Bishop et al., 2000; Mallamaci et al., 2000; Rash and Grove, 2006). 
Similarly, a high caudal to low rostral gradient of Coup-TF1 expression is important for establishing the 
proper balance between caudal and rostral cortical areas (Armentano et al., 2007). The zinc-finger 
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transcription factor Sp8 is expressed in a high rostro-medial to low caudo-lateral gradient, and has been 
shown to specify rostral motor identity, at least partially via direct activation of Fgf8 (Sahara et al., 
2007; Zembrzycki et al., 2007). Additional, or complementary, arealization might be conferred by 
caudo-rostral gradients of Lhx2 and Emx1 expression, a rostro-caudal gradient of Tbr1 expression 
(Donoghue and Rakic, 1999b; Bishop et al., 2002), and spatially restricted compartmental expression of 
Dlx1, Dlx2, and Gbx2 (Bulchand et al., 2003). 
As development progresses, these broad gradients are refined to sharp boundaries of gene 
expression, which parallel sharpening of anatomical and cytoarchitectonic boundaries of primary 
sensory areas. Mechanisms by which these broad gradients are converted to sharp boundaries of 
expression in the cortex are still largely unknown. Attempts to identify genes with restricted expression 
in clearly defined ‘protoareas’ of the VZ have been unsuccessful, instead finding only genes with 
graded regional expression in proliferative layers of the developing neocortex (Sansom et al., 2005). As 
such, area identities are likely controlled by complex programs of overlapping spatial and temporal 
molecular controls (Rash and Grove, 2006; Joshi et al., 2008b; Tomassy et al., 2010). Studies in 
Drosophila have demonstrated that sharp borders of expression can be established by combinatorial 
action of multiple broadly-expressed transcriptional regulators, even generating, in the case of the pair-
rule gene even-skipped (Eve), a discrete stripe pattern (Stanojevic et al., 1991). Similar pathways have 
been identified in developing spinal cord, where graded, partially overlapping expression of multiple 
transcription factors, induced by a morphogen gradient of secreted Sonic hedgehog (SHH) from the 
notocord and floor plate, gradually refines into sharp boundaries of transcription factor expression in 
VZ progenitors, which in turn specifies discrete lineages of progenitors of motorneurons and 
interneurons (Jessell, 2000). 
Such mechanisms are beginning to come to light in the neocortex with the identification of 
molecular controls that regulate specification and development of distinct subtypes of projection 
neurons in both a laminar and area-specific manner. For example, although the transcription factor 
AP2γ (also known as Tcfap2c) is expressed by a subset of apical ventricular zone progenitors  
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Figure 1.11: Functional and molecularly defined neocortical areas 
(A) Functional and molecularly defined cortical areas 
The neocortex has four primary areas (three sensory and one motor): the somatosensory cortex (S1, 
blue), which processes sensory information from the body; the visual cortex (V1, yellow), which 
processes visual information relayed from the retina; the auditory cortex (A1, green), which 
receives input from the ears; and the primary motor cortex (M1, red) which controls voluntary 
movement. Many molecular controls act early in progenitors to define these areas, while others act 
postmitotically to refine cortical areas. Two examples of molecular controls that act in part 
postmitotically to refine precise neuronal differentiation and identity within cortical areas are Coup-
tf1 (grey) and Bhlhb5 (pink).  Coup-tf1 is expressed in a high caudal to low rostral gradient 
throughout layers II-IV, and is highly expressed in layer IV in S1. Bhlhb5 is expressed throughout 
layers II-V, high in S1 and V1. 
(B) Molecular controls over area identity 
Molecular controls determine refinement of areal identity and, subsequently, the identity of 
projection neurons. In the absence of Coup-tf1 expression, for example, M1 (red) expands at the 
expense of the S1 area. Therefore, fated S1 CThPN “motorize” and extend axons to the spinal cord, 
while both rostral and caudal fated CSMN axons arrest at or before the pons. Areally disrupted 
caudal CSMN are most severely affected and do not even reach the pons. In the absence of Bhlhb5, 
in contrast, S1 is selectively disrupted. Fated CSMN on the boarder of M1 and S1 do not extend 
axons to the spinal cord, while rostral CSMN in less-affected central M1 maintain projections to the 
pyramidal decussation.  
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throughout the cortex at mid-neurogenesis, deletion of AP2γ leads to a specific reduction of superficial 
layer neurons in occipital (visual) cortex, resulting in impaired function of adult visual cortex (Pinto et 
al., 2009). AP2γ, acting in apical progenitors, directly regulates expression of basal progenitor fate 
determinants Math3 and Tbr2, and loss of AP2γ results in a mis-specification of basal progenitors in 
occipital cortex at the time of superficial layer neuron generation. This leads to a significant reduction 
of CPN in layers II/III in occipital cortex, while leaving layer V CPN and more rostral layer II/III CPN 
unaltered. The area-restricted role of AP2γ is further emphasized by over-expression experiments, 
which demonstrate that AP2γ is sufficient to induce increased generation of superficial layer neurons in 
caudal, but not rostral, cortex. This may be due to interaction of AP2γ with Pax6 and partial redundancy 
in regulation of basal cell determinants (Pinto et al., 2009). Pax6 also directly regulates expression of 
Tbr2 and Math3, in addition to regulating AP2γ itself. As such, Pax6 might compensate for loss of 
AP2γ in rostral cortex, where Pax6 expression is high, but would be unable to fully compensate for 
AP2γ in caudal regions, where its expression is low.  
The transcription factor CoupTF-I also imparts area-specific temporal control over development of 
a specific projection neuron subtype, namely CSMN (Figure 1.11). In contrast to AP2γ, CoupTF-I is 
expressed in a gradient in the neocortex, with highest expression in progenitors and postmitotic neurons 
in parietal (presumptive sensory) and occipital areas of the neocortex, and lowest expression in frontal 
(presumptive motor) cortex (Zhou et al., 2001; Armentano et al., 2007). Forebrain-specific loss of 
function of CoupTF-I results in a marked expansion of motor areas, occupying most of the neocortex, 
concomitant with a compression of sensory areas to the caudal occipital cortex (Armentano et al., 
2007). These shifts are accompanied by changes in molecular profiles and axonal projections of parietal 
cortical neurons to match their new modified motor identity: layer IV neurons in this region do not 
express Rorβ, an orphan nuclear receptor specifically expressed in primary sensory areas (Nakagawa 
and O'Leary, 2003), but express cadherin 8 (cad8), a cell adhesion molecule that demarcates rostral 
motor areas (Hamasaki et al., 2004); layer VI corticothalamic projection neurons express elevated 
levels of Fezf2 typical of motor areas, and preferentially project to motor rather than sensory thalamic 
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nuclei (Armentano et al., 2007). CSMN are also born prematurely in somatosensory cortex in the 
absence of CoupTF-I, thus expanding layer V at the expense of layer VI corticothalamic neurons 
(Tomassy et al., 2010). Axons of these aberrantly specified corticothalamic neurons project to 
subcerebral structures, including the spinal cord, while CSMN differentiate imprecisely and do not 
project beyond the pons. These results indicate that CoupTF-I plays a critical role in regulating area-
specific temporal development of CSMN by repressing a ‘motorizing’ genetic program of 
differentiation in neurons of somatosensory cortex. That adult CoupTF-I conditional mutant mice 
display impaired fine motor skills further reinforces the necessity for precision in both areal and 
temporal control of projection neuron differentiation (Tomassy et al., 2010). 
In addition to identifying molecular controls that function at the progenitor level to govern 
development of areal-specific projection neuron subtypes, there is growing knowledge of molecular 
controls that function post-mitotically to sharpen the boundaries between these areas. Bhlhb5 is a class 
B helix-loop-helix TF (Brunelli et al., 2003) that is expressed by postmitotic projection neurons in layer 
II-V, and exhibits a dramatic refinement in expression from a high caudo-medial to low rostro-lateral 
gradient, similar to the Emx2 expression gradient in VZ progenitors, which transforms into to a sharp 
border between motor and sensory cortex. Bhlhb5 regulates postmitotic acquisition of identity in 
sensory and caudal motor neocortical projection neurons, where it is expressed in discrete domains 
(Figure 1.11). These areas are mis-specified in the absence of Bhlhb5 function, without significantly 
affecting frontal motor identity, resulting in area-specific changes in molecular identity of projection 
neurons across layers II-V, as well as abnormal differentiation of CSMN located in caudal motor cortex 
(Joshi et al., 2008b). Bhlhb5, therefore, translates the graded transcription factor expression in 
progenitors and early postmitotic neurons to sharply delineated area-specific molecular and anatomical 
properties. It is likely that Bhlhb5 acts in a combinatorial manner with other area and lamina restricted 
postmitotic transcription factors to control precise areal identity of projection neurons in a lamina and 
projection neuron subtype-specific manner.  
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One such postmitotic transcription factor might be Tbr1. Tbr1 is expressed in an opposing gradient 
to Bhlhb5 in embryonic cortical plate (high rostral), with a complementary laminar expression profile in 
later embryonic development (Bedogni et al.). In frontal cortex, Tbr1 is highly expressed in all layers, 
while in more caudal regions, Tbr1 is highly detected in layer VI, subplate, and Cajal-Retzius neurons, 
with much lower expression in layers II – V. In the absence of Tbr1 function, there is a loss of rostral 
identity, and an expansion in caudal gene expression, including Bhlhb5 (Bedogni et al.). Furthermore, 
there is an increase in subcerebral projection neurons (layer V) at the expense of earlier born 
corticothalamic projection neurons (layer VI), as determined by both projection pattern and gene 
expression profiles (including up-regulation of Fezf2 and down-regulation of Sox5) (Bedogni et al.). 
Together, these findings further underscore the incredibly refined, progressive differentiation of 
neocortical projection neurons, not only along the radial axis, but also within a single layer in different 
tangential areas. These post-mitotic arealizing programs enable developing neurons to gradually acquire 
their mature identity, specialized to perform a specific sensory or motor function within the intricate 
neocortical circuitry. 
 
1.6 Progressive Restriction and Refinement of Cortical Projection Neuron Subtypes 
Progressive restriction of neuronal identity at multiple progressive levels of specification suggests 
that populations of dividing progenitors, transitioning progenitors, and early post-mitotic neurons have 
increasingly restricted plasticity. The initial subtype fate decisions early in the life of a neuron, and 
potential malleability of this fate when the balance of key signals is modified, reveals not only that a 
neuron is deterministically set on a general developmental path at its birth, but also that this program 
must be precisely executed during postmitotic differentiation (Figure 1.10). As an example, CPN and 
subcerebral projection neurons in layer V of the neocortex share aspects of molecular identity that are 
progressively resolved during differentiation. The LIM-HD-related genes Lmo4 and Clim1, as well as 
the transcription factors Ctip2 and Satb2, are initially expressed by both CPN and subcerebral 
projection neurons in layer V, and only during mid to late differentiation does expression of Lmo4, 
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Satb2, Clim1, and Ctip2 become largely segregated into these two distinct neuronal subtypes (Arlotta et 
al., 2005; Alcamo et al., 2008; Britanova et al., 2008; Azim et al., 2009b). This progressive postmitotic 
resolution of molecular identity reveals similarities and possible shared evolutionary origin between 
layer V CPN and subcerebral projection neurons, and provides insight into how and when these 
neuronal subtypes achieve their distinct identities during cortical development. 
At many stages of neocortical projection neuron specification, manipulation of specific molecular 
controls can fully or partially fate-switch a progenitor, transitioning progenitor, or immature post-
mitotic neuron, indicating even more cortical plasticity than previously detected through transplantation 
studies. These directed misexpression experiments suggest that late progenitors that are normally fated 
to generate late-born, superficial layer neurons can still be induced to generate early fates (e.g. 
Molyneaux et al., 2005). In Drosophila, expression of Hunchback, which is normally expressed by 
early progenitors and their neuronal progeny, is sufficient to allow later progenitors to generate neurons 
with an early phenotype. However, this plasticity decreases over time; progenitors at advanced stages of 
development are resistant to Hunchback expression, and do not revert to an earlier phenotype (Isshiki et 
al., 2001; Pearson and Doe, 2003). In an analogous fashion in the mammalian neocortex, 
overexpression of Fezf2 in progenitors soon after the generation of layer V and VI is completed (i.e. in 
progenitors that give rise to layer IV neurons), or in progenitors that would normally give rise to layers 
II/III, is sufficient to at least partially override the fate restriction, and induce later-stage progenitors to 
produce neurons with some molecular and anatomical features of earlier-born neurons (Chen et al., 
2005a; Molyneaux et al., 2005). Further analysis of Fezf2 transfected neurons with additional positive 
and negative markers of subcerebral projection neurons is needed to determine the extent of the effect 
of Fezf2 on neuronal phenotype. Interestingly, in contrast to the more restricted window of Hunchback 
effect, Fezf2 appears to, at least in part, affect progenitor plasticity late in development; forced 
expression of Fezf2 in E17 progenitors results in generation of superficial layer neurons that 
inappropriately express Tbr1 at a higher frequency than is normally observed in superficial layer 
neurons, and extend axonal projections to the pons (a feature of deep layer neurons) (Chen et al., 
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2005b). In agreement with the limitations of plasticity seen with Hunchback in Drosophila, Fezf2 over-
expressing neurons are still able to migrate to the layer appropriate for their late birth date instead of 
layer V. While the extent to which these late born neurons change their identity in response to Fezf2 
over-expression remains to be elucidated, together, these experiments indicate that cortical progenitors 
might be more plastic than previously suspected, even late in neurogenesis, if manipulated by the 
appropriate molecular controls (Molyneaux et al., 2007).   
There is also increasing evidence that cortical plasticity is maintained to a certain extent in post-
mitotic differentiating neurons. Normally, Sox5 acts post-mitotically to control sequential generation of 
corticofugal neurons. Gain-of-function analysis reinforces this critical role of Sox5, as over-expression 
at late stages of corticogenesis causes re-emergence of neurons with corticofugal features (Lai et al., 
2008). Further, Ctip2 and Satb2, post-mitotic effector molecular controls specifically expressed by 
CSMN and CPN (Arlotta et al., 2005; Alcamo et al., 2008), respectively, are able to redirect these 
projection neuron axons to abnormal, reciprocal targets when over-expressed in embryonic 
development (Alcamo et al., 2008; Chen et al., 2008a), suggesting postmitotic, early neuronal plasticity 
in the cortex. 
 
1.7 Disease Relevance 
Autism spectrum disorders (ASD) are increasingly viewed as due in substantial part to anatomically 
and cellularly subtle, but functionally overt, disorders of cortical associative connectivity, especially of 
higher cognitive and social integrative systems(Geschwind and Levitt, 2007). Cortical connectivity in 
ASD has been described as over-connectivity in local circuits, with disconnection in long-distance 
circuits(Courchesne and Pierce, 2005). Such long distance disconnection is highlighted by weak 
functional connectivity and synchronization between the cerebral hemispheres (Dinstein et al., 2011; 
Schipul et al.). 
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Since CPN are the cortical commissural neurons that connect the two cerebral hemispheres via 
the corpus callosum, and since they are critical for long-distance bilateral transfer and integration of 
cortical information, they have been centrally implicated in ASD. A smaller CC relative to overall brain 
volume is one of only a few anatomically identified pathologies in a substantial number of ASD 
patients (Egaas et al., 1995; Vidal et al., 2006; Herbert and Kenet, 2007; Minshew and Williams, 2007; 
Frazier and Hardan, 2009; Freitag et al., 2009; Mcalonan et al., 2009), and absence of the CC in humans 
is associated with defects in abstract reasoning, problem solving, and generalization (Paul et al., 2007). 
Currently, little is known about the molecular development and heterogeneity of CPN, and even less is 
known about subpopulations of CPN with distinct and likely important associative functions, and 
potentially important roles in subtypes of ASD. Thus, CPN and callosal biology have very substantial 
significance in ASD. 
Increased knowledge of specific neuronal subpopulations affected in this heterogeneous set of 
disorders, and of functions of genes playing a role in their development will likely allow specific 
subclasses of disorders to be separated from the broader spectrum of disorders.  This increasing division 
of these diseases will enable work toward directed preventative and therapeutic approaches based on 
knowledge of specific neuronal and molecular subtypes.  Identification of Mecp2 as the gene mutated in 
ASD Rett’s syndrome (Amir et al., 1999) enabled increased understanding and directed research on this 
branch of ASD.  Continuing to break down the spectrum into individual disorders has great potential to 
encourage directed research of this type for many such unique disorders. 
 
1.8 Dissertation Overview 
In this dissertation, I identify and begin to functionally characterize molecular controls over diverse 
subpopulations of midline-crossing callosal neocortical projection neurons (CPN), and I investigate 
expansion of CPN subpopulations in primates, employing some of these specifically expressed genes.  I 
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investigate functions of three of these candidate molecular controls in mice (Cited2, Caveolin1, and 
TMTC4) over specific identity acquisition of CPN subpopulations. 
I open with an introduction of neocortical neuronal subtypes, their generation, diversity, and some 
of the progress made in identifying molecular controls over the development of these subpopulations.   
In Chapter 2, I focus on identification and analysis of molecular controls over CPN subtype 
diversity.   This work includes identification of novel molecular controls over CPN development, and 
newly identified molecular subtypes of CPN, as serves as the basis for functional analysis of CPN 
controls in the following chapters. 
In Chapter 3, I investigate functions of one candidate molecular control, Cited2, over 
somatosensory CPN fate acquisition.  The transcriptional co-activator Cited2 acts early in 
corticogenesis to control neuronal birth and survival.  It is also required later in development to 
specifically ensure somatosensory CPN territory. 
In Chapters 4 and 5, I examine functions of two additional controls, Cav1 and TMTC4, over unique 
populations of frontal / callosally projecting CPN and disease relevant superficial layer CPN, 
respectively.  
In Chapter 6, I investigate molecular evolution of CPN by examining similarities and differences 
between a select number of molecular CPN subpopulations throughout evolution, using comparative 
gene expression analysis between mouse and macaque sensory cortex.   
I conclude with a discussion of the implications of these results for understanding neocortical 
development and function, and disorders of precise cortical connectivity such as ASD and agenesis of 
the corpus callosum. 
The contents of the Appendix covers work I joined early in my doctoral studies, expanding the 
understanding of parcellation of progenitor domains in the forebrain, and generation of interneuron 
diversity, through functions of the SRY-box transcription factor Sox6.   
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Chapter 2: 
 
Novel Subtype-specific Genes Identify Distinct Subpopulations of Callosal Projection Neurons 
 
 
Author contributions:  I joined this project in the revisions stage when the FACS purification, 
comparative microarray analysis, candidate selection, and single in situ hybridization characterization 
were complete.  I worked closely with first author Bradley Molyneaux and co-second author Jessica 
MacDonald to strengthen the paper by adding all of the neuron type-specific validation by using 
fluorescent in situ hybridization with fluorescent retrograde label, an approach that I had been developing 
for other use, and was optimizing with Jessica MacDonald.  We also tested many antibodies and 
optimized staining for the Nectin-3 primary antibody combined with retrograde labeling.   All of the 
double in situ hybridization co-expression analysis is new, and was not included in the publication.  This 
approach was developed in collaboration between the Allen Brain Institute for Brain Science’s Zachary 
Riley, co-second author Jessica MacDonald, and me. 
 
Publication: Bradley J. Molyneaux*, Paola Arlotta*, Ryann M. Fame†, Jessica L. MacDonald†, Kyle L. 
MacQuarrie, and Jeffrey D. Macklis. “Novel Subtype-specific Genes Identify Distinct Subpopulations of 
Callosal Projection Neurons.” J. Neurosci. 2010. Sept. 30; 29(39):12343-12354. (* equally-contrubuting 
first authors, †equally-contributing second authors) 
 
This chapter has been kept largely unchanged from its published form, with the exception of double 
in situ hybridization data and minor changes in figure organization and numbering. 
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2.1 Abstract  
Little is known about the molecular development and heterogeneity of callosal projection neurons 
(CPN), cortical commissural neurons that connect homotopic regions of the two cerebral hemispheres via 
the corpus callosum, and that are critical for bilateral integration of cortical information. Here we report 
on the identification of a series of genes that individually and in combination define CPN and novel CPN 
subpopulations during embryonic and postnatal development.  We used in situ hybridization analysis, 
immunocytochemistry, and retrograde labeling to define the layer-specific and neuron-type-specific 
distribution of this series of newly identified CPN genes across different stages of maturation.  We 
demonstrate that a subset of these genes (e.g. Hspb3 and Lpl) appear specific to all CPN (in layers V-VI 
and II/III), while others (e.g. Nectin-3, PlexinD1, and Dkk3) discriminate between CPN of the deep layers 
and those of the upper layers.  Further, the data show that several genes finely subdivide CPN within 
individual layers, and appear to label CPN subpopulations that have not been previously described using 
anatomical or morphological criteria. The genes identified here likely reflect the existence of distinct 
programs of gene expression governing the development, maturation, and function of the newly identified 
subpopulations of CPN.  Together, these data define the first set of genes that identify and molecularly 
subcategorize distinct populations of callosal projection neurons, often located in distinct subdivisions of 
the canonical cortical laminae. 
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2.2 Introduction 
The neocortex is the region of the brain responsible for cognitive function, sensory perception, and 
consciousness, and, as such, it has undergone pronounced expansion and development during evolution. 
The cortex is composed of many different subtypes of neurons, which are organized in six cortical layers 
and numerous cortical areas (Molyneaux et al., 2007). In addition to locally integrated neurons, which 
include multiple subclasses of GABAergic interneurons across all layers, and Cajal-Retzius cells located 
in layer I (Ramón y Cajal, 1995; Markram et al., 2004), a rich variety of glutamatergic projection neuron 
subtypes exist. Projection neurons, representing approximately 80% of all neuron types of the cortex, can 
be classified by the target of their axonal projections to distinct intracortical, subcortical, and subcerebral 
targets, as well as by their location in specific cortical layers and areas (Molyneaux et al., 2007). The 
molecular identity of distinct projection neuron types, and the signals that control lineage-restricted 
neurogenesis are only beginning to be defined for most projection neuron types of the cortex(Weimann et 
al., 1999; Hevner et al., 2001; Arlotta et al., 2005; Chen et al., 2005a; Chen et al., 2005b; Molyneaux et 
al., 2005; Szemes et al., 2006; Alcamo et al., 2008; Britanova et al., 2008; Joshi et al., 2008b; Lai et al., 
2008).  
 In this report, we focus on the molecular development of callosal projection neurons (CPN), a 
broad population of cortical commissural neurons that connect homotopic regions of the two cerebral 
hemispheres via the corpus callosum, the largest fiber tract of the brain (Richards et al., 2004).  While all 
callosal projection neurons have axonal projections through the corpus callosum, they show substantial 
heterogeneity in their axonal projection properties, with some CPN having single projections to the 
contralateral cortex, and others maintaining either dual projections to the contralateral cortex and 
ipsilateral/contralateral striatum, or dual projections to the contralateral cortex and ipsilateral frontal 
cortex (Wilson, 1987; Koralek et al., 1990; Reiner et al., 2003; Gao and Zheng, 2004; Mitchell and 
Macklis, 2005).  Adding further to this diversity of subtypes, CPN are found across multiple cortical 
layers, with the vast majority located in layers II/III (~80%) and V (~20%), and a smaller population 
present in layer VI (Conti and Manzoni, 1994; Ramos et al., 2008). Of interest, the origin and time of 
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birth of CPN destined to populate these different layers is distinct.  While deep layer CPN (located in 
layers VI and V) are born during early stages of corticogenesis (between E12 and E14 in the mouse), 
primarily from progenitors located in the ventricular zone (VZ) of the dorsal pallium, upper layer CPN 
(located in layers II/III) are born later (between E15 and E17), and many of them derive from 
intermediate progenitors (also known as basal progenitors) located in the subventricular zone (SVZ), a 
second germinal zone that develops above the VZ during late neurogenesis (Smart and McSherry, 1982; 
Wu et al., 2005; Kriegstein et al., 2006). Together, these data indicate that CPN are highly heterogeneous, 
and potentially as diverse as the many subtypes of corticofugal projection neurons (e.g. corticospinal, 
corticothalamic, corticostriatal, and subplate).  CPN are likely composed of multiple molecularly distinct 
subpopulations that are not currently resolved at the anatomical level. 
 It is likely, but yet unclear, that CPN populations located in different cortical layers, or presenting 
different patterns of connectivity, ultimately play different functional roles. Substantial previous work 
demonstrates that callosal connections are central for the bilateral integration of cortical information in 
response to incoming sensory input from the thalamus (Nicolelis and Shuler, 2001; Hlushchuk and Hari, 
2006). This is evident in cases of agenesis or surgical transection of the corpus callosum in humans, often 
associated with abnormal emotional and social behavior, and with the impairment of higher cognitive 
function (Paul et al., 2007). Abnormalities of CPN have been one of the central neuroanatomic findings in 
autism spectrum disorders, including Rett syndrome, and are implicated in abnormalities of associative 
function in autism (Saitoh and Courchesne, 1998). Detailed functional and molecular studies of the roles 
of different CPN subpopulations have been complicated by the heterogeneity of neuron types that are 
present within individual cortical layers, and by the scarcity of CPN-specific antigenic markers to define 
neurons of this broad class as they develop in vivo.  
 To discover sub-type specific molecular controls over the development of CPN and corticofugal 
populations and to identify new markers of these neuronal populations, we previously purified CPN and 
two subtypes of subcerebral projection neurons – corticospinal motor neurons (CSMN) and corticotectal 
projection neurons (CTPN) – from the murine neocortex at distinct stages of late-embryonic and early 
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postnatal development (Arlotta et al., 2005).  Using microarrays, we identified genes that in specific 
combinations mark CSMN and control development of this neuron type and related corticofugal 
projection neuron populations in vivo, but are excluded from CPN (Arlotta et al., 2005; Molyneaux et al., 
2005; Lai et al., 2008).  
Here we report on the identification of a set of genes that are progressively restricted to CPN, and that 
are novel markers of this broad projection neuron lineage during embryonic and postnatal development. 
Some of these genes appear specific to all CPN (in layers V-VI and II/III), whereas others discriminate 
between CPN of the deep layers and those of the upper layers.  Further, we show that a subset of genes 
finely subdivides CPN within individual layers, and appear to label CPN subpopulations that have not 
been previously described using anatomical and morphologic criteria.  Together, these data define the first 
set of genes that identify and likely play central roles in the subtype-specific development of CPN, 
providing molecular evidence for the presence of multiple CPN subpopulations often located in distinct 
subdivisions of the canonical cortical laminae.  
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2.3 Materials and Methods 
2.3 a. Retrograde labeling 
All procedures to retrogradely label and purify CPN and the comparative populations CSMN and CTPN 
are previously described in Arlotta et al. (2005). In brief, for CPN, neurons were retrogradely labeled at 
E18, P3, P6, and P14 by injection of green fluorescent microspheres (Lumafluor Corp., FL) into 
contralateral cortex (E17, P1, P4, P12) of C57BL/6 mice (Charles River Laboratories, MA), as previously 
described (Catapano et al., 2001). Cholera toxin subunit B conjugated to Alexa 555 (CTB555; Invitrogen) 
was used for retrograde labeling of CPN and CSMN for in situ hybridization and immunocytochemistry 
experiments. Embryonic injections were performed using a Vevo 660 ultrasound system (VisualSonics, 
Toronto). All animal studies were approved by the Massachusetts General Hospital Institutional Animal 
Care and Use Committee and performed in accordance with institutional and federal guidelines. 
 
2.3 b. CPN dissociation and FACS purification  
Labeled areas of somatosensory cortex were dissociated essentially as described (Catapano et al., 
2001). In brief, dissociated cortex was enzymatically digested with 0.16 gm/L L-cysteine HCl and 11.7 
U/ml papain at 37°C for 30 min. Neurons were mechanically dissociated to create a single cell suspension 
by gentle trituration in iced OptiMem (Life Technologies, Gaithersburg, MD) containing 20 mM glucose 
and both 0.4 mM kynurenic acid and 0.025 mM APV to protect against glutamate-induced neurotoxicity. 
Microsphere-labeled CPN were purified from the cortical cell suspension by fluorescence-activated cell 
sorting (FACS), and neurons were collected directly in RNAlater (Ambion). Additional details and 
methods to purify CSMN and CTPN are reported in (Arlotta et al., 2005). 
 
2.3 c. Microarrays  
Microarray probe synthesis and microarray analysis were all previously performed and are described 
in Arlotta et al. (2005). In order to optimize identification of CPN specific genes, the same hybridization 
solutions were now applied to the newly available Affymetrix 430 2.0 microarrays, and hybridized and 
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processed according to Affymetrix protocols. Microarray data were normalized using two independent 
methods: the RMA function within Bioconductor (Irizarry et al., 2003) and the "error model" method 
within Rosetta Resolver (version 5.0; Rosetta Biosoftware, Seattle, WA). Statistical significance of gene 
expression differences between neuronal subtypes was determined by pair-wise comparisons at each age 
using statistical analysis of microarrays (SAM) (Tusher et al., 2001). Using a SAM D-score cutoff of 
greater than 2 or less than -2, we selected significantly differentially expressed genes, and further 
analyzed their temporal dynamics of expression to identify a refined set of genes for further analysis 
(Arlotta et al., 2005). For example, genes with similar dynamics of expression that are simply shifted a 
few days later in CPN compared with CSMN demonstrate statistical difference at each independent time 
point but likely represent the same biological process in each population, shifted simply due to population 
birthdate and developmental stage.  All microarray data have been deposited in the Gene Expression 
Omnibus database at the National Center for Biotechnology Information, and are available via accession 
numbers GDS1076 (Affymetrix 430a microarray data) and Affymetrix 430 2.0 microarrays will be 
submitted upon acceptance of this manuscript.  
 
2.3 d. In situ hybridization and immunocytochemistry 
All clones for in situ hybridization (ISH) were generated by RT-PCR. Sequences of all primers used 
are listed in table 2.1. Nonradioactive colorimetric in situ hybridization was performed using reported 
methods (Berger and Hediger, 2001). Probes were labeled with dig-UTP for all single ISH, and second 
probes were labeled with DNP-UTP for double fluorescent ISH.  Sense probes were used as negative 
controls in all experiments.  
For fluorescent single and double in situ hybridization, 14 µm cryosections mounted on superfrost 
plus slides were postfixed in 4% PFA in PBS for 20 min., rinsed in PBS for 3 min., rinsed for 3 min. in 
0.1M triethanolamine (Sigma St.Louis,MO), acetylated for 10 min. in 0.1M triethanolamine/ 0.25% acetic 
anhydride (Sigma), and then dehydrated through a series of increasing concentrations of EtOH in DEPC-
treated double distilled H2O for 3 min. in each solution: 50% EtOH, 70% EtOH, 95% EtOH, 100% EtOH.  
84 
Sections were dried completely and stored at -20°C.  Slides were warmed to RT, then secured in capillary 
flow-through chambers (Tecan, Männedorf), and slides remained in the chambers for the remainder of the 
procedure. Endogenous peroxidases were inactivated by incubation in 3% H2O2 in MeOH (Sigma).  After 
a PBS rinse, tissue was permeabilzed first in 0.2M HCl, followed by proteinase K (Sigma) treatment 
[0.0175U/mL in 0.005M EDTA, 0.05M Tris, 0.005% Tween 20].  Sections were then postfixed in 4% 
PFA in PBS for 20 min., and preybridizied in 63.5°C hybridization buffer (Ambion custom mix 
B8807G).  Slides were incubated overnight at 63.5°C in 300ng/mL in hybridization buffer in a well-
humidified oven.  Slides were then subjected to stringency washes in decreasing salt concentrations at 
61°C: 5x SSC (Ambion), 4x SSC in 50% diFormamide (Fisher Scientific, Pittsburgh, PA), 2x SSC in 
50% diFormamide, 0.1x SSC, and 0.1x SSC at RT. Sections were then blocked in 0.1g blocking reagent 
(Roche) / mL maleate [0.9M maleic acid (Sigma), 0.1M NaCl (Sigma), 0.0005% Tween 20 (Sigma), 
0.175M NaOH (Sigma)], rinsed in maelate, then in NTE [0.5M NaCl, 0.01 Trizma, 0.005M EDTA, 
0.005% Tween 20], followed by incubation in 20mM iodoacetamide in NTE.  Sections were rinsed in 
TNT [0.1M Trizma, 0.15M NaCl, 0.00075% Tween 20], blocked in TNB [0.05g NEN blocking buffer 
(Perkin Elmer) / mL TNT], and incubated for 1 hour in horseradish peroxidase-conjugated anti-dig 
(Roche) primary antibody, rinsed with TNT, followed by signal amplification using a tyramide 
amplification system, TSA-plus ® biotin (Perkin Elmer), TNT rinse, and streptavidin labeled with alexa 
flurophore 647, followed by 4% PFA fixation.  Single fluorescence in situ ends here with PBS rinse.  For 
double in situ, peroxidases were inactivated in 3% H2O2 in PBS, rinsed in PBS, blocked in TNB, 
incubated for 1hour in horseradish peroxidase-conjugated anti-DNP (Roche), rinsed in TNT, amplified 
with TSA-plus ® DNP for 45 min., rinsed in TNT, incubated in anti-DNP secondary antibody labeled 
with alexa flurophore 488, rinsed in TNT, postfixed in 4% PFA, and rinsed in PBS.  Slides were 
coverslipped with Fluromount ®, dried, and edges were protected with clear nailpolish. 
For Nectin-3 immunocytochemistry, brains were fixed and stained using standard methods (Fricker-
Gates et al., 2002). Briefly, brains were fixed by transcardial perfusion with PBS, followed by 4% 
paraformaldehyde, and postfixed overnight at 4°C in 4% paraformaldehyde. Brains were sectioned 
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coronally at 50 µm a vibrating microtome (Leica). Sections were blocked in 0.3% BSA (Sigma), 8% goat 
serum, and 0.3% Triton X-100 (Sigma) for 30 min. at room temperature, before incubation in rabbit-anti-
Nectin-3 primary antibody at 1:100 (Abcam ab63931). Secondary antibodies were from the Invitrogen 
Alexa series.  Images were acquired using a Nikon E1000 microscope, using a cooled CCD digital camera 
(QImaging Retiga) and Openlab acquitsition software (Improvision).  
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Table 2.1: Detailed Information About the Clones Used for In Situ Hybridization  
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Gene 
Name 
GenBank ID Left primer Right primer Amplicon(bp) 
Btg1 NM_007569 TGCCATAGTTTGGACAGTACC CAAAATAGATGGTGGTTTGTGG 635 
Cav1 NM_007616 ACCTCTCTGGACTGGCAGAA AGTGTCGGCAAGACTGAAGG 653 
Chn2 NM_023543 GCATGAGATTTCCACACCAA TTTCCTTCCATTACACTGTCATAA 407 
Cited2 NM_010828  TGCTGCCACTTTTTCCTATTC TCTGTGAAATGTTTGCCACTG 501 
Cpne4 NM_028719 TGACACAAATTCCTGGACAATC CAGTGAGCTCAAAGACCAAGC 551 
Cux2  NM_007804 TCAGTCAACAGCTCCATTCG GACAGCGAGAAAGTCCTTGG 626 
Dkk3 NM_015814 ATTGGGTTCACCATTTCAGG CAGGCGTTTAAGAGGTACTCG 617 
Epha3 NM_010140 GTCCAAATGCCTTAAAATGG CAATAGCATTTGGCACTTGG 595 
Frmd4b NM_145148 AGCTCCTGAATCGTGGCTTA TCCTGCAGCTCGGAGTAAAT 603 
Gfra2 NM_008115 GATGTGAACATGTCTCCCAAAG ATTTTGTCAGGCGGGAGTTC 382 
Gm879 NM_001034874 AATGGGTTTGGCATTGTAGC AATTTCCATTGGTGCTTTGC 523 
Gpr88 NM_022427 CAAATGAAACCAATGGTCAGG TATCTGTTTCCCGTGTCTCC 514 
Hspb3 NM_019960 TGATTCAGCCCCAATTAAGC CTGGGGTATGAAGAGCAACC 632 
Inhba NM_008380 GCGATCAGAAAGCTTCATGTG AGACTGGCACCACTCTCCTG 506 
Limch1 NM_001001980 AGCCAGACACGAAAGGAATG GCAAACACCTCCGAGAGAAG 509 
Lpl NM_008509 TGCTGTGCAAAGAGAAGAGC CGGACACAAAGTTAGCACCA 658 
Nectin-3 NM_021495 AAACAACCTGATCCGCAAAG CAGTGAAAACTGTAAAGCAGCTC 466 
Nnmt NM_010924 CCTATGTGTGTGATCTTGAAGG AGATCTGCCTGGCTTTCG 455 
PlxnD1 NM_026376 CAGGAAATGAACGCACACC TGAGGGACACAGACAACTGC 656 
Ptn NM_008973  GCCTACCCGTCCAAATATCC GCCAGTTCTGGTCTTCAAGG 590 
TcrB X67128 GGGTTCTGTCTGCAACCATC AAGGTGTCAACGAGGAAGGA 244 
Tmtc4  
(J22rik) 
NM_028651 GAAGCAGAGCAGAGCTACCG TCTGAACAGAGGCTTCATGC 579 
T
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2.4 Results 
2.4 a. Purification and Microarray Analysis of Callosal Projection Neurons, Corticospinal Motor 
Neurons, and Corticotectal Projection Neurons. 
To identify genes that control the cell-type specification and differentiation of callosal projection 
neurons, we compared the gene expression profiles of CPN to two other pure populations of cortical 
projection neurons: corticospinal motor neurons and corticotectal projection neurons.  The general 
approach used, and the analysis of data to identify genes involved in the development of the corticospinal 
motor neuron and related corticofugal populations, was previously described (Arlotta et al., 2005).  Here, 
we report on the identification and further characterization of genes that define the broad population and 
distinct subtypes of interhemispheric callosal projection neurons. 
CPN were retrogradely labeled via injections of green fluorescent microspheres into their axonal 
projection fields in contralateral sensorimotor cortex at four different stages of development, followed by 
dissociation and FACS of the labeled neurons to typically greater than 99% purity (Catapano et al., 2001; 
Catapano et al., 2004; Arlotta et al., 2005; Ozdinler and Macklis, 2006). Specifically, callosal projection 
neurons that were purified at multiple stages of development, including E18, P3, P6, and P14, were 
labeled as schematically depicted in Figure 2.1. For precise targeting and purification of E18 CPN, 
fluorescent microspheres were microinjected in the contralateral hemisphere of E17 embryos, in utero, 
under high-resolution ultrasound backscatter microscopic guidance (Arlotta et al., 2005). Similar methods 
were used to label corticospinal motor neurons and corticotectal projection neurons [Figure 2.1; (Arlotta 
et al., 2005)].   
In the study by Arlotta et al. (2005), we previously used these pure neuronal preparations to compare 
the molecular development of corticospinal motor neurons and callosal projection neurons using 
Affymetrix 430A microarrays (data available at NCBI Gene Expression Ominbus accession number 
GDS1076).  In order to optimize identification of CPN-specific genes, and to maximize the number of 
genes examined by microarray to provide the most inclusive investigation of gene expression through 
development, we now hybridized samples to the newly available and more inclusive Affymetrix 430 2.0 
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arrays, which contain a substantially expanded probe set.  Using this approach, we identified a large 
number of genes that are expressed at higher levels in callosal projection neurons compared to CSMN and 
corticotectal projection neurons.  The forty genes with the most biologically significant and distinctive 
expression profiles following temporal analysis (see methods) are listed in Table 2.2.  These genes can be 
classified in several ontology groups and include, among others, transcription factors (e.g. Cux1, Cux2, 
Lhx2, Pdzrn3, Cited 2), cell signaling molecules and receptors (e.g. Gfra 2, Gpr6, Gpr88, Ptprk, TCRβ), 
and axon guidance molecules (e.g. Chimerin 2, Dcc, EphA3, Plxdc2, PlxnD1). Although many of these 
genes are relatively uncharacterized in the cortex, and none of them has been previously demonstrated to 
specifically label the broad CPN population or CPN subtypes, we find that selected genes previously 
demonstrated to be restricted to the upper layers (where most CPN are located), are specifically and 
highly expressed in CPN within those layers [e.g. Cux1, Cux2 – (Nieto et al., 2004; Zimmer et al., 2004), 
confirming the validity of our approach in identifying candidates with restricted expression to CPN and 
distinct CPN subtypes.  
 
2.4 b. Many CPN specific genes identify anatomic diversity and distinct CPN populations.  
Previous anatomical and birthdating analysis have shown that the broad CPN population is 
heterogeneous, including neurons born at different developmental times (e.g. E12.5-13.5 for layer VI and 
V CPN, E15.5 for layer II/III CPN), located in different cortical layers (e.g. II/III, V, and VI), with some 
extending collateral projections to distinct targets (e.g. striatum, ipsilateral frontal cortex) (Wise and 
Jones, 1976; Mitchell and Macklis, 2005). This is in striking contrast to the much more homogeneous 
population of corticospinal motor neurons, which are born at ~E13.5, populate one layer (layer V) and a 
limited area (sensorimotor) of cortex, and extend projections to the spinal cord (though with a range of 
spinal segmental specificity)(O'Leary and Koester, 1993). Based on such previous anatomical data, we 
reasoned that CPN specific genes might fall into at least two general categories:  (i) broad CPN “identity 
genes” that might label most or all CPN; and (ii) genes that subparcellate CPN into multiple subtypes,  
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Figure 2.1: Schematic representation of the experimental approach used to identify CPN-specific genes. 
Callosal projection neurons (CPN), corticospinal motor neurons (CSMN), and corticotectal projection 
neurons (CTPN) were retrogradely labeled at distinct stages of development from the contralateral 
hemisphere, the spinal cord, and the superior colliculus, respectively. Labeled neurons were dissociated, 
FACS purified, and submitted to comparative microarray analysis. 
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Table 2.2: Selected subset of the genes identified by microarray analysis that are expressed at higher 
levels in callosal projection neurons compared to corticospinal motor neurons and corticotectal projection 
neurons. The forty genes listed are those with the most biologically significant and distinctive expression 
profiles following temporal analysis of gene expression data. Genes that were further investigated here 
with in situ hybridization are listed in bold.  
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Gene Name Full Name GenBank ID 
Adamts3 ADAM metallopeptidase with thrombospondin type 1 motif, 3 NM_001081401 
Btg1 B-cell translocation gene 1  NM_007569 
C030017B01Rik EST (located 3' of Kctd16) AK046738 
Cav1 Caveolin (caveolae protein 1) NM_007616 
Cdh10 Cadherin 10 NM_009865 
Chn2 Chimerin 2 NM_023543 
Cited2 
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-
terminal domain, 2 NM_010828  
Coup-tfI Chicken ovalbumin upstream promoter-transcription-factor 1 NM_010151 
Cpne4 Copine 4 NM_028719 
Cux1 Cut-like 1 NM_009986 
Cux2  Cut-like 2 NM_007804 
DCC Deleted in colorectal carcinoma NM_007831 
Dkk3 Dickkopf homolog 3 NM_015814 
Epha3 Eph receptor A3 NM_010140 
Frmd4b FERM domain containing 4B NM_145148 
Gfra2 Glial cell line derived neurotrophic factor family receptor alpha 2 NM_008115 
Gm879 Gene model 879 NM_001034874  
Gpr6 G-protein-coupled receptor 6 NM_199058 
Gpr88 G-protein coupled receptor 88  NM_022427 
Gria4 Glutamate receptor, ionotropic, AMPA4  BB130399 
Grp Gastrin releasing peptide NM_175012 
Hspb3 Heat shock protein 3 NM_019960 
Inhba Inhibin beta-A  NM_008380 
Kcnh1 Potassium voltage-gated channel, subfamily H, member 1 NM_001038607 
Klhl4 Kelch-like 4 NM_172781 
Lhx2 LIM homeobox protein 2 NM_010710 
Limch1 LIM and calponin homology domains 1 NM_001001980 
Lpl Lipoprotein lipase; NM_008509 
Nectin-3 Nectin-3 NM_021495 
Nnmt Nicotinamide N-methyltransferase NM_010924 
Pdzrn3 PDZ domain containing RING finger 3 NM_018884 
Plxdc2 plexin domain containing 2  NM_026162  
PlxnD1 Plexin D1 NM_026376 
Ptn Pleiotrophin  NM_008973 
Ptprk Protein tyrosine phosphatase, receptor type, K NM_008983 
Satb2 Special AT-rich sequence binding protein 2 NM_139146 
TcrB T-cell receptor beta X67128 
Tmtc4  (J22rik) transmembrane and tetratricopeptide repeat containing 4 NM_028651 
Unc5d Unc-5 homolog D NM_153135 
Vglut2 Vesicular glutamate transporter 2 NM_080853 
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potentially reflecting anatomic, connectivity, and functional heterogeneity.  Genes in the second set would 
only be expressed in distinct subtypes of CPN.  
To investigate this possibility and determine whether the anatomical complexity of the broad CPN 
population is mirrored at the molecular level, we investigated the fine spatial expression of a subset of 
these newly identified CPN genes via in situ hybridization. We find that a small number of these genes 
are expressed in a laminar distribution suggestive of their presence in all CPN (Fig. 2.2), showing high 
levels of expression in layers II/III, the CPN proportion of V, and in a smaller number of layer VI neurons 
consistent with CPN. These include the genes Lpl (lipoprotein lipase) (Figure 2.2A), an enzyme involved 
in lipoprotein metabolism with unknown function in the brain (Vilaro et al., 1990); Hspb3 (Figure 2.2B), 
a small heat shock protein not previously described in the brain (Sugiyama et al., 2000); and Cited2 
(Figure 2.2C), thought to function as a transcriptional coactivator and interact with Lhx2 (Glenn and 
Maurer, 1999). The spatial expression of these genes matches the distribution of CPN obtained via 
retrograde tracing of all CPN from the contralateral hemisphere (Figure 2.2D). 
In addition to genes that label all CPN and distinguish them from other types of cortical projection 
neurons within the same layers, in situ hybridization for 20 additional CPN genes reveals that they are 
distributed in distinct, individual laminar and sublaminar patterns within the cortex (Figures 2.2-2.6). 
These data confirm and extend at the molecular level previous anatomical data on the heterogeneity of 
connections and functional diversity of CPN, and provide the first demonstration that distinct CPN 
populations exist in the cortex that can be identified by the combinatorial expression of newly identified 
CPN genes (see Figure 2.8).  
 
2.4 c. CPN-specific genes mark distinct temporal stages of CPN development. 
 To identify genes expressed by CPN at distinct stages of development, and thus likely functioning 
to control distinct aspects of cell-fate specification and differentiation of this neuronal lineage in vivo, we 
further investigated by in situ hybridization the fine spatial expression of genes that by microarray appear 
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to be preferentially expressed at early (E18), mid (P3, P6), or late (P14) stages of CPN development. We 
identified several CPN-restricted genes that, aside from subdividing the CPN population spatially in 
layers and sublayers, are also expressed selectively at distinct times of development (Figures 2.3-2.6 and 
Table 2.1). Genes expressed early during CPN development, and thus potentially functioning in lineage 
specification, neuronal migration, and initial axonal extension, include to following: Cux2, Inhba, Btg1 
(see Figure 2.3A, 2.3B, and G); Frmd4b, EphA3 (see Figure 2.4A and C); and Ptn (see Figure 2.5C).  
Other genes are virtually absent at E18, but are highly expressed at P3, by which time CPN have already 
reached their final location in the neocortex, have sent axonal projections through the corpus callosum, 
and are connecting to targets in the contralateral hemisphere. These genes expressed at mid-stage of CPN 
development include the following: Cpne4 and Tmtc4 (see Figure 2.3D and E); Nnmt, Cav1 (see Figure 
2.4B and D); Nectin-3, Chn2, Gm879  (see Figure 2.5A, B, and F).  Finally, genes highly expressed at 
later stages of CPN development, and thus that might be important in later CPN maturation, maintenance, 
and/or control of late events of CPN connectivity include: Plexin-D1, Gfra2, Tcrβ, and Dkk3 (see Figure 
2.6A-D).  
 
2.4 d. Genes that distinguish upper layer from deep layer CPN 
CPN are located in both superficial (II/III) and deep (V and VI) layers of neocortex, but those of 
layers II/III are very different in their time and place of origin from those of V and VI. CPN of the deep 
layers are born during early corticogenesis (E11.5- E13.5 in the mouse) from progenitors located in the 
ventricular zone underlying neocortex (Angevine and Sidman, 1961; Caviness and Takahashi, 1995). In 
contrast, superficial layer CPN are born later, with a peak of birth around E15.5, and they derive largely 
from a second pool of progenitors (basal progenitors; also known as intermediate progenitors) located in 
the subventricular zone (SVZ), a second germinal layer that develops above the VZ during late 
corticogenesis (Kriegstein et al., 2006). The SVZ and its intermediate progenitors are thought to be 
central to the marked expansion of the superficial cortical layers of late evolution (Kriegstein et al., 2006).  
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Figure 2.2: CPN-genes that label most callosal projection neurons across layers II/III and V. 
(A-C), Temporal profiles of gene expression from microarray analysis in CPN (red) versus CSMN (blue) 
during embryonic (E18) and early postnatal (P3, P6, P14) stages of development. Bars indicate standard 
errors of the mean. (A’-C’), in situ hybridization in coronal sections of cortex showing that the expression 
of selected genes closely resembles the typical distribution of the retrogradely labeled, broad CPN 
population (D). (A’’-C’’), magnification of selected areas from A’-C’. Ages are as indicated in A’-C’. E–
N, Lpl and Hspb3 are expressed by CPN across layers II/III and V and not in CSMN. E, Fluorescent in 
situ hybridization for Lpl (green) in a coronal section of P8 cortex demonstrates that it is expressed in 
CPN identified by retrograde labeling via injection of CTB555 (red) in the contralateral cortex at P6. F, 
G, Magnification of selected areas in layers II/III and V from E; arrows indicate Lpl-expressing CPN. H, 
Fluorescent in situ hybridization for Hspb3 (green) in a coronal section of P8 cortex demonstrates that it 
is expressed in retrogradely labeled CPN (red). I, J, Magnification of selected areas in layers II/III and V 
from H; arrows indicate Hspb3-expressing CPN. K, Fluorescent in situ hybridization for Lpl (green) in a 
coronal section of P8 cortex demonstrates that it is not expressed in CSMN 
identified by retrograde labeling via injection of CTB555 (red) in the spinal cord at P4 (high 
magnification shown in L).M, Fluorescent in situ hybridization for Hspb3 (green) in a coronal section of 
P8 cortex demonstrates that it is also not expressed in retrogradely labeled CSMN (red) (high 
magnification shown in N). Scale bars: A”-C”, 100 µm; E, H, K,M, 200 µm; F, G, I, J, L, N, 50 µm. 
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To determine whether CPN of the superficial and deep layers are distinct at the molecular level, and 
to identify potential molecular-genetic controls over the subtype-specific differentiation of these distinct 
CPN populations, we investigated whether any of the newly-identified CPN-specific genes are restricted 
to CPN in either superficial or deep laminae. Indeed, we identified several genes that label only 
superficial layer CPN (Figure 2.3). These include early expressed genes like Cux2 (Figure 2.3A) and 
Inhba (Figure 2.3B), as well as Btg1 (Figure 2.3G), a transcriptional coactivator that regulates myoblast 
differentiation and might play a similar role in CPN development. In addition, later genes like Cpne4 and 
Tmtc4 specifically label superficial layer CPN (Figure 2.3D, E), suggesting potential functional roles in 
the maturation of these CPN. While Cux2 was previously reported to label the upper layers of the 
neocortex (Nieto et al., 2004; Zimmer et al., 2004), acting as a confirmatory positive control for the 
current analysis, here we refine the prior results by demonstrating that Cux2 is expressed by CPN within 
the superficial layers. Other genes identified here are both novel markers of CPN and, more broadly, of 
superficial cortical layers. Together, expression of these genes as superficial layer CPN markers enables 
the demarcation and molecular classification of CPN of the superficial layers, and indicates that upper 
layer CPN are molecularly distinct even at early stages of differentiation from CPN located in deep layers 
of neocortex  
 
2.4 e. A subset of CPN-specific genes defines novel sub-lamina within the normally unresolved 
murine upper layer II/III. 
Although many of the newly identified upper layer CPN genes are broadly expressed across the 
thickness of layer II/III, we find, interestingly, that several CPN-specific genes label only narrow sub-
lamina, subparcellating what has been traditionally termed layer II/III in rodents.  For example, Frmd4b, 
Nnmt, and EphA3 (Figure 2.4A-C) label only a very thin strip of CPN in the most superficial portion of 
layer II/III.  In contrast, other genes label CPN populations in the middle (Nectin-3, Chn2; Figure 2.5A 
and B), or deeper (Ptn, Cav1, Gm879; Figure 2.5 C, D, F) portions of nominal layer II/III. Genes that 
distinguish the most superficial and deepest aspects of nominal layer II/III from the broader middle 
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portion of the layer are of particular interest, since retrograde labeling of CPN from contralateral cortex 
indicates that the largest number and concentration of CPN are located within the middle portion of layer 
II/III, suggesting special functional and connectivity roles for the most superficial and deepest layer II/III 
CPN compared with the predominant layer II/III population.  
To further investigate the specificity of expression of these genes within upper layer CPN, we chose 
Nectin-3 as a prototypical gene and evaluated its cell-type-specific expression. We retrogradely labeled 
CPN using a cholera toxin subunit B Alexa 555 conjugate, which clearly labels upper layer CPN and their 
axons coursing through the corpus callosum (Fig. 2.5G). Immunocytochemistry for Nectin-3 
demonstrates colocalization with CPN axons in the corpus callosum, as well as within the somas and 
apical dendrites of superficial cortical CPN (Fig. 2.5H–K). 
Together, these genes define a previously unrecognized molecular parcellation of the superficial 
cortical layers, refining previous histological and anatomical definitions, and enabling new functional and 
evolutionary hypotheses regarding distinct CPN populations.  
 
2.4 f. Other CPN-specific genes are expressed only in deep layer CPN, and identify distinct 
populations in layers Va, Vb, and VI. 
In a complementary fashion to genes expressed selectively by CPN of upper layers, many of the 
newly identified CPN genes are specifically expressed in deep layers V and VI, and are excluded from 
layers II/III, thus defining distinct sets of early-born CPN of the deep layers. These genes include Plexin-
D1, Gfra2, Tcrβ, and Dkk3 (Figure 2.6 A-D).  Quite interestingly, layer V and VI CPN can be further 
defined by combinatorial expression of selected deep layer CPN genes, and thus classified into 
subpopulations occupying distinct sub-portions of these canonical layers.  For example, in situ 
hybridization reveals that CPN in layer Va express the unique combination of Plexin-D1 and Gfra2 
(Figure 2.6 A, B); they likely represent callosal neurons that maintain collateral projections to ipsilateral 
and/or contralateral striatum (Gao and Zheng, 2004).  CPN located in deeper positions within layer V 
(e.g. layer Vb) can be defined by the expression of Gfra2, Dkk3, and TcrB (Figure 2.3 C-D), and by the  
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Figure 2.3: CPN-genes that selectively label callosal neurons of the superficial layers II/III and IV.  
(A-F), Temporal profiles of gene expression from microarray analysis in CPN (red) versus CSMN (blue) 
during embryonic (E18) and early postnatal (P3, P6, P14) stages of development. Bars indicate standard 
errors of the mean. (A’-F’), in situ hybridization in coronal sections of cortex showing preferential CPN-
gene expression in the superficial layers. (A’’-F’’), magnification of selected areas from A’-F’. Ages are 
as indicated in A’-F’. Scale bars: A”-F”, 100 µm. 
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Figure 2.4: CPN-genes that preferentially label the outermost portion of layer II/III and layer I.   (A-C), 
Temporal profiles of gene expression from microarray analysis in CPN (red) versus CSMN (blue) during 
embryonic (E18) and early postnatal (P3, P6, P14) stages of development. Bars indicate standard errors of 
the mean. (A’-C’), in situ hybridization in coronal sections of cortex showing preferential CPN-gene 
expression in the most superficial portions of layer II/III. (A’’-D’’), magnification of selected areas from 
A’-C’. Ages are as indicated in A’-C’. Scale bars: A”-C”, 100 µm.  
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Figure 2.5: CPN-genes that preferentially label the deepest portion of layer II/III and layer IV. (A-F), 
Temporal profiles of gene expression from microarray analysis in CPN (red) versus CSMN (blue) during 
embryonic (E18) and early postnatal (P3, P6, P14) stages of development. Bars indicate standard errors of 
the mean. (A’-F’), in situ hybridization in coronal sections of cortex showing preferential CPN-gene 
expression in the deepest portions of layer II/III and IV. (A’’-E’’), magnification of selected areas from 
A’-F’. G–K, Nectin-3 is expressed in CPN in layer II/III and in CPN axons in the corpus callosum at 
P1.G, CPN retrogradely labeled with CTB555 (red) via injections into contralateral cortex at P0.H, I, 
Nectin-3 immunocytochemistry (green) detects Nectin-3 expression in CPN in layer II/III, as well as in 
CPN axons in the corpus callosum. J, Magnification of selected area in I. J_, Magnification of selected 
area in J, showing expression of Nectin-3 in a subset of CPN axons in the corpus callosum. K, 
Magnification of selected area in I. K_, Magnification of selected area in K, showing expression of 
Nectin-3 in CPN in layer II/III. CTB inj, Site of CTB555 injection; CC, corpus callosum; LV, lateral 
ventricle; Str, striatum. Ages are as indicated in A’-E’, and G. Scale bars: A”-E”, 100 µm; G–I, 500 µm; 
J, K, 100 µm; J’, K’, 50 µm.  
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Figure 2.6: Genes that preferentially label CPN of the deep layers V and VI. (A-D), Temporal profiles of 
gene expression from microarray analysis in CPN (red) versus CSMN (blue) during embryonic (E18) and 
early postnatal (P3, P6, P14) stages of development. Bars indicate standard errors of the mean. (A’-D’), in 
situ hybridization in coronal sections of cortex showing preferential CPN-gene expression in the deep 
layers V and VI. (A’’-D’’), magnification of the areas boxed in A’-D’. Ages are as indicated in A’-D’. 
Scale bars: A”-D”, 100 µm.  
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Figure 2.7: Specific expression of Plexin-D1 and Dkk3 in retrogradely labeled CPN of the deep layers V 
and VI.A–H, Plexin-D1 is expressed by CPN of the deep layer V and not by CSMN.A, Fluorescent in situ 
hybridization for Plexin-D1 (green) in a coronal section of P8 cortex demonstrates that it is expressed 
within CPN (red) identified via injection of CTB555 into contralateral cortex at P6. B–D, Magnification 
of selected area from A reveals that essentially all Plexin-D1-expressing cells are CPN (arrows). E–H, 
Fluorescent in situ hybridization for Plexin-D1 (green) in a coronal section of P8 cortex demonstrates that 
it is not expressed in CSMN (red) identified retrogradely labeled via spinal cord injection of CTB555. F–
H, Magnification of selected area from E, with the arrow indicating a CSMN that is adjacent to a 
PlexinD1-expressing cell (arrowhead). I–P, Dkk3 is expressed by CPN of the deep layers V and VI and 
not by CSMN. I, Fluorescent in situ hybridization for Dkk3 (green) in a coronal section of P8 cortex 
demonstrates that it is expressed in CPN (red) identified via injection of CTB555 into contralateral cortex 
at P6. J–L, Magnification of selected area from I, with arrows indicating Dkk3-positive CPN; notably, a 
subset of Dkk3-expressing cells are not retrogradely labeled. M, Fluorescent in situ hybridization for Dkk3 
(green) in a coronal section of P8 cortex demonstrates that Dkk3 is not expressed in CSMN (red) 
retrogradely labeled via spinal cord injection of CTB555.N–P, Magnification of selected area fromM, 
with arrows indicating CSMN that do not express Dkk3. Scale bars: A, E, I,M, 200 µm; B–D, F–H, J–L, 
N–P, 50 µm. 
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absence of Plexin-D1 expression (Figure 2.3A).  The relatively small population of CPN located in layer 
VI appears to express higher levels of Gfra2, Tcrβ, and Dkk3 (Figure 2.6B-D), and lack Plexin-D1.   
We further investigated cell-type-specific expression of the representative genes Plexin-D1 and 
Dkk3.We find that Plexin-D1 RNA is expressed at high levels within retrogradely labeled CPN in layer 
Va and at lower levels within CPN of more superficial layers (Fig. 2.7A–D). In contrast, retrograde 
labeling of CSMN demonstrates that they are located in layer Vb, below the Plexin- D1-positive layer Va. 
Of note, the border between these two layers is indistinct, with CSMN intermingled with PlexinD1- 
expressing CPN. Even at this interface, CSMN do not express Plexin-D1, clearly demonstrating the true 
cell-type specificity of this CPN marker. In addition, we examined the cell-type-specific expression of 
Dkk3 and find that it labels a large portion of layerV and VI retrogradely labeled CPN (Fig. 2.7I–L), 
whereas layer V CSMN do not express Dkk3 (Fig. 2.7M–P). 
It is intriguing to note that each of the genes expressed highly and somewhat selectively in layer VI 
appears to label more cells than the number of CPN estimated to be located in this layer from many prior 
retrograde tracing experiments. This suggests 1) that each gene might also label other neuronal and glial 
types within layer VI, including perhaps the preponderant population of corticothalamic projection 
neurons of layer VI, and 2) that this layer VI subset (and perhaps other subsets) of CPN might be 
molecularly related to, or even evolutionary derived from, corticofugal projection neurons. Expression of 
genes such as Dkk3 with other CPN genes (e.g., Hsbp3) may be used to further delineate subtypes of 
CPN within deep cortical layers.  
 
2.4 g. Combinatorial codes of genes define distinct subpopulations of CPN, and identify novel 
subdivisions of canonical cortical layers.  
 To directly compare the laminar and sublaminar distribution of individual CPN genes and to 
provide a first spatial map of combinatorial molecular expression by these distinct CPN subpopulations, 
we investigated the cellular level of expression of a selected set of CPN genes within the same brain. We 
chose genes that have distinct laminar distributions, also selecting for those that show a similar temporal 
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expression, enabling detection and comparison at the same stage of development. We chose P6 as a mid-
point in CPN development at which a large number of CPN-specific genes are expressed, and we 
performed in situ hybridization for all selected genes on 10 µm thick serial sections from the same brain 
(Figure 2.8 A). Cresyl violet staining of the first section of the series was used to distinguish canonical 
cortical layers at the histological level. For this analysis, we chose 8 representative genes: Nectin-3, Cav1, 
and Chn2 (all expressed in distinct sub-lamina of layer II/III); Hspb3 and Lpl (both expressed in layers 
II/III and V); Plexin-D1 (expressed in layer Va); Tmtc4 (expressed in layers II/III and Va); and Dkk3 
(expressed in layer VI).  This series of in situ hybridizations allowed us to delineate the relative laminar 
location of the cells expressing each of the genes.  For example, we found that, at P6, Cav1-expressing 
cells are overlapping with Plexin-D1 labeling within layer Va .  To investigate whether these partially 
overlapping gene expression domains reflect distinct populations of neurons expressing only one or a 
restricted combination of these genes, we performed double fluorescent in situ hybridization for a select 
set of genes at P8.  We find that, indeed, with only Lpl and Plexin-D1 expression, there exist three distinct 
populations of CPN, a superficial population expressing Lpl a deep population expressing Plexin-D1, and 
a middle population expressing both (Figure 2.8B).  Additionally, even though Hspb3 is expressed by 
CPN in layers II/III, and V, a very superficial portion of layer II/III is devoid of Hspb3-expressing 
neurons, but contains cells highly expressing Inhba (Figure 2.8C).  This analysis reveals that distinct 
subpopulations of CPN can be identified at the molecular level that express unique combinations of these 
genes; these distinct CPN populations occupy different layers, and, in some cases, different sub-laminae 
of the same layer (Figure 2.8). Together, these results demonstrate that CPN are a molecularly diverse set 
of populations and suggest that functionally and connectionally distinct subgroups of CPN are defined 
during their differentiation by distinct combinatorial codes of gene expression that govern their 
development. These data provide a new “molecular anatomy” of CPN via the expression of genes that 
classify this highly diverse set of neuronal populations at the molecular level with a precision not 
previously possible using standard anatomical and histological criteria.  
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Figure 2.8: Combinations of genes identify CPN within sub-compartments of canonical cortical laminae. 
(A), in situ hybridization at P6 for representative genes in sequential coronal sections of cortex from the 
same mouse, showing molecularly distinct populations of CPN identify subcompartments within the 
canonical cortical layers. Solid lines identify layers, and dotted lines identify subdivisions of the layers 
demarcated by CPN-gene expression. (B-C) Double fluorescent in situ hybridization at P8 for Lpl and 
Plexin-D1 (B-B’), and Inhba and Hspb3 (C-C’) in coronal sections of P8 cortex demonstrates distinct 
laminar distributions of these CPN genes, with only partial overlap. Scale bars: B,C, 200 µm; B’,C’, 50 
µm. 
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2.5 Discussion 
Despite knowledge of the developmental and anatomical properties of some broad classes of 
projection neurons types of the cortex, the genes that distinguish individual neuronal lineages and that 
instruct their lineage-specific development are only beginning to be identified.  We previously reported 
on the identification of genes that mark and control the development of the lineage of corticospinal motor 
neurons, a major corticofugal projection neuron population of layer V(Arlotta et al., 2005).  Here we 
report on the identification of genes that identify at the molecular level the lineage of inter-hemispheric 
callosal projection neurons of the cortex.   
Previous anatomical, histological, and birthdating analyses have highlighted the anatomical 
complexity and the cellular heterogeneity of the broad population of callosal projection neurons (Koralek 
et al., 1990; Conti and Manzoni, 1994; Reiner et al., 2003; Mitchell and Macklis, 2005; Ramos et al., 
2008). However, detailed functional and molecular studies of different CPN subpopulations have been 
complicated by the heterogeneity of neuron types within individual cortical layers and by the scarcity of 
CPN-specific antigenic markers to identify them as they develop in vivo. Few genes have been reported 
that label neurons of the upper cortical layers (Molyneaux et al., 2007). These include Satb2 a nuclear 
matrix protein that was recently reported to be a critical regulator of CPN development, controlling 
molecular events that induce the formation of callosal connections by CPN during corticogenesis 
(Britanova et al., 2005; Szemes et al., 2006). In the absence of Satb2, postmitotic neuroblasts that are 
normally destined to become CPN of layers II/III begin to express Ctip2, a gene required for the 
formation of projections to subcerebral targets, and extend axons through the internal capsule instead of 
through the corpus callosum (Alcamo et al., 2008; Britanova et al., 2008). Other genes, such as Cux1, 
Cux2 (Nieto et al., 2004; Zimmer et al., 2004), and Unc5d (Tarabykin et al., 2001; Zhong et al., 2004; 
Sasaki et al., 2008), are expressed in the SVZ during the generation of upper layer neurons and, 
postnatally, in neurons of the upper layers.  Finally, genes with broader patterns of expression in different 
neuronal layers have been reported to label neurons in the upper layers of cortex. These include Lhx2, a 
gene that is critical for the specification of the dorsal progenitor domain that gives rise to the cortex, and 
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that postnatally labels layer II/III (Bulchand et al., 2001; Bulchand et al., 2003); Gpr6, a marker of 
postnatal layers II/III-IV (Chenn et al., 2001); Brn1 and Brn2, two markers of layer II/III-V neurons that 
regulate differentiation and migration of these layers (McEvilly et al., 2002; Sugitani et al., 2002); and 
Kitl and Dtx4, markers of layers II/III-IV (Zhong et al., 2004), among others. While these genes can 
identify the upper cortical layers, their patterns of expression are typically too broad to identify individual 
neuronal populations within these layers, and it is not currently known whether they specifically label 
CPN among other upper layer neuron types.  Further, there is a paucity of genes that specifically identify 
CPN of the deep layers, and distinguish them from corticofugal neurons located within the same layers.  
Here we provide the first demonstration that distinct classes of callosal neurons can be defined in vivo 
based on the expression of different molecular markers, suggesting distinct molecular controls over their 
subtype-specific development, connectivity, and function.  Some of the CPN genes are expressed by most 
callosal neurons, spanning layers II/III, V, and VI (e.g. Lpl, Hspb3), suggesting that they may play 
broader roles during the development of all callosal neurons. In contrast, other genes are more restricted 
to only callosal neurons of selected layers: for example Cpne4, Btg1, Inhba, Gm879, Tmtc4 are expressed 
in layer II/III, while PlexinD1, Gfra2, Tcrβ, and Dkk3 mark CPN of the deep layers V and VI. Our data 
reveal the presence of callosal neuron subpopulations that were not previously recognized at the 
anatomical and histological levels, by demonstrating that different subtypes of callosal projection neurons 
can be identified by combinations of molecular markers within subdivisions of the same canonical 
lamina. The identification of genes that uniquely define distinct callosal subpopulations will now make it 
possible to investigate the function and connectivity of individual subpopulations via genetic 
manipulation and targeting of distinct callosal projection neuron types. 
Interestingly, we find that callosal projection neurons of the upper layers (II/III) exhibit a higher 
degree of molecular heterogeneity than those located in the deep layers (V and VI), as indicated by the 
fact that CPN located in different portions of layer II/III express different genes.  For example, genes 
including Grsp1, Nnmt, EphA3 and Cav1 all selectively label CPN located in the most superficial portion 
of layer II/III, while genes including Nectin-3, Chn2, and Ptn are preferentially restricted to the deeper 
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part of the same layer.   Of note, a number of layer-specific genes have been identified via large-scale in 
situ efforts, including the Allen Brain Atlas (http://www.brain-map.org). Interestingly, examination in the 
Allen Brain Atlas of the expression profile of the CPN genes identified here reveals that some of these 
genes maintain layer-specific expression in the adult. For these genes, our data extend these layer-specific 
expression data to provide an indication of the neuron types that express the individual genes. Many other 
genes are not identified in the Allen Brain Atlas as layer-specific in the adult, further supporting 
functional roles during embryonic and early postnatal stages of CPN development. Finally, a small 
number of the CPN genes reported here (e.g., Lhx2 and COUPTF1) have been shown previously to be 
expressed only in restricted cortical areas (Nakagawa et al., 1999; Liu et al., 2000), suggesting that 
additional CPN populations might be distinguished at different rostrocaudal and mediolateral locations. In 
the future, it will be useful to further define the boundaries of arealization of the CPN genes reported here. 
 It is interesting to speculate that the presence of a molecularly more diversified population of callosal 
neurons in the superficial layers of the rodent cortex might reflect the early stages of the expansion and 
diversification of these layers that occurred during evolution of the primate cortex.  Since the divergence 
of reptiles, birds, and mammals, the cortex has undergone substantial radial expansion, with major 
addition of new neurons within the superficial cortical layers II-IV of mammalian species (Reiner, 1991; 
Marín-Padilla, 1992; Aboitiz and Montiel, 2003). For example, the reptilian cortex has only three layers, 
thought to be homologous to layers I, V and VI of the six-layer mammalian cortex, and they lack neurons 
with properties of mammalian upper layer projection neurons (Reiner, 1991). Among mammals, the 
primate cortex exhibits further expansion; the six canonical layers seen in rodents and lower mammals 
have enlarged to include new subdivisions that can be easily distinguished at the histological level (Rakic 
and Kornack, 2001). Of particular note is the subdivision of the expanded layer II/III of the rodent into the 
multiple histologically distinct layers and sublayers seen in primates.   
While these layers cannot be distinguished at the histological level in the rodent, it is intriguing to 
speculate that our identification of genes that mark neurons located in distinct radial positions within layer 
II/III might support the hypothesis that the specialization of distinct populations of CPN within upper 
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layers is already occurring in the rodent cortex both molecularly and almost certainly with regard to 
connectivity and function. Future work that investigates the expression of the genes identified here within 
the cortex of primates will likely provide important insight into the evolution of the neocortex. This 
subject is further investigated in Chapter 3 of this dissertation. 
The expansion of the superficial layers during cortical evolution has been accompanied by the 
expansion of a new germinal zone, the subventricular zone (SVZ), and by the appearance of intermediate 
progenitors within the SVZ that are fated to produce neurons of the upper layers(Smart and McSherry, 
1982; Martinez-Cerdeno et al., 2006; Molyneaux et al., 2007).  This is in contrast to reptiles and birds, in 
which cortical neurogenesis occurs only in the ventricular zone (VZ)(Cheung et al., 2007). In mammals, it 
is now becoming clear that VZ progenitors give rise to neurons of the deep cortical layers, while SVZ 
progenitors largely generate the upper cortical layers (Tarabykin et al., 2001; Wu et al., 2005).  In 
agreement with existing data, we find that callosal neurons of the deep cortical layers (V and VI) express 
a unique set of genes (e.g. Tcrβ, Dkk3) that are not expressed by callosal neurons of the upper layers, 
likely reflecting the different evolutionary origin of these two populations.  
The data presented here provide the first molecular classification of the callosal projection neuron 
population in the cortex. Distribution analysis of the newly identified CPN genes reveals the presence of 
molecularly distinct subpopulations that were not previously described at the histological, morphological, 
or anatomical levels. This likely reflects the distinct origin of different callosal neuron subpopulations, 
and it might be predictive of their evolutionary diversification in higher mammalian species. It is likely 
that distinct combinations of molecular developmental controls define key aspects of CPN diversity – 
subtype-specific differentiation, axon collateralization, synaptic connectivity, and physiologic function – 
underlying their central roles in interhemispheric association and connectivity.  Together, these data 
provide the foundation for future studies in which molecular and genetic approaches can be combined 
with anatomical and cellular data to dissect the mechanisms of development of the diverse and likely 
functionally critical populations of callosal projection neurons.  
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Chapter 3: 
 
Cited2 functions broadly in early intermediate progenitor cell development and in  
somatosensory callosal projection neuron identity acquisition 
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3.1 Abstract 
 
The development of diverse neuronal populations with precise projections for refined patterns of 
connectivity within the neocortex is essential to its proper function and processing of information. 
Neocortical excitatory neurons are diverse in the location of their cell bodies, input received from other 
neurons, and targets of axonal connectivity.  In addition to these diverse qualities that define a variety of 
neuronal types, functional area differences convey additional sybtype specificity to neocortical neuronal 
populations.  Callosal projection neurons (CPN) reside in neocortical layers II/III, V, and VI; extend 
axons to the contralateral hemisphere across the midline; and connect through all functional areas of the 
neocortex to integrate sensory and motor information.  While molecular controls over neuronal type 
specification and areal patterning have begun to be explored, there has been no identification and 
characterization of gene products that function throughout cortical development to integrate both areal 
and neuron-type information into a definable neuronal subtype.  Here we report that the transcriptional 
co-activator CITED2 (Cbp/p300-interacting transactivator with aspartic acid (E), glutamic acid (D), rich 
carboxy-terminal domain, family member 2) is required early and broadly for correct neocortical 
intermediate progenitor number, and later specifically for acquisition of somatosensory (SS) CPN 
identity. In this later role, CITED2 might act as an integrator of projection neuron subtype identity and 
areal identity in the specific subpopulation of SS CPN.   
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3.2 Introduction 
 Recent investigations into neocortical neuronal diversity have identified many genetic controls both 
over functional areal specification (O'Leary and Nakagawa, 2002; Rash and Grove, 2006; O'Leary et al., 
2007; Joshi et al., 2008), and over neuronal-type specification and developmental fate acquisition(Arlotta 
et al., 2005; Molyneaux et al., 2005; Molyneaux et al., 2007; Alcamo et al., 2008; Britanova et al., 2008; 
Molyneaux et al., 2009); however, very little is known about the intersection of areal and neuronal-type 
identity acquisition and, what, if any, genetic controls function specifically to define areal identity within 
a specific neuronal population.  Callosal projection neurons (CPN) are distributed throughout all 
functional neocortical areas in rodent, and connect homotypic regions of the two hemispheres to enable 
interhemisphereic communication and information integration.  Therefore, dependent on the areal 
location of their cell bodies, CPN send distinct projections transmitting assorted information, making 
them a unique population to address the question of molecular controls over areal subpopulations of 
neuronal types.   
As described in more detail in Chapter 1, specification of neocortical functional areas is a complex, 
progressive process involving early broad gradients of morphogens and gene expression, refined by 
functional input and molecular interactions to fully segregate functional areas throughout the process of 
areal specification.  Simultaneous to this arealization process, neuronal type specification and maturation 
occurs.  Additive overlap of molecular controls over these two processes has been shown to induce areal 
subpopulations of neuronal types. In the case of AP2-γ function, AP2-γ is expressed broadly in cortical 
progenitors, and only by overlapping with an arealizing rostro-caudal gradient, such as the one exhibited 
by Pax6, is it required specifically for caudal visual cortex CPN development(Pinto et al., 2009).  
However, genes that function to integrate this subtype and areal information into a single subpopulation 
identity likely exist, and would be critical to generate the level of neuron type diversity utilized in 
complex neocortical function.  Areal differences are obvious histologically throughout the neocortex, and 
CPN have been specifically shown to exhibit area-specific properties in primates, including differential 
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Figure 3.1: CPN areal diversity  (A) Schematic representation of the rough distribution of primary 
neocortical functional areas at P6 as viewed from above and in a sagittal section.  (B) Schematic 
representation of differences in axonal fiber thickness across the rostro-caudal extent of the human adult 
corpus callosum. P, postnatal day; OB, olfactory bulb; Crb, cerebellum; Roman numerals indicate 
neocortical layer; F, frontal; M, motor; Ss, somatosensory; A, auditory; TP, temporoparietal; V, visual. 
(B) Adapted and expanded from (Aboitiz and Montiel, 2003), with data from(Aboitiz et al., 
2003),(Aboitiz et al., 1992b),(Aboitiz et al., 1992a). 
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axonal thickness and myelination in various areas (Figure 3.1).  This known areal diversity further 
motivates investigation of areal- and subtype-specific controls over CPN identity acquisition. 
As areal and subtype identity acquisition proceeds, timing of action is of particular importance for 
controlling progressive development of neocortical neurons.  Gene expression varies over time to act in 
distinct processes, and single gene products can act at multiple times in different contexts to perform 
many unique, discrete functions.  Examples of differential context-dependent gene function are 
ubiquitous, though one specific example pertinent to CPN development and identity acquisition that acts 
critically in neocortical development is the compound action of transcription factor cut-like homeobox 2 
(Cux2). Cux2 is expressed by a subset of dividing cells in the SVZ during generation of superficial layer 
neurons, and postnatally by some neurons of layers II-IV.  Early in cortical development, Cux2 has been 
found to be critical for proliferation of intermediate progenitors, while, postmitotically, Cux2 regulates 
neuronal maturation, specifically dendritic arborization and synapse formation(Nieto et al., 2004; Zimmer 
et al., 2004; Cubelos et al., 2007; Cubelos et al., 2010). Thus, maintaining parsimony, gene products have 
multiple distinct context-dependent purposes in neocortical neuronal development. 
One gene highly expressed by CPN, Cited2(Cbp/p300-interacting transactivator with aspartic acid 
(E), glutamic acid (D), rich carboxy-terminal domain, family member 2), is poised to act broadly early, 
then specifically as an integrator of subtype and areal identity later in development.  Cited2, like AP2-γ, is 
expressed throughout cortical areas early in development, but, unlike AP2-γ, its expression refines to 
somatosensory cortex postnatally.  Far from being a pan-somatosensory control, Cited2 has previously 
been identified to be significantly more highly expressed by CPN than by other projection neuron 
populations (Chapter 2 and (Molyneaux et al., 2009)).  CITED2 (also known as MRG1 or P35srj) is a 
transcriptional coactivator with no DNA binding domains, but with the ability to recruit histone 
modifying elements, such as the CPB histone acetyltransferase, and link them to one of its many 
identified DNA-binding partners, regulating their activity.  The three other members of the CITED 
family, CITED1, CITED3, and CITED4 have similar functionalities, but with distinct binding partners.  
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They are divergent except for three conserved homology domains, one of which (CR2) is required for 
binding the transcriptional co-activator CBP/p300(Rodriguez et al., 2004).  CITED3 is not part of the 
mammalian genome, however CITED1 and CITED4 have identified functions in mouse.  CITED2 has 
been shown to act in the development of other systems including heart, kidney, neural crest, lens, liver, 
thymus, and sex determination(Bamforth et al., 2001; Qu et al., 2007; Val et al., 2007; Chen et al., 2008; 
Michell et al., 2010), and it exhibits abnormal copy number variation (CNV) in a subset of autism 
spectrum disorder (ASD) patients(Szatmari et al., 2007). In the non-neuronal systems listed above, 
identified roles of CITED2 can be divided into functional pathway categories, including a general 
convergence of CITED2 action in pathways critically involved in cell proliferation, differentiation, 
mobility, and survival (e,g, CITED2 activates TFAP2 (AP2)(Bamforth et al., 2001) and PPARγ(Tien et 
al., 2004; Gonzalez et al., 2008; Li et al., 2012); co activates WT1 pathways(Val et al., 2007; Buaas et al., 
2009); downregulates HIF-1α via binding partner competition(Xu et al., 2007); and is downregulated by 
TGFβ  (including Nodal)(Bamforth et al., 2004; Chou, 2006; Chou and Yang, 2006b; Chou et al., 2012)). 
All of the above listed interactors are expressed in developing neocortex(Visel et al., 2004), but have no 
specifically explored neocortical function.  Both TGFβ and  PPARγ signaling pathways are critical for 
progenitor proliferation, survival/death, mobility, and differentiation in other systems (Bottner et al., 
2000; Roberts-Thomson, 2000; Chou et al., 2012).  TFAP2 has been shown to be involved with eye, face, 
neural crest, neural tube, and limb development(Zhao et al.; Chou and Yang, 2006a), while WT1 
signaling regulates mRNA splicing or metabolism to specifically control cell development and 
survival(Val et al., 2007).   Therefore, we hypothesized that Cited2 likely functions in processes of 
proliferation, survival, and/or differentiation of CPN within the neocortex. 
Several interactors of CITED2 with DNA-binding transcription factor properties have already been 
implicated in neocortical development, and are expressed in neocortex concurrently with CITED2.  Some 
of these include AP2γ {Braganca, 2003 #2631}(Pinto et al., 2009), Lhx2(Porter et al., 1997; Glenn and 
Maurer, 1999), and PAX6(Englund et al., 2005; Chen et al., 2008). AP2γ controls developmental 
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regulation of caudal visual cortex CPN(Braganca et al., 2003; Pinto et al., 2009). Lhx2 regulates early 
cortical hem and neocortical identity(Porter et al., 1997; Glenn and Maurer, 1999).  PAX6 controls early 
neocortical arealization, and radial glia progenitor identity and function(Englund et al., 2005; Chen et al., 
2008).  In addition, CITED2 has been shown to interact genetically with the critical neocortcical control 
gene coactivator LIM-domain only 4 (LMO4)(Huang et al., 2009; Michell et al., 2010; Asprer et al., 
2011).  Thus, CITED2 interacts with a number of critical neocortical developmental controls; this further 
supports its potential to play critical roles in specific neocortical projection neuron development.   
I hypothesize that specific properties of unique CPN subpopulations are controlled progressively, 
including post-mitotically, on top of a more “default” CPN identity.  These progressive steps translate 
areal identity to specific neuronal subtype identity, and are controlled by genes with the ability to 
integrate multiple overlapping signals into one specific neuronal subtype identity. To address this 
hypothesis directly, I investigated function(s) of the transcriptional co-activator CITED2 in broad early 
CPN development, and in developmental acquisition of unique properties of somatosensory (SS) CPN. 
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3.3 Materials and Methods 
3.3 a. Mouse Lines 
C57/Bl6 wildtype mice were obtained from Charles River Laboratories (Wilmington, MA, USA), and 
were used for retrograde label, Western blotting, and determining gene expression. 
Cited2 null mice (C2D) (Bamforth et al., 2001) and Cited2 conditional floxed mice (C2f) (Preis et al., 
2006)were a generous gift from Professor Sally Dunwoodie at the Victor Chang Cardiac Research 
Institute in Darlinghurst, Australia.   
The following PCR primers and genotyping protocols were used: 
C2Δ: 
  WT: F: 5’- GGC CAA ACT GCT TAA TCT TGT- 3’ 
   R: 5’- GAA ATG TTT GCC ACT GAC GA -3’ 
Product size: ~350bp 
 
  Neo:  F: 5’-GAC AAC CCC CCC CAA ATG ACT GAC-3’ 
   R: 5’-GGC GAT GCC TGC TTG CCG AAT ATC-3’ 
  Product size: ~650bp 
 
C2f  (transgenic):  
    F:  5’ - GTC TCA GCG TCT GCT CGT TT - 3’ 
    R: 5’- CTG CTG CTG TTG GTG ATG AT -3’ 
  Product sizes:  WT: ~166bp 
    Floxed allele: ~210bp 
The following cycling parameters were used: initial denaturation at 94°C for 4 min., denaturation at 
94°C for 30 sec., annealing at 58°C for 30 sec., and extension at 72°C for 30 sec. (C2f) or 45 sec. (C2Δ), 
128 
for 35 cycles, followed by extension for 10 min. (C2f) or 2 min. (C2Δ) at 72°C.  The products were 
separated by gel electrophoresis on a 4% (C2f) or 2% (C2Δ) agarose gel. 
Mice with Cre recombinase under the Emx1 promoter element were generated by (Gorski et al., 
2002b) and obtained from The Jackson Laboratory (Bar Harbor, Maine, USA), strain number 005628. 
Cre: 5’- TAG CAC CGC AGG TGT AGA GAA GG -3’ 
5’- CAG ACC AGG CCA GGT ATC TCT GA -3’ 
Product size: ~300 bp 
WT: 5’- GAA GGG TTC CCA CCA TAT CAA CC -3’ 
5’- CAT AGG GAA GGG GGA CAT GAG AG -3’ 
Product size: ~500 bp 
The following cycling parameters were used: initial denaturation at 94°C for 3 min., denaturation at 
94°C for 30 sec., annealing at 65°C for 45 sec., and extension at 72°C for 45 sec. for 33 cycles, followed 
by extension for 3 min. at 72°C.  The products were separated by gel electrophoresis on a 1.5% agarose 
gel. 
	  
3.3 b. Immunocytochemistry 
For embryonic tissue collection, timed pregnant females were anesthetized with a lethal dose of 
Avertin (1.25% 2-2-2 tribromoethanol in 0.63% isoamyl alcohol), death was confirmed by cervical 
dislocation, and embryos were removed from the uterine horns. Embryos were anesthetized by 
hypothermia, and the whole head was fixed in 4% paraformaldehyde (PFA) overnight at 4°C, rinsed 3 
times for 10 min. in 0.1 M phosphate buffered saline (PBS, pH 7.35), and stored in 0.025% sodium azide 
in PBS (PBS-azide). Postnatal pups were anaesthetized by hypothermia (P6 and younger) or with a lethal 
does of Avertin (P7 and older), and mice were perfused transcardially with PBS followed by 4% PFA, 
post-fixed overnight in 4% PFA at 4°C, and stored in PBS-azide until sectioning.  For DAPI and BrdU 
labeling, brains were cryoprotected overnight in 30% sucrose in 0.1M PB [81mM dibasic sodium 
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phosphate, 18.9 mM monobasic sodium phosphate], and then sectioned on a CM3050S cryostat (Leica 
Microsystems, Wetzlar, Germany) to a thickness of 14µm in Tissue Freezing Medium (TBS-Triangle 
Biomedical Sciences).  For all other assays, brains were sectioned at 50 µm coronally or sagittally on a 
VT1000S vibrating microtome (Leica Microsystems). 
Antigen retrieval methods were required to expose antigens for some of the primary antibodies, 
including TUJ1.  Sections were incubated in 0.1M citric acid (pH=6.0) for 10 mi. at 95-98°C, and 
sections were rinsed in PBS prior to blocking.  For thymidine analogues (IdU, CldU, BrdU), HCl antigen 
retrieval was required.  Tissue was rinsed quickly in ddH2O, incubated in 4N HCl for 10 min. at room 
temperature, treated as described above with 0.1M citric acid, and sections were then rinsed in PBS prior 
to blocking.   
Floating sections were incubated for 30 min. at room temperature in blocking solution (0.3% BSA 
[Sigma, St. Louis, MO], 0.3% Triton X-100 [Sigma], and 8% goat or donkey serum in 0.025% PBS-
azide) before incubation in the primary antibody diluted in blocking solution overnight at 4°C. Primary 
antibodies and dilutions were used as follows:  goat anti-β−galactosidase, 1:2000 (Biogenesis 4600-
1409); rabbit anti-Ki67, 1:500 (Abcam ab15580); goat anti-LMO4, 1:200 (Santa Cruz Biotech SC- 
11122), rabbit anti-TBR2 1:500 (Abcam ab23345); mouse anti-TUJ1,1:500 (Covance mms-435P); mouse 
anti-PCNA 1:1000 (Sigma WH0005111M2); rabbit anti-activated caspase 3, 1µg/mL (Becton Dickinson 
557035); rat anti-CTIP2 1:500 (Abcam ab18465); mouse anti-BrdU, 1:750 (Chemicon);  rabbit anti-GFP, 
1:500 (Molecular Probes).  Sections were washed (3 times 10 min. in PBS) prior to incubation for 3 hours 
at room temperature in secondary antibodies. Appropriate secondary antibodies were selected from the 
Molecular Probes Alexa series (Invitrogen, Carlsbad, CA). After incubation, sections were washed again 
(3 times 10 min. in PBS), counterstained for 1 min. in 1:10,000 4',6-diamidino-2-phenylindole (DAPI) 
when needed, rinsed in 0.033M PB [27mM dibasic sodium phosphate, 6.3mM monobasic sodium 
phosphate], and mounted with the aqueous-based Fluoromount-G (Southern Biotech. Inc, Birmingham, 
Alabama) on Superfrost ® glass slides (Fisher Scientific, Pittsburgh, PA). 
130 
 
3.3 c. In situ hybridization  
Nonradioactive colorimetric in situ hybridization was performed using probes labeled with 
digoxigenin (dig)-UTP.  Sense probes were used as negative controls in all experiments.  
For in situ hybridization, fixed (4% PFA) tissue was either sectioned on a CM3050S cryostat (Leica 
Microsystems) to a thickness of 14µm, as detailed above, or vibratome sectioned on a VT1000S vibrating 
microtome (Leica Microsystems) to a thickness of 50 µm, as described above.  Sections were then 
mounted on Superfrost plus slides ® (Fisher Scientific) and were postfixed in 4% PFA in PBS for 10 
min., rinsed in PBS for 3 min., permeabilized in 0.3% Triton X-100 (Sigma) followed by RIPA cell lysis 
buffer [150 mM Sodium chloride, 1% Triton X-100, 1% deoxicholic acid sodium salt, 0.1% sodium 
dodesil sulfate, 50 mM Tris-HCl, pH 7.5, 2mM EDTA], re-fixed in 4% PFA, acetylated for 15 min. in 
0.1M triethanolamine/ 0.4% HCl/0.25% acetic anhydride (Sigma), and then preybridizied in 65°C 
hybridization buffer [50% formamide, 5x SSC, 5x Denhardts [1µg/mL Ficoll 400, 1µg/mL 
Polyvinilpyrrolidone, 1µg/mL BSA] , 500µg/mL sheared salmon sperm DNA, 250µg/mL Yeast RNA].  
Slides were incubated overnight (14-20 hours) at 65°C in 2µg/17mL dig-labeled probe in hybridization 
buffer in a plastic mailer.  Slides were then subjected to stringency washes in 2x SSC/ 50% formamide/ 
0.1% Tween-20 at 65°C for 2 hours. Sections were then rinsed in MABT [0.9M maleic acid (Sigma), 
0.1M NaCl (Sigma), 0.0005% Tween 20 (Sigma), 0.175M NaOH (Sigma)] at RT, blocked in 10% goat 
serum in MABT, and incubated overnight in goat alkaline phosphatase-conjugated anti-dig (1:1000, 
Roche) primary antibody in block.  The following day, the slides were rinsed with MABT, followed by a 
30 min. wash in alkaline phosphatase	  reaction buffer [100mM Tris pH 9.5, 50mM MgCl2, 100mM NaCl, 
0.1% Tween-20].  The alkaline phosphatase reaction was developed with 0.25 mg/mL nitro-blue 
tetrazolium (NBT) / 125µg/mL 5-bromo-4-chloro-3'-indolyphosphate (BCIP) in phosphatase reaction 
buffer, changing to fresh solution every 1-4 hours at RT or every 6-9 hours at 4°C.  When the reaction 
was judged complete (48-100 hours), tissue was rinsed in 0.1% Tween-20 in PBS, postfixed in 4% PFA 
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for 30 min, counterstained for 1 min. in 1:10,000 4',6-diamidino-2-phenylindole (DAPI), and rinsed in 
0.033M PB [27mM dibasic sodium phosphate, 6.3mM monobasic sodium phosphate].  Slides were 
coverslipped with Fluromount ® (Sigma), dried, and edges were protected with clear nailpolish. 
 The probes were synthesized as described in previous publications: Cited2(Molyneaux et al., 
2009), Rorβ, EphrinA5 ((Allen Brain Atlas Resources, http://www.brain-map.org)), Eph A7 (Mori et al., 
1995), Cadherin8(Joshi et al., 2008).   
 
3.3 d. Retrograde labeling of cortical projection neurons 
For retrograde projection neuron labeling, P2-P4 pups were anesthetized by hypothermia.  Axons 
were labeled with Alexa555-conjugated cholera toxin subunit B (CTB-555) (2 mg/ml, Molecular Probes, 
Carlsbad, CA), using a pulled glass micropipette (tip diameter 80-100µm) under ultrasound guided 
microscopy. For CPN, axons were labeled from the corpus callosum on the contralateral hemisphere with 
three injection sites along the rostro-caudal axis of the neocortex, each consisting of 10 injections of 4.6 
nl each, starting in the white matter, then retracting through the grey matter in a step-wise fashion.   For 
retrograde labeling of CSMN, CTB-555 was injected into the corticospinal tract at cervical vertebrae 
segment (C2/C3). Six injections of 32 nl per injection site were performed on each side of the midline. 
Mice were transcardially perfused for analysis at P6, as outlined previously. 
 
3.3 e. Fluorescence activated cell sorting (FACS) 
FACS purification was performed essentially as described in (Arlotta et al., 2005) and(Molyneaux et 
al., 2009), and summarized in Chapter 2.   
 
3.3 f. Western blotting  
Immunoblotting was performed as described previously (Cowan et al., 2001; Macdonald et al., 2010).   
Briefly, neocortical tissue, FACS purified neurons, or HEK cells were isolated.  Protein was extracted 
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using 1% sodium dodecyl sulfate (SDS, Sigma) in PBS. Protein homogenates were separated by 10% 
SDS–polyacrylamide gel electrophoresis, and transferred to nitrocellulose membrane (Bio-Rad Trans-
Blot).  Membranes were blocked for 1 hour at room temperature with 5% nonfat milk in Tris-buffered 
saline (TBS), and incubated for 12–20 hours at 4 °C in the following primary antibody diluted in in 2% 
milk/TBS: sheep anti-CITED2 (R&D Systems, Minneapolis, MN).  Membranes were then washed three 
times for 5 min. each in 0.1% Tween-20 in TBS, and incubated for 1 hour at room temperature in 
peroxidase-coupled goat anti-rabbit IgG (BioRad) diluted in 2% milk/TBS.  Signals were detected with 
chemiluminescence (Pierce, Rockford, IL). 
 
3.3 g. In utero electroporation 
In utero electroporations were performed essentially as described in (Saito and Nakatsuji, 2001) and 
(Molyneaux et al., 2005). For all in utero experiments, the morning of vaginal plug detection was 
designated as E0.5. At age E15.5, C57/Bl6 or Cited2 floxed  pregnant mice were deeply anesthetized with 
Avertin, abdominal hair was removed, and mice were placed on a heating pad for the duration of the 
surgery and recovery period. A small incision was made at the midline through the skin, a vertical midline 
laparotomy was performed along the abdominal wall linea alba, and the skin and abdominal wall were 
gently separated using blunt dissection techniques on intervening fascia. 690 nl of purified DNA (1.5 - 2 
µg/ µl, endotoxin-free) with 0.005% Fast Green FCF (Sigma) for immediate visualization of injected 
DNA, and 0.1% DiI for postnatal detection in vivo of electroporated pups, were injected under guidance 
by ultrasound backscatter microscopy into the lateral ventricle (Vevo 770, VisualSonics). Five pulses of 
30 volts each of 50 ms duration at 1 second intervals were delivered into the ventricular zone progenitors 
at the desired orientation using 5 mm diameter CUY650-P5 platinum electrodes (Protech International, 
San Antonio, Texas) and a Nepa Gene CUY21EDIT square wave electroporater (Nepa Gene, Japan).  
Non-sequential embryos along each horn (excluding the two closest to the birth canal) underwent DNA 
delivery and electroporation.   
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3.3 h. Birthdating 
For BrdU birthdating, equimolar delivery of IdU (57.5 mg per kg) or CldU (42.5 mg per kg) at E15.5 
was performed(Vega and Peterson, 2005), calculating embryonic age with E0.5 as the morning of 
observed vaginal plug. We euthanized and perfused mice at P3, and prepared brains for 
immunocytochemistry.  To assess migration of neocortical cells born at E15.5, the neocortical thickness 
was divided into six equal bins (see Figure 3.15).  Superficial layers were denoted as the 2 most 
superficial bins; validation with CUX2 immunocytochemistry confirmed alignment with layer II/III. 
 
5.3 i. Microscopy and image analysis 
Whole mount images were acquired using an SMZ1500 fluorescence dissecting microscope (Nikon, 
Melville, NY) with a SPOT CCD digital camera (Diagnostic Instruments, Sterling Heights, MI) and 
SPOT acquisition software. 
Tissue sections were imaged on a Nikon E1000 microscope (Nikon Instruments, Melville, NY) 
equipped with an XCite 120 illuminator (EXFO, Mississauga, ON, Canada) and Q-imaging Retixa EX 
cooled CCD camera (Q-imaging Corp., Surrey, BC, Canada), or a Nikon 90i microscope using a 1.5 
megapixel cooled CCD digital camera (Andor Technology, Dublin, Northern Ireland), or a 5 megapixel 
color CCD digital camera (Nikon Instruments, Melville, NY).   Images were collected and analyzed with 
Volocity image analysis software (Version 4.0.1; Improvision Inc., Waltham, MA) or Elements 
acquisition software (Nikon Instruments, Melville, NY).  Laser confocal analysis was performed using a 
BioRad Radiance 2100 confocal microscope with LaserSharp2000 imaging software (BioRad 
Laboratories, Hercules, CA).  
Images were processed using a combination of functions provided by ImageJ (Rasband, W.S., 
ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-
2011.) and Adobe Photoshop/ Illustrator software packages (Adobe, San Jose, CA). 
134 
 
3.3 j. Cortical thickness/length quantification 
All length and thickness measurements were performed with images of matched sagittal 50µm 
sections using ImageJ to trace with the curvature of the neocortical surface being measured.  Length of 
E15.5 CP and VZ, N=5 per genotype, was normalized to average of WT.  P3 whole mount diagonal 
length, N=5 per genotype, was normalized to average of WT. P21 cortical length, N=3 per genotype, was 
normalized to average of WT.  Functional areal lengths at P3, (N=5 per genotype), P0 (N=3 per 
genotype), and P8 (N=5 per genotype), were measured at 4 medio-lateral levels (labeled a, b, c, d; see 
Figure 3.11).  Motor cortex was determined by rostral region expressing high levels of LMO4 in 
superficial layers; somatosensory cortex was determined by region not expressing LMO4 in superficial 
layers; and caudal regions were delineated as caudal region expressing high levels of LMO4 in superficial 
layers.  For analysis of SS cortical length with multiple markers, N=4 per genotype, in situ hybridization 
for Cadh8-negativity, EphA7-negativity, EphrinA5-positivity, and Rorβ-positivity were used to delineate 
SS cortex.   p-values were calculated using the unpaired two-tailed Student’s t-test. 
Neocortical thickness at P3, N=4 per genotype, were measured in matched sagittal 50µm sections.  
Superficial layers were defined as cellular layers superficial to CTIP2 expression (layers II-IV), and deep 
layers were defined as cellular layers including CTIP2 expression and deeper (layers V-VI).  Areas were 
determined as described above using LMO4 immunoreactivity. p-values were calculated using the 
unpaired two-tailed Student’s t-test. 
 
3.3 k. Axonal quantification 
Sections were matched with respect to electroporation location in sensory cortex and matched 50 µm 
sections where the CC, hippocampus, and AC were all visible at P3 or P8 were selected for analysis.  P3 
axonal extension, N=4 Cited2 fl/wt and N=5 Cited2 fl/fl, ratio was calculated normalized to the number of 
electroporated axons entering whitematter tracts and expressed as a ratio in comparing Cited2 fl/fl to 
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Cited2 fl/wt controls. P8 axonal extension, N=5 per genotype, ratio was calculated normalized to the 
number of electroporated axons entering contralateral grey matter after crossing through the CC, and 
expressed as a ratio in comparing Cited2 fl/fl to Cited2 fl/wt controls.  p-values were calculated using the 
unpaired two-tailed Student’s t-test.   
 
3.3 l. Tbr2-positivity, cell proliferation and death, and cellular density quantification 
Cell death was quantified at E15.5, N=6 Cited2cKO and N=11 Cited2wt controls, using 
immunoposititivty for activate cleaved caspase 3.  The mitotic fraction was defined as PCNA+ cells, and 
the postmitotic fraction was defined as PCNA- cells.   
Neocortical cellular density at P3, N=3 per genotype, was measured in matched sagittal 14 µm 
cryosections stained for DAPI to mark nuclei and immunolabeled for LMO4 and CTIP2 to mark areas 
and laminae.  Superficial layers were defined as described above, using CTIP2 immunoreactivity, 
neocortical functional areas were defined as described above using LMO4 immunoreactivity.   Boxes of 
standard width were digitally placed over images and volume was calculated using 14 µm thickness, 
measured laminar thickness for each sample, and 280 µm wide box; and is expressed as cells/100 µm3. p-
values were calculated using the unpaired two-tailed Student’s t-test. 
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3.4 Results 
3.4 a. Cited2 is expressed by a restricted population of CPN and excluded from CSMN 
Cited2 is more highly expressed by CPN relative to CSMN in the developing neocortex, with a peak 
of expression as early as retrograde labeling can be used for the purification process (E18.5) (Molyneaux 
et al., 2009) (Figure 3.2A).  We confirmed and more deeply investigated Cited2 expression by 
developmental Western blotting, revealing even higher CITED2 expression at E15.5 (Figure 3.2 B); and 
with retrograde label confirming that Cited2 is expressed by CPN and excluded from CSMN at P3 
(Figure 3.2 C).  Developmental in situ hybridization reveals that there is no pallial expression of Cited2 at 
E13.5, but CITED2 is highly expressed in developing cortex during early CPN development at E15.5, 
with expression decreasing as differentiation proceeds.  Postnatally, Cited2 expression is maintained in 
neocortical layers II/III, V, and VI (Figure 3.3). Closer evaluation of the peak E15.5 expression both via 
in situ hybridization and using β-galactosidase expression under the control of the Cited2 promoter 
(Cited2-LacZ)(Bamforth et al., 2001) reveals that, at E15.5, Cited2 is most highly expressed in the Tbr2-
expressing subventricular zone (SVZ), and mostly excluded from the Ki-67-expressing proliferating 
ventricular zone (VZ) (Figure 3.4). Embryonically, Cited2 is expressed across the rostro-caudal extent of 
neocortex, largely as immature neurons exit the cell cycle and begin migrating, with cortical expression 
becoming much more restricted to CPN of somatosensory (SS) cortex by P3 (in layers II/III and V) 
(Figure 3.5). This expression pattern suggests that Cited2 might function broadly in early specification 
and development of CPN, and might have an areally-restricted developmental function in postnatal SS 
cortex.  
3.4 b. Cited2 function is not required for early corticogenesis (E10-E15.5)  
We performed experiments to investigate development of CPN in Cited2 null neocortex, both as a 
general population, and specifically within SS cortex, where Cited2 expression becomes progressively 
restricted. To bypass a set of early patterning defects in homozygous Cited2 null mutants(Bamforth et al., 
2001), and to eliminate any role Cited2 might have in the subpallial domain, we generated forebrain-
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specific conditional knockouts using Emx1-promoter driven cre-recombinase (Emx1-Cre)(Guo et al., 
2000; Jin et al., 2000) to recombine a floxed locus surrounding the entirety of the Cited2 translated 
sequence (exon2) (Figure 3.6). Emx1 expression begins in the forebrain at E9.5 medially and 
encompasses the full extent of forebrain by E11 (Yoshida et al., 1997), and therefore bypasses neural tube 
closure defects and defects in other organ systems including heart and kidney(Bamforth et al., 2001), but 
removes Cited2 function before corticogenesis begins.  In all experiments, we compared Cited2 fl/fl; 
Emx1-Cre+ conditional knockout mice (cKO) to littermate controls, both Cited2 fl/fl; Emx1-Cre-, and 
Cited2 fl/wt; Emx1-Cre+. Because no significant differences were observed between the two control 
genotypes, they were combined as Cited2 WT in most analyses.  
Because Cited2 is highly expressed throughout the SVZ at E15.5, the peak of superficial layer CPN 
birth, we first examined the development of the Cited2 cKO neocortex at this age. Careful analysis of 
early neocortical establishment indicates that there is no change in the length or thickness of the cortex, 
length of the proliferative zone, or thickness of postmitotic Tuj1+ immature migrating neurons (p>>0.05) 
(Figure 3.7).   In addition, there is no change in the overall number of proliferating progenitors (Figure 
3.8).  These results support expression data that Cited2 is most highly expressed by neocortical cells at 
E15.5, and confirms specificity of the conditional null scheme with precise excision enabling proper 
neural tube closure and robust formation of early neocortical progenitor domains. 
 
3.4 c. Cited2 function is required for regulation of Tbr2+ intermediate progenitors in E15.5 
neocortex. 
While there is no overt change in cortical size or progenitor or post-mitotic domain length/ thickness 
in the E15.5 Cited2 conditional null neocoertex, we specifically investigated whether the population of 
Tbr2+ intermediate progenitor cells (IPCs), which most highly express Cited2 at E15.5, are altaered in the 
absence of Cited2 function.  Directed analysis of this population reveals that there is a reduction in the 
number of IPCs at all regions sampled across the rostro-caudal axis (24% reduction, p=0.007) (Figure 
3.8). Since a reduced number of Tbr2+ IPCs could be the result of reduced IPC production, IPC death, 
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Figure 3.2: Cited2 is developmentally expressed by CPN and excluded from CSMN  
(A) Comparative microarray analysis at critical times in development (E18.5, migration; P3, process 
extenstion; P6, target finding; and P14, connectivity refinement) detects Cited2 as more highly expressed 
by a retrogradely labeled, FACS purified population of CPN (red line) than by CSMN (blue line).  Error 
bars indicate standard deviation. (B) CITED2 is expressed most highly early in development, as detected 
by CITED2 immunoblotting. (C) Retrograde label combined with in situ hybridization confirms 
comparative microarray data that Cited2 is expressed by CPN, and excluded from CSMN at P3. 
 
CSMN, corticospinal motor neurons; CPN, callosal projection neurons; E, embryonic day; P, postnatal 
day.  Panel (A) taken from Molyneaux, Arlotta, et al.  J. Neurosci.  2005. 
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 Figure 3.3: Cited2 is expressed at early and mid-stage CPN development (A) Cited2 is excluded from 
pallial progenitors at E13.5, but is expressed in subpallial regions. (B, C) At E15.5 and E18.5, Cited2 is 
highly expressed in both pallial and subpallial ventricular/ peri-ventricular domains. (D-F) Postnatally, 
Cited2 is expressed neocortical layers II/III and V, and along the lateral ventricle and in hippocampus. 
 
Scale bars (A, B, C) 500 µm, (D, E, F) 1mm, (D’, D”,E’, E”, F’, F”) 100 µm. E, embryonic day; P, 
postnatal day. 
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Figure 3.4: At E15.5, peak time of neocortical Cited2 expression, Cited2 is most highly expressed in 
immature neurons of the SVZ. (A) in situ hybridization for Cited2 reveals that the highest levels of 
Cited2 expression are just basal to the VZ, likely the SVZ.  (A’) magnification of region in A (B) 
Immunocytochemistry against β-galactosidase (red) under the Cited2 promoter in Cited2 heterozygous 
mice reveals that most CITED2-expressing cells are outside of the Ki67-expressing mitotic zone and 
overlap with the popultion of Tbr2-expressing intermediate progenitors. 
  
Scale bars: (A) 1mm, (A’-B) 200µm SVZ, subventricular zone; VZ, ventricular zone; LV, lateral 
ventricle; E, embryonic day; P, postnatal day 
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Figure 3.5: Cited2 expression becomes progressively restricted to sensory neocortical areas (A-A”) 
Cited2 is expressed evenly across the rostro-caudal axis embryonically (E18.5) (arrowheads), but (B-B”) 
becomes restricted to SS (arrows) and far caudal cortex postnatally (P3). CP = cortical plate, LV = lateral 
ventricle 
 
CP, cortical plate; LV, lateral ventricle; SVZ, subventricular zone; VZ, ventricular zone; Roman 
numberal indicate neocortical layers; E, embryonic day; P, postnatal day.  Scale bars (A, B, A’, B’) 1mm,  
(A”,B”) 100 µm.  
  
145 
 
  
Figure	  3.5	  (Continued)	  
146 
Figure 3.6: Conditional deletion of Cited2 via Emx1 driven cre recombinase expression results in 
specific loss of Cited2 expression in the forebrain (A) Schematic representation of  conditional 
knockout (cKO) approach for Cited2 in the neocortex using floxed Cited2 alleles and the Emx1Cre line. 
(B) This approach yields forebrain specific loss of Cited2 mRNA in noecortex (arrows) and hippocapus, 
but subpallial expression (here in the thalamus), is maintained.  Shown here at P3. (B’) Reported showing 
Emx1 Cre excision pattern. 
WT, wildtype; IRES, internal ribosomal entry site; CreRecom, Cre Recombinase; UTR, untranslated 
region; cKO, conditional null. (B’) Taken from (Gorski et al., 2002a) 
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Figure 3.7: Specific reduction in IPCs in E15.5 Cited2 cKO (A) At E15.5, Cited2 cKO cortex (light 
grey) has no change in cortical or progenitor domain length or thickness compared to WT cortex (dark 
grey) (N=5). (B) At E15.5, Cited2 cKO cortex (light grey) has no change in thickness of Tuj1-positive 
region of immature post-mitotic migrating neurons. 
White bars in (A) indicate motor, SS, and caudal region analyzed in (B).  
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Figure 3.8: Loss of Cited2 function results in a loss of Tbr2+ intermediate progenitors at E15.5 
Cited2 cKO is not changed in number of PCNA+ proliferative progenitors, but there is a reduction of 
Tbr2+IPCs (24% reduction, N=6 cKO and 11 WT, p=0.007). 
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loss of IPC maintenance, or a combination of two or three of these processes; we investigated whether 
any of these processes are affected by loss of Cited2 function.  We began by asking if there is increased 
cell death in E15.5 developing Cited2 cKO cortex.  Indeed, we found that there is almost double the cell 
death in E15.5 Cited2 cKO cortex than WT (p= 0.0006), evenly distributed between mitotic progenitors 
and post-mitotic neurons (Figure 3.9).   However, this increase in death does not likely account for all of 
the loss of Tbr+ IPCs, and birthdating analyses are currently underway (see Discussion). 
 
3.4 d. Reduced superficial layer thickness in somatosensory and occipital Cited2 cKO neocortex. 
Superficial layer CPN arise predominantly from IPCs; therefore, we investigated whether there is a 
postnatal reduction in superficial layer CPN, resulting either radially in a change in the thickness of the 
superficial layers, and/or tangentially in the cortical length.  Additionally, because the majority of mouse 
CPN (~80%) reside in layers II/III, and they are the predominant projection neuron subtype in this layer, 
measurement of thickness of the superficial layers provides a relative approximation of CPN number. 
Analysis of neocortical layer thickness at P3 reveals a significant reduction in superficial layer thickness 
(including layers II/III and IV) in the LMO4-negative SS area (17% reduction, p=0.02), and caudal 
occipital cortex (caudal: 10% reduction, p=0.01; far caudal: 25% reduction, p=0.007), with no apparent 
change in motor cortex (p=0.11), or within deep layers (where CPN account for only a minority of 
projection neurons) (Figure 3.10). These data suggest that the reduction in Tbr2+ IPCs observed early in 
the development of Cited2 null neocortex is not recovered, and is translated to reduction in superficial 
layer neurons.  Additionally, these results indicate that CPN in different cortical areas are differentially 
affected by loss of CITED2 function, suggesting that CITED2 might interact with area-specific 
transcriptional co-activators and/or target genes.   
 
3.4 e. Reduced neocortical length specifically in somatosensory areas of Cited2 cKO neocortex. 
In addition to radial reduction in cKO neocortex, early loss of Tbr2+ progenitors could also result in 
neocortical length decrease on the tangential axis.  Measurements of cortical surface length at P3 reveal a 
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5% smaller cKO diagonal cortical length than WT (p=0.02) (Figure 3.11A).  This translates to a 10% 
reduction in rostro-caudal length in P3 Cited2 cKO neocortex (p=0.0006) (Figure 3.11B).  These data 
indicate that, not only is there a significant loss in cortical thickness as a result of Cited2 loss of function, 
likely through the early reduction of Tbr2+ progenitors along with additional Cited2 function throughout 
corticogenesis, it also results in significant reduction in neocortical tangential length.  This ~10% loss of 
cortical length is not recovered, and the Cited2 cKO neocortex is still significantly shorter at P21 than that 
of WT littermates (10% reduction, p=0.005) (Figure 3.11C), indicating that the reduction is not a delay in 
maturation, but a persistent loss of ~10% of the neocortical rostro-caudal length. 
Due to restricted Cited2 expression to SS cortex, and functional areal differences observed upon 
analysis of Cited2 cKO neocortical thickness, we also investigated whether there is areal specificity in 
Cited2 cKO cortical length reduction.   Analysis based on three broad cortical areas divided by LMO4 
expression at P3(Joshi et al., 2008) indicates that there is a highly specific and substantial reduction (28% 
reduction, p=0.003 SS; versus p=0.3 motor and p=0.9 for caudal) in the rostro-caudal length of only SS 
Cited2 cKO cortex, resulting in an overall reduction in cortical length (Figure 3.12). At P0, before motor 
and sensory cortical areas are refined, Cited2 cKO neocortical length is already reduced in mixed sensory-
motor areas. (12% reduction motor, p=0.08; 17% reduction SS, p=0.002). At P8, the specific reduction in 
somatosensory cortical length is maintained in Cited2 cKO compared to WT (28% reduction, p=0.0005).  
To avoid relying on expression of a single gene as full indication of a neocortical area, we confirmed 
the SS-specific reduction of cortical length in P3 Cited2 cKO mice using independent molecular markers 
of cortical areas. Strikingly, superficial layer measurements of SS cortex length (Cadh8 (19% reduction, 
p=0.01), EphrinA5 (17% reduction, p=0.0009), EphA7 (13% reduction, p=0.01)) confirmed the reduced 
length observed with LMO4 measurements, while measurements of acallosal layer IV SS cortex 
(EphrinA5, p=0.25; and Rorβ, p=0.6) did not detect a significant difference in SS cortex in the Cited2 
cKO (Figure 3.13). These results indicate a highly specific and significant disruption of superficial layer 
SS cortex in the absence of Cited2 function, likely SS CPN development.  
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Figure 3.9: Loss of Cited2 function results in increased cell death at E15.5 (A) Image of ac-3 
immunocytochemistry at E15.5 in WT and (B) Cited2 cKO littermates.  (C) At E15.5, Cited2 cKO cortex 
(light grey) has an increased number of cells undergoing apoptosis compared to WT cortex (dark grey) 
(~50% reduction, N=6 cKO and 11 WT, p=0.0006).  Error bars indicate standard error of the mean. 
 
Scale bar: 100 µm. WT, wildtype; cKO, conditional null; E, embryonic day; ac3, activated (cleaved) 
caspase-3 
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Figure 3.10: Loss of Cited2 function results reduced superficial layer thickness at P3  
 
(A) Sagittal section of P3 neocortex, showing four rostro-caudal regions where thickness measurements 
were made (a-d), and immunocytochemistry for CTIP2 (green) and LMO4 (red). (B) Superficial layers 
(II-IV) in Cited2 cKO (light grey bars) have reduced thickness in sensory areas (b-d) as compared to WT 
(dark grey bars) (SS area: 17% reduction, p=0.02; caudal: 10% reduction, p=0.01; far caudal: 25% 
reduction, p=0.007), but not motor areas (a) (p=0.11). (C) There is no change in deep layer thickness in 
any region in Cited2 cKO as compared to WT. (N=4 per genotype) 
 
Scale bar: 1mm. WT, wildtype; cKO, conditional null; P, postnatal day  
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Figure 3.11: Loss of Cited2 function results in reduced cortical length at P3 that is maintained at 
least until P21. (A) Measurements of cortical surface length at P3 reveal an ~5% smaller cKO diagonal 
cortical length than WT (N=5 per genotype, p=0.02) (B) This translates to an ~10% reduction in rostro-
caudal length in P3 Cited2 cKO neocortex (N=5 per genotyps, p=0.0006) at all but the most lateral of four 
medio-lateral levels (A-D). (C) This ~10% loss of cortical length is not recovered, and the Cited2 cKO 
neocortex is still significantly shorter at P21 (~10% reduction, N=3, p=0.005). 
 
Scale Bar: 1mm.  WT, wildtype; cKO, conditional null; P, postnatal day   
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Figure 3.12: Loss of Cited2 function results in reduced cortical length in somatosensory neocortex at 
P3 that is restricted to the unrefined sensorimotor cortex at P0, and maintained until at least P8.  
(A) Analysis based on three broad cortical areas divided by LMO4 expression at P3 indicates that there is 
a highly specific and substantial reduction (28% reduction, N=5 per genotype, p=0.003 SS; versus p=0.3 
motor and p=0.9 for caudal) in the rostro-caudal length of the somatosensory area in the Cited2 cKO 
cortex (light grey bars) comparted to WT controls (darker grey bars). (B) The reduction in somatosensory 
cortex length (red) accounts for nearly all of the total reduction in cortical length with no change in caudal 
(green) or motor (blue). (C) At P0, before motor and sensory cortical areas are refined, Cited2 cKO (light 
grey bars) has length reduction in mixed sensory-motor areas. (N=3 per genotype, 12% reduction motor, 
p=0.08; 17% reduction SS, p=0.002)   (D) At P8, the specific reduction in somatosensory cortical length 
is maintained in Cited2 cKO (light grey bars) compared to WT (dark grey bars) (28% reduction, N=5 per 
genotype, p=0.0005).  Error bars indicate standard error of the mean. 
 
WT, wildtype; cKO, conditional null; P, postnatal day   
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Figure 3.13: Loss of Cited2 function results in reduced cortical length in somatosensory neocortex 
only in superficial layer neurons, and not in acallosal layer IV. 
 
Superficial layer measurements of SS cortex length (Cadh8 (19% reduction, p=0.01), EphrinA5 (17% 
reduction, p=0.0009), EphA7 (13% reduction, p=0.01)) confirmed the reduced length in the Cited2 cKO 
compared to WT observed with LMO4 measurements (black arrowheads), while measurements of 
acallosal layer IV SS cortex (EphrinA5, p=0.25; and Rorβ, p=0.6) did not detect a significant difference in 
SS cortex in the Cited2 cKO compared to WT (black arrows). (N=4 per genotype). 
 
WT, wildtype; P, postnatal day. 
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To investigate potential causes of this reduction in area size, we explored whether any of the size  
reduction was be due to increased cellular density, rather than all being accounted for by early IPC 
reduction.  There is an increase in cellular density in superficial neocortical layers of Cited2 cKO 
neocortex, but only in SS areas (23% increase in superficial layer cell density, p=0.01) (Figure 3.14).  
Increased cell density suggests either smaller soma size, reduced neuropil in existing SS superficial layer 
neurons, or both. Volumetric calculations suggest that a greater than 70% increase in density would be 
necessary to account entirely for the observed ~28% reduction in SS length (Section 3.4 e.) and ~17% 
reduction in superficial layer thickness (Section 3.4 d.).  Therefore, this observed 23% increase in 
superficial layer SS cortex density likely accounts for some, but not all of the loss on SS neocortical size.  
Taken together, these data support the interpretation that the observed reduction in SS cortex size is likely 
a combination of a reduction in early cell number compounded by reduction in either neuropil size and/or 
cell soma size.   
 
3.4 f. Cited2 functions cell autonomously in superficial layer CPN migration and axonal extension. 
To investigate potential cell autonomous function(s) of CITED2 in development of CPN, we 
disrupted expression of Cited2 in a directly targeted subpopulation of superficial layer CPN in SS cortex. 
We electroporated an expression construct containing Cre recombinase-IRES-farnesylated-GFP into 
dorsal progenitors at E15.5, the peak of superficial layer formation  (Figure 3.15A), in Cited2 fl/wt 
control brains and fl/fl littermates. At P0, the vast majority of WT GFP-positive cells within the control 
neocortex are located in layers II/III, with a few cells with immature, migrating neuronal morphologies 
observed throughout the layers of the neocortex. In striking contrast, in Cited2 fl/fl brains, there are many 
GFP-positive cells throughout deeper layers of the SS cortex (Figure 3.15B). However, by P3 and P8, the 
majority of GFP-positive neurons are found in the superficial layers in both fl/wt and fl/fl brains (Figure 
3.15C). This observed migrational delay was also observed in the cKO cortex, as assessed via BrdU 
birthdating at E15.5, and assessment at P3 across all functional areas.  These results reveal an ~15% 
reduction (p ≤	 0.001) in the proportion of neurons born at E15.5 that reach superficial layers (Figure 
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3.15D). These results suggest cell autonomous roles for Cited2 in CPN development, including migration 
and/or survival of developing CPN.   
Because even a migrational delay can lead to death or extensive dendritic and axonal extension 
disruption of superficial layer CPN(Alfano et al.), we further investigated the connectivity of Cited2 null 
CPN, employing both Cited2 cKO mice and approaches to more deeply investigate cell autonomous loss 
of Cited2.  To observe SS CPN axon extension before the CPN axons reach final targets, we quantified 
distance extended by axons of individual SS superficial layer neurons of either Cited2 fl/fl or fl/wt 
littermate controls with E15.5 cre electroporation.  At P3, there is a significant delay in axonal extension, 
first to the ipsilateral CC white matter flexure, and then to the midline itself.  Normalized to the total 
number of electroporated axons entering the white matter, in comparison to fl/wt controls, Cited2 fl/fl 
neuron axons were only half as likely to reach the first landmark, and only one quarter as likely to reach 
the midline (p=0.004 and p=0.003) (Figure 3.16A).    By P8, there was no difference between Cited2 null 
and WT neurons’ ability to extend axons into contralateral cortex parenchyma, normalized to the number 
entering contralateral grey matter (p=0.5 layer IV, p=0.9 at layer II/III) (Figure 3.16B).  However this 
metric does not assess the proportion of axons able to cross the midline.  A sparser electroporation 
scheme will be needed to allow total initial axon counts in the densely packed CC at this age.  At P6, 
when retrograde label from contralateral grey matter superficial layer targets is possible, SS CPN extend 
across the midline equally, but Cited2 cKO CPN axons consistently show evidence of imprecise targeting 
(Figure 3.16C).   
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Figure 3.14: Loss of Cited2 function results in increased somatosensory superficial layer cellular 
density at P3  
At P3, superficial layers (II-IV) of somatosensory Cited2 cKO noecortex (light grey bars) have increased 
cellular density in comparison to WT neocortex (dark grey bars) (23% increase in superficial layer cell 
density N=3 per genotype, p=0.01). There is no change in density in deep layers (V-VI). Error bars 
indicate standard error of the mean. 
 
 
Scale bar: 50µm. WT, wildtype; cKO, conditional null; P, postnatal day   
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Figure 3.15: Loss of Cited2 function results in cell-autonomous migration delay. 
(A) Schematic of approach to dirupt expression of Cited2 in a directly targeted subpopulation of 
superficial layer CPN in SS cortex by electroporating an expression construct containing Cre recombinase 
with GFP into dorsal progenitors at E15.5, the peak of superficial layer formation in Cited2 fl/wt control 
brains and fl/fl littermates. (B) At P0, the vast majority of WT GFP-positive cells within the control 
neocortex are located in layers II/III, with a few cells with immature, migrating neuronal morphologies 
observed throughout the layers of the neocortex. In striking contrast, in fl/fl brains, there are many GFP-
positive cells throughout the layers of the SS cortex. (C) At P3 and P8, the majority of GFP-positive 
neurons are found in the superficial layers in both fl/wt and fl/fl brains.  (D) This cell autonomously 
observed migrational delay was also observed across all functional areas in the P3 cKO cortex (light grey) 
compared to WT cortex (dark grey), as assessed via both BrdU birthdating at E15.5 and determining what 
percentage of birthdated cells were in superficial layers by P3 (N=3 per genotype, motor:17% reduction, 
p=0.001; somatosensory: 15% reduction, p=0.007; caudal: 15% reduction, p=0.003).  
 
 
WT, wildtype; cKO, conditional null; LV, lateral ventricle; E, embryonic day; P, postnatal day. 
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Figure 3.16: Loss of Cited2 function results in cell-autonomous axon extension delay. (A) At P3, 
there is a significant delay in axonal extenstion to first the ipsilateral CC whitematter flexure and to the 
midline itself.  Normalized to the total number of elecroporated axons entering the white matter, in 
comparison to fl/wt controls (dark grey bars), Cited2 fl/fl neuron axons (light grey bars) were half as likely 
to reach the first landmark and only a quarter as likely to reach the midline (N=4 fl/wt and N=5 fl/fl, 
p=0.004 at ipsilateral flexure and p=0.003 at midline) (B) By P8, there is no difference between Cited2 
null and WT neurons’ ability to extend axons into contralateral cortex normalized to the number entering 
contralateral grey matter (N= 5 per genotype, p=0.5 layer IV, p=0.9 at layer II/III).  (C) At P8, when 
retrograde label from contralateral targets is possible, CPN extend across the midline equally, but 
consistently show evidence of imprecise targeting.  Error bars indicate standard error of the mean. 
 
Scale bar: (C) 1mm.WT, wildtype; cKO, conditional null; CPN, callosal projection neurons; P, postnatal 
day; Ipsiflex, ipsilateral flexure of the corpus callosum. 
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3.5 Discussion	    
Subpopulations of callosal projection neurons (CPN) of the cerebral cortex display heterogeneity with 
respect to laminar location, connectivity, and gene expression.  In addition, CPN reside in, and 
homotypically connect, distinct functional areas within the cerebral cortex to convey different modalities 
of information, even though all CPN extend axons to homotopic mirror image targets on the contralateral 
hemisphere to enable bilateral information integration.  Here, I present CITED2 as a broad early control 
over Tbr2+ intermediate progenitor cells (IPCs), and as a specific, later-acting control over identity 
acquisition of the specific subpopulation of somatosensory (SS) CPN.   
I began investigation of Cited2 function by confirming and expanding projection neuron-type-specific 
comparative microarray expression analysis(Molyneaux et al., 2009).   I verified that, among projection 
neuron subtypes, Cited2 is expressed by CPN, and excluded from CSMN. However, postnatally, Cited2 is 
expressed by a restricted population of CPN in cortical layers II/III, V, and VI of SS cortex.  Interestingly, 
early, before CPN axons have extended, Cited2 is expressed broadly across all areas by immature Tbr2+ 
IPCs, and by cortical plate neurons.  This first broad, then restricted, expression pattern lead me to 
investigate whether Cited2 functions broadly, in a restricted fashion, or both, in a context-dependent 
manner. 
We employed Cited2 conditional null mice with a floxed Cited2 gene excised with forebrain specific 
Emx1-driven cre recombinase to investigate Cited2 function in neocortical projection neuron 
development.  After validating the specificity of the system, and confirming that Cited2 function is not 
required for early corticogenesis (E10-E15.5) before its peak expression, we directly investigated the 
Tbr2+ IPCs that express Cited2.  We find that Cited2 function is required for regulation of Tbr2+ IPCs in 
E15.5 cKO mouse brains.  The number of Tbr2+ cells in Cited2 null neocortex is reduced by about 20% 
in comparison to WT control brains.  Such a reduction could theoretically be due to decreased generation, 
increased death, or both.  We find that the 20% reduction in Tbr2+ cells is accompanied by a 50% 
increase in cell death at E15.5; however, the amount of increased cell death does not fully account for the 
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absolute numbers of decreased Tbr2+ cells.  Therefore, while there is excess cell death in Cited2 cKO 
cortex, there is likely also reduction in generation of Tbr2+ cells to explain the reduction in Tbr2 
positivity.  We are currently examining the neurogenic quotient at E14.5 and E15.5 using short pulses of 
BrdU birthdating, to determine if loss of Cited2 affects the number of dividing cells at each age giving 
rise to Tbr2+ IPCs, and how many produce neurons.  This will enable direct analysis of the question of 
how the reduction in generation of Tbr2+ IPCs arises in the absence of Cited2 function.  If fewer IPCs are 
generated at E15.5, it would suggest either decreased symmetric proliferation of IPCs, or decreased 
generation of IPCs from radial glia ventricular progenitors, which could be distinguished via shorter time 
course birthdating analyses or live imaging of living cortical slices expressing a Pax6-driven fluorescent 
reporter (Schedl et al., 1996; Ashery-Padan et al., 2000).  
A function for Cited2 at the transition generating IPCs is compelling, particularly because of its 
known interaction with Pax6(Englund et al., 2005; Chen et al., 2008).  Loss of Pax6 function in Pax6sey/sey 
mutants has been shown to overproduce Tbr2+ progenitors at E12.5, but drastically increase cell cycle 
length at E15.5 (Estivill-Torrus et al., 2002), leading to premature neuronal differentiation and reduced 
later generation of Tbr2+ progenitors.  These results are similar to what we observe after loss of Cited2 
function.  Cited2 is, therefore, poised to act by interacting with Pax6 around E15.5 to convey its time 
dependent change in function.  We are currently performing directed immunoprecipitation studies to 
determine whether Pax6 and CITED2 directly interact in developing neocortex.  If there is no detected 
interaction, these experiments will allow us to rule out direct interaction, but not indirect interaction or 
function through a co-partner.  However, if there is a direct interaction, these results will inform directed 
experiments to determine how closely the Cited2 null phenotype resembles the later function of Pax6, and 
focus on whether there is a specific decrease in Pax6+ cells producing IPCs. 
Reduction in progenitors early would likely translate into fewer cortical neurons postnatally.  Indeed, 
superficial layer thickness is reduced in somatosensory and occipital Cited2 cKO neocortex, but, 
interestingly, there is no significant change in superficial layer thickness in motor cortex, nor any change 
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in deep layer thickness in any area.  The unchanged thickness in deep layers likely reflects the fact that 
Cited2 expression is highest during the second half of corticogenesis, when superficial layers are 
generated, or because CPN make up a minority of deep layer projection neurons.   Unchanged thickness 
in motor cortex superficial layers could be a reflection of the fact that superficial layers in motor cortex 
are thinner naturally and, therefore, a gross change is harder to detect.  However, since far occipital 
superficial layers are normally even thinner than those in motor cortex, this lack of change in motor 
cortex is likely representative of an areal specific function of Cited2.  Strikingly, the thinning of Cited2 
cKO occipital cortex (25% reduction) very closely resembles the reduction in visual cortex in AP2-γ loss-
of-function neocortex(Pinto et al., 2009), suggesting that this occipital cortex effect could be altogether 
separate from the SS cortex effect, and might be modulated by the known CITED2 interaction with  
AP2-γ (Braganca et al., 2003). 
While thickness results indicate a radial reduction in neocortical projection neurons, we also 
examined potential tangential effects of reduced Tbr2+ IPC numbers.  We find reduced neocortical length 
by ~10% in Cited2 cKO cortex.  However, because we observed areal differences in neocortical 
thickness, and because Cited2 expression refines to SS postnatally, we asked if this reduction is specific 
to a particular functional area.  Using LMO4 as a marker of motor and caudal areas that is excluded in 
superficial layers of SS cortex, we find that the ~10% reduction in cortical length is specifically lost from 
somatosensory areas of Cited2 cKO neocortex.  Length measurements of motor and caudal cortical areas 
show no difference between WT and Cited2 null brains.  However, ~30% of SS cortex length is lost in P3 
Cited2 cKO cortex.  This area specific loss is maintained at P8, and neocortical length is still reduced at 
P21, suggesting that there is no later compensation for the loss in SS cortex length.   We employed a 
variety of functional genetic controls over SS cortex identity, either expressed in or excluded from SS 
cortex, to confirm and expand these results.  We find similar reductions in SS cortex as measured by 
genes expressed in superficial layers.   However, there is no change in layer IV SS cortex, suggesting that 
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this reduction is neither a pan-SS nor a pan-superficial layer effect, but rather this reduction is seemingly 
specific to CPN, none of which reside in layer IV.    
Such areal and neuron type-specificity in function, particularly in sensory processing regions of the 
neocortex, is relevant to diseases of complex sensory information integration as is observed in ASD, in 
which reduced corpus callosum volume has already been implicated (Egaas et al., 1995; Frazier and 
Hardan, 2009; Hardan et al., 2009; He et al., 2010).  Notably, Cited2 genetic abnormalities have been 
identified in ASD patients(Szatmari et al., 2007). Magnetic resonance diffusion tensor imaging (DTI) 
analysis of Cited2 null brains is currently underway to assess corpus callosum size, extent, and fiber tract 
organization in a way that can be compared to human disease morphometry data. Such a global analysis 
of the fiber tract pattern might also reveal targeting imprecisions that have been difficult to identify using 
target-based labeling approaches. 
 The areal specificity for somatosensory cortex reduction in length, with a broad early reduction in 
Tbr2-expressing progenitors, and broad increase in cellular death in Cited2 null cortex, suggests two 
distinct functions for Cited2 in neocortical development.  Cited2 might have an early, broad function at 
the time of generation of Tbr2+ IPCs, and a later, more specific function in maintaining the 
somatosensory neocortical domain of CPN, and their specific subtype identity acquisition.  A later 
function is likely driven by a different set of interactors for CITED2 than its early function(s).   
One particularly compelling candidate interactor for late CITED2 function is LMO4.  Results 
presented above indicate that, despite a global reduction in Tbr2+ IPCs, there is highly specific and 
significant reduction in the length of superficial layers in LMO4-negative SS cortex, in addition to 
reduced superficial layer thickness in this area. In contrast, motor cortex, where LMO4 is highly 
expressed, does not appear to be affected. In thymus development, the transcriptional co-regulator Lmo4 
can partially functionally compensate for Cited2(Michell et al., 2010), leading us to hypothesize that 
Lmo4 might functionally compensate for loss of Cited2 in some aspects of CPN development in motor 
cortex.  
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To test this hypothesis regarding potential LMO4 interaction and compensation, we are currently 
performing immunoprecipitation experiments to determine if LMO4 and CITED2 interact in neocortex, 
and we plan to employ two cell autonomous approaches via in utero electroporation: 1) disrupt Lmo4 
expression via knock-down in motor cortex of Cited2 cKO mice; and 2) ectopically express Lmo4 in 
superficial layer CPN of SS cortex. These experiments would allow us to ask if Lmo4 can compensate for 
Cited2 loss when ectopically expressed in SS cortex, or if it is compensating for Cited2 loss in motor 
cortex. Additionally, at a more global level, we are currently breeding double conditional null mice for 
Lmo4 and Cited2 to investigate whether losing Lmo4 function as well as Cited2 function rescues the areal 
specific size decrease, resulting in all areas being equally reduced in size.  Future experiments to 
distinguish early and late function(s) of Cited2 include using an inducible cre recombinase mouse line 
(such as the tamoxifen-inducible Cux2-cre line) to disrupt Cited2 function after E15.5, and to isolate 
potential late arealization roles of Cited2. 
Since most of the analyses of Cited2 function presented here are based in a forebrain null for Cited2 
analyzed on a population level, we investigated Cited2 loss of function in a chimeric system in which we 
electroporated a small number of neocortical progenitors at E15.5 with an expression plasmid of cre 
recombinase to determine which, if any, functions of Cited2 are cell-autonomous.  We observed an early 
migrational delay, both in cell autonomous studies and in Cited2 cKO cortex.  This is similar to previous 
studies linking Cited2 to TGFβ and PPARα signaling pathways that regulate cellular mobility (Bottner et 
al., 2000; Lai et al., 2008; Molyneauz et al. 2005). We also observed cell-autonomous axonal extension 
delays, and possible imprecise SS CPN axonal targeting.  However, currently ongoing anterograde 
labeling experiments will better allow for direct investigation of axonal targeting than allowed by the 
retrograde data presented here.  Migration and axonal extension delays could be a result of CITED2 
interaction with specific migration pathways including TGFβ and PPARα.  However, they could also be a 
reflection of one of the many other cellular differentiation pathways in which Cited2 has been shown to 
function, because disrupted differentiation can also cause arrested migration(Harrison-Uy and Pleasure, 
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2012). Additional biochemical analyses of what CITED2 binds in developing neocortex will enable more 
directed pathway analyses. 
Since we have shown that Cited functions cell autonomously in neocortical development, we are 
currently investigating what processes Cited2 is sufficient to affect by overexpressing Cited2 at E13.5 in 
progenitors that do not normally express it.  Exogenous expression of Cited2 might induce opposite 
functions as does loss of Cited2 or, perhaps, even opposite functions as have been shown for loss of 
function of candidate Cited2 interactors for neocortical Cited2 function.  
Because of the nature of CITED2 as a transcriptional co-activator, knowing what transcription 
factors and transcriptional modulators it interacts with in developing neocortex is important to dissecting 
Cited2 function.  We have recently optimized a protocol for performing complete quantitative 
immunoprecitiation of CITED2 from developmental cortical tissue samples.  With this ability, it is now 
conceivably possible to perform proteomics analysis of CITED2’s interactors, first early at E15.5 in the 
developing cortex, and, separately, later around P0 when areal refinement is underway.  We are currently 
collecting samples to perform non-biased assessment of some context-dependent CITED2 interactors 
across different developmental times.  Results from these experiments will give important mechanistic 
insight into how CITED2 functions during neocortical development. 
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Chapter 4: 
 
Caveolin1 identifies a specific subpopulation of CPN including dual projecting CPN/FPN 
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4.1 Abstract 
Molecular controls over broad callosal projection neuron (CPN) development have begun to be 
identified.  However, CPN are a broad set of distinct subpopulations each with unique function based on 
area, laminar, or connectivity properties.  The postmitotic development of specific subpopulations of CPN 
gives rise to their unique connectivity and activity, and, therefore, function in the neocortex.  Here, we 
show that Caveolin1 (Cav1) is a molecular control that is poised to execute one or a few of these 
postmitotic events in a specific subpopulation of CPN, including CPN with ipsilateral frontal projections 
to premotor cortex (CPN/FPN).  Cav1 is a lipid-bound scaffolding domain protein expressed by over 80% 
of CPN/FPN, localized to cell bodies and dendritic spines, excluded from the nucleus, with peak 
expression postmitotically as axon and dendrite targets are being reached and refined.  Cav1 function is 
not required by CPN/FPN for their early specification or for reaching their axonal targets, and, even 
though Cav1 interacts with neurotransmitter receptors, its expression is not dependent on connectivity.  
Both of these lines of evidence support a role for Cav1 in maturation.  The ability of Cav1 misexpression 
to induce aberrant migration delay, its roles as a scaffolding protein for neurotransmitter receptors, and its 
known interaction with the local adhesion molecule Rac1 all provide insight into potential roles in 
adhesion and activity-based post-mitotic maturation of CPN subpopulations.  The defining properties of 
this CPN/FPN subpopulation are still being identified and characterized, but this analysis of Cav1 
expression and function identifies and characterizes a first molecular control over this functionally unique 
projection neuron population.  
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4.2 Introduction 
Callosal projection neurons (CPN) include a diverse set of subpopulations, as described in Chapters 
1-3.   Multiple properties can describe and identify some of these subpopulations, including cell body 
location, birthdate, electrophysiological and neurochemical properties, dendritic tree distribution, axonal 
target(s), and molecular expression.  While these properties are convenient for categorization, all of them 
are also critically interrelated to determine the final function(s) of a neuron.   For example, populations of 
projection neurons with multiple axonal targets send information to diverse brain regions at once and, 
therefore, likely have critical functions in information integration.  One population of dual projecting 
CPN extend homotopic axonal connections to mirror image locations in the contralateral hemisphere, as 
well as rostrally to ipsilateral frontal areas, sending information from sensory or motor modalities to 
higher hierarchical cortical areas (here, referred to as CPN/FPN)(Mitchell and Macklis, 2005).   CPN/ 
FPN were identified anatomically in mouse by members of the Macklis lab in 2005 (Mitchell and 
Macklis, 2005), and they showed that the majority of these CPN/FPN are located in neocortical layer Va 
primary sensory areas (S1), with a large expansion in caudo-lateral neocortex (S2) (see Figure 4.7A).  
While this population has been identified anatomically, no molecular controls over this population’s 
unique connectivity or function have been described.   
Caveolin 1 (Cav1) encodes for a membrane-bound scaffolding protein known to play a role in 
neurotrophin response, and that has the ability to interact with synaptosome complexes (Bilderback et al., 
1997; Bilderback et al., 1999; Head and Insel, 2007).  Here, I identify Cav1 to be highly expressed during 
axonal and dendritic development at P3 in this laminarly and regionally-restricted subset of CPN that 
enable long distance, complex information integration by maintaining dual projections 
interhemispherically and to frontal cortex (CPN/FPN).  Cav1 function has been shown to be necessary for 
a wide range of cellular processes in other systems, including functions related to the unique lipid raft 
structures that it forms, caveolae.   Cav1 is highly expressed in developing blood vessels and endothelial 
cells, broadly, and is required for their proper proliferation (Razani et al., 2001) and adhesion to give 
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correct microvascular permeability(Schubert et al., 2002).  In addition, Cav1 is necessary for proper lipid 
metabolism in mice(Razani et al., 2002), and for smooth muscle calcium influx(Sathish et al., 2012).  No 
caveolae lipid raft structures are present in mice that lack Cav1 expression. 
Members of the Caveolin family, of which Cav1 is the most abundant, have a distinct structure for 
transmembrane proteins(Williams and Lisanti, 2004).  While the 33 amino acid long transmembrane 
domain is longer than needed to pass the membrane once, it is not long enough for a double pass, and, 
therefore, results in both the N and C termini localized cytoplasmically(Dupree et al., 1993; Monier et al., 
1995).  This results in a horseshoe shaped helix-break-helix intramembrane domain, and a palmitoylated 
residue before membrane exit on the C terminal intracellular region, which establishes membrane 
curvature and allows for Cav1 to participate in forming its namesake membrane invaginations, 
caveolae(Lee and Glover, 2012), as well as to have a prominent cytoplasmic scaffolding region.   
While the caveolae structure does not exist in neurons(Head and Insel, 2007), Cav1 knockout mice 
exhibit neurological abnormalities including limb clasping, abnormal spinning, muscle weakness, reduced 
activity, and gait abnormalities (Trushina et al., 2006).  Interestingly, human Cav1 is located at the locus 
7q31.1, part of autism-linked locus 9 (Auts9), immediately upstream of MET, which shows direct pre-
transcription start-site mutations associated with ASD (Campbell et al., 2006). This suggests that Cav1 
might also be directly relevant in ASD and potentially contribute to some of the Auts9 linkage to the 
disorders, perhaps via CPN.  Cav1 is also close genomically to Foxp2 in Auts9, which had been suspected 
to underlie ASD language defects, but later shown to not be causal of the Auts9 ASD linkage (Newbury 
et al., 2002).   Other potential gene linkages in this locus (NRCAM and ST7) are relatively weak, 
indicating that the linkage must be accounted for, at least in part, by other Auts9 genes, potentially by 
Cav1. 
As a lipid raft scaffolding molecule, Cav1 has been shown to interact with multiple binding partners, 
some of which are particularly compelling for neuronal function.  Interestingly, Cav1 binds directly to the 
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calmodulin-dependent scaffolding protein striatin(Gaillard et al., 2001a), which acts as a signaling 
platform in dendritic spine signal transduction (Benoist et al., 2006), and SNAP25, which complexes to 
Cav1 presynaptically upon synaptic potentiation (Braun and Madison, 2000).  Cav1 known functions that 
are directly linked to neuronal function also include a requirement for Cav1 for estrogen receptor α (ERα) 
activation of a specific metabotrophic glutamate receptor, mGluR1α, in hippocampal neurons, potentially 
playing a role in long-term depression through this pathway(Takayasu et al., 2010).  Specificity for 
particular caveolin activity is reflected by caveolin functional diversity in estradiol signaling through 
mGluRs, since Cav3 is necessary for mGluR2/3 signaling, but not for mGluR1 signaling (Boulware et al., 
2007).  It was later identified that Cav1 provides a support function for an interaction that regulates 
transcriptional activity by providing a scaffold for both the ERα  voltage-dependent anion receptor and 
one of its interactors, the IGF-1 receptor(Maggi et al., 2002; Marin et al., 2009), a known positive 
regulatory factor for corticospinal projection neuron axonal outgrowth (Ozdinler and Macklis, 2006). 
Cav1 has also been implicated in neuronal differentiation from progenitors (Li et al., 2011), synaptic 
ribbons in photoreceptors (Kachi et al., 2001), and other neurotransmitter receptor functions including 
muscarinic cholinergic receptors (Lai et al., 2004).  These neuro-specific processes might account for 
some of the neurological deficits found with Cav1 loss-of-function described above, and motivates this 
study of Cav1 in CPN/FPN. 
Additionally, a more general role of Cav1, its interaction with Rho-family GTPase RAC1, might 
underlie a neuronal function for Cav1.  In non-neuronal systems, Cav1 and Rac1 have been shown to 
directly interact (Zuluaga et al., 2007), and Cav1 controls Rac1 protein levels through ubiquitylation and 
degradation(Nethe et al., 2010). The Cav1/ Rac1 interaction has been directly implicated in neurite 
outgrowth in induced neuroblastoma cell lines (Kang et al., 2006).   In other systems, the Cav1/Rac1 
interaction has been shown to play important roles in critical functions relating to cytoskeletal dynamics, 
focal adhesion, and migration (Beardsley et al., 2005; Joshi et al., 2008a). Further, Rac1 is required for 
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midline crossing of CPN(Chen et al., 2007; Kassai et al., 2008), and Rac1, when recruited by CDKL5, 
can regulate neuronal migration and dendritic arborization of superficial layer CPN(Chen et al., 2010).   
Expression of Cav1 in a specific population of CPN including CPN/FPN during early stages of 
neuronal maturation, and the known interaction between Cav1 and Rac1 in other systems, suggests a 
potential function for Cav1 in the specific subpopulation of CPN by which it is expressed, during such 
processes as early migration, neurite outgrowth, and branching.  The identified scaffolding roles of Cav1 
at synapses, and its interactions with neurotransmitter receptors, suggest that Cav1 might influence 
neuronal activity and/or axonal/ dentrite connectivity, and/or function.  This study defines neocortical 
Cav1 expression, and investigates a potential requirement for Cav1 in migration, axonal extension, and 
branching. 
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4.3 Materials and Methods 
4.3 a. Mouse Lines 
Caveolin1 null mice on a congenic C57/ Bl6 background (B6.Cg-Cav1tm1Mls/J ) were obtained from 
The Jackson Laboratory (Bar Harbor, Maine, USA), strain number 007083.  The original targeted null 
mutation was generated by Michael Lisanti at The Albert Einstein College of Medicine. A 2.2 kb region 
of the gene including exons 1 and 2 and a portion of the promoter region was replaced with a neomycin 
resistance cassette via homologous recombination(Razani et al., 2001).  
The following PCR primers and genotyping protocols were used: 
Cav1tm1Mls/J : 
Wild-type:    F: 5’- GTG TAT GAC GCG CAC ACC AAG - 3’ 
    R: 5’- CTT GAG TTC TCT TCA CCA G -3’ 
  Product size: ~690 bp 
 
Cav1  (transgenic):  
    F:  5’ – CTA GTG AGA CGT GCT ACT TCC - 3’ 
    R: 5’- CTT GAG TTC TCT TCA CCA G -3’ 
  Product size: ~410 bp 
 
  
The following cycling parameters were used: denaturation at 94°C for 30 sec, annealing 
at 65°C for 60 sec, and extension at 72°C for 60 sec. for 35 cycles, followed by extension for 2 min. at 
72°C.  The products were separated by gel electrophoresis on a 1.5% agarose gel. 
BTBR acallosal mice on a congenic background (BTBR T+ tf/J) were obtained from The Jackson 
Laboratory (Bar Harbor, Maine, USA), strain number 002282 (Wahlsten et al., 2003).  LP/J mice have 
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been shown to be an appropriate callosal control population for BTBR mice.  LP/J mice (LP/J) were 
obtained from the Jackson Laboratory (Bar Harbor Maine, USA), strain number 000676. 
C57/Bl6 wildtype mice were obtained from The Jackson Laboratory (Bar Harbor, Maine, USA), and 
were used to breed with Cav1 null mice, and for birthdating and electroporation experiments. 
4.3 b. Immunocytochemistry 
 Immunocytochemistry was performed as described in Chapter 3.  
 Antigen retrieval methods were required to expose antigens for some of the primary antibodies, 
including Cav1.  Sections were incubated in 0.1M citric acid (pH=6.0) for 10 min. at 95-98°C and 
sections were rinsed in PBS prior to blocking.  For thymidine analogues (IdU, CldU, BrdU), HCl antigen 
retrieval was required.  Tissue was rinsed quickly in ddH2O and incubated in 2N HCl for 2 hours at room 
temperature and sections were rinsed in PBS prior to blocking.   
Primary antibodies and dilutions were used as follows:  rabbit anti-Caveolin-1, 1:500 (Cell 
Signaling #3238); mouse anti-Caveolin-2, 1:500 (BD Biosciences); rat anti-Caveolin-3, 1:500 (BD 
Biosciences); goat anti-LMO4, 1:200 (Santa Cruz Biotech SC- 11122); rat anti-CTIP2 1:500 (Abcam 
ab18465), mouse-anti-Map2, 1:500 (Sigma M1406); mouse anti-BrdU, 1:500 (Becton Dickinson) (detects 
IdU); rat anti-BrdU, 1:500 (Accurate) (detects CldU); mouse anti-BrdU, 1:750 (Chemicon); rabbit anti-
GFP, 1:500 (Molecular Probes).   
 
4.3 c. In situ hybridization  
Nonradioactive colorimetric in situ hybridization was performed using probes labeled with dig-UTP 
as described in Chapter 3.  Sense probes were used as negative controls in all experiments.  
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4.3 d. Retrograde labeling of cortical projection neurons 
 
Perinatal retrograde labeling of CPN and CSMN 
Perinatal retrograde labeling of CPN and CSMN was performed as described in Chapter 3. 
 
Post-natal dual CPN/ FPN retrograde labeling 
P6 pups were anesthetized with hypothermia. P21 mice were deeply anesthetized with Avertin 
(0.02mL/g body weight, injected I.P.).  Tracers were injected transcranially with sharp pulled glass 
micropipettes (tip diameter 80-100µm in presumptive premotor and sensory-motor areas, as described 
below.  Double fluorescent tracer injections were performed to label simultaneously:1) CPN in sensory-
motor cortex, and 2) frontal projection neurons with long-distance ipsilateral projections to the premotor 
cortex.  CPN with projections to the contralateral neocortex were labeled with Alexa 647 conjugated 
cholera toxin subunit B (2 mg/ml, Molecular Probes) with 25 injection sites, 46nL (10 injections of 
4.6nL) each site at a depth of 250 µm at P6 and 450µm at P21.  Ipsilateral corticocortial projections to the 
premotor cortex were simultaneously retrogradely labeled with injections of Alexa 555 conjugated 
cholera toxin subunit B (2 mg/ml, Molecular Probes) with 5 injection sites, 46nL each site and a depth of 
250 µm at P6 and 450µm at P21 (see Figure 4.7). 
Full craniotomies were not performed, rather, small punctures were made in the skull at the location 
of each injection point with either a pulled glass pipette (P6) or a fine suture needle (P21) prior to 
lowering the injection needle to the proper depth.  This minimized insult and improved recovery while 
allowing for exact depth measurements to be accurately made.  
4.3 e. Birthdating 
For IdU and CldU birthdating, equimolar delivery of IdU (57.5 mg per kg) or CldU (42.5 mg per kg) 
at 12 hour intervals from E11 to E15.5 was performed(Vega and Peterson, 2005), calculating embryonic 
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age with E0.5 as the day of observed vaginal plug. We sacrificed and perfused mice at P6, and prepared 
brains for immunocytochemistry. 
 
4.3 f. Gain-of-function constructs 
For control gain-of-function experiments, a vector containing a constitutively active CMV enhancer / 
β actin promoter driving GFP after an internal ribosomal entry site (IRES) was used (GFPcontrol , generous 
gift of C. Lois, MIT; (Molyneaux et al., 2005)). For the Cav1 overexpression construct, called Cav1GFP, 
full length Cav1 cDNA was cloned into the same vector backbone using a Sal1 /Not1 digest  (New 
England Biolabs, Ipswich, MA) of the Cav1 cDNA from a pSport1 vector purchased from Open 
Biosystems (Lafayette, CO; clone ID 30062454 ).  A sequenced clone with perfect alignment to the NCBI 
reference sequence NM_007616 in both the sense and antisense orientations was selected for 
experiments. 
For 2A tagged constructs (used in Figure 4.11), the following primers were used to amplify the Cav1 
cDNA coding sequence only from the Cav1GFP construct, above, and clone it into an AAV plasmid 
backbone with the 2A sequence from the picornavirus virus to create a bicistronic vector(de Felipe et al., 
1999) with a following GFP using an SpeI/NotI digest.  This construct is called Cav12AG. The control 
vector, called GFP2ASTOP, the GFP was followed by the 2A sequence and a stop codon. 
F: 5’- gcACTAGTatgtctgggggcaaatacgt-3’ (with 5’ SpeI site (capital letters) added on) 
R: 5’ - ggGCGGCCGCtcatatctctttctgcgtgc -3’ (with 3’ NotI, (capital letters) and STOP (underlined) 
added on). 
 
4.3 g. In utero electroporation 
In utero electroporations were performed essentially as described in (Saito and Nakatsuji, 2001; Saito, 
2006), and (Molyneaux et al., 2005); and summarized in Chapter 3. 
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4.3 h. Quantification of FPN/CPN 
For P8 quantification of Cav1-expressing CPN/FPN, anatomically matched sections were selected 
(N= 4 WT) Cav1 immunocytochemistry was performed.  Digital boxes of fixed width indicated the S2 
cortical region and the number of CPN/FPN, and Cav1+ CPN/FPN were counted.  Percentages of 
FPN/CPN that express Cav1 in each region were calculated from total numbers.  Error bars or “±” 
indicate the standard error of the mean.  It was not possible to count all of the CPN or all of the Cav1-
expressing neurons due to high neuronal density. 
For P8 quantification of CPN/FPN in the Cav1-null, anatomically matched sections were selected  
(N = 5 WT, N= 5 Cav1–/–). Digital boxes of fixed width indicated the S2 cortical region and the number of 
CPN/FPN, and FPN were counted in S1 and S2.  The percent of FPN with concurrent callosal projections 
was also calculated.  No significant differences were detected between WT and Cav1–/–. Error bars or 
“±” indicate the standard error of the mean.   
 
4.3 i. Microscopy and image analysis 
Whole mount images were acquired using a SMZ1000 fluorescence dissecting microscope (Nikon, 
Melville, NY) with a SPOT CCD microscope digital camera (Diagnostic Instruments, Sterling Heights, 
MI) and SPOT acquisition software. 
Tissue sections were imaged on a Nikon E1000 microscope (Nikon Instruments, Melville, NY) 
equipped with an XCite 120 illuminator (EXFO, Mississauga, ON, Canada) and Q-imaging Retixa EX 
cooled CCD camera (Q-imaging Corp., Surrey, BC, Canada), or a Nikon 90i microscope using a 1.5 
megapixel cooled CCD digital camera (Andor Technology, Dublin, Northern Ireland), a 5 megapixel 
color CCD digital camera (Nikon Instruments, Melville, NY).   Images were collected and analyzed with 
Volocity image analysis software (Version 4.0.1; Improvision Inc., Waltham, MA) or Elements 
acquisition software (Nikon Instruments, Melville, NY).   
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Laser confocal analysis was performed using a BioRad Radiance 2100 confocal microscope with 
LaserSharp2000 imaging software (BioRad Laboratories, Hurcules, CA).  Images were processed using a 
combination of functions provided by ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes of 
Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2011.) and Adobe Photoshop/ 
Illustrator software packages (Adobe, San Jose, CA). 
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4.4 Results 
4.4 a. Cav1 is expressed by a restricted population of CPN, and is excluded from CSMN 
Cav1 is highly expressed by CPN relative to CSMN in the developing neocortex, with a peak of 
expression between P3 and P6 (Molyneaux et al., 2009) (Figure 4.1A), when CPN are making axonal and 
dendritic connections. Cav1 is not detected in CPN by P14. I more thoroughly investigated Cav1 
expression by immunocytochemistry, and similarly detected that Cav1 is indeed expressed by CPN, and 
is excluded from subcerebral projection neurons (SCPN, of which CSMN are a subpopulation) by 
combining Cav1 immunocytochemistry and dual retrograde labeling of CPN (from the contralateral 
cortex) and SCPN (from the pons). The Cav1-expressing population of CPN is clearly superficial to the 
SCPN. This highly restricted expression pattern suggests that Cav1 functions in a very specific 
subpopulation of CPN, rather than playing a broad role in CPN development (Figure 4.1B).   
Additionally, Cav1 mRNA and Cav1 protein is beginning to be expressed by cortical neurons at 
E18.5 (in addition to developing blood vessels), is highly expressed at P3 and P6, and is no longer 
detectable by P14.   Cav1-expressing cells are distributed uniquely in cortical layer V, and in caudo-
lateral areas.  This pattern is not a developmental gradient, and is maintained specifically at all 
developmental agest at which Cav1 is expressed (Figure 4.1C, D).   
Interestingly, at P8, Cav1 is restricted to a subpopulation of CPN extending in layer V throughout 
somatosensory (SS) cortex, and expanding in the caudo-lateral cortex, but is excluded from motor cortex.  
This exclusion is shown by comparison between LMO4, which has high motor cortex expression, and 
Cav1 immunocytochemistry (Figure 4.2A).  This area-specific expression further supports a 
subpopulation-specific function of CAV1 in CPN.  Because of the strong expression of Cav1 at all 
developmental ages in layer V, particularly in caudo-lateral areas close to archicortex, where canonical 
cortical neuron subpopulations breakdown, I investigated whether Cav1-expressing neurons exclude 
CTIP2, the canonical SCPN control gene expressed highly in specific SCPN layer V populations. 
Unexpectedly, a subset of Cav1-expressing neurons in far caudo-lateral S2 do express CTIP2  
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Figure 4.1: Caveolin1 is expressed by a restricted population of caudo-lateral CPN  
(A) Caveolin1 is more highly expressed by purified CPN than by purified CSMN 
Comparative microarray analysis at critical times in development (E18.5, migration; P3, process 
extenstion; P6, target finding; and P14, connectivity refinement), detects Caveolin1 (Cav1) as more 
highly expressed by a retrogradely labeled, FACS purified population of CPN (red line) than by CSMN 
(blue line).  Error bars indicate standard deviation. 
(B)  CAV1 is expressed by CPN and excluded from SCPN at P3 
Retrograde label at P1 with CAV1 immunocytochemistry at P3 confirms that CAV1 is expressed by CPN 
and excluded from SCPN at P3. B’ inset from B.  B’’ confocal Z-stack of region in B.  Open arrows 
indicate labeled CPN, closed arrows indicate labeled SCPN. 
(C) Caveolin1 is expressed in caudo-lateral cortex during midstage cortical development 
Cav1 mRNA is expressed by a restricted population of caudo-lateral, layer Va cells as shown by in situ 
hybridization over time (E18.5, P3, P7, and P14). 
 (D) CAV1 is expressed in caudo-lateral cortex during midstage cortical development 
CAV1 protein is expressed by a restricted population of caudo-lateral, layer Va cells as shown by 
immunocytochemistry over time (E18.5, P3, P6, and P14).  Scale bars: (B) 30µm, (D) 100 µm.  SCPN, 
subcerebral projection neurons; CPN, callosal projection neurons; E embryonic day; P, postnatal day; Va, 
superficial portion of neocortical layer V.  Panel A taken from Molyneaux, Arlotta, et al.  J. Neurosci.  
2005. 
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Figure 4.2 CAV1 is expressed in an areally restricted fashion at P8, and is excluded from motor 
cortex 
 
(A) Expression of CAV1 is areally restricted; co-immunocytochemistry against LMO4 and CAV1 at P8 
reveals that CAV1 is not expressed in motor cortex CPN. A’, inset from A.   
Scale bar: (A’) 500 µm. SCPN, subcerebral projection neurons; CPN, callosal projection neurons; P, 
postnatal day. 
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(Figure 4.3A), but are not subcerebrally projecting neurons (Figure 4.3 B, C).  This quite unique 
population of non-SCPN, CTIP2+ neurons has not been extensively defined, but they might likely be a 
subpopulation of neurons with a transient developmental spinal projection that is later lost (Polleux et al., 
2001; Arlotta et al., 2005), and which fail to prune these spinal projections in Ctip2-/- mice. 
 In order to investigate more closely what subpopulation(s) of CPN expresses Cav1, both to better 
define the population(s) and enable correct targeting of the population via in utero electroporation in 
future experiments, I performed birthdating analysis every 12 hours throughout corticogenesis with 
thymidine analogs.  These experiments reveal that Cav1 expressing neurons are born between E12.5 and 
E13, consistent with the dominant birthdate ranges for neocortical neurons residing in layer V (Figure 
4.4).   Cav1-expressing neurons in caudo-lateral S2 cortex are born earlier (peak at E12.5) than those of 
S1 layer V (peak at E13). 
 
4.4 b. Cav1 is expressed by CPN cell bodies and dendrites endogenously, and when overexpressed. 
 Cav1 is a membrane-bound scaffolding protein, and, thus, its subcellular distribution can provide 
insight into its function in a given cell type. I examined the expression of Cav1 in P3 CPN, and found it to 
be highly expressed around the soma, with expression extending throughout the apical dendrite and 
dendritic tuft (Figure 4.5A).  This suggests potential roles for Cav1 in migration and dendrite function.   
Cav1 is not highly detected in axons. Further, I generated a Cav1-2A-GFP over-expression construct to 
test Cav1 function in later analyses.  Over-expressed CAV1 via in utero electroporation at E15.5 in 
superficial layer CPN of the SS cortex, which do not normally express Cav1, has a similar cellular 
distribution as endogenous, and is highly detected in superficial layer CPN cell bodies and dendrites at P6 
(Figure 4.5B).  
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4.4 c. Cav1 is expressed by over 80% of dual-projecting FPN/CPN 
Development of CPN does not end when early progenitors are specified, but includes acquisition of 
specific CPN subpopulation identities. Cav1 is much more highly expressed in CPN versus CSMN, but is 
expressed in a very restricted pattern in neocortex.  Because many uniquely projecting subpopulations of 
CPN reside in restricted cortical areas, I examined localization of forward projecting neurons from 
somatosensory cortex to frontal areas (FPN), backward projecting neurons (BPN), CPN with striatal 
projections (CStrPNi), and anterior commissure projection neurons (ACN). The pattern of Cav1 
expression closely resembles the restricted location of dual projecting frontal/callosal projection neurons 
(FPN/CPN) (Mitchell and Macklis, 2005) and partially overlaps with CStrPNi and ACN.  Expression is 
highest at the time of axon and dendrite elongation, and stabilization of neuronal connections (P3) (Figure 
4.6; Figure 4.7 A, B, C, D).  Cav1 is not expressed in all dual projecting CPN populations, because the 
range of BPN does not overlap with the Cav1 expression domain, suggesting that is specifically important 
for CPN/FPN and not all dual CPN populations.   
To test the specific hypothesis that Cav1 might be acting in the dual projecting FPN/CPN sub-
population, I retrogradely co-labeled callosal- and frontal-projecting neurons by stereotaxic injection of 
the beta subunit of cholera toxin conjugated to two different Alexa fluorophores into the contralateral 
somatosensory cortex and the ipsilateral premotor cortex (Figure 4.7E). In support of this hypothesis, I 
found that over 80% of dual projecting CPN/FPN are Cav1+, and only a small population of non-dual 
projecting cortical neurons expresses Cav1; therefore, the highly restricted expression of Cav1 almost 
precisely labels this dual projecting population (Figure 4.7F).  Due to the membranous location of Cav1 
protein, and the incomplete label achieved by the CTB injections, I have not been able to reciprocally 
quantify the percentage of Cav1+ cortical neurons that are dual-projecting.  Performing such counting 
with DAPI counterstain and a more diffusible dye (such as FluoroGold and DiI), might overcome these 
problems. 
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Figure 4.3: A subset of CAV1-expressing neurons co-express CTIP2, but CAV1 is not expressed by 
SCPN.  
(A) CAV1 and CTIP2 are co-expressed by a subpopulation of caudo-lateral neurons. 
CAV1 is largely excluded from the CTIP2 expression domain, though a subpopulation of CAV1 
expressing neurons also expresses the canonical SCPN control gene, CTIP2. 
(B) CTIP2 is expressed by SCPN and is excluded from CPN.  As has been described in detail 
elsewhere, CTIP2 is expressed by SCPN and excluded from CPN.  This holds true in the far caudo-lateral 
S2 region as well. Not all CTIP2-expressing neurons are SCPN.   
(C) CAV1 and CTIP2 are co-expressed, but Caveolin1 is not expressed by SCPN. 
Caudo-lateral (S2) CAV1-expressing neurons are not SCPN, as determined by retrograde label analysis, 
and are therefore likely to be some of the non-SCPN CTIP2-expressing neurons. A’, inset from A.   
Scale bars: (A) 500 µm (A’) 100 µm (B,C) 60µm,.  SCPN, subcerebral projection neurons; CPN, callosal 
projection neurons; P, postnatal day. 
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Figure 4.4: Caveolin1-expressing neurons are born between days E12.5 and E13 
 
(A) deoxyUridine analog (CldU or IdU) injections at 24-hour intervals throughout corticogenesis reveal 
that CAV1-expressing neocortical neurons, both in S1(somatosensory layer V) and S2 (caudolateral 
expansion) are born close to E12.5.  (B) Focused analysis with deoxyUridine analog injections at 24-hour 
intervals at peak birth times identified above reveals that the majority of this population is born between 
E12.5 and E13, with S2 peak CAV1-neurogenesis at E12.5 and S1 peak CAV1- neurogenesis at E13.  
Scale bars: 100µm. E embryonic day; P, postnatal day; V, neocortical layer V. 
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Figure 4.5: Caveolin1 is expressed in neuronal cell-bodies and dendrites at postnatal ages 
 
(A) Caveolin1 is expressed in neuronal cell bodies and dendrites at P3 
MAP2 immunocytochemistry reveals that CAV1 expression overlaps with the dendritic and cell body 
compartments of neuronal plasma membrane. 
(B) Exogenously expressed CAV1 correctly traffics to localize in the dendritic and cell body 
compartments of superficial layer neurons at P6. 
Exogenously expressing Cav1 in superficial layer neurons by in utero electroporation at E15.5 results in 
CAV1 protein trafficking that is similar to that of the endogenous protein (A), and localized to the cell 
body and dendritic compartments of the neuronal plasma membrane. SCPN, subcerebral projection 
neurons; CPN, callosal projection neurons; E embryonic day; P, postnatal day. 
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4.4 d. Cav1 function is not necessary for dual-projecting FPN/CPN to reach their axonal targets 
Because the membrane-bound scaffolding protein Cav1 is expressed by the overwhelming majority of 
dual-projecting FPN/CPN at P8, and most highly at P3, I hypothesized that Cav1 might be necessary for 
the correct maturation (pruning, extension, or guidance of neuronal processes) and/or maintenance of this 
specific population of CPN.  I first tested whether axons  of FPN/CPN without Cav1 initially reach their 
targets correctly, which would suggest that Cav1 is not necessary for axonal extension or pathfinding, or 
establishment of CPN identity.  I retrogradely labeled FPN/CPN in both Cav1 null mice and their WT 
littermate controls at P6, and examined them at P8.  At this early time (P8), when CPN exuberance is 
most pronounced, there is no change in the overall number of FPN/CPN in nulls, nor in the specific bin 
corresponding to the secondary somatosensory cortical area (S2), where both Cav1 expression and the 
abundance of FPN/CPN change dramatically (Figure 4.8). Thus, Cav1 function is not required for 
CPN/FPN to extend dual-projecting axons to specific targets.  Due to the fact that Cav1 is expressed 
around the neuronal cell body as well as the dendritic tree, but not broadly in the axon or growth cone, it 
is not surprising that FPN/CPN reach their targets at P8.  I am currently testing the hypothesis that Cav1 
is required for the maintenance/strengthening of FPN/CPN synapses, by examining the final connectivity 
pattern in mature (P21) Cav1 null cortex,  by performing dual retrograde labeling at P21.  I am also 
examining dendritic morphology via electroporation of farnisylated GFP at the time of Cav1+ CPN birth, 
over expressing Cav1 tagged with the same membrane-targeted GFP, and examining synapses via 
synapse-specific antigens on FPN/CPN in Cav1 null mice. 
4.4 e. Cav1 is not expressed by brain cell populations expressing Cav2 or Cav3, and Caveolin family 
members do not compensate for Cav1 in its absence. 
Because there are three members of the Caveolin family in the mouse genome, and because these 
members interact with each other in other systems(Hnasko and Lisanti, 2003), I investigated whether 
Cav2 or Cav3 are expressed by the same population(s) of neurons expressing Cav1.  Both Cav2 and Cav3 
are expressed in mouse brain, but are excluded from the Cav1-expressing population(s) at P3.  Cav2 is 
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expressed along the surface of the lateral ventricles.  Cav3 is expressed by mitral cells, projection neurons 
in the olfactory bulb (Figure 4.9A, B). This fact is particularly interesting in light of evidence that, in 
other systems, Cav2 protein localization and, therefore, stability, is dependent on Cav1 expression(Mora 
et al., 1999).  In Cav1 loss of function mutants, neither family member extends its expression domain into 
neocortex projection neurons (Figure 4.9C, D), indicating that no Caveolin family member is 
compensating for Cav1 function in the mutant neocortex.  Therefore, findings in the Cav1 null cortex are 
not likely explained by a compensation event. 
4.4 f. Cav1 expression is not dependent on correct callosal connectivity 
Since Cav1 is known to interact with striatins for correct signal transduction at synapses (Gaillard et 
al., 2001a) and multiple neurotransmitter receptors (Boulware et al., 2007; Takayasu et al., 2010), I 
hypothesized that Cav1 expression might be regulated by neuronal activity.   Since I have shown that 
Cav1 is expressed by CPN, I asked whether Cav1 expression is altered in the acallosal BTBR mouse 
strain (Wahlsten et al., 2003).   These mice exhibit largely normal cortical development, but no axons 
extend across the CC; even though they perform quite well on physical coordination tasks, they display 
behavioral abnormalities.  Additionally, these mice exhibit a reduced hippocampal commissure, 
accompanied by improper wiring reflected by tangles of axons known as probst bundles.  I find that Cav1 
expression is independent of correct callosal connectivity, and Cav1 is expressed normally in P4 BTBR 
neocortex (Figure 4.10).   Based on the early neonatal expression of Cav1, it might be hypothesized that 
final connectivity is not needed for Cav1 expression.  These results indicate that, although Cav1 had been 
previously shown to act at synapses(Gaillard et al., 2001a), its expression in CPN is, indeed, not 
dependent on correct connectivity. 
 
4.4 g. Exogenous Cav1 function is sufficient to cause migrational defects 
 As discussed in section 4.4 b., Cav1 is subcellularly highly concentrated in cell bodies and dendritic 
arbors within cerebral cortex, and exogenously expressed Cav1 is correctly trafficked.  Cav1 is known to  
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Figure 4.6: CAV1 developmental expression includes overlap with dual projecting CPN/FPN. (A). 
Schematic representation of CPN (blue), FPN (red), and CPN/FPN (purple overlap) distribution over 
neocortical development. (B) Schematic representation of CAV1 expression (green) over the same 
developmental times denoting the similar distribution of CAV1 expressing neurons and CPN/FPN, as 
quantified in Figure 4.6. 
CPN, callosal projection neurons; FPN, ipsilateral frontal projection neurons; P, postnatal day.  
 
A is adapted and expanded from Mitchell and Macklis, J. Comp. Neurol., 2005.
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Figure 4.7: CAV1 is expressed by restricted subpopulations of neocortical neurons including dual 
projecting CPN/FPN at P8. 
 
(A, B, C, D) Diverse populations of neocortical projection neurons with CPN projecting subsets 
including CPN, FPN, BPN, and CStrPNi/ ACN.  Schematic representations of diverse cortico-cortical 
projection neurons labeled (CPN, red; CPN/FPN, blue; CPN/BPN, purple; CStrPNi, green; ACN, 
yellow).  Retrograde labels of CPN (green) (A), FPN (B), BPN (C), and CStrPNi/ ACN (D) (all red).  
Other than CPN, the only pure population of cortico-cortical projection neurons in the CAV1 expression 
domain are FPN.  However, the mixed population of CStrPNi/ ACN also overlaps with the CAV1 
expression domain laterally. 
(E) Schematic representation of the dual CPN/FPN retrograde labeling scheme. FPN are isolated to 
layers V, and VIb (subplate) in largely lateral cortical locations, with caudo-lateral S2 expansion. CPN are 
located in layers II/III, V, and VI.  The populations overlap in the subpopulation of dual projecting 
CPN/FPN.  These projections were assessed following CTB injection into ipsilateral premotor cortex, and 
simultaneously into contralateral somatosensory cortex. 
(F) CAV1 is expressed by over 80% of dual projecting CPN/FPN. Dual projecting CPN/FPN were 
labeled as shown in (E), and the percentage of dual projecting CPN/FPN that also express CAV1 was 
calculated for four medio-lateral regions with standard error. 
CPN, callosal projection neurons; FPN, ipsilateral frontal projection neurons; BPN, ipsilateral backward 
projecting neurons; CStrPNi, intratelencephalic corticostriatal projection neurons; ACN, anterior 
commissure projection neurons; E, embryonic day; P, postnatal day. BPN retrograde label by G. 
Cederquist. 
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Figure 4.8: Loss of Cav1 function does not disrupt formation of dual projecting CPN/FPN axonal 
projections at P8. 
 
(A, D) CPN form in the absence of Cav1 function.  CPN were retrogradely labeled from contralateral 
cortex in Cav1 null animals and WT controls. There is no significant difference between the two 
genotypes. N=5 WT and 5 Cav1 null. 
 
(B, E, H) FPN form in the absence of Cav1 function. FPN were labeled as described above, and the 
number of labeled FPN was calculated for 2 medio-lateral regions (S1 and S2) with standard error.  There 
is no significant difference between the two genotypes. N=5 WT and 5 Cav1 null. 
 
(C, F, G, I) Dual projecting CPN/FPN form in the absence of Cav1 function. Dual projecting 
CPN/FPN were labeled as described above, and the percentage of dual projecting CPN/FPN was 
calculated for 2 medio-lateral regions (S1 and S2) with standard error. The percentage of labeled FPN 
with a callosal projection was also calculated for 2 medio-lateral regions (S1 and S2) with standard error. 
There is no significant difference between the two genotypes. N=5 WT and 5 Cav1 null. 
 
Error bars: standard error of the mean.  CPN, callosal projection neurons; FPN, ipsilateral frontal 
projection neurons; WT, wildtype; P, postnatal day. 
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Figure 4.9: Caveolin family members are expressed in non-overlapping patterns in the developing 
brain, and do not appear to compensate for loss of Cav1 function. 
 
(A) Caveolin family members are expressed in non-overlapping regions of the P6 brain.  CAV1 is 
expressed in layer Va of S1 cortex and more broadly in S2 cortex; CAV2 is expressed along the lateral 
ventricle; and CAV3 is expressed in mitral cells of the olfactory bulb. 
 
 (B) Focused examination of the CAV2 and CAV3 expression domains indicates that CAV1 is not 
expressed in overlapping regions as its family members, in particular, CAV1 is not expressed along the 
lateral ventricle or in mitral cells. 
 
(C) Caveolin family members CAV1 and CAV2 do not change expression patterns in the P3 Cav1 
loss-of function brain. While CAV1 expression is lost in the Cav1 loss-of-function brain, CAV2 and 
CAV3 do not have altered expression patterns. 
 
(D) CAV2 and CAV3 are not expressed in Cav1 loss-of-function caudo-lateral cortex. Focused 
examination of the normal CAV1 expression domains in the CAV1 null brain indicate that CAV2 and 
CAV3 do not appear to compensate for loss of CAV1 function. 
 
Scale bars: 2mm (A, C), 100µm (B), 200µm (D); WT, wildtype; P, postnatal day; OB, olfactory bulb; LV, 
lateral ventricle. 
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Figure 4.10: Correct Cav1 expression is not dependent on formation of the corpus callosum at P4. 
 
(A) Acallosal BTBR mice express CAV1 at comparable levels, and in an identical pattern, to their closely 
related callosal LPJ strain, suggesting that CAV1 expression is not dependent on correct CPN 
connectivity. 
 
Scalebar: 1mm.  WT, wildtype; P, postnatal day. 
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Figure 4.11: Exogenous CAV1 expression leads to delayed neuronal migration and excess axonal 
branching in the CC 
 
Exogenous overexpression (OE) of CAV1 in superficial layer neurons leads to immature neuronal 
phenotypes at P1, including delayed migration (A) and less complex dendrite branching (B) as compared 
to expression of a GFP control (G2A-Stop).  At P6, the earlier migration phenotypes are no longer visible 
(C).  However, images indicate extra axonal branching in the CC (D) when CAV1 is mis-expressed, in 
contrast to GFP control expression construct (G2A-stop). 
 
Scale bars: 100 µm.  CC, corpus callosum; E, embryonic day; P, postnatal day; OE, overexpression. 
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interact with striatins at synapses and Rac1 at focal adhesion points in other systems(Gaillard et al., 
2001b; Nethe et al., 2010).  Therefore, I hypothesized that Cav1 might function in proper neuronal 
adhesion. Such a role might affect critical neuronal processes such as migration, axonal extension and 
branching, and/or correct formation and/or maintenance of complex dendritic arbors for this unique 
population of CPN/FPN.   
 To investigate a potential function for Cav1 in early neuronal maturation processes, I employed in 
utero electroporation at E15.5 to exogenously express GFPcontrol and Cav1GFP in superficial layer 
projection neurons, a population that does not endogenously express Cav1.  I found that exogenous 
expression of Cav1 results in superficial layer neurons that display immature morphologies at P1 (Figure 
4.11A, B).  These immature phenotypes indicate delayed migration, and suggest potential extra aberrant 
adhesion points. By P6, no delayed neurons are detected, either due to elimination of improperly located 
neurons, or due to a recovery of the migrational delay (Figure 4.11C).  Interestingly, exogenous Cav1 
expression might also result in excess axonal branching within the developing CC (Figure 4.11D), a 
phenotype that could also be linked to potential extra aberrant adhesion points or to the dependence of 
neurotrophin signaling on Cav1 (Bilderback et al., 1997; Bilderback et al., 1999; Rico et al., 2004). 
 Studies demonstrating Cav1 interaction with Rac1 at focal adhesion sites in non-neuronal cells 
(Nethe et al., 2010), and of Cav1 regulation of neurotrophin signaling pathways (Bilderback et al., 1997; 
Bilderback et al., 1999) support a hypothesis of Cav1 function in process ramification.  Future directions 
include extending these overexpression studies to later times, performing focused axonal branching 
analysis, and employing dendritic analysis techniques already available in the lab to examine dendritic 
development/ maintenance, both in Cav1-mis-expressing neurons and Cav1-null CPN/FPN.  
 219 
4.5 Discussion 
 Callosal projection neurons (CPN) of the cerebral cortex reside in cortical layers II/III, V, and VI, 
and all extend axons to homotopic mirror image targets in the contralateral hemisphere.  Some 
subpopulations extend second axons to distinct targets including frontal or caudal ispsilateral neocortex, 
or even subcortically into ipsi- or contralateral striatum.  Identifying molecular determinants of CPN that 
are neuron subtype-specific or subpopulation-specific will enable specific and thorough study of these 
unique subpopulations critical for information integration by providing molecular markers.  In addition, 
such studies will also allow for in-depth functional analysis of these determinants themselves throughout 
development, to gain insight on their roles in establishing the precise connectivity that endows these 
subpopulations with critical roles in neocortical information transfer and correlation. 
 Previously, I presented comparative microarray analysis designed to identify molecular 
determinants of CPN populations, and subsequent evaluation of these data revealing molecular diversity 
within the broad population of CPN.  This diversity includes not only laminar and areal subpopulations, 
but also includes some unique expression patterns that reflect subpopulations of CPN with diverse axonal 
projection patterns.  Here, I show that Cav1, a lipid raft scaffolding protein enriched in CPN over CSMN, 
is expressed in a restricted fashion in the neocortex, and is expressed by over 80% of one such 
subpopulation, dual projecting CPN extending axons contralaterally and to ipsilateral frontal areas 
(CPN/FPN).  Specifically, Cav1 is localized to neuronal cell bodies and to dendrites, but has not been 
detected in axons.  The temporal developmental expression of Cav1 coincides with the middle time period 
of CPN development, including low-level expression during neuronal migration, and highest levels of 
expression from P3 to P6, when CPN are extending and refining axonal and dendritic processes. 
Together, these results suggest functions for Cav1 in post-mitotic establishment of innervation or 
connection pruning. 
Cav1 function is not necessary for specification and early development of dual projecting 
CPN/FPN, as shown by precise dual retrograde labeling approaches in Cav1 null neocortex, consistent 
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with its later developmental timing of expression, and absence of subcellular localization to axons. This 
lack of requirement for Cav1 function in establishment of CPN/FPN is not a result of simple 
compensation by close family members, as neither Cav2 nor Cav3 are co-expressed with Cav1, nor do 
these two family members change expression domains in the absence of Cav1 function.  Because these 
CPN/FPN projections continue to prune and establish precise connectivity until P21 (Mitchell and 
Macklis, 2005), it would be interesting to employ the same dual labeling approaches at P21 to investigate 
potential changes in axonal pruning that might result from potentially improper dendritic arborization, 
dendritic synaptogenesis, and/or axonal target-finding. If there is a change in the number of CPN/FPN in 
Cav1 null mice at P21, comparison between the number of CPN/FPN detected with retrograde labeling at 
P21 to the number detected at P21 from retrograde labeling performed at P8 would be able to distinguish 
between axonal pruning of one or both projections, versus a loss of these neurons altogether. 
Because of Cav1’s known interaction with neurotransmitter receptors (Boulware et al., 2007) (Lai 
et al., 2004) (Takayasu et al., 2010), dendritic spine signaling scaffolds(Gaillard et al., 2001a), and 
synaptosome components (Bilderback et al., 1997; Bilderback et al., 1999; Braun and Madison, 2000) the 
function of CAV1 in CPN/FPN might only be comprehensible through electrophysiological functional 
analysis of these neurons lacking their endogenous Cav1 function in in vivo circuits.  I find that Cav1 
expression is not dependent on correct CPN connectivity by examining Cav1 expression in the acallosal 
BTBR mouse line; however, Cav1 might be critical for CPN/FPN neuronal activity.  Since neuronal 
activity is very tightly tied to axonal and dendritic connectivity(Wang et al., 2007), especially 
maintenance and establishment, careful examination of P21 CPN/FPN axonal and dendritic morphologies 
with loss- or gain-of-function of Cav1 might very likely reveal a Cav1 function in CPN/FPN activity. 
Exogenous expression of Cav1 in superficial layer CPN that do not endogenously express Cav1 
results in neurons that display immature morphologies at P1, with delayed migration and P6 axonal 
morphologies that resemble extra branching, suggesting potential additional adhesion points. To 
investigate whether Cav1 function is sufficient to promote adhesion that gives rise to neurite branching 
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(similar to processes likely necessary for dual axonal projection formation by CPN or to direct or modify 
dendritic development) the Cav1 overexpression studies could be extended from Section 4.4g to a scheme 
that would allow detailed axonal and dendritic analysis at P6 and later, as CPN/FPN are extending 
neurites. Electroporating Cav1-2A-EGFP and a control GFP construct at E15.5 will produce high EGFP 
expression throughout CPN axons.  It would then be possible to visualize potential bifurcation of Cav1 
overexpression CPN axons and dendrites in comparison to GFP-expressing control CPN, in addition to 
the precision of their contralateral targeting at specific postnatal time points. Using a construct with the 
2A peptide labeling Cav1 protein could allow for higher sensitivity in localizing overexpressed Cav1, to 
determine if any is in the axon, either at growth cones or at branching points.  This single set of 
experiments would allow for analysis of both axonal and dendritic development of Cav1 overexpression 
and control electroporated CPN of the superficial layer SS cortex.  
Overexpression studies, like the ones discussed above, should take into account caveats of not only 
expressing proteins in unnatural cell populations, but also temporal misplacement of expression.  Since 
expression of Cav1 in the caudo-lateral cortex begins around E18.5, and is up-regulated postnatally, over-
expression of Cav1 in progenitors might, therefore, result in gain-of-function phenotypes different from 
the endogenous function of Cav1 in CPN/FPN. However, these phenotypes might provide valuable 
mechanistic insight into Cav1 action in cortical projection neurons, and could inform the investigation of 
general processes in which Cav1 can participate, providing insight regarding potential binding partners. 
To directly examine the function of Cav1 in the postnatal development of CPN, it would be possible to 
alter the over-expression strategy to give correct temporal expression in an incorrect neuronal population 
by employing early postnatal injections of Cav1 expressing adenovirus, or by the electroporation of an 
inducible Cav1 expression construct. 
Because Cav1 is highly concentrated in cell bodies and dendritic arbors of CPN/FPN, future work 
on this project could examine dendritic development and maintenance in Cav1 null CPN/FPN in 
comparison to wildtype. Together, these studies would provide important insight into the development of 
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this newly molecularly identified dual projecting population of CPN that likely functions in a variety of 
complex and critical processes integrating cortical information. 
Cav1 is a scaffolding domain protein with a number of known protein interactors from studies in 
other systems. Informed, directed, and refined by the results of the above proposed experiments, it would 
be possible to investigate whether Cav1 directly interacts with a carefully selected subset of known Cav1 
binding partners in CPN (particularly those shown to act in neuronal-relevant processes), and whether 
Cav1 functions in the development of defined subpopulations of CPN through these interactions.   One 
particularly compelling potential interacting protein for first analysis is Rac1, for reasons described 
above, including that it has been shown in other systems to play roles in important neuronal functions 
relating to cytoskeletal dynamics and focal adhesion, such as neurite growth, adhesion, and migration 
(Beardsley et al., 2005; Kang et al., 2006; Joshi et al., 2008a).  In particular, Rac1 is required for midline 
crossing of CPN(Chen et al., 2007; Kassai et al., 2008), and Rac1, recruited by CDKL5, can regulate 
neuronal migration and dendritic arborization of some CPN(Chen et al., 2010). Identification of 
neocortical binding partners of Cav1 will provide valuable insight into mechanisms of CPN subtype 
development / refinement through complex networks of discrete protein-protein interactions, with likely 
implications for subtypes of ASD.  The emerging “cortical connectivity/synaptogenic hypothesis” of ASD 
suggests that such a process change caused by Cav1 function might contribute to ASD phenotypes. 
These data are, to my knowledge, the first identification and functional analysis of a potential 
molecular control over a uniquely projecting subpopulation of CPN.  While Cav1 function itself reveals 
unique properties of CPN/FPN, and reveals itself as a specific direct actor in specific functionalities of 
CPN/FPN, it will also likely function as a molecular “hook” to identify potential upstream controls over 
CPN/FPN.  The defining properties of this subpopulation, likely critical for “feed forward” information 
integration, are yet to be completely understood, but this analysis of Cav1 expression and function 
identifies and characterizes a first molecular control over this functionally unique projection neuron 
population. 
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Chapter 5: 
 
TMTC4 is critical for human corpus callosum formation and functions in axonal development of a 
subpopulation of callosal projection neurons in mice 
 
 
 
 
 
 
 
 
 
Author contributions: The murine work on this project was an equal collaboration between Jessica 
L. MacDonald, PhD, a post-doctoral fellow, and me. We jointly designed all experiments and interpreted 
all data. Jessica performed the majority of the FACS purification, qPCR, protein gels, and protein 
localization work; and I performed the majority of the mutant construct design, axonal analysis, ISH, and 
confocal imaging.  All human genetic work presented in the introduction was performed in Elliott Sherr’s 
laboratory at UCSF. Our two labs are collaborating on this project. 
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5.1 Abstract 
Molecular controls over key processes in callosal projection neuron (CPN) development are only very 
recently being discovered and functionally characterized.  However, many developmental disorders 
involving CPN and the corpus callosum (CC) have already been clinically characterized.  The overlap of 
CPN developmentally expressed genes, and disorders involving improper development of CPN, likely 
converge on gene products critical to controlling  CPN development.  Tmtc4 (Transmembrane and 
tetratricopeptide repeat containing 4) is a previously uncharacterized protein-binding, transmembrane 
protein that we identified to have expression increasingly restricted to CPN during the first postnatal 
week, when CPN axons are crossing the midline and targeting to the contralateral hemisphere.  While the 
function of Tmtc4 is unknown, mutations in Tmtc4 were recently identified in human cases of corpus 
callosum agenesis (AgCC) (Elliott Sherr’s lab, UCSF; Li et al., SFN 2008) concurrent with our work in 
mouse, suggesting that Tmtc4 might be a critical regulator of CPN axon outgrowth and/or targeting.  
Here, I show in mice that Tmtc4 is expressed by CPN of neocortical layers II/III and Va in endoplasmic 
reticulum, and is excluded from early midline structures and other cortical projection neuron populations.   
Strikingly, overexpression of disease causing human point mutations affects axonal projections.  
Specifically, Tmtc4ΔR506Q drives exogenous axonal CPN branching, and Tmtc4ΔE463K results in some 
misrouting of CPN axons on the ipsilateral side.  Together, these results suggest that Tmtc4 can act in 
CPN development, and that cell-autonomous function of Tmtc4 in CPN axons potentially causes the 
effects of mutated Tmtc4 in human patients with AgCC. 
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5.2 Introduction 
Callosal projection neurons (CPN), the corpus callosum (CC), and their dysfunction have been 
implicated in numerous neurodevelopmental disorders including autism spectrum disorders (ASD)(Booth 
et al., 2011), schizophrenia(Innocenti et al., 2003), dyslexia(von Plessen et al., 2002), and agenesis of the 
corpus callosum (AgCC) (Paul et al., 2007; Kaufman et al., 2008; Wahl et al., 2008; Booth et al., 2011).  
Therefore, we hypothesized that some of the genes more highly expressed by CPN than by other 
projection neuron populations might be “disease genes (when mutated or variant), functioning cell-
autonomously in CPN.   
Recently our group identified Tmtc4 (Transmembrane and tetratricopeptide repeat containing 4) as 
more highly expressed by CPN than by CSMN, specifically during early postnatal neuronal development, 
via comparative developmental gene expression analysis between purified populations of projection 
neurons (Chapter 2 and (Molyneaux et al., 2009)).  Simultaneous to our identification of Tmtc4 as a 
candidate gene for functioning in CPN development, Elliott Sherr’s lab at the Comprehensive Center for 
Brain Development at UCSF identified Tmtc4 as mutated in 3/140 examined patients with AgCC (Li et 
al., 2008). Together these data suggest that Tmtc4 might be one such gene acting in CPN development, 
and whose dysfunction results in human disease.  
Tmtc4 is the last identified member of a largely functionally uncharacterized family of proteins; while 
nothing has been characterized about TMTC4, TMTC1 mutations are associated with heart failure from a 
genome wide screen (Smith et al., 2010; Della-Morte et al., 2011), and both TMTC2 and TMTC3 have 
been identified to be localized to endoplasmic reticulum (ER)(Simpson et al., 2000; Racapé et al., 2011).  
TMTC4 is predicted to contain twelve transmembrane domains, followed by eight tetra-trico-peptide 
repeat (TPR) domains (www.uniprot.org − ID Q8BG19) (Figure 5.1A). TPRs are protein-protein 
interaction modules found in multiple copies in many functionally different proteins.  More specifically, 
each TPR motif unit contains two antiparallel α helices; and tandem repeats of individual TPR motifs, as 
present in TMTC4, generate a right-handed helix with an amphipathic channel that can bind such a 
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complimentary region in a target protein(Blatch and Lässle, 1999).  Therefore, TPR-containing proteins 
like TMTC4 are associated with multiprotein complexes, form homodimers, and have been shown to be 
involved in cell cycle, transcription and splicing, protein transport, protein folding (co-chaperones), and 
phosphate turnover(Blatch and Lässle, 1999).  Some TPR-containing proteins have specifically been 
implicated in nervous system development and function including: dyslexia susceptibility gene (Dyx1c1), 
which functions during neuronal migration in the embryonic neocortex(Wang et al., 2006; Rosen et al., 
2007) and white matter formation(Darki et al., 2012); and TPR containing Down syndrome gene (TPRD 
or TTC3), a candidate gene in pathophysiology of Down Syndrome that is highly expressed in human and 
mouse neocortex, and is critical for neuronal differentiation through RhoA GTPase cell cycle 
regulation(Berto et al., 2007). Therefore, while no specific function has yet been attributed to TMTC4, 
family members and other TPR-motif containing proteins play critical roles in critical cellular processes 
and neuronal development. 
Complementary to our work, Elliott Sherr’s group at UCSF independently identified Tmtc4 as a 
candidate disease gene in an 11-year-old patient with complete AgCC with misrouted axons in bilateral 
probst bundles.  This child has a balanced reciprocal chromosomal translocation between chromosome 1 
and chromosome 13, spanning a 10kb sequence in the Tmtc4 gene intron 6 (mouse intron 5) between the 
coding sequence producing the 4th and 5th transmembrane domains (Figure 5.1B).  After identifying this 
genomic abnormality, members of the Sherr lab performed focused analysis of Tmtc4 sequences in their 
140 AgCC patients.  They found two more AgCC patients with single point missense mutations in Tmtc4 
that result in altered amino acids with dissimilar properties that were predicted to be disease causing: 1. 
glutamic acid to lysine at amino acid 463 (E463K) in exon 12 (mouse exon 11); and 2. arginine to 
glutamine at amino acid 506 (R506Q) in exon 13 (mouse exon 12) (both are conserved residues in mouse 
TMTC4).  These variations were not found in the control cohort (Figure 5.1C,D).  Due to the complexity 
of midline formation and correct midline crossing, consensus mutations causing AgCC are rare, and, 
therefore, Tmtc4 is a high priority candidate for functional analysis. However, while the Sherr lab  
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Figure 5.1: Tmtc4 has a predicted structure of 12 transmembrane domains and 8 tetra-
tricopeptide repeats; human mutations occur in the TPR domain.  (A) Schematic representation of 
the predicted functional domain structure of TMTC4.  (B) The identified human 
chromosome1:chromosome3 balanced translocation with agenesis of the corpus callosum (AgCC) occurs 
in a 10kb sequence in the Tmtc4 gene intron 6 (mouse intron 5) between the coding sequence producing 
the 4th and 5th transmembrane domains.  (C) Single point missense mutation (black swirl) in Tmtc4 found 
in a patient with AgCC results in an amino acid change from glutamic acid (E) to lysine (K) at amino acid 
463, which is located at the junction of the last transmembrane domain and the first TPR motif.  (D) 
Single point missense mutation (grey swirl) in Tmtc4 found in a patient with AgCC results in an amino 
acid change from arginine (R) to glutamine (Q) at amino acid 506, which is located in the second TPR 
motif.   Amino acid “R” groups are depicted on the right-hand side to illustrate changed chemical 
properties resulting from the mutations.  TM, helical transmembrane domain; TPR, tetratricopeptide 
repeat motif; P, phosphorylation point; Ch, chromosome. 
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specializes in human genetics of AgCC and other brain malformations, they do not pursue directed 
genetic functional analyses.  Our labs agreed to collaborate on this project, so they provided us with their 
unpublished human mutation data.   
Many human congenital syndromes are associated with AgCC, likely because of the many diverse 
processes required for proper formation of the CC.  In fact, AgCC occurs in approximately 1:4,000 
individuals(Paul et al., 2007).  Most generally, holoprosencephly, or the failure of the telencephalon to 
form two hemispheres, precludes existence of any CC.  However, since holoprosencephly is so severe and 
not specific to CC, it is customarily categorized as a separate neurological malformation from traditional 
AgCC(Richards et al., 2004).   
After the two hemispheres are formed, the midline must correctly fuse if CPN axons are to cross the 
midline.  Midline fusion occurs around E14 in mouse, and a population of midline cells termed midline 
zipper glia (MZG) are required for this process to complete(Lindwall et al., 2007).  Blockages, or cysts, at 
this midline structure can also cause AgCC by physically obstructing axons (Richards et al., 2004).  By 
E15.5 in mouse, the first CPN axons have begun to cross the midline.  At this stage in development, both 
CPN-autonomous and CPN-nonautonomous processes must work together to correctly form the CC and 
avoid AgCC.  Midline structures, including the subcallosal sling, glial wedge, and indusium griseum glia, 
must form and secrete appropriate guidance signals (Lindwall et al., 2007; Paul et al., 2007) (see Figure 
5.3A).  Inability of CPN themselves, particularly the first to cross, to respond correctly to attractive and 
repulsive cues, could also result in AgCC(Rash and Richards, 2001; Richards et al., 2004; Lindwall et al., 
2007; Paul et al., 2007; Donahoo and Richards, 2009).  Finally, CPN axons prune as a result of input 
received (Cusick and Lund, 1981; Elberger, 1994), and, as a consequence of making incorrect 
connections on the contralateral side, there is a possibility of partial degeneration of axons that have 
already crossed the midline.  AgCC, therefore, can be caused by defects in any one of these collective 
critical complex processes, including both those that are CPN-autonomous or CPN-nonautonomous.   
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Focused analyses of single disturbed processes that cause subtypes of AgCC will allow for specific 
disease characterization, directed diagnosis, and potentially therapeutic  prevention. 
Taken together, 1) TMTC4 expression in CPN during a critical period of axonal and dendrite 
extension and refinement, 2) evidence that related functional TPR domain-containing proteins are 
involved in neuronal differentiation and white matter formation, and 3) recent unpublished data from the 
Sherr lab that Tmtc4 is mutated in in 3/140 patients with corpus callosum agenesis (two missense 
mutations and one translocation patients with AgCC), suggest that Tmtc4 plays a critical role in the 
development of CPN. Further, these data suggest that TMTC4 function is likely necessary cell-
autonomously for correct CPN development, particularly in axonal guidance.  
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5.3 Materials and Methods 
5.3 a. Mouse Lines 
C57/Bl6 wildtype mice and CD-1 wildtype mice were obtained from Charles River Laboratories 
(Wilmington, MA, USA), and were used for labeling, primary neuronal culture, and electroporation 
experiments. 
5.3 b. Immunocytochemistry 
Immunocytochemistry on tissue sections was performed as described in Chapter 3, with dilutions as 
follows rabbit-anti-2A 1:500 (Millipore ABS31), rabbit-anti-GFP 1:500 (Invitrogen A-11122), mouse-
anti-KDEL 1:150 (Enzo Life Sciences SPA-827). 
  
5.3 c. In situ hybridization  
Nonradioactive colorimetric in situ hybridization was performed using probes labeled with dig-UTP 
as described in Chapter 3.  Sense probes were used as negative controls in all experiments.  
 
5.3 d. Retrograde labeling of cortical projection neurons 
Perinatal retrograde labeling of CPN and CSMN 
For retrograde CPN labeling, P2-P4 pups were anesthetized by hypothermia.  The axons of CPN were 
labeled from the corpus callosum on the contralateral hemisphere with Alexa555-conjugated Cholera 
toxin subunit B (CTB-555) (2 mg/ml, Molecular Probes, Carlsbad, CA), under ultrasound guided 
microscopy, and transcardially perfused at P4 or P6. Three injection sites each consisting of 10 injections 
of 4.6 nl each, starting in the white matter, then retracting through the grey matter in a step-wise fashion 
were performed along the rostro-caudal axis of the neocortex.  
For retrograde labeling of CSMN, P4 pups were anesthetized by hypothermia.  CTB-555 (2 mg/ml, 
Molecular Probes, Carlsbad, CA) was injected into the corticospinal tract at cervical vertebrae segment 
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C2/C3 using a pulled glass micropipette (tip diameter 80-100µm) under ultrasound backscatter 
microscopy. Six injections of 32 nl per injection site were performed on each side of the midline. Mice 
were transcardially perfused for analysis at P6. 
   
5.3 e. Fluorescence activated cell sorting (FACS) 
FACS purification was performed essentially as described in (Arlotta et al., 2005) and(Molyneaux et 
al., 2009), and summarized in Chapter 2.   
 
5.3 f. Western blotting  
Immunoblotting was performed as described previously(Cowan et al., 2001; Macdonald et al., 2010).   
Briefly, HEK cells were isolated and membrane protein was extracted using 1% sodium dodecyl sulfate 
(SDS, Sigma) in PBS. Protein homogenates were separated by 10% SDS–polyacrylamide gel 
electrophoresis, and transferred to nitrocellulose membrane (Bio-Rad Trans-Blot).  Membranes were 
blocked for 1 hr at room temperature with 5% nonfat milk in Tris-buffered saline (TBS), and incubated 
for 12–20 hours at 4 °C in the following primary antibodies diluted in in 2% milk/TBS: rabbit anti-2A 
peptide (1:2000; Abcam).  Membranes were then washed three times for 5 min. each in 0.1% Tween 20 in 
TBS, and incubated for 1 hour at room temperature in peroxidase-coupled goat anti-rabbit IgG (BioRad) 
diluted in 2% milk/TBS.  Signals were detected with chemiluminescence (Pierce, Rockford, IL). 
 
5.3 g. Quantitative real-time PCR (qPCR) 
RNA was extracted from FACS-purified cells using the StrataPrep Total RNA Micro Kit (Stratagene, 
La Jolla, CA), and cDNA was synthesized using SuperScript II reverse transcriptase (Invitrogen).   qPCR 
was performed with a LightCycler 1.5 system (Roche, Branford, CT) according to the manufacturer’s 
instructions.  Primer pairs for Tmtc4_c-terminus, Tmtc4_exon7, Satb2, Ctip2, and Gapdh were as follows; 
each primer of each primer pair was designed in different exons, so as not to amplify genomic DNA: 
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c-terminus Tmtc4: 
F: 5’-CTG AAG AGC TGC TGT CGT TG-3’ 
R: 5’-CTG CTC TGC TTC CTC AAA CC-3’ 
exon 7 Tmtc4: 
F: 5’-AGG CAA ACT CGA CAT TCT GG-3’ 
R: 5’-AGG GCT ATT CGG AAA AGG AG-3’ 
Satb2 (gift from M. Woodworth, L. Custo-Greig, and K. Liu; Macklis Lab): 
F:  5’- CTT TGC AAG AGT GGC ATT CA-3’ 
R: 5’- GCA GGT TGA GGA AGT TCT GC-3’ 
Ctip2 (gift from M. Woodworth, L. Custo-Greig, and K. Liu; Macklis Lab): 
F: 5’- ACC TAC TGT CAC CCA CGA AA-3’ 
R: 5’- GTA GAT TCG GAA GCC ATG TG-3 
Gapdh: 
F: 5’- GGC ATT GCT CTC AAT GAC AA-3’ 
R: 5’- TGT GAG GGA GAT GCT CAG TG-3’ 
Each polymerase chain reaction consisted of 1X LightCycler FastStart DNA Master SYBR Green I 
mixture, 0.125 - 0.25 µM primers, and cDNA.  We generated a standard curve for each gene, and 
performed relative quantification analysis in triplicate for each sample, using three independent RNA 
samples from each genotype.  The results are reported as the ratio of target DNA sequence to a calibrator 
sample, following normalization to a reference gene, Gapdh.  The average of the ratios of wild-type 
samples were set as “1”. p-values were calculated with an unpaired Student’s t-test.  To verify the 
specificity of the amplicons, we ran the amplicons on agarose gels and confirmed the molecular size of 
the amplicons, in addition to melting curve analysis.  Error bars indicate standard error of mean (SEM).  
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5.3 h. Loss- and gain-of-function constructs 
Gain-of-function 
For control expression experiments, vectors constructs of either GFP or full length Tmtc4, tagged 
with the T2A peptide sequence from the Thosea asigna virus (T2A) were used.  Tmtc4 cDNA in a 
pSport6 vector was purchased from Open Biosystems (Lafayette, CO; clone ID 5029461	  ), however the 
full sequence was not included in that vector.  The following primers were used to amplify the missing 
portion of the Tmtc4 cDNA coding sequence from a P3 neocortical cDNA library and clone it into 
pSport6 and then into an AAV plasmid backbone with the chicken β-actin promoter (CβA), woodchuck 
hepatitis post-transcriptional regulatory element enhancer (WPRE), and the T2A peptide sequence from 
the Thosea asigna virus (T2A) peptide (first identified in the picornavirus virus) to create a bicistronic 
vector(de Felipe et al., 1999) by taking advantage of a weak proline peptide bond (see figure 5.4).  This 
construct is called Tmtc4FL. In the control vector, called GFP2ASTOP, the GFP was followed by the T2A 
sequence and a stop codon. 
Tmtc4 primers for amplification of missing piece from cDNA library are as follows: 
F: 5’-gcGAATTC|ACTAGTgccaccatggttgagctggatgctga-3’ (with 5’ EcoR1 & Spe1 sites (capital 
letters) and Kozak initiation sequence (underlined)) 
Rsmall: 5’ – gGATATCgaacacagcattca-3’ (with 3’ EcoRV site (capital letters) added on) 
The amplicon and pSport6Tmtc4 (Open Biosystems) were digested with EcoR1 and EcoRV and 
ligated.  The following primers were used to amplify the full length coding sequence of Tmtc4 from the 
pSport vector: 
F: 5’-gcGAATTC|ACTAGTgccaccatggttgagctggatgctga-3’ (with 5’ EcoR1 & Spe1 sites (capital 
letters) and Kozak initiation sequence (underlined)) 
R: -ggCTCGAGgacatctttcttctgcgttt (with 3’ Xho1 (capital letters) added on) 
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The amplicon and pAAV T2A vector was digested with SpeI and XhoI and ligated.  A sequenced 
clone with perfect alignment to the NCBI reference sequence NM_028651.2 in both the sense and 
antisense orientations was selected for experiments. 
For human mutation constructs, the homologous region of mouse Tmtc4 was identified and point 
mutations were introduced via PCR site-directed mutagenesis of G à A at nucleotide 1387 in the Tmtc4 
coding sequence for Tmtc4ΔE463K and of G à A at nucleotide 1517 in the Tmtc4 coding sequence for 
Tmtc4ΔR506Q. 
Loss-of-function 
Since no loss-of-function mouse genetic model exists for Tmtc4, we employed an RNAinterference 
(RNAi) knockdown approach using a short-hairpin microRNA precursor RNA (shRNA-miR) (Cullen, 
2005; Silva et al., 2005).  Three shRNA-mir sequences in the miR-30 context with the following loop 
sequence and antisense hairpin sequences were selected for their perfect, and unique, homology to Tmtc4 
sequence NM_028651.2:  
Loop: 5’-TAG TGA AGC CAC AGA TGT A-3’ 
1. shTmtc4F (Open Biosystems, RMM4431-99009154, clone ID: V2LMM_101825) 
Antisense Hairpin: 5’- TTT GCC AAT GAG AAC ATA AGG G-3’ 
2. shTmtc4H (Open Biosystems, RHS4430-99138868, clone ID: V2LHS_177667) 
Antisense Hairpin: 5’- AAT TGC CTT GAG GAA TAA AGC T-3’ 
3. shTmtc4D (Open Biosystems, RMM4431-98727668, clone ID: V2LMM_116685).   
Antisense Hairpin: 5’- ATG TAT TTG ATC TTG ATG GCG G-3’ 
All shRNA-mir constructs were received in the pGIPZ lentiviral construct and were cloned into the 
pAAV expression construct as detailed above. In all experiments, a “scrambled” shRNA-mir that contains 
no homology to any known gene of the mouse genome was used as a control (Open Biosystems).  The 
non-silencing shRNAmir control antisense hairpin sequence is as follows:  
5’-aTC TCG CTT GGG CGA GAG TAA G-3’. 
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To measure efficiency of translational inhibition, the Tmtc4 coding sequence or the 3’ UTR were 
cloned using a XhoI /NotI digest into the psi-CHECK2 vector (Promega, Madison, WI) downstream of 
the Renilla luciferase gene STOP codon.  ShRNA binding to the mRNA of the gene of interest results in 
degradation of the fusion mRNA, and reduces expression of the reporter gene Renilla luciferase. A 
second reporter gene, firefly luciferase, was used to normalize Renilla luciferase activity. The psiCHECK 
luminescence assay (Promega) was performed as described in the manufacturer’s instructions.  Briefly, 
293T Human Embryonic Kidney (HEK) cells plated in a 96-well format at 70-80% confluency were 
transfected with a 1:10 ratio of psiCHECK2-Tmtc4 and the desired shRNA or control scrambled shRNA, 
using the Arrestin transfection reagent (Open Biosystems) in 100 µl serum-free medium, which 3-6 hr 
later was supplemented with serum. 48 hours after transfection, Renilla and firefly luciferase activities 
were measured using the Dual-Luciferase Reporter 1000 Assay System (Promega) on a Victor3 1420 
plate reader (Perkin Elmer, Waltham, Massachusetts). Renilla luciferase assay reagent (100 µl) was added 
to each well, incubated for 10 min., and luminescence was measured. The normalization control reading 
was measured by adding STOP&GLO reagent (100 µl) to each well to quench Renilla activity and 
provide the substrate for firefly activity, followed by measuring luciferase activity. Average luminescence 
of wells of untransfected HEK cells was subtracted as background. The luminescence of each well was 
normalized individually, and results from four replicates were averaged for each condition. Percent 
mRNA levels are expressed as average luminescence normalized to the average luminescence of control 
scrambled shRNA (scrambled shRNA) wells, ± SEM.  shTmtc4F gave the most knockdown of about 
80%. 
 
5.3 i. In utero electroporation 
In utero electroporations were performed essentially as described in (Saito and Nakatsuji, 2001; Saito, 
2006), and (Molyneaux et al., 2005); and summarized in Chapter 3.   
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5.3 j. Microscopy and image analysis 
Tissue sections were imaged on a Nikon E1000 microscope (Nikon Instruments, Melville, NY) 
equipped with an XCite 120 illuminator (EXFO, Mississauga, ON, Canada) and Q-imaging Retixa EX 
cooled CCD camera (Q-imaging Corp., Surrey, BC, Canada), or a Nikon 90i microscope using a 1.5 
megapixel cooled CCD digital camera (Andor Technology, Dublin, Northern Ireland), a 5 megapixel 
color CCD digital camera (Nikon Instruments, Melville, NY).   Images were collected and analyzed with 
Volocity image analysis software (Version 4.0.1; Improvision Inc., Waltham, MA) or Elements 
acquisition software (Nikon Instruments, Melville, NY).  Laser confocal analysis was performed using a 
BioRad Radiance 2100 confocal microscope with LaserSharp2000 imaging software (BioRad 
Laboratories, Hurcules, CA).  Images were processed using a combination of functions provided by 
ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, 
http://imagej.nih.gov/ij/, 1997-2011.) and Adobe Photoshop/ Illustrator software packages (Adobe, San 
Jose, CA). 
 
5.3 k. Axonal quantification 
Contralateral axonal branching quantification: 
Sections were matched with respect to electroporation location in sensory cortex and matched 50 µm 
sections where the CC, hippocampus, and AC were all visible at P8 were selected for analysis.  From 4x 
montages of the contralateral cortex electroporated axons, four curves were drawn with the curvature of 
the cortex as follows: 1. immediately above the white matter tract when axons turn to enter the grey 
matter, 2. just below the layer VI barrel cortex, 3. just above the layer VI barrel cortex in layer II/III, and 
4. in the process-dense, nearly acellular layer I (See figure 5.7).  All axons and axon branches crossing 
each of these lines were counted using ImageJ cell counter plugin.  The number of axons and axon 
branches in cortical layers was then normalized to the number of axons entering the grey matter and 
expressed as the averaged normalized proportion of axons entering the cortical grey matter ± S.E.M. for 
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each GFP2ASTOP (N= 5),  Tmtc4FL(N=6),   Tmtc4ΔE463K (N=6), and  Tmtc4ΔR506Q (N=5).  p-values were 
calculated using the unpaired two-tailed Student’s t-test. 
 
 
Axon target quantification: 
Sections were matched with respect to electroporation location in SS cortex and matched 50 µm 
sections where the CC, hippocampus, and AC were all visible at P8 were selected for analysis.  From 4x 
montages of the electroporated axons in the entire section, brains were given a discrete score of 1 (axons 
present) or 0 (axons absent) in the following locations : 1. ipsilateral striatum, 2. ipsilateral globus 
pallidus, 3. high density in ipsilateral globus pallidus, 4. ipsilateral anterior commissure, and 5. 
contralateral anterior commissure. The proportion of brains with electroporated axons in each of these 
regions was calculated for each GFP2ASTOP (n= 8), Tmtc4FL(n=6),   Tmtc4ΔE463K (n=9), and  Tmtc4ΔR506Q 
(n=5).  p-values were calculated using the parametric z-test for comparing two proportions (XLSTAT, 
Addinsoft SARL). 
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5.4 Results 
5.4 a. TMTC4 is expressed by a restricted population of CPN, and is excluded from CSMN 
Previously published comparative microarray data show that Tmtc4 is highly expressed by CPN 
compared to CSMN during the first postnatal week ((Molyneaux et al., 2009) and Chapter 2), suggesting 
that TMTC4 functions post-mitotically at the time of axonal targeting and refinement (Figure 5.2A). We 
more specifically investigated Tmtc4 expression by combining retrograde labeling of CPN (from the 
contralateral cortex) and subcerebral projection neurons (SCPN) (from the pons), followed by FACS 
purification and qPCR. We validated the purification method by priming for Ctip2 and Satb2, which at P4 
are virtually segregated between SCPN and CPN, respectively(Arlotta et al., 2005; Alcamo et al., 2008; 
Britanova et al., 2008; Chen et al., 2008a).  Ctip2 is enriched in SCPN three-fold over CPN, and Satb2 is 
enriched in CPN over two-fold over SCPN, validating our sorting efficacy.  We find, that in this validated 
population of CPN at P4, Tmtc4 is two-and-a-half-times enriched in CPN over SCPN (Figure 5.2B).  
Two major splice variants of Tmtc4 have been identified in mouse, one “canonical” isoform including 
all 18 exons (17 coding exons), and a second isoform containing only 8 exons, and excluding the c-
terminus.  Since the in situ hybridization probe recognizes regions of the c-terminus and, therefore, the 
long isoform, we asked if the short variant is expressed at different levels, in different populations, or at 
different developmental times from the full length isoform in mouse cortex.  We designed PCR primers to 
exon 7 (which would identify the full length and alternative sequence) and to the c-terminus (which 
would identify the full length isoform only), and find no difference in the level or timing of expression 
between the two, suggesting that it is the full length isoform that is expressed in developing mouse 
neocortex from E12.5 to P14, and not the splice variant (Figure 5.2C).  Additionally, we confirmed and 
expanded the microarray developmental expression data with developmental in situ hybridization, and 
find that Tmtc4 becomes restricted to superficial layer and layer Va CPN at P3 and P6 (Figure 5.3). These 
data combined indicate that Tmtc4 is expressed by CPN during the first postnatal week of mouse brain 
development and is, therefore, poised to act specifically in CPN during axon and dendrite extension.  
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These results, taken together with microarray, qPCR, and retrograde labeling/in situ hybridization data, 
indicate that Tmtc4 is indeed specifically expressed in the developing neocortex by CPN during the first 
postnatal week.  
5.4 b. Tmtc4 is not expressed in early midline structures 
The analysis presented above indicates that postnatally, Tmtc4 is specifically expressed by CPN over 
other projection neuron subtypes.  However, because Tmtc4 has been implicated in human AgCC, we 
investigated in mice whether it could be acting early in development during midline formation, one of the 
most commonly malformed structures leading to AgCC(Richards et al., 2004; Paul et al., 2007; Donahoo 
and Richards, 2009).  At the time of midline formation by glial and neuronal populations (from E15.5- 
E17.5) (Lindwall et al., 2007), Tmtc4 is not expressed at the midline (Figure 5.3A,B), indicating that by 
extension any effects of Tmtc4 mutations in human AgCC are not likely a result from a change in midline 
structure formation, but, rather, are likely the result of CPN-autonomous function for TMTC4. 
5.4 c. Tmtc4-T2A is localized subcellularly to endoplasmic reticulum 
To identify where TMTC4 acts in developing neurons, we investigated the subcellular localization of 
overexpressed TMTC4-T2A in conjunction with subcellular molecular markers.   No antibody able to 
detect endogenous TMTC4 in tissue has been identified (although we have tried multiple native 
polyclonal and affinity purified monoclonal versions); therefore, we took advantage of the short T2A 
peptide sequence tagged onto TMTC4 in the expression plasmid, and performed immunocytochemistry 
against 2A in electroporated neocortical superficial layer neurons expressing the tagged protein (Figure 
5.4A,C).  The T2A peptide was differentially localized subcellularly when it was on TMTC4 versus GFP 
(Figure 5.5A,B).  TMTC4-T2A localization closely resembles the pattern of endoplasmic reticulum (ER). 
To further investigate whether TMTC4-T2A is localized to the ER, we took advantage of the fact that 
most lumenal ER proteins have COOH-terminal Lys-Asp- Glu-Leu (KDEL)(Ellgaard et al., 1999), and 
co-stained for KDEL to identify ER.  Even though TMTC4 does not contain the canonical KDEL  
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Figure 5.2: Tmtc4 is expressed by CPN at mid-stage CPN development (A) Tmtc4 is more highly 
expressed by CPN than by CSMN via comparative microarray analysis of FACS purified retrogradely 
labeled neurons. (B) Tmtc4 is more highly expressed by FACS-purified CPN than by CSMN via q-PCR 
on purified neuronal populations at P4.  (C) Tmtc4 full length mRNA is expressed at equal levels in the 
cortex to exon 7 of Tmtc4, indicating that the short splice variant of Tmtc4 is not a major contributor to 
Tmtc4 expression.  
 
CSMN, corticospinal motor neurons; CPN, callosal projection neurons; E, embryonic day; P, postnatal 
day; FACS, fluorescence activated cell sorting. A from(Molyneaux et al., 2009). 
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  (Continued)	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Figure 5.3: Tmtc4 is not expressed at the midline at the time of midline structure formation, and is 
expressed postnatally by superficial layer and layer Va neurons. (A) Schematic representation of 
early midline structures and first-crossing CPN axons. (B) Tmtc4 is not expressed in early midline 
structures at E15.5 or E17.5 (C-E) Tmtc4 is expressed by postmitotic superficial layer and layer Va 
neurons of the early postnatal neocortex.  
 
Scale bars (B) 500 µm, (C, D, E) 1mm, (C’, C”,D’, D”, E’, E”) 100 µm. A from(Fame et al., 2011), B-E 
in situ hybridization. CP, cortical plate; IZ, intermediate zone; SVZ, subventricular zone; VZ, ventricular 
zone; IGG, indusium gresium glia; GW, glial wedge; SCS, subcallosal sling; MZG, midline zipper glia; 
E, embryonic day; P, postnatal day.   
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Figure 5.4:  Overexpression scheme for analyzing human mutations of Tmtc4, which produce full-
length protein. (A) Schematic representation of Tmtc4-T2A overexpression construct including the CβA 
promoter, the WPRE enhancer, and the T2A peptide that both tags the preceeding protein product, and 
also allows for peptide cleavage between the two peptide products (B) All of the overexpressed TMTC4 
variations (Tmtc4FL, Tmtc4ΔE463K, and Tmtc4ΔR506Q) produce full-length TMTC4 protein, and result in 
dimerization, as detected by 2A immunoblotting. (C) Schematic representation of in utero electroporation 
approach at E15.5 to target superficial layer cortical projection neurons at the peak time of their birth.   
 
CβA, chicken beta-actin; T2A, Thoseaasigna virus 2A peptide; GFP, green fluorescent protein; WPRE, 
woodchuck hepatitis post-transcriptional regulatory element; bp, basepairs; kD, kilodaltons; LV, lateral 
ventricle; E, embryonic day; P, postnatal day. 
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Figure 5.5: Wildtype Tmtc4-2A and human mutations of Tmtc4-2A are localized to neuronal 
endoplasmic reticulum. (A) At P8, overexpressed GFP-T2A fills the cytoplasm and processes of 
superficial layer pyramidal neurons.  (B) At P8, overexpressed full-length Tmtc4-T2A is trafficked to 
superficial layer neuronal ER. (C) At P8, overexpressed Tmtc4ΔR506Q -T2A is trafficked to superficial 
layer neuronal ER. (D) At P8, overexpressed Tmtc4ΔE463K -T2A is trafficked to superficial layer neuronal 
ER.   
 
Scale bar indicates 100 µm.  ER, endoplasmic reticulum; T2A, Thoseaasigna virus 2A peptide; GFP, 
green fluorescent protein; KDEL, lysine-aspartic acid-glutamic acid-leucine endoplasmic retention 
peptide sequence; P, postnatal day. White arrows indicate examples of electroporated cells analyzed.  
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carboxy-terminus, TMTC4-T2A localization overlaps with KDEL expression in ER, while GFP-T2A 
localization is much more broad (Figure 5.4A,B).  While overexpression of proteins can sometimes lead 
to trafficking defects, these localization data, combined with evidence that other TMTC family members 
localize to and act in ER, strengthen the interpretation that TMTC4 might also act in ER. 
5.4 d. Eighty percent knockdown of Tmtc4 in vitro does not result in significant knockdown in vivo 
To test the hypothesis that TMTC4 function is critical for CPN maturation and CC development, we 
selected a short-hairpin RNA (shRNA) knockdown approach, introduced via in utero electroporation at 
E15.5, the peak of superficial layer CPN birth (Figure 5.6A). The shRNA constructs for knockdown of 
Tmtc4 were first validated using the psiCheck system (Promega), and we identified an shRNA construct 
(shTmtc4F) with unique homology to mouse Tmtc4 that gives greater than 80% knockdown consistently 
in vitro (Figure 5.6B).  This results in knockdown at the protein level in 293T HEK cells (Figure 5.6C). 
This construct also contains GFP, and therefore allows visualization of the cell body, axon, and principal 
dendrites.  
Because the artificial system of knocking down an overexpressed construct in non-neuronal cells is 
quite different than knocking down gene expression in vivo at endogenous levels, we closely examined 
the level of Tmtc4 knockdown in vivo in superficial layer neurons.  In this system, even the best construct 
from the psiCheck and protein level validation did not give sufficient Tmtc4 knockdown at the mRNA 
level in vivo (Figure 5.6D).   Without sufficient knockdown in vivo, and with no observed differences 
between knockdown and control neurons, this system is not suitable for studying reduced Tmtc4 function 
in vivo. 
5.4 e. Human point mutations of TMTC4 generate full-length transcripts that correctly localize to ER 
in superficial layer CPN 
Since human AgCC patients with Tmtc4 mutations have mutations on only one of the two copies, and 
because point mutations, especially in transmembrane proteins like members of the TMTC family that 
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bind to protein partners, can act as a dominant negative by sequestering binding partners, we designed 
overexpression vectors for homologous point mutations in mouse Tmtc4 as were identified in human 
patients to investigate whether the mutated protein has an effect when expressed in otherwise wildtype 
neurons.  The amino acids and nucleotide sequences where the identified mutations occurred are 100% 
conserved in human and mouse. To determine whether the mutations affect completion of transcription or 
translation, we overexpressed Tmtc4FL, Tmtc4ΔE463K, and Tmtc4ΔR506Q in 293T HEK cells, and determined 
protein size via Western blot analysis.  All three are translated and generate full-length proteins of the 
same molecular weight at the wildtype protein (predicted size ~70 kd) that likely duplex, as TPR domain 
proteins are known to do (Figure 5.B). 
To investigate whether the mutations affect Tmtc4 trafficking to ER, we performed immunological 
colocalization of the 2A and KDEL peptides in superficial layer CPN that had been electroporated at 
E15.5 with mutated Tmtc4 constructs.  Tmtc4ΔR506Q trafficked to the ER, as did Tmtc4ΔE463K (Figure 
5.5C,D).  Together, these results suggest that TMTC4 is localized to, and therefore acts in, neuronal ER. 
5.4 f. Overexpression of human mutations of Tmtc4 in superficial layer CPN cause axonal defects in 
mouse CPN development 
Because AgCC results in misrouted CPN axons in Probst bundles, and improper CPN axonal 
targeting, we investigated whether the human disease-causing mutations in Tmtc4 affected CPN axonal 
outgrowth.  We performed systematic investigation of CPN axons expressing GFP only, Tmtc4FL, 
Tmtc4ΔE463K, or Tmtc4ΔR506Q.  Since axons do cross the midline through the CC in the overexpression 
model, we investigated axonal branching and targeting in contralateral cortex.  Strikingly, overexpression 
of Tmtc4ΔR506Q results in extra branching of CPN axons in layer I as compared to the GFP control (18% 
increase; p=0.02), Tmtc4FL control (26% increase, p=0.004), and Tmtc4ΔE463K experimental (18% increase, 
p=0.009) (Figure 5.7A, B).  Interestingly, the Tmtc4FL control showed significantly less branching than 
Tmtc4ΔR506Q in layer II/III as well (22% less, p=0.01), suggesting that potentially Tmtc4FL has an opposite  
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Figure 5.6: shRNA construct that provides eighty percent knockdown of Tmtc4 in vitro does not 
result in significant Tmtc4 mRNA knockdown in vivo. (A) Schematic representation of the miR-30 
context shRNA hairpin design. (B) Luciferase assay for candidate shRNA efficacy indicates that, relative 
to scrambled shRNA control, shTmtc4D causes 20% knockdown, shTmtc4H causes 70% knockdown, 
andshRNATmtc4F gives the best knockdown at 80% reduction of mRNA levels. (C) At the protein level, 
shRNATmtc4F gives product knockdown in 293T HEK cells.  (D) Expression of the shTmtc4F 
knockdown construct in vivo does not result in significant reduction of Tmtc4  mRNA levels.   
 
Scale bars: D, 1mm; D’, 100 µm; D” 20 µm.  Error bars: standard error of the mean.  shRNA, short-
hairpin RNA, scramshRNA, scrambled control shRNA, T2A, Thoseaasigna virus 2A peptide; kD, 
kiloDaltons; P, postnatal day.  White arrows (D) indicate limits of knockdown electroporation, white 
arrows in (D’) indicate eletroporated cells magnified in D”.  Dashed lines in D” indicate cellular outline 
of electroporated cells.  
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Figure 5.7: Human mutations of Tmtc4ΔR506Q result in aberrant axonal branching/ failure to stop in 
mouse superficial layer neurons at P8. (A) Quantification of number of axon branches of superficial 
layer neurons electroporated with Tmtc4 expression constructs reaching each noted radial cortical 
landmark in the contralateral cortex.  Results are expressed as the average relative number of axonal 
branches normalized to the number of axons reaching the contralateral grey matter ±S.E.M. 
Quantification at P8 reveals an increase in axonal branches in superficial layer I by neurons expressing 
Tmtc4ΔR506Q  by 18% (N=6, p = 0.02) compared to GFP control, 26% increase (N=5, p=0.004) compared 
to Tmtc4FL wildtype control, and 18% increase (N=6, p=0.009) compared to Tmtc4ΔE463K experimental. 
The Tmtc4FL control-expressing neurons showed significantly less branching than those expressing 
Tmtc4ΔR506Q in layer II/III as well (22% less, p=0.01), suggesting that potentially Tmtc4FL has an opposite 
effect to that of the Tmtc4ΔR506Q mutated form, although neither is different from the GFP control in layer 
II/III (B) Representative images of contralateral axonal innervation for each condition (B’) GFP (B’’) 
Tmtc4FL, (B”’) Tmtc4ΔR506Q, and (B””) Tmtc4ΔE463K.  
 
Error bars: standard error of the mean. Roman numerals indicate neocortical layers.  Scale bar: 500 µm.  
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effect as the Tmtc4ΔR506Q mutated form, although neither is different from the GFP control in layer II/III 
(Figure 5.7A).   No other significant differences were observed in this analysis. Therefore, correct Tmtc4 
function might be critical for appropriate local target finding, and/or accurate response to inhibitory stop 
signals. 
Additionally, we investigated axonal targeting to areas other than contralateral cortex through the CC, 
since some populations of CPN axons expressing mutant forms of TMTC4 might not cross through the 
CC at all.  In all conditions, CPN axons projected to ipsilateral striatum, as expected.  TMTC4 
overexpressing axons of all types – WT and both mutations – trend toward being more likely to have 
axons targeting the globus pallidus, a typical target for striatal neurons, but not cortical neurons, than 
those electroporated with GFP control.  However, only Tmtc4ΔE463K - expressing experimental neurons 
were significantly more likely than the GFP control neurons to extend axons to the globus pallidus (64% 
increase, p=0.001).   Although absolute quantification was not performed, large numbers of axons 
expressing the Tmtc4ΔE463K mutated protein were repeatedly detected densely covering the entirety of the 
globus pallidus domain, while only a few axons overexpressing the other Tmtc4 variations were found in 
the globus pallidus (67% more than GFP, p<0.0001; 50% more than Tmtc4FL, p=0.02; 47% more than 
Tmtc4ΔR506Q , p= 0.05).  Interestingly, brains with neurons expressing the Tmtc4ΔE463K mutated protein 
were more likely to have axons crossing to the contralateral hemisphere in the anterior commissure 
compared with either the GFP control (43% increase, p=0.03) or the  Tmtc4ΔR506Q  experimental (55% 
increase, p=0.001).   
This result is particularly compelling because ~10% of canonical AgCC includes enlargement of the 
AC(Paul et al., 2007), and the initial patient identified by the Sherr lab with the translocation in Tmtc4 
exhibits an enlarged anterior commissure in addition to AgCC.  These axon targeting data are interesting, 
and encourage further study of axon targeting in the overexpression system to determine how and when 
the mistargeting occurs, particularly looking at earlier developmental times.  These two sets of data 
combined suggest that TMTC4 can play critical roles in axonal branching, targeting, and stopping, and 
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that the human missense mutations of TMTC4 likely disrupt important and potentially distinct functions 
of this protein that could result in CPN malfunction and mistargeting. 
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Figure 5.8: Human mutations of Tmtc4ΔE463K result in aberrant axonal targeting in mouse 
superficial layer neurons at P8. 
(A) TMTC4 overexpressing axons of all types –WT and both mutations – trend toward being more likely 
to have axons targeting the globus pallidus (GP), a typical target for striatal neurons, but not cortical 
neurons, than those electroporated with GFP control.  However, only Tmtc4ΔE463K experimental-
expressing neurons were significantly more likely than the GFP control neurons to extend axons to the 
GP (N=9, 64% increase, p=0.001).   Although normalized quantification was not performed, large 
numbers of axons expressing the Tmtc4ΔE463K mutated protein were repeatedly detected densely covering 
the entire GP domain, while only small numbers of axons expressing the other Tmtc4-expression 
constructs were found in the GP (67% more than GFP, N=8, p<0.0001; 50% more than Tmtc4FL, N=5,  
p=0.02; 47% more than Tmtc4ΔR506Q , N=6, p= 0.05).  Brains with neurons expressing the Tmtc4ΔE463K 
mutated protein were more likely to have axons crossing to the contralateral hemisphere in the anterior 
commissure than either the GFP control (43% increase, N=8, p=0.03) or the  Tmtc4ΔR506Q  experimental 
(55% increase, N=6, p=0.001). (B) Representative images of axon targeting for each condition (B’) GFP 
(B’’) Tmtc4FL, (B”’) Tmtc4ΔR506Q, and (B””) Tmtc4ΔE463K. 
 
*, p <0.05; **, p<0.001; ***, p< 0.0001, WT, wildtype; P, postnatal day; Str, striatum; GP, globus 
pallidus; AC, anterior commissure. 
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5.5 Discussion	    
 Callosal projection neurons (CPN) of the cerebral cortex reside in cortical layers II/III, V, and 
VI,and all extend axons to homotopic mirror image targets on the contralateral hemisphere enabling 
bilateral information integration within the cerebral cortex.  Dysfunction and malformation of CPN have 
been implicated in diseases of associative function, including autism spectrum disorders (ASD), 
schizophrenia, and agenesis of the corpus callosum (AgCC).  Some CPN subpopulations likely play 
preferential roles in specific disorders of CPN development and associative function.  We hypothesized 
that some of the molecular determinants expressed by specific populations of CPN would not only be 
likely developmental regulators of this specific neuronal population, but their absence or mutation could 
also be associated with incorrect development or function of CPN in human disease.  Identifying disease 
genes within the set of genes expressed by CPN provides a useful filter to enrich for genes whose 
functions are likely specific and cell-autonomous. Tmtc4 is one such gene at the intersection of human 
disease, AgCC, and CPN-enriched developmental expression.  Focused in-depth functional analysis of 
these determinants throughout development in unique subpopulations of CPN will likely provide insight 
into critical processes disrupted in human disease.  
 In Chapter 2, comparative microarray analysis designed to identify molecular determinants of 
CPN populations is presented. In subsequent chapters, functional investigation of some of these 
determinants in CPN development is presented.   Data revealing molecular diversity within the broad 
population of CPN has identified regulators of CPN development. Here, I show that Tmtc4, a 
transmembrane protein with a TPR protein interaction domain whose mutated forms are associated with 
patients with a deformation of CPN, AgCC, is enriched in CPN over CSMN, and is expressed in a 
restricted fashion in the neocortex. Specifically, Tmtc4 expression is restricted to neocortical layer II/III 
and Va CPN.  The temporal developmental expression of Tmtc4 coincides with an intermediate time 
period of CPN development, including low-level expression during neuronal migration, and highest levels 
of expression from P3 to P6, after neuronal birth and migration when CPN are extending and refining 
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axonal and dendritic processes.  Together, these data suggest that Tmtc4 might function in post-mitotic 
establishment of innervation or connection pruning.  In addition, Tmtc4 is not expressed in developing 
midline structures in mice, indicating that it does not function in formation of the midline in mice; rather, 
function of Tmtc4 in mouse and human CC development is likely CPN-autonomous.  Strengthening this 
interpretation for specificity of Tmtc4 function, no isoforms of Tmtc4 other than the canonical isoform 
measured by in situ hybridization and qPCR are expressed in the developing neocortex.  This suggests 
that the spatially and temporally restricted expression pattern detected by in situ hybridization and qPCR 
of canonical full-length Tmtc4 denotes the only restricted involvement of Tmtc4 in neocortical 
development. 
Peptide tagged TMTC4 localizes to the endoplasmic reticulum, as has been shown for other TMTC 
family members; this suggests that TMTC4 might function in ER-specific roles in CPN.  With an 
artificial overexpression scheme, there is always the possibility that the large amount of protein results in 
mistrafficking. However, data that other family members act in the ER (Racapé et al., 2011) reinforces the 
current results showing TMTC4 specific localization to the ER.  The ER plays many roles in cellular 
processes, including being the site of synthesis and maturation of proteins destined for secretion, for the 
plasma membrane, and for the secretory and endocytic organelles(Ellgaard et al., 1999); being the site of 
lipid and steroid synthesis; being the location of carbohydrate and toxin metabolism; and acting as a 
regulator of cytosolic Ca2+ levels(Tojima, 2012).  Some of these roles are specifically critical for neuronal 
development and function.   While the protein synthesis function of ER acts more generally in all cell 
types, the metabolic and folding chaperone roles of ER have been connected to neurodegeneration of 
large excitatory neurons such as CSMN and spinal motor neurons that degenerate in amyotrophic lateral 
sclerosis (ALS)(Riboldi et al., 2011).  Additionally, closely regulated Ca2+ levels plays critical roles in 
apoptosis, axonal outgrowth, guidance, and neurotransmission(Limke et al., 2004; Shen and Shuai, 2011; 
Tojima, 2012).   These crucial functions of ER in neuronal development and survival suggest the 
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possibility that ER-localized TMTC4 might be acting in one of these important processes either directly, 
or through chaperone/ protein sorting roles acting on other critical players in these processes. 
While any of these roles of ER could be applicable to TMTC4 function in AgCC, those involved in 
cytosolic Ca2+ level regulation are most directly connected to axonal development.  Cytosolic Ca2+ levels 
are generally kept quite low in neurons (50–100 nM). However, in response to axon guidance cues or 
neurotransmitters, Ca2+ stores in the ER can be released into the cytosol through the opening of inositol 
triphosphate receptor (IP3R) channels by IP3 upon hydrolysis of PIP2 from cellular membrane(Shen and 
Shuai, 2011).   This, in turn, signals either growth cone attraction or replusion(Limke et al., 2004; Tojima, 
2012), or signal propagation(Shen and Shuai, 2011).   
A number of axonal growth cone behaviors, including turning, stopping, extension, and responding to 
external cues, have been shown to require precise regulation of intracellular Ca2+(Kater and Mills, 1991; 
Aridor and Fish, 2009), and could be affected by TMTC4 mutations – particularly by mutations in the 
protein binding TRP region, like those described here. Data presented in this chapter show that expression 
of disease-associated mutations in Tmtc4 can result in excess axonal branching  (Tmtc4ΔR506Q) or 
mistargeting (Tmtc4ΔE463K).  These phenotypes could be results of an inability of axons to respond to stop 
signals, or inappropriate axonal response to attractive and repulsive guidance cues, respectively.   These 
axon guidance data from overexpression of human disease associated mutations of Tmtc4 additionally 
lend support to the hypothesis that TMTC4 acts in neuronal ER to control correct growth cone targeting.  
The function of intracellular Ca2+ regulation in how guidance cues are interpreted is particularly pertinent 
to the above results suggesting potential mistargeting as a result of Tmtc4 mutations.   Cues involving 
cellular membrane Ca2+ that result in intracellular ER Ca2+ release cause growth cone attraction, while 
cues involving cellular membrane Ca2+ without intracellular ER Ca2+ release cause growth cone 
repulsion.(Tojima, 2012).  Therefore, controlled regulation of ER protein localization and Ca2+ release are 
critical for appropriate interpretation of attractive and repulsive guidance cues, and Tmtc4 is poised to be 
involved with these processes in the ER. 
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In addition to axonal growth cone response, the ER and ER-localized proteins play critical roles in 
neuronal activity(Shen and Shuai, 2011). This role for ER in neuronal activity is also connected to 
cytosolic Ca2+ levels, and the fact that ER is a continuous network that extends to all parts of the neuron, 
including the axon and dendrites. Individual IP3R channels can release a small amount of Ca2+ locally, a 
small cluster of IP3R channels can have a larger effect releasing more Ca2+, and slowly propagating waves 
of Ca2+ release along large portions of the ER can affect the neuron globally(Parker et al., 1996).  While 
investigations reported in this chapter do not directly address neurofunctional activity after the artificial 
expression of Tmtc4 mutant gene products, functional aberrations could affect neuron migration, target 
finding, and axon maintenance (Koralek and Killackey, 1990; Innocenti and Price, 2005).  Since Tmtc4 is 
poised to potentially affect such processes, further analysis including electrophysiological functional 
assays of neurons with inappropriate Tmtc4 expression or loss of Tmtc4 function might contribute to 
understanding roles of Tmtc4 in projection neuron development.   
 These experimental results, while informative and motivating for further analysis of TMTC4 
function in neuronal development, do not fully recapitulate either the human AgCC disease state or a full 
loss-of-function. For example, chromosomal translocation mutations such as the one detected in the first 
human patient to be identified, are inexact and difficult to correctly recapitulate with an expression 
plasmid.  While the resulting situation is likely a functional null of the protein product, there is also the 
possibility of producing a product with some chimeric properties.  This possibility could potentially be 
illuminated by full sequencing of the chromosomal abnormality in the human patient with the 
translocation mutation. Additionally, in the overexpresssion system used here, all neurons still express 
two wildtype copies of Tmtc4 and, therefore, neurons in which mutant Tmtc4 has been misexpressed 
likely retain more TMTC4 function than patients carrying the mutations.  In addition, in this chimeric 
system of in utero electroporation, neurons expressing mutant forms of Tmtc4 might be able to cross the 
corpus callosum by following neighboring wildtype neurons, which would not be possible in the case of 
human patients.  
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To thoroughly investigate Tmtc4 function in developing CPN it will be necessary either to design and 
test new Tmtc4 shRNA constructs that more completely reduce mRNA levels in vivo, or to generate a set 
of Tmtc4 targeted gene deletion mice (global and conditional nulls).  While such mice are not yet 
available, the International Knockout Mouse Consortium has now successfully created a Tmtc4 deletion 
line in embryonic stem cells, and it will be quite interesting and useful for basic developmental analysis 
of Tmtc4 function to perform subsequent investigations of CPN and CC development in Tmtc4 
heterozygote and null mice when they are generated.  These analyses will likely inform future research 
into AgCC disease causing properties of Tmtc4, in addition to providing a loss-of-function tool that will 
allow investigators to more deeply study basic functional requirement(s) of TMTC4 in CPN development. 
Taken together with the involvement of Tmtc4 mutations in human AgCC, the data presented in this 
chapter showing: 1) Tmtc4 expression by developing CPN at the time of axon and dendrite extension; 2) 
ER localization of TMTC4; 3) aberrant axon targeting with Tmtc4ΔE463K expression; and 4) exuberant and 
inappropriate layer I axonal branching with Tmtc4ΔR506Q expression, suggest that TMTC4 might likely 
function in axonal guidance during neuronal development.  Critical function in ER-influenced growth 
cone response to stop or guidance cues might result in axonal pathfinding roles for TMTC4, potentially 
including cytosolic Ca2+ levels, and are supported by the mutant overexpression data revealing atypical 
axonal development.   The excess layer I axonal branching in Tmtc4ΔR506Q aligns with known roles of ER 
Ca2+ in proper response to stop signals (Kater and Mills, 1991), while aberrant axon targeting with 
Tmtc4ΔE463K supports a connection to many studies implicating correct Ca2+ levels and ER protein 
retention in attraction, repulsion, and targeting(Kater and Mills, 1991; Aridor and Fish, 2009; Shen and 
Shuai, 2011; Tojima, 2012). Further studies of Tmtc4 null CPN, and of direct connections between Tmtc4 
function and neuronal activity/ axonal pathfinding, might likely prove fruitful for understanding roles of 
Tmtc4 in CPN development, and critical processes in CPN development that contribute to AgCC. 
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Chapter 6: 
 
Subtype-specific genes that identify distinct subpopulations of callosal projection neurons in 
mice identify molecularly homologous populations in macaque cortex 
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6.1 Abstract  
Callosal projection neurons (CPN) as a population have undergone striking differential expansion 
throughout recent evolution.  This is evident from the disproportionately large, histologically recognizable 
variety of primate superficial layers (that contain~90% of CPN), as compared to rodent superficial layers 
(that contain only ~80% of CPN), and from the noticeably larger relative volume of cortical white matter 
tracts found in primates than rodents, including the corpus callosum, through which CPN axons project 
(Smart et al., 2002a). Recent studies in mouse have identified genes enriched in distinct populations of 
CPN, including those of deep layers, superficial layers, and sublaminae within each population (Chapter 2 
and (Molyneaux et al., 2009)).   
In the work presented here, I address the hypothesis that cortical neuronal diversity in primates might 
include molecular expression conserved with that in rodent, revealing more comparative commonality 
and subpopulation diversity in subpopulations of CPN in macaque and mice than previously recognized.  
Newly identified molecular controls over CPN subtype diversity in mouse might reflect a non-
histologically recognizable molecular pattern shared among mammals that likely arose before the 
divergence of rodents and primates, and the dramatic expansion of primate superficial layers.  I find that, 
while expression of CPN-enriched genes in early cortex (Ptn, Nnmt, Dkk3, Lmo4, Inhba, and Tmtc4) and 
later deep neocortical layers are conserved (Cited2, Dkk3, Plexin-D1, and Gfra2), gene expression in 
superficial layer CPN shows more varied levels of conservation of expression, suggesting conservation 
and/or expansion of some superficial CPN populations in macaque (Nnmt ,Chn2, and EphA3), 
independent expansion of some in mouse (Limch1), and even emergence of others in macaque (Gfra2).   
Together, these data inform future comparative studies of the many subpopulations of CPN that can be 
effectively studied in mouse, which ones are unique to primates, and evolutionary relationship(s) between 
the two. 
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6.2 Introduction 
The neocortex is the seat of complex cognitive, perceptive, and motor function in mammals(Rakic, 
1988).  As such, it has undergone dramatic expansion throughout mammalian evolution, reflected in 
taxonomical size and complexity increase in primates not present in rodents.   
The fossil record of soft tissues, including the nervous system, is lacking(de Sousa, 2007); therefore, 
comparative analysis of current species enables study of conserved features that likely arose from 
common ancestors containing the shared features that were then independently selected upon by 
evolutionary forces to produce contemporary species present today.  Since the divergence of mammalian 
ancestors from the sauropsid ancestors of reptiles and birds over 315 million years ago, the cortex has 
undergone considerable radial expansion with substantial, disproportionate increase in neuronal numbers 
in the superficial cortical layers II-IV among mammalian species (Reiner, 1991; Marín-Padilla, 1992; 
Reiner, 1993; Aboitiz et al., 2003). The sauropsid cortex contains only three layers, which are thought to 
be homologous to layers I, V and VI of the six-layered mammalian cortex because of the output 
properties of the neurons present, and because of a lack of neurons with properties of mammalian 
superficial layer projection neurons (Reiner, 1991). Distinct members of the mammalian class exhibit 
neocortical expansion as complexity arises, with the primate cortex exhibiting further expansion than 
rodents.  The basal state of six canonical layers seen in mammals has enlarged in primates to include new 
subdivisions that can be easily distinguished at the histological level, while rodents and other small-
brained mammals have less prominent neocortical variety(Rakic and Kornack, 2001; Smart et al., 2002b).  
Of particular note and of direct relevance to callosal projection neurons (CPN), is the 
disproportionately large expansion of superficial layers in primate cortex.  Rodent layer II/III is 
histologically indistinguishable.  Hhowever, in primate neocortex, superficial layers are discrete layers II 
and III, containing multiple histologically distinct sublayers, not found in rodents (Figure 6.1). Since there 
is definitive support for the SVZ origin of superficial layer neurons (Wu et al., 2005), expansion of the 
SVZ might represent an evolutionary mechanism to increase the number of neurons within the neocortex, 
especially during generation of neurons of superficial layers (Smart et al., 2002a; Kriegstein et al., 2006). 
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Most CPN are contained within superficial cortical layers not present in sauropsids (Manzoni et al., 
1986). In fact, the corpus callosum (CC), and thus CPN, are found exclusively in placental mammals 
(eutheria) and have not been observed in any non-placental animal species studied(Aboitiz and Montiel, 
2003; Mihrshahi, 2006).  The presence of cortical superficial layers correlates quite well with emergence 
of CPN, although a significant proportion of CPN reside in deeper layers (~10% in primates; ~20% in 
rodents).  However, not all six-layered cortices contain CPN.  Particularly interesting are non-placental 
mammals, including marsupials.  For example, the marsupial short-tailed opossum possesses a six-layered 
cortex quite similar histologically and molecularly to that of rodents (Puzzolo and Mallamaci, 2010), but 
does not have a CC.  Together, these data suggest that a six-layered cortex with superficial layer neurons 
is required for, but not sufficient to guarantee modern CPN.  However, the presence of deep layer CPN 
suggests that the first CPN might have arisen in a cortical structure without superficial layer neuronal 
populations. 
With delineation of layers II and III in primate cerebral cortex, it is possible to address distinct cell 
types that populate these neuroarchitecturally distinct laminar units.  Just as in rodents, both layers II and 
III contain associative local neurons.  The expanded superficial layers also reflect a larger population of 
CPN since (as noted above) only ~80% of mouse CPN are in superficial layers, while over 90% of 
primate CPN are located in superficial layers, with layer V CPN remaining a significant, but smaller 
population of CPN (Manzoni et al., 1986).  In addition, expansion of cortical superficial layers correlates 
with expansion of cortical and interhemispheric white matter, indicating that expansion of superficial 
layers is, at least in part, due to expansion of CPN populations. However, while CPN in mouse are evenly 
distributed throughout layer II/III (See Figure 6.2D), essentially all superficial layer primate CPN in 
sensorimotor neocortex are restricted to layer III, and most specifically concentrated in deeper layer III 
(IIIb) (Jones and Wise, 1977; Killackey et al., 1983; Manzoni et al., 1986).  Layer II in primate cortex 
(external granular layer) is very dense, and contains small local interneurons (granule cells) and some 
slightly larger ipsilateral associative pyramidal cells(Lund et al., 1993; Swenson, 2006), but essentially no 
contralateral projecting CPN.  These data suggest that either mouse layers II/III contain a mixture of all of  
 270 
Figure 6.1: Schematic representation and cytoarchitectural view of mouse and macaque somatosensory 
neocortex. 
 
(A) Schematic representation of developing and adult mouse and macaque cortex in S1, drawn to a 
common internal scale.  (B) DAPI nuclear stain at mid-corticogenesis (E14/ E94) and after neuronal 
migration (P3/ E108) in macaque to show cytoarchitectural layers in S1.  
 
Scale bars: B,100 µm. E, embryonic day; P, postnatal day; VZ, ventricular zone; SVZ, subventricular 
zone; SP, subplate; ISVZ, inner subventricular zone; IFL, inner fibrous layer; OSVZ, outer subventricular 
zone; OFL, outer fibrous layer; CP, cortical plate; S1, primary somatosensory area; Roman numerals 
indicate cortical layers.  A adapted from (Fame et al., 2011) 
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these neuron types that segregated upon expansion in primate cortex, and/or new neuron types have 
emerged to populate the expanded regions of primate neocortex.   
By routine histology, it has appeared that the level of diversity evident in primates does not exist in 
mouse; however, our recently published data revealing molecular diversity of rodent CPN (Molyneaux et 
al., 2009) potentially reveals parallel diversity in mouse.  Cortical neuronal diversity in primates might 
have molecular correlates in mice, and newly identified molecular controls over CPN subtype diversity in 
mice might reflect an evolutionarily older, non-histologically recognizable, shared molecular expression, 
and therefore function, not revealed by examining the overall expansion of superficial layer size in 
primates.  To test this hypothesis, I have selected a set of genes expressed by distinct populations in mice 
that I hypothesize might be new candidates to identify heterogeneity within laminar populations in 
primates and investigate whether they are likely homologous populations with conserved gene expression 
patterns between the two species. 
Unlike many genome-wide, layer-specific, or microdissection regional-specific gene expression 
analyses in primate and mouse (Donoghue and Rakic, 1999b; Donoghue and Rakic, 1999a; Johnson et al., 
2009; Wang et al., 2009; Ip et al., 2011; Bernard et al., 2012), this study addresses the intersection of 
laminar molecular diversity within a specific population of neocortical projection neurons, CPN, and 
which subtypes of this evolutionarily-motivated population have been conserved or expanded molecularly 
during primate evolution. In addition, many studies of comparative genomics have identified a trend that 
most mutations in developmentally acting genes occur in regulatory regions rather than coding regions, 
further motivating the importance of examining gene expression patterns and timing to gain insight into 
conservation of critical developmental controls(Stern and Orgogozo, 2008).  Here, I report that many of 
the molecular controls over CPN diversity are conserved in general expression between mouse and 
macaque, with notable distinctions, predominantly in superficial layer CPN.  These distinctions in 
superficial layer CPN likely reveal cell-type complexity in mouse and macaque that has not yet been 
correlated between the two species, nor molecularly defined in macaque. 
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6.3 Materials and Methods 
6.3 a. In situ hybridization probe design 
All macaque in situ hybridization probes were designed to closely match homologous regions of 
corresponding mouse mRNA that were recognized by Molyneaux, et al (Molyneaux et al., 2009), reported 
here in Chapter 2.  Optimized primers were then chosen to amplify between 400 and 900 bp of this 
conserved region (see Table 6.1).  Since the macaque genome is not fully annotated, not all of the 
sequences could be obtained from verified sequences and, therefore, some were obtained from NCBI 
predicted homologs or whole chromosome shotgun sequencing data.   
 
6.3 b. RNA extraction, and first strand cDNA synthesis and library construction 
Total RNA was extracted from frozen E85 macaque neocortex tissue following the product insert 
instructions for organic RNA extraction with TRIzol ® Reagent (Invitrogen Life Sciences). First-strand 
cDNA was synthesized using Oligo(dT) primers (25ng/µL) and total RNA (0.5ng/µL),  following the 
product insert instructions for Superscript II ® reverse transcriptase (Ambion Life Sciences). To remove 
RNA complementary to the cDNA, E. coli RNase H (0.1U/µL) was added and incubated at 37° C for 20 
min.  This single stranded DNA was then used as template for PCR (sequences of all primers used are 
listed in table 6.1), and cloned into TOPO II ® (Invitrogen Life Sciences) bacterial vectors using 
appropriate restriction enzymes (New England Biolabs). 
 
6.3 c. In situ hybridization  
Nonradioactive colorimetric in situ hybridization was performed using probes labeled with dig-UTP.  
Sense probes were used as negative controls in all experiments.  
For in situ hybridization, 25 µm cryosections of fixed (4% PFA), cryoprotected (30% sucrose) E94 or 
E108 macaque forebrain were mounted on superfrost plus slides ® (Fisher Scientific) and were postfixed 
in 4% PFA in PBS for 10 min., rinsed in PBS for 3 min., permeabilized in 0.3% Triton X-100 (Sigma) 
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followed by RIPA cell lysis buffer [150 mM Sodium chloride, 1% Triton X-100, 1% deoxicholic acid 
sodium salt, 0.1% sodium dodesyl sulfate, 50 mM Tris-HCl, pH 7.5, 2mM EDTA], re-fixed in 4% PFA, 
acetylated for 15 min. in 0.1M triethanolamine/ 0.4% HCl/0.25% acetic anhydride (Sigma), and then 
preybridizied for 1 hour in 65°C hybridization buffer [50% formamide, 5x SSC, 5x Denhardts [1µg/mL 
Ficoll 400, 1µg/mL Polyvinilpyrrolidone, 1µg/mL BSA] , 500µg/mL sheared salmon sperm DNA, 
250µg/mL Yeast RNA].  Slides were incubated overnight (14-20 hours) at 65°C in 2µg/mL dig-labeled 
probe in hybridization buffer coverslipped with GeneFrame ® adhesive spacers (Thermo Scientific) in a 
well-humidified oven.  Slides were then subjected to stringency washes in 2x SSC/ 50% formamide/ 0.1% 
Tween-20 at 65°C for 1 hour each. Sections were then rinsed in MABT [0.9M maleic acid (Sigma), 0.1M 
NaCl (Sigma), 0.0005% Tween 20 (Sigma), 0.175M NaOH (Sigma)] at RT, blocked in 10% goat serum 
in MABT, and incubated overnight in goat alkaline phosphatase-conjugated anti-dig (1:1000, Roche) 
primary antibody in block, rinsed with MABT, followed by 30 a min. wash in alkaline phosphatase 
reaction buffer [100mM Tris pH 9.5, 50mM MgCl2, 100mM NaCl, 0.1% Tween-20].  The alkaline 
phosphatase reaction was developed with NBT/BCIP in phosphatase reaction buffer, changing to fresh 
solution every 1-4 hours at RT or every 6-9 hours at 4°C.  When the reaction was judged complete (48-
100 hours), tissue was rinsed in 0.1% Tween-20 in PBS, postfixed in 4% PFA for 30 min, counterstained 
for 1 min. in 1:10,000 4',6-diamidino-2-phenylindole (DAPI), and rinsed in 0.033M PB [27mM dibasic 
sodium phosphate, 6.3mM monobasic sodium phosphate].  Slides were coverslipped with Fluromount ® 
(Sigma), dried, and edges were protected with clear nailpolish. 
For older E108 tissuse, an additional permeabilization step with proteinase K (Sigma) treatment 
[10µg /mL enzyme in 0.005M EDTA, 0.05M Tris, pH 8.0] for 10 min. at room temperature was added 
after the RIPA permeabilization. 
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6.3 d. Immunocytochemstry  
Immunostaining was largely performed as described in Chapter 3.  However, all 
immmunocytochemical reactions were performed on 25 µm  cryosections of fixed (4% PFA), 
cryoprotected (30% sucrose) E94 or E108 macaque forebrain mounted on superfrost plus slides ® (Fisher 
Scientific).  These were then warmed to room temperature and postfixed in 4% PFA in PBS for 10 min., 
rinsed in PBS for 3 min. and stained as previously described.  Antigen retrieval in 0.1M citric acid 
(pH=6.0) for 10 min. at 95-98°C was used for CAV1 and LMO4 staining as described in Chapters 3 and 
4.  Primary antibodies were used as follows: mouse-anti-CAV1, 1:500 (Cell Signaling #3238), goat-anti-
LMO4, 1:200 (Santa Cruz Biotech SC- 11122), rabbit-anti-Nectin-3, 1:500 (Abcam ab63931).   
 
6.3 e. Microscopy and image analysis 
Images were acquired using a Nikon E90i microscope, using a 1.5 megapixel cooled CCD digital 
camera (Andor Technology, Dublin, Northern Ireland), a 5 megapixel color CCD digital camera (Nikon 
Instruments, Melville, NY), and Elements acquisition software (Nikon Instruments, Melville, NY). All 
analysis was performed in primary somatosensory area (S1) unless otherwise noted. 
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Table 6.1: Detailed Information About the Clones Used for In Situ Hybridization 
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6.4 Results 
6.4 a. In situ hybridization protocol detects mRNA in macaque tissue 
Because each new tissue preparation and worksite setup is different and can influence the outcome of 
in situ hybridization results, and particularly because this tissue was prepared in a different lab than that in 
which analysis of gene expression was to be performed, I chose a control probe known to be highly 
conserved with laminar expression in layers V (high expression) and VI (low expression) between mouse 
and primate, Fezf2 (Molyneaux et al., 2005; Ip et al., 2011) (Kwan et al., 2008) (Padmanabhan, HK and 
Sohur, US; unpublished observations).  In mouse, Fezf2 is expressed at high levels by corticospinal motor 
neurons (CSMN) at at lover levels by corticothalamic projection neurons (related corticofugal neurons), 
and is necessary and sufficient to produce CSMN, but is excluded from CPN.   I confirmed that the 
macaque tissue, handling, and protocol can provide accurate gene expression results. 
At E94 in macaque (mid-corticogenesis), Fezf2 expression is conserved as strongly expressed in the 
cortical plate. (Figure 6.2A).  At E108, when neocortical projection neurons have fully migrated to their 
final laminar positions, Fezf2 is expressed highly in layer V, and at lower levels in layer VI (Figure 6.2B).  
This is similar to reported expression of Fezf2 in mouse by layer V CSMN (high level) and layer VI 
CThPN(Chen et al., 2005a; Chen et al., 2005b; Molyneaux et al., 2005; Rouaux and Arlotta, 2010). This 
expression in macaque both confirms previous findings (Ip et al., 2011) (Kwan et al., 2008), and validates 
the chosen approach for comparing macaque and mouse gene expression. 
  
6.4 b. Genes expressed by CPN early in mouse development are similarly expressed in macaque 
Because some of the CPN subtype-specific genes are expressed very highly early in development, and 
because early expression is thought to be more likely conserved between species than later (Donoghue 
and Rakic, 1999b; Donoghue and Rakic, 1999a), I examined expression of 7 genes in E94 macaque 
cortex that are expressed early in mouse CPN development.  Strikingly, subventricular zone (SVZ) 
expressed genes are conserved in expression between mouse and macaque, including Ptn, Nnmt, Dkk3, 
and Lmo4.  In addition, most post-mitotic, cortical plate gene expression is also conserved with Lmo4, 
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Nnmt, Dkk3, and Inhba..  In addition, cortical plate gene Epha3 has been shown previously to have 
similar cortical plate expression in macaque earlier at E65, but restricted to caudal cortex(Donoghue and 
Rakic, 1999b; Donoghue and Rakic, 1999a).  Together, thes data suggest that these early populations of 
progenitors and immature post-mitotic neurons are extremely similar in early gene expression between 
mouse and macaque.   
Populations of neurons and progenitors are molecularly defined not only by positive expression of 
genes, but also by the lack of expression of other, inappropriate factors.  Therefore, I also investigated 
expression of 3 genes expressed by CPN at late stages in development, but not expressed early in mouse: 
Gfra2 and Tmtc4.  Neither of these exclusively later genes were expressed in the early E94 macaque 
cortical plate or progenitor zone, suggesting that the examined CPN genes expressed in early macaque 
cortex are both positively and negatively regulated in similar populations as in mouse.   
A notable exception to the largely conserved early expression of developmentally regulated 
neocortical control genes is that of the cell adhesion and guidance molecule Plexin-D1.  By E14 in mouse, 
Plexin-D1 is strongly expressed by immature neurons of the cortical plate as they begin to extend their 
axons, however no Plexin-D1 expression is observed in E94 macaque cortical plate (Figure 6.3D).  In 
section 6.4c, below, I show that postmigratory expression of Plexin-D1 is conserved between mouse and 
macaque.  Therefore, this lack of  Plexin-D1 expression in early macaque cortex likely reflects changes in 
gene regulation affecting timing of Plexin-D1 expression by migrating immature neurons.  
The above data add to a growing body of work revealing similarities and differences between rodents 
and primates in this population of progenitors and early post-mitotic neurons(Donoghue and Rakic, 
1999b; Donoghue and Rakic, 1999a; Johnson et al., 2009; Ip et al., 2011; Bernard et al., 2012). This 
current focused study specifically examines radial similarities between mouse and primate, and finds 
general conservation of expression during early developmental processes in mouse and macaque 
neocortex.  This work does not, however, address tangential areal molecular compartmentalization, which 
have been shown to be additionally complex in primates compared to mouse (Donoghue and Rakic, 
1999b; Donoghue and Rakic, 1999a).   At the earliest areal organization stages of development, most  
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Figure 6.2: Fezf2 is detectable in macaque tissue using current in situ hybridization approach 
(A) in situ hybridization at E94 in macaque and E14 in mouse for Fezf2, showing early similarities in 
expression between mouse and macaque. (B) in situ hybridization at E108 in macaque and P3 in mouse 
for Fezf2, confirming early similarities in expression between mouse and macaque, and validating the 
chosen approach.   
 
Scale bars: A,  µm;  B,100 µm. E, embryonic day; P, postnatal day; VZ, ventricular zone; SVZ, 
subventricular zone; IZ, intermediate zone; CP, cortical plate; S1, primary somatosensory area; Roman 
numerals indicate cortical layers.  E14 mouse in situ from GenePaint digital expression atlas 
www.genepaint.org 
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Figure 6.3: At E14.5 and E94, early expressed CPN genes are similarly expressed in mouse and macaque 
(A) in situ hybridization at E94 in macaque and E14 in mouse for early expressed CPN genes, shows 
early similarities in expression between mouse and macaque. (B) in situ hybridization at E94 in macaque 
for exclusively later expressed CPN genes in mouse demonstrates negative, as well as positive, molecular 
similarities between radial populations in mouse and macaque neocortex. (C) in situ hybridization at E94 
in macaque reveals some non-conserved timing in gene expression by early neocortical neurons.  
 
Scale bar: A, 100 mm. E, embryonic day; P, postnatal day; VZ, ventricular zone; SVZ, subventricular 
zone; IZ, intermediate zone; CP, cortical plate; S1, primary somatosensory area; Roman numerals indicate 
cortical layers.  E14 mouse in situ from GenePaint digital expression atlas www.genepaint.org, except 
Tmtc4, which was performed in house as described in Chapter 5. 
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CPN have not yet emerged, though radial similarities found in this early population lend support for 
further investigations (addressed below) of these genes in specific, cell-type specific roles when the 
neocortex has formed. 
 
6.4 c. CPN genes expressed after migration reveal related CPN populations in mouse and macaque 
superficial cortical layers 
Throughout independent evolutionary divergence between rodent and primate neocortex, the 
superficial layers, which contain over 80% of CPN in rodents, have expanded the most of any of the 
laminar populations.  These expanded superficial layers in primate exhibit discernable subpopulations of 
cellular density and cell size that are not recognizable in mouse superficial layers.  Since some of the 
diversity identified in primate cortex superficial layers by traditional histology might exist as molecular 
diversity within superficial layer CPN in mouse, but might simply not be possible to observe by 
traditional histological analyses (Molyneaux et al., 2009), I directly compared expression of CPN-
enriched genes in mouse and macaque.  By E108 in macaque, all cortical neurons have migrated to their 
final laminar locations, but the neurons are still immature and likely to express genes critical to 
neocortical developmental processes.  Therefore, I chose E108 to first study CPN expressed genes in 
macaque.   
Both Nnmt and Chn2 very closely match expression between mouse and macaque.  Nnmt is expressed 
exclusively in the superficial portion of mouse layer II/III, and is limited to macaque layer II.  Chn2 is 
expressed in the deeper portion of mouse layer II/III, and is restricted layer III in macaque.  Interestingly, 
Chn2 is not expressed throughout macaque layer III, only in the more superficial regions of this layer, 
suggesting an even more segregated population of Chn2-expressing neurons in macaque(Figure 6.4A).  
Potentially, these might include populations of local associative neurons or even dual CON/local 
association neurons, since most CPN in macaque S1 are in deeper portions of layer III (Jones and Wise, 
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1977; Killackey et al., 1983; Manzoni et al., 1986), but this would have to be verified by retrograde 
labeling or other hodological analyses. 
The selected subset of superficial layer CPN genes also hints at populations of neurons that, while 
present in both rodent and macaque, are differentially dominant.   EphA3+ neurons are a quite restricted 
population in mouse cortex, yet they extend more broadly in macaque.   Limch1 is expressed in a 
specifically defined microlayer of most superficial layer II in macaque, but Limch1 is expressed 
throughout layer II/III in mouse (Figure 6.4A).  These examples suggest that mouse molecular diversity 
of CPN provides insight into some expanded populations of primate CPN, but does not contain all of the 
primate molecular diversity.  
 
6.4 d. CPN genes expressed after migration reveal related CPN populations in mouse and macaque 
deep cortical layers 
Deep cortical layers have not undergone the dramatic expansion of the superficial layers(Smart et al., 
2002b; Fame et al., 2011), however a significant proportion of CPN reside in deep layers (~20% in mouse 
and ~10% in macaque), and, therefore CPN are a very interesting deep layer population to study to gain 
insight into what expanded diversity, and if any, exists within deep layers.  Strikingly, all of the deep 
layer mouse CPN genes examined (Cited2, Dkk3, Plexin-D1, and Gfra2) are conserved in their deep layer 
expression in macaque, suggesting that deep layer CPN are likely to be evolutionarily consistent from 
rodent to primate (Figure 6.4B).  Interestingly, in addition to its conserved expression in layer Va and VI 
CPN in mouse and macaque, Gfra2 is also expressed strongly in superficial layer neurons in macaque, 
suggesting a potentially novel neuronal population of superficial layer macaque CPN.  Together these 
data suggest that, while expanded superficial layer CPN populations likely have refined and expanded, 
deep layer, evolutionarily older CPN have remained largely molecularly, and therefore potentially 
functionally, consistent. 
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Figure 6.4: At early postnatal times in mouse, and at E108 in macaque CPN genes reveal related CPN 
populations in mouse and macaque superficial and deep cortical layers. 
(A) in situ hybridization at E108 in macaque, and at P3/P6/P14 in mouse, for subpopulation-specific CPN 
genes, showing molecular similarities and differences in distinct populations of CPN in subcompartments 
within the canonical superficial cortical layers between mouse and macaque. (B) in situ hybridization at 
E108 in macaque and P3/P6 in mouse for subpopulation specific CPN genes, showing molecular 
similarities between deep layer radial populations in mouse and macaque neocortex   
 
Scale bars: A, B 100 µm. E, embryonic day; VZ, ventricular zone; SVZ, subventricular zone; IZ, 
intermediate zone; CP, cortical plate.  Postnatal mouse in situ from (Molyneaux et al., 2009). 
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6.4 e. Subcellular and functional areal localization of CPN-expressed proteins suggest related 
functions for conserved genes expressed by CPN populations 
The above analyses reveal molecular conservation and divergence between populations of CPN in 
distinct laminar locations within somatosensroy neocortical areas.  While comparative genomics has 
found many more changes in regulatory regions than in coding regions(Stern and Orgogozo, 2008), it 
remains unknown if genes expressed in mouse and macaque CPN have shared functionality within these 
neurons.  As a second read-out of potential conserved gene function (after temporal and laminar specific 
expression, as investigated above), I investigated whether proteins developmentally expressed in macaque 
cortex shared subcelular localization with those expressed by mouse CPN.   
To compare subcellular localization of subtype-specific proteins, I selected three proteins with 
distinct subcellular localization in mouse CPN: Nectin-3, with axonal white matter expression by 
superficial layer CPN axons in the CC (see Chapter 2), CAV1, with cell body and dendritic localization 
by a subpopulation of deep layer CPN (see Chapter 4), and LMO4, with nuclear expression in deep layer 
CPN of somatosensory cortex (see Chapter 3).  Strikingly, at E94, Nectin-3 is expressed specifically in 
white matter tracts in macaque developing neocortex (Figure 6.5A).  There is low expression in the cell-
dense cortical plate, higher expression throughout the cell-sparse subplate, and very high, fiber-localized 
expression in both the outer and inner fibrous layers.  With similar conservation, at E108, CAV1 is 
localized to neuronal cell membranes and apical dendrites, as well as to developing blood vessels, and 
LMO4 is expressed in nucleae of deep layer somatosensory neocortical neurons, as is seen in mouse. 
These data strongly support conserved function within shared neuronal populations for these gene 
products, suggesting not only that rodents and primates likely arose from shared ancestors with specific 
genetic controls over complex neocortical neuronal populations, but also support the viability of relating 
rodent studies of these proteins’ functions to human development and disease. 
Interestingly, both LMO4 and CAV1 are differentially expressed in particular neocortical areas in 
mouse.  I investigated whether this was a shared property between mouse and macaque, even though it 
might be modified by the increasingly complex process of primate cortical arealization as compared to 
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rodent.  Strikingly, areal restriction for both LMO4 and CAV1 are conserved.  LMO4 expression in motor 
cortex is throughout all neocortical layers instead of the more restricted expression in somatosensory 
cortex.  CAV1 expression is reduced in motor cortex in comparison to somatosensory.  Together, these 
data suggest that gene product function is likely shared for Nectin-3, CAV1, and LMO4 in rodents and 
primates, based on conserved protein subcellular localization and areal-specific expression between the 
two species, highly motivating current and future functional analyses of these proteins in mouse 
neocortical development, especially for human disease-linked genes.    
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Figure 6.5: Subcellular and functional areal localization of CPN-expressed proteins suggests related 
functions for conserved genes expressed by CPN populations 
Three proteins with distinct subcellular localization in mouse CPN were selected: LMO4, with 
nuclear expression in deep layer CPN of somatosensory cortex (see Chapter 3); Nectin-3, with axonal 
white matter expression by superficial layer CPN axons in the CC (see Chapter 2); and CAV1, with cell 
body and dendritic localization by a subpopulation of deep layer CPN (see Chapter 4).  (A) At E94, 
Nectin-3 is expressed specifically in white matter tracts in macaque developing neocortex.  There is low 
level expression in the cell-dense cortical plate, higher level expression throughout the cell-sparse 
subplate, and very high level, fiber-localized expression in both the outer and inner fibrous layers.  (B) 
LMO4 shows nuclear localization in deep layer somatosensory neocortical neurons, and CAV1 is 
localized to neuronal cell membranes and apical dendrites, as well as to developing blood vessels, as is 
seen in mouse. (C), Areal restriction for both LMO4 and CAV1 are conserved.  LMO4 expression in 
motor cortex is throughout all neocortical layers, instead of the more restricted expression in 
somatosensory cortex.  CAV1 expression is reduced in motor cortex compared to somatosensory cortex. 
 
Scale bars: 100 µm. E, embryonic day; P, postnatal day; VZ, ventricular zone; SVZ, subventricular zone; 
SP, subplate; ISVZ, inner subventricular zone; IFL, inner fibrous layer; OSVZ, outer subventricular zone; 
OFL, outer fibrous layer; CP, cortical plate; S1, primary somatosensory area; MCtx, motor cortex; Roman 
numerals indicate cortical layers. 
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6.5 Discussion 
It is interesting to speculate that the presence of a molecularly more diversified population of callosal 
neurons in the superficial layers of the rodent cortex (Molyneaux et al., 2009) might reflect a common 
ancestor for rodent and primate that had already undergone early stages of the expansion and 
diversification of these layers that occurred conspicuously during evolution of the primate cortex. While 
these layers cannot be distinguished at the histological level in rodents, genes that mark neurons located 
in distinct radial positions within layer II/III might support the hypothesis that specialization of distinct 
populations of CPN within upper layers are at least partially conserved in rodent cortex molecularly, and 
likely, then, also with regard to connectivity and function. This work directly investigates the expression 
of genes identified in distinct populations of mouse CPN within the macaque neocortex, to provide 
insight into cortical evolution and conservation/ expansion of neocortical projection neuron populations.  
The expansion of the superficial layers during cortical evolution has been accompanied by the 
expansion of a new germinal zone, the subventricular zone (SVZ), and by the appearance of intermediate 
progenitors within the SVZ that are larely fated to produce neurons of the superficial layers(Smart and 
McSherry, 1982; Martinez-Cerdeno et al., 2006; Molyneaux et al., 2007).  This is in contrast to reptiles 
and birds, in which cortical neurogenesis is reported to occur only in the ventricular zone (VZ)(Cheung et 
al., 2007). In mammals, progenitor populations have greatly expanded as cortical complexity has 
expanded(Smart et al., 2002a) from VZ and SVZ in rodent, to include and inner and outer SVZ region in 
primate cortex.  The progenitors of the inner SVZ (ISVZ) more closely resemble rodent SVZ intermediate 
progenitors; they express Tbr2, but down-regulate Pax6 (Fietz et al., 2010). The progenitors of the 
primate outer SVZ (OSVZ), conversely, are more similar to radial glial cells, both molecularly and 
morphologically (Smart et al., 2002a; Fietz et al.; Hansen et al.). Further, the radial glial-like progenitors 
of the OSVZ can undergo both symmetric, self-renewing divisions, as well as asymmetric, neurogenic 
and self-renewing divisions (Fietz et al., 2010; Hansen et al.). This capacity of OSVZ progenitors to 
undergo self-renewing asymmetric divisions to also generate progenitors that can further proliferate 
greatly enhances neuronal output, and may have been an important evolutionary step in the expansion of 
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the neocortex.  I find that many of the early expressed genes are consistent between rodent and primate 
(Ptn, Nnmt, Inhba, and  Dkk3), but none are overtly restricted to any of the primate-specific progenitor 
zones.  This likely reflects a more ancient evolutionary origin of CPN than previously identified, but also 
the potential for additional molecular complexity in primate progenitor domains than is observed in 
mouse.  
Superficial neocortical layers contain the overwhelming majority of CPN (~80% in mouse and ~90% 
in macaque), and have undergone extensive expansion over mammalian evolution.  Therefore, I 
hypothesized that some of the newly identified molecular controls over CPN development that divide 
superficial layers in mice might reflect a common origin for superficial layer CPN expansion identified in 
primates.  I found that some gene expression identified in mouse, including Nnmt and Chn2, very closely 
matches expression in macaque.  However, while mouse molecular diversity of CPN can suggest 
correlates to some expanded populations of primate CPN, it does not contain all of the primate molecular 
diversity, and has likely independently acquired unique populations critical for rodent cortical function.  
For example, EphA3 and Limch1, while both are expressed in rodent and macaque superficial layers, are 
expressed by differentially expansive populations. This suggests that some CPN populations common to 
mouse and macaque were additionally expanded in primates, whereas others were preferentially expanded 
in rodents.  These populations might reveal functional processing differences between mouse and 
macaque, and provide insight into CPN functions that are more dominant in human cognition. 
Deep neocortical layers contain a significant proportion of CPN (~20% in mouse and ~10% in 
macaque), but have undergone less extensive expansion over mammalian evolution than superficial 
layers.  Therefore, I hypothesized that most of the newly identified molecular controls over deep layer 
CPN development in mouse might be conserved in macaque.  I found that, indeed, all of the deep layer 
CPN genes that I studied are conserved between mouse and macaque (Cited2, Dkk3, Plexin-D1, and 
Gfra2).  Unexpectedly, Gfra2, expressed exclusively in layer Va and VI CPN in mouse, is, in addition to 
deep layer expression, also expressed strongly by superficial layer neurons in macaque, suggesting a 
potentially entirely new population of CPN that acquired genetic controls first employed by deep layer 
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CPN.  Deep layer CPN cross the midline before superficial layer CPN in development, and are related 
molecularly and by birthdate to corticofugal neurons, leading to the hypothesis that deep layer CPN were 
modified from existing corticofugal neuronal populations to become the first to cross the midline early in 
evolution(Lai et al., 2008; Azim et al., 2009a; Fame et al., 2011).  Therefore, similar mechanisms of 
repurposing existing populations might be at play in the Gfra2-expressing population of superficial layer 
neurons in macaque, to expand superficial layer CPN from other populations, potentially from associative 
neurons.        
In addition to CPN, both superficial and deep neocortical layers contain other populations of neurons.  
Deep layers predominately contain corticofugal neurons.  Superficial layers, while mostly CPN, also 
contain large populations of local associative neurons.  In addition, all layers contain interneurons.  While 
the genes examined here were identified in a comparative microarray analysis to identify genes more 
highly expressed by CPN than by CSMN, and while many were validated as CPN-expressed in mouse 
(Chapter 2 and (Molyneaux et al., 2009)), knowing the connectivity of the neurons expressing these genes 
in macaque will likely give significant insight into CPN populations in macaque.  Due to the difficultly of 
manipulating embryonic macaques, we were not able to perform retrograde labeling early enough to have 
E108 tissue with labeled CPN.  However, now that expression of some of the target genes is validated at 
this age, it will now be possible to perform CPN retrograde labeling, and look for expression of these 
CPN genes later in development.  While expression levels for most of the superficial layer genes decrease 
as neurons mature in mouse, it is possible that some could still be expressed in macaque at a time when 
CPN retrograde labeling is possible.  
Complementary to comparative gene expression results in radially expanded neocortical neuronal 
populations, I also investigated comparative subcellular localization of CPN-expressed gene products 
between mouse and macaque to gain insight into conserved gene function within these comparative 
subpopulations of CPN. I found that protein subcellular localization for Nectin-3, CAV1, and LMO4 is 
conserved between mouse and macaque, with Nectin-3 in axonal white matter, CAV1 in cell membranes 
and apical dendrites, and LMO4 localized to nuclei.  Additionally, differential expression in distinct 
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cortical functional areas is also conserved for CAV1 and LMO4.  While conserved gene expression 
reflects conserved gene regulatory regions, this identified conserved protein localization also suggests 
conserved gene product function. 
While evident differential expansion has occurred in rodent and primate neocortices, both contain 
CPN, and, therefore, it is likely that conserved gene expression at least partially maps onto conserved 
CPN populations.  However, cortical expansion in marsupials is not as easily compared.  Significant 
cortical expansion to distinct layers II and III in some marsupial species has occurred without CPN.  
Therefore, understanding relationships between gene expression in particular CPN subpopulations in 
mouse and macaque, and comparing with large cortices in marsupials, might give interesting insight into 
evolutionary origins of marsupial connectivity and cortical expansion. 
The data presented here provide the first molecular comparison of callosal projection neuron 
subpopulations in the rodent and primate cortex. Such comparative information will likely be useful for 
defining both abilities and limits of rodent research to understand some of the complex integrative 
functions of primate neocortex.  Laminar distribution analysis of some recently identified mouse CPN 
genes in macaque reveals the comparative identity of molecularly distinct subpopulations that had not yet 
been previously described at the histological, morphological, or anatomical levels in mouse.  It is likely 
that distinct combinations of molecular developmental controls define key aspects of CPN diversity in 
both species – subtype-specific differentiation, axon collateralization, synaptic connectivity, and 
physiologic function – underlying their central roles in interhemispheric association and connectivity.  
Together, these data provide a foundation of evolutionary relationships to inform future studies about 
which complex subpopulations of primate CPN can be studied with molecular and genetic approaches in 
mouse and which are uniwue to primate neocortex.   
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7.1 Discussion  
Around the beginning of the 19th century, a building fascination with the brain and nervous system 
began to focus on the neuron as the basic cellular unit of the brain, enabling its function.  Santiago Ramón 
y Cajal, armed with the Golgi method to sparsely label individual neurons, argued passionately in support 
of the “neuron hypothesis”, and against contemporaneous “protoplasmic” and “diffuse” network 
hypotheses(Cimino, 1999; López-Muñoz et al., 2006; DeFelipe, 2010).  Even though the debate 
continued for almost another century, it was clear that neurons were not merely identical, repeating units 
of neural tissue, but, rather, great diversity of neuronal types from distinct areas of the nervous system 
were described by physical features, and their organization in relation to one another suggested diversity 
even within populations of neurons with the same general location and cell body properties.  The cerebral 
cortex is particularly interesting because it is highly organized into laminae, with all layers containing 
large pyramidal projection neurons.   
With the emergence of advanced optical, molecular, connectivity tracing, and electrophysiological 
techniques, more and more evidence supports functionally important diversity among pyramidal 
neocortical projection neurons, clearly indicating that better understanding of neuronal subtypes and their 
development is essential to understanding brain function.  Within this decade, molecular controls over 
specification, development, and maturation of neocortical projection neuron subtypes have begun to be 
identified, and their functions characterized(Ma et al., 2002; Arlotta et al., 2005; Chen et al., 2005a; Chen 
et al., 2005b; Mitchell and Macklis, 2005; Molyneaux et al., 2005; Molnár and Cheung, 2006; Hattox and 
Nelson, 2007; Alcamo et al., 2008; Britanova et al., 2008; Chen et al., 2008a; Joshi et al., 2008b; Kwan et 
al., 2008; Lai et al., 2008; Anderson et al., 2010; Cubelos et al., 2010) (Leone et al., 2008). 
 Here, in this dissertation, I describe further diversity between subtypes within one broad 
projection neuron population, callosal projection neurons (CPN).  CPN are excitatory pyramidal neurons 
that connect the two cerebral hemispheres via axons that pass through the corpus callosum (CC).  They 
are restricted to placental mammals, and are a disproportionately large portion of the neocortical 
projection neurons of animals with larger brains, suggesting their critical roles in information processing 
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and cognition.  I begin by identifying new molecularly defined subpopulations of CPN that reside within 
distinct neocortical laminae(Molyneaux et al., 2009).  I follow this identification with functional analysis 
of three genes and their products that are candidate controls over development of CPN diversity: 1) 
Cited2 early in broad development of intermediate progenitor cells, and later specifically in CPN of 
somatosensory cortex; 2) Caveolin1 (Cav1) in a specific population of dual projecting CPN with an 
additional connection to ipsilateral frontal neocortex; and 3) Tmtc4 in axonal development of CPN 
projections.  I end with a comparative molecular analysis of genes expressed by specific CPN 
subpopulations in mice compared to expression in macaque, which contain disproportionately more CPN 
compared to other neocortical projection neurons in their large cerebral cortex.  Together, the results 
support the hypotheses that 1) CPN are an immensely diverse set of subpopulations controlled by 
specific, combinatorialy interacting genes that function progressively to enable acquisition of CPN 
subtype identities in addition to broad laminar, cell type, or areal controls over neocortical development; 
and 2) that many of these combinatorially interacting genes are conserved between rodents and primates, 
while others have diverged in their expression over evolution. 
 
7.1 a. Progressive acquisition of neocortical projection neuron identity 
  Establishing progenitor domains 
In the neocortex, the first broad division of neuron type, excitatory versus inhibitory, is segregated at 
the progenitor domain level.  Neocortical excitatory projection neurons arise from dorsal, or pallial, 
progenitors, while inhibitory neurons arise from ventral, or subpallial, progenitors.  Upon induction of the 
telencephalon by gradients of extracellular signaling molecules such as sonic hedgehog, fibroblast growth 
factors, and bone morphogenetic proteins (Rallu et al., 2002), a set of repressive transcription factor 
interactions establish a pallial neocortical progenitor identity as distinct from subpallial progenitor 
identity. These transcription factors include Lhx2, Foxg1, Emx2, Pax6, and Sox6, each of which plays 
crucial roles in specifying the progenitors that give rise to projection neurons of the neocortex. Together, 
these five transcriptional regulators establish the neocortical progenitor domain by repressing dorsal 
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midline (Lhx2 and Foxg1) and subpallial fates (Emx2, Pax6, and Sox6), a critical first step in the initial 
specification of neocortical projection neuron identity.   
Work described in the Appendix of this dissertation further explores this early process of progenitor 
domain formation involving the SRY-type HMG box (SOX)-containing transcription factors Sox5 and 
Sox6, which play a critical cross-repressive role in parcellation of the proliferative neuroepithelium at the 
pallial-subpallial boundary(Azim et al., 2009a). Sox6 and Sox5 are complementarily expressed in pallial 
and subpallial progenitors, respectively, and Sox6 controls the segregation of pallial from subpallial 
progenitors by repressing the expression of Mash1 and downstream subpallium-specific programs in 
pallial progenitors(Azim et al., 2009a). Interestingly, despite the partial ventralization of Sox6 null pallial 
progenitors, Pax6 and Ngn2 are expressed normally in the Sox6 null pallium, and projection neuron 
laminar distribution and subtype- and layer-specific molecular expression are largely normal, though 
inappropriate subpallial and interneuron genes are co-expressed, forming seemingly “confused” neurons. 
Thus, Sox6 critically maintains pallial progenitor identity by repressing subpallial programs of gene 
expression, but redundant and/or compensatory controls (for example, Ngn2 and Ngn1) persist that are 
sufficient to ensure somewhat appropriate pallial corticogenesis, indicating that Sox6 likely acts 
cooperatively with Ngn2 to control the segregation of telencephalic progenitor domains during 
development(Azim et al., 2009a). 
 
Projection neuron type specification 
All neocortical projection neurons arise from pallial progenitors that progressively generate projection 
neuron types.  The broad types of neocortical projection neurons are corticofugal projection neurons 
(CFuPN), including corticothalamic projection neurons (CThPN) and subcerebral projection neurons 
(SCPN), which in turn include corticospinal motor neurons (CSMN) and corticotectal projection neurons 
(CTPN); and commissural callosal projection neurons (CPN).  Differences in birthdate translate to 
differences in laminar location, with deep layers born early, and more superficial layers born later.  
CThPN all reside in layer VI, and are, therefore, born from early progenitors.  SCPN reside in layer V and 
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are born from slightly later progenitors than CThPN.  A molecularly controlled temporal shift in 
progenitor capacity can help explain generation of these distinct neuron types. In addition to progenitor 
change, sequential generation of neuronal types is postmitotically controlled from subplate neurons 
(earliest born corticofugal projection neurons), through corticothalamic neurons, to corticospinal motor 
neurons. Sox5 controls this sequential generation of corticofugal projection neuron subtypes by 
progressively reducing its repression (via Sox5 down-regulation) of genes required for differentiation of 
later generated subtypes, ultimately CSMN, preventing premature emergence of normally later-born 
neurons during early stages of corticogenesis (Lai et al., 2008).   
CPN, however, are generated throughout neocortical development, and reside in layers II/III, V, and 
VI; they are intermingled with CFuPN, and temporal differences in generation cannot alone explain their 
neuron type identity.  In 2008, the first critical molecular regulator of broad CPN specification, special 
AT-rich sequence-binding protein 2 (SATB2), was identified and characterized as a DNA-binding 
transcription factor expressed by CPN(Alcamo et al., 2008; Britanova et al., 2008).  SATB2 is necessary 
for specification of CPN through repression of COUP-TF interacting protein 2 (CTIP2), a transcription 
factor critical for CSMN axon outgrowth and fasciculation(Arlotta et al., 2005; Molyneaux et al., 2007).  
In the absence of SATB2 function, neurons that would have extended axons across the corpus callosum 
instead project subcortically through the internal capsule and take on some molecular and 
electrophysiological characteristics of CFuPN(Chen et al., 2008a).   Other pan-callosally expressed genes 
such as Lpl and Hspb3, identified in work presented here in Chapter 2, might similarly be broad controls 
over CPN identity, specifying them from other projection neuron types. 
 
Projection neuron subtype identities 
Subtypes exist within all populations of neocortical projection neurons and have been identified by 
physical cell body location or shape, connectivity, electrophysiological properties, or molecular 
expression.   As a first level of diversity, many of these subtypes have been defined by axonal projection 
specificity and cell body location.  For example, CThPN are defined by their projections from the 
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neocortex to the thalamus, however subpopulations within this broad population exist that project to 
unique functional thalamic nuclei(Galazo et al., 2008{Miller, 1993 #2653; Watakabe et al., 2012)}.   
Similarly, tightly regulated subpopulations of CSMN are diverse and extend axons to specific levels of 
the spinal cord to control motor function in diverse body sections(Penfield, 1937). Within CPN, 
subpopulations are found in distinct functional areas and laminae(Koralek et al., 1990; Conti and 
Manzoni, 1994; Reiner et al., 2003; Ramos et al., 2008; Molyneaux et al., 2009), with homotopic and, 
sometimes, additional heterotopic axonal connections}(Wilson, 1987; Cauller et al., 1998; Mitchell and 
Macklis, 2005).  Thus, subpopulations within broad types of neocortical projection neurons exist and have 
critical functions that are distinct and specialized even more than those of the more general neuron type.  
 
7.1 b. CPN diversity 
Results published earlier, and those presented here, indicate many categories of subtype diversity 
within the broad population of CPN(Wilson, 1987; Cauller et al., 1998; Mitchell and Macklis, 2005; 
Molyneaux et al., 2009)}(Koralek et al., 1990; Conti and Manzoni, 1994; Reiner et al., 2003; Ramos et 
al., 2008).  These include birthdate, laminar location, axonal projection connectivity, areal identity, and 
molecular expression.  These levels of diversity are all significant, and likely influence one another.   
Molecular expression is rarely simply a marker of no function but, rather, expressed genes are typically 
controls over specific properties or developmental processes.  Location of CPN cell bodies in multiple 
cortical laminae not only reflects distinct birthdates from progenitors with distinct potential and/or 
subtype restriction, but also indicates distinct connectivity patterns. In rat, deep layer CPN (layers V and 
VI) provide about 80% of the CPN collaterals connecting primary motor cortex to primary somatosensory 
cortex, and some deep layer CPN have also been shown to project to secondary somatosensory cortex and 
the claustrum, in addition to the striatum(Veinante and Deschenes, 2003).  In contrast, superficial layer 
CPN more likely participate in local column circuitry, sending short collaterals to pyramidal neurons 
within layer II/III, more strongly to layer V, and to pyramidal and stellate neurons in layer VI, in both 
ipsilateral and contralateral hemispheres (Petreanu et al., 2007). CPN in distinct functional areas have 
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been shown to be differentially myelinated in human brain (Aboitiz et al., 1992a), they respond 
differently to activity-based pruning(Innocenti et al., 1977; Norris and Kalil, 1992), and they send 
homotypic axons to different functional areas to transmit diverse functional modalities.  Gene expression 
in distinct populations of CPN might convey some of these attributes, and restricted CPN gene expression 
in not yet functionally uncategorized populations, might allow identification of new functional subtypes. 
Recently, molecular controls that act specifically in subclasses of CPN have begun to be identified.  
The transcription factor activator enhancing binding protein 2 gamma (AP2γ)  acts specifically in a subset 
of radial glia cortical progenitors to specify SVZ intermediate progenitors to enable the switch from 
proliferative to neurogenic division, and generating a specific subpopulation of superficial layer CPN in 
visual cortex(Pinto et al., 2009). Interestingly, while the action of AP2γ  is highly area specific, the 
expression of AP2γ is not, suggesting an areally-restricted partner or compensatory activity. In addition, 
Cux1 and Cux2, previously discussed as layer-specific identifiers, regulate dendrite branching, spine 
development, and synapse formation specifically in layer II/III CPN(Cubelos et al., 2010). These subtype-
specific controls are important for understanding the diversity that exists within, and is integral to, the 
broad CPN population. 
Data presented in this dissertation begin to identify and functionally characterize molecular controls 
over CPN subpopulations.  Identification of genes expressed by CPN in distinct sublaminae suggest 
controls over birthdate and connectivity, such as those presented in Chapter 2.  Cav1 identifies a unique 
subpopulation of CPN in deep layers that includes dual projecting CPN/FPN, and potentially other 
specific populations of dual projecting CPN.  Functional analysis of Cav1 in CPN in Chapter 4 indicates 
that, while it is not necessary for generic establishment of CPN projections, its expression in dendrites 
and its ability to affect early migration suggest that it might be acting in unique dendritic branching or 
activity required for relaying information from dual projecting CPN.  Analysis of Cited2 function in 
somatosensory CPN presented in Chapter 3 indicates it as a molecular control that specifically acts in 
CPN of different functional areas.  These examples provide functional evidence in support of the overall 
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hypothesis that these genes expressed in restricted populations of CPN act to control and identify the 
unique properties of these subpopulations. 
 
7.1 c. Mechanisms of progressive generation of diverse CPN subpopulations 
Identifying which gene products control which phenotypic properties, anatomic and function, of 
distnct CPN subtypes identity and function will be useful at least three levels: 1) to molecularly identify 
subpopulations so that they are genetically accessible for in-depth study; 2) to provide understanding into 
how individual populations develop their unique properties; and 3) to identify human “disease genes” that 
are likely critical for proper function of specific, functionally important CPN subpopulations.  More 
broadly, however, investigation into functions of subtype-specifically expressed genes will provide 
insight into how subtype identity is acquired by CPN.  More specifically, this work will elucidate whether 
the cumulative overlap of a general CPN control with areal and laminar controls alone defines 
subpopulations of CPN, or whether there are specific molecular controls acting in these diverse 
subpopulations to integrate overlapping signals into distinct neuron types. 
The investigation of Cited2 function presented in Chapter 3 most directly addresses this final, broad 
question.  Cited2 is more highly expressed by CPN by than other projection neuron subtypes, and its 
expression becomes refined to somatosensory functional areas postnatally.  Cited2 function is required for 
proper formation of somatosensory (SS) superficial layers, where ~80% of mouse CPN reside.   In the 
absence of Cited2 function, there is a significant, specific reduction in superficial layer thickness in SS 
cortex, but not in deep layers or motor cortex.  The reduction in SS superficial layers is neither a pan-SS 
nor a pan-superficial layer effect, because both superficial layers in motor cortex, and SS acallosal layer 
IV, are unaffected by loss of Cited2 function.  Therefore, it is probable that Cited2 function is areal and 
neuron subtype-specific, integrating diverse controls to endow the subtype identity of CPN of sensory 
processing regions of the neocortex.   These data support the hypothesis that specific projection neuron 
areal subtype populations are defined and controlled by specific genes, such as Cited2, acting in this role, 
rather than by strict addition of two distinct, more broadly acting signals.  
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A combined goal of the research presented here, and all investigation of molecular control over 
neocortical development, more broadly, is not only to understand mechanism determining final subtype 
identity and characteristics, but, rather, to identify functional steps required to generate unambiguous, 
functional neurons.  My early work presented in the Appendix on specification and parcellation of pallial 
and subpallial progenitor domains(Azim et al., 2009a) builds on earlier work in the field identifying broad 
controls over telencephalon identity.  Sox6-expressing, pallial progenitors progressively acquire CPN 
subtype identity, first by specification as CPN through mechanisms involving Satb2 (Alcamo et al., 2008; 
Britanova et al., 2008; Chen et al., 2008a; Gyorgy et al., 2008), and likely by broad CPN controls 
identified in Chapter 2(Molyneaux et al., 2009).  Built on this braod CPN identity, subtype identities are 
acquired by what current data suggests as directed and specific molecular mechanisms, likely induced 
collaboratively controlled by broad subtype, areal, and laminar controls.  My work elucidates two such 
subtype controls: Cited2 over somatosensory CPN; and Cav1 over specific properties of subtypes of dual 
projecting CPN in layer V and far lateral neocortex. 
Interestingly, a single molecular control such as Cited2 can act at multiple levels in these progressive 
processes in distinct temporal and areal contexts. The areal specificity for Cited2 function in 
somatosensory cortex superficial layer length is preceded in development by a broad early requirement of 
Cited2 for proper development of Tbr2-expressing intermediate progenitors (IPCs), and loss of Cited2 
function also results in a broad increase in cellular death in Cited2 null cortex early in development.  This 
suggests at least two distinct functions for Cited2 in neocortical development, with a broad, early function 
at the time of generation of specific basal progenitors, Tbr2+ IPCs, and later function in maintaining  the 
somatosensory neocortical domain of CPN and their specific subtype identity acquisition.  These two 
functions are likely controlled combinatorially by different sets of interactors for CITED2, a 
transcriptional co-activator that binds multiple distinct transcription factors. 
Thus, this work adds support for the general interpretation that mechanisms of cell-type identity 
acquisition are controlled progressively throughout development.  This work also specifically addresses 
how individual neuronal subtype identities can be acquired, supporting the hypothesis that there are 
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specific molecular controls acting in diverse subpopulations to integrate various axes of signals into 
distinct neuron type identities. 
   
7.1 d. Evolutionary neocortical expansion, implications for CPN disease, and future directions 
CPN have been implicated in many human diseases of subtle behavioral, language, or cognitive 
dysfunction, including autism spectrum disorders (ASD)(Booth et al., 2011), schizophrenia(Innocenti et 
al., 2003), dyslexia(von Plessen et al., 2002), and agenesis of the corpus callosum (AgCC) (Paul et al., 
2007; Kaufman et al., 2008; Wahl et al., 2008; Booth et al., 2011).  Mice lacking CPN exhibit largely 
normal survival, breeding, and motor output, but show reduced social interactions, impaired play, low 
exploratory behavior, unusual vocalizations, and high anxiety as compared to other inbred strains 
(McFarlane et al., 2008) (Scattoni et al., 2008) (Moy et al., 2007).  Association of CPN with such 
disorders of higher cognitive functions that are more fully developed in humans suggest that CPN 
function in some of the most complex intellectual processes.  In addition, the proportion of neocortical 
projection neurons that are CPN increases with increased intellectual and computational 
capacity(Manzoni et al., 1986), suggesting a dependence on many CPN (and potentially expanded 
subtypes of CPN) for high-level cognitive processing.  
In this dissertation, I pursued comparative analysis of some of the molecular CPN subtypes identified 
in mouse with macaque cortex.  I identified many CPN-expressed genes as conserved in expression 
between the mice and macaques, and others that have subtly diverged in expression.  Studies of 
comparative gene expression by CPN are particularly interesting because CPN as a population have 
undergone differential expansion throughout recent mammalian evolution.  This expansion is reflected by 
the disproportionately large and varied primate superficial layers (that contain~90% of CPN), as 
compared to rodent superficial layers (that contain only ~80% of CPN), and the noticeably larger relative 
volume of cortical white matter tracts in primates as compared to rodents, including the CC (Smart et al., 
2002a). I find that expression of CPN-enriched genes in early cortex and later deep neocortical layers is 
conserved, supporting the hypothesis that early developmental processes and deep layer neurons (present 
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in birds and reptiles, in addition to mammals) are highly conserved.  I also show that gene expression by 
superficial layer CPN, which are recent evolutionarily additions in mammals, exhibits more varied levels 
of conservation of expression.  These results suggest that, in these more recently emerged populations, 
there is specific conservation and/or expansion of some superficial CPN populations in macaque, 
independent expansion of others in mouse, and even emergence of distinct populations in macaque.    
This dissertation research enables both extended comparative evolutionary analysis of this broad 
neocortical population of CPN, and also contributes toward understanding which human disease genes 
and affected CPN subpopulations can be effectively studied in mouse, and how these studies can be 
related back to human patients.  All three of the genes (each expressed by distinct subsets of CPN) 
regarding which I pursued functional analysis in this dissertation are closely related to human cognitive 
disease.   Cited2 exhibits abnormal copy number variation (CNV) in a subset of ASD patients(Szatmari et 
al., 2007).  Human Caveolin1 is located at the locus 7q31.1, part of autism-linked locus 9 (Auts9).   Other 
potential gene linkages in the Auts9 locus (Nrcam, Foxp2, and ST7) are relatively weak, indicating that 
the linkage must be accounted for, at least in part, by other Auts9 genes, potentially Cav1.  Finally, and 
most directly connected to human disease, Tmtc4 was identified in a forward genetic screen of human 
AgCC patients to occur in 3/140 patients in the cohort(Li et al., 2008) concurrently with our identification 
of Tmtc4 as a candidate control over CPN development in mouse(Molyneaux et al., 2009).  My 
comparative studies in mouse and macaque identified conservation of gene expression for all three of 
these genes in CPN subpopulations.  These results reinforce the views that mouse developmental biology 
is higly relevant to human development and disease, and that directed functional analyses of human 
“disease genes” in mouse can provide understanding of what neuron populations are affected, and how 
they contribute to human disease.   
Data presented in this dissertation – identifying molecular subtypes of CPN, and functionally 
investigating three of these gene products as candidate controls over specific CPN subpopulations –
enables a range of future studies that were not previously possible.  Each gene with restricted CPN 
subpopulation expression identified in Chapter 2 is a candidate control over these subpopulations.  
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Directed functional analyses of well-motivated candidates will likely reveal controls over individual 
populations.  The mechanisms by which each of these gene products controls CPN development will 
provide insight into characteristics of CPN subsets that are important for their diversity and function.  In 
addition, using molecular expression of select genes/ products as markers for specific subpopulations of 
CPN will enable deeper and more insightful instigation of previously identified molecular controls over 
CPN, identifying with more precision which CPN subpopulations are affected, and how.  Use of new 
markers will potentially also enable isolation of distinct CPN subpopulations, and identification of 
additional subtype-specific genes enabling deeper investigation of each subpopulation’s role in brain 
organization, and, therefore, function.  For example, isolation of Cav1–expressing neurons, followed by 
additional gene expression analysis, might identify earlier molecular controls over the development of 
CPN with dual projecting axons, and over formation of dual projection axons, more broadly.  
Identification of both similarities and differences in CPN gene expression between rodents and primates 
will not only enable investigations of and connections to human disease as discussed above, but might 
also direct further analysis of neuron subtypes that most specifically express these genes in primates. 
Taken together, these comparative connections between mouse and primate, coupled with functional 
analyses of candidate controls over development and function in mice, begin to identify additional 
characteristics and subtleties of neuronal subtypes making precise, complex, and diverse connections 
from between functional cortical areas, in particular that enable the most complex integrative functions of 
the cerebral cortex.   
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Appendix-Chapter 8: 
SOX6 controls dorsal progenitor identity and interneuron diversity during neocortical development 
 
 
 
Author contributions:  I joined this project during my rotation in the Macklis lab.  I worked closely with 
first author Eiman Azim, who designed the overall experimental directions, specific analyses, and figures.  
Denis Jabaudon co-performed the microarray experiments and assisted with interneuron quantification, 
microarray data evaluation, experimental design and data analysis, and manuscript writing and editing. I 
optimized whole embryo in situ hybridization and immunolaeling to generate Figure A1b, c.  I also 
assisted with BrdU/PH3 pallial progenitor analysis, and developed and implemented the quantification 
scheme for evaluating interneuron migration delay in the marginal zone stream, quantified in Figure A8b, 
c, and described in Figure A9.  Additionallly, I worked with first and second authors Eiman Azim and 
Denis Jabaudon to systematically analyze candidate genes from the Sox6 null vs wildtype comparative 
microarray analysis (Table A1), quantify interneuron subtypes Figures A10-A13), and edit the 
manuscript. 
Publication:  Eiman Azim, Denis Jabaudon, Ryann Fame, and Jeffrey D Macklis. “SOX6 controls dorsal 
progenitor identity and interneuron diversity during neocortical development.” Nat. Neurosci. 2009 
Oct;12(10):1238-47. 
 
This chapter has been kept largely unchanged from its published form, with the exception of minor 
changes in figure organization and numbering. 
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8.1 Abstract 
The neuronal diversity of the CNS emerges largely from controlled spatial and temporal segregation 
of cell type-specific molecular regulators. We report that the transcription factor SOX6 controls the 
molecular segregation of dorsal (pallial) from ventral (subpallial) telencephalic progenitors and the 
differentiation of cortical interneurons, regulating forebrain progenitor and interneuron heterogeneity. 
During corticogenesis in mice, SOX6 and SOX5 are largely mutually exclusively expressed in pallial and 
subpallial progenitors, respectively, and remain mutually exclusive in a reverse pattern in postmitotic 
neuronal progeny. Loss of SOX6 from pallial progenitors causes their inappropriate expression of 
normally subpallium-restricted developmental controls, conferring mixed dorsal-ventral identity. In 
postmitotic cortical interneurons, loss of SOX6 disrupts the differentiation and diversity of cortical 
interneuron subtypes, analogous to SOX5 control over cortical projection neuron development. These 
data indicate that SOX6 is a central regulator of both progenitor and cortical interneuron diversity during 
neocortical development. 
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8.2  Introduction 
Two broad functional classes of cortical neurons, excitatory projection neurons and inhibitory 
interneurons, arise from spatially and molecularly segregated pallial (dorsal) and subpallial (ventral) 
proliferative ventricular zones of the telencephalon, respectively(Schuurmans and Guillemot, 2002; 
Wonders and Anderson, 2006; Molyneaux et al., 2007). Parcellation of these proliferative regions into 
molecularly segregated domains separated at the pallial-subpallial boundary (PSB) is critical for the 
generation of these distinct classes of neurons. Within these broad excitatory and inhibitory neuronal 
classes, tremendous subtype diversity arises largely from the dynamic temporal expression of progenitor 
and postmitotic transcriptional regulators. Both of these developmental mechanisms (inter- and intra-
domain segregation of molecular regulators) combine to give rise to the extraordinary neuronal diversity 
of the adult mammalian brain. 
The parcellation of the proliferative neuroepithelium at the PSB is defined and maintained by the 
interactions of several critical early patterning transcription factors, exemplified by the repressive 
interaction of pallium-expressed Neurogenin2 (Ngn2, also known as Neurog2) on the generally 
subpallium-expressed Mash1 (also known as Ascl1)(Schuurmans and Guillemot, 2002). Accordingly, loss 
of Ngn2 function results in dorsal expansion of Mash1 expression and a consequent ventralization of 
pallial progenitors, which aberrantly give rise to subpallial-like neurons(Fode et al., 2000; Parras et al., 
2002). The dynamic interaction between this pair of transcription factors exemplifies the delicate balance 
of molecular regulators required to establish and maintaining the PSB. 
Throughout corticogenesis, these pallial and subpallial progenitors give rise to neurons whose fates 
depend largely on the location and time at which they are born(Butt et al., 2005; Flames et al., 2007; 
Miyoshi et al., 2007; Molyneaux et al., 2007; Wonders et al., 2008). In the pallium, distinct excitatory 
projection neuron subtypes are born sequentially under the control of temporally coordinated programs 
that guide their subtype specification and differentiation(Molyneaux et al., 2007). Simultaneously, 
inhibitory cortical interneurons, which constitute approximately 25% of all cortical neurons, are primarily 
born in the subpallial medial (MGE) and caudal ganglionic eminences (CGE)(Wonders and Anderson, 
2006). Acquisition of distinct interneuron subtype identities, distinguishable by molecular, 
morphological, and electrophysiological phenotypes, depends on both the place and time of birth in the 
MGE and CGE(Butt et al., 2005; Flames and Marin, 2005; Wonders and Anderson, 2006; Flames et al., 
2007; Fogarty et al., 2007; Miyoshi et al., 2007; Ascoli et al., 2008; Wonders et al., 2008). Differentiating 
interneurons then migrate tangentially toward and then radially into the cortex to populate their final 
laminar destinations alongside concurrently born pallium-derived excitatory projection neurons(Corbin et 
al., 2001; Wonders and Anderson, 2006). Because cortical interneurons are implicated in several 
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developmental disorders(Levitt et al., 2004), including epilepsy(Armijo et al., 2002), autism(Rubenstein 
and Merzenich, 2003), and schizophrenia(Lewis, 2000), understanding the molecular controls over their 
subtype diversity might clarify some causes of and potential therapeutic approaches to these important 
disorders. 
Although major progress has been made in understanding the regulation of broad aspects of neuronal 
heterogeneity during development(Schuurmans and Guillemot, 2002), only recently have specific controls 
over excitatory(Molyneaux et al., 2007) (Arlotta et al., 2005; Chen et al., 2005a; Chen et al., 2005b; 
Molyneaux et al., 2005; Alcamo et al., 2008; Britanova et al., 2008; Joshi et al., 2008; Kwan et al., 2008; 
Lai et al., 2008) and inhibitory(Cobos et al., 2005; Liodis et al., 2007; Butt et al., 2008; Du et al., 2008; 
Zhao et al., 2008) cortical neuron subtype differentiation been characterized. We recently reported that 
SOX5 postmitotically controls the sequential generation of distinct pallium-derived excitatory 
corticofugal projection neuron populations, regulating their subtype diversity (Kwan et al., 2008; Lai et 
al., 2008). Motivated by the complementary and largely redundant functions of SOX5 and SOX6 in other 
systems(Smits et al., 2001; Stolt et al., 2006), we hypothesized that SOX6 might also function in the 
generation of forebrain neuronal diversity. 
SOX6 and SOX5 belong to the SRY-type HMG box (SOX)-containing transcription factor family, 
which is composed of 20 members in mammals, many of which have precise temporal and spatial 
functions in cell-fate specification and differentiation in multiple organ systems including the 
CNS(Wegner, 1999; Wegner and Stolt, 2005). SOX6 and SOX5, which share 93% identity in their HMG 
DNA-binding domains and 61% overall identity(Connor et al., 1995), interact and functionally overlap 
during chondrogenesis and oligodendroglial development in the spinal cord. During chondrogenesis, 
SOX6 and SOX5 are coexpressed in prechondrocytes, where they have overlapping and additive roles in 
promoting appropriate and timely differentiation into chondroblasts. The loss of either gene alone 
produces mild skeletal defects and perinatal death, while the loss of both genes results in major cartilage 
dysgenesis and death during late gestation(Smits et al., 2001). Similarly, SOX6 and SOX5 are 
coexpressed in developing oligodendroglia in the spinal cord, where they act as functionally equivalent 
repressors of specification and terminal differentiation(Stolt et al., 2006). SOX6 is expressed in the 
forebrain during mid-gestation, as seen by whole-mount in situ hybridization(Connor et al., 1995), and in 
the early postnatal brain, as determined by northern blot and real-time quantitative RT-PCR(Narahara et 
al., 2002), but its cell type-specific expression and function in the brain have not been investigated. 
We found that, in contrast with their overlapping expression and largely redundant functions in other 
systems, SOX6 and SOX5 are almost entirely mutually exclusively expressed in the forebrain and have 
distinct, complementary functions. SOX6 and SOX5 are complementarily expressed in pallial and 
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subpallial progenitors, respectively, and this expression is reversed in differentiating postmitotic neurons, 
as progeny of subpallial progenitors (at least largely composed of cortical interneurons) express SOX6, 
and corticofugal projection neuron progeny of pallial progenitors express SOX5. During development, 
SOX6 controls the segregation of pallial from subpallial progenitors by repressing the expression of 
Mash1 and downstream subpallium-specific programs in pallial progenitors. Postmitotically, SOX6 
regulates multiple aspects of cortical interneuron differentiation, ultimately controlling the molecular 
diversity of cortical interneuron subtypes. We conclude that SOX6 and SOX5 have independent and 
complementary roles in the generation of neuronal diversity during neocortical development. 
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8.3 Materials and Methods 
8.3 a. Mice.  
Sox6+/– and Sox5+/– mice were the generous gift of V. Lefebvre (Cleveland Clinic)(Smits et al., 
2001) (Sox6 GeneID 20679; Sox5 GeneID 20678). The GAD67-gfp (delta-neo) mice were the generous 
gift of Y. Yanagawa (Gunma University)(Narahara et al., 2002; Liodis et al., 2007). Ngn2+/–; Ngn1+/– 
mice were a generous gift from F. Guillemot (NIMR)4. The Sox6 and Sox5 transgenic mice are on a pure 
C57BL/6 background. The Ngn2; Ngn1 transgenic mice are on a pure CD1 background. The Sox6; 
GAD67-gfp transgenic crosses are a mix between C57BL/6 and Swiss Webster; controls always had the 
same degree of mixed background. The day of vaginal plug detection was designated as E0.5. The day of 
birth was designated as P0. All mouse studies were approved by the Massachusetts General Hospital 
Institutional Animal Care and Use Committee and were performed in accordance with institutional and 
federal guidelines. 
7.3 b. Immunocytochemistry and in situ hybridization.  
Brains were fixed and stained using standard methods(Arlotta et al., 2005). For primary 
antibodies, we used rabbit antibody to SOX6 (1:500, Abcam), goat antibody to SOX5 (1:250, Santa Cruz 
Biotech), mouse antibody to BrdU (1:500, Becton Dickinson; detects IdU), rat antibody to BrdU (1:500, 
Accurate; detects CldU), mouse antibody to BrdU (1:750, Chemicon), rabbit antibody to PH3 (1:200, 
Upstate); mouse antibody to PH3 (1:400, Abcam), mouse antibody to PCNA (1:5,000, Sigma), rabbit 
antibody to TBR1 (1:1,500, gift of R. Hevner (University of Washington)), rabbit antibody to TBR1 
(1:500, Abcam), rat antibody to CTIP2 (1:1,000, Abcam), mouse antibody to Reelin (1:500, Chemicon), 
rabbit antibody to GFP (1:500, Molecular Probes), mouse antibody to PV (1:500, Sigma), rat antibody to 
SST (1:100, Chemicon), mouse antibody to calbindin (1:500, Chemicon), rabbit antibody to calretinin 
(1:1,000, Chemicon), mouse antibody to calretinin (1:400, Chemicon), rabbit antibody to NPY (1:500, 
Immunostar), rabbit antibody to VIP (1:100, Immunostar), and rabbit antibody to LHX6 (1:1,000, gift of 
V. Pachnis (NIMR)). Appropriate secondary antibodies were from the Molecular Probes Alexa series. 
When double immunocytochemistry was performed with two primary antibodies raised in the same 
species (only in the case of SOX6 colocalization with NPY and VIP and NPY colocalization with TBR1 
and LHX6), immunocytochemistry for each antibody was performed sequentially using different 
secondary antibodies, tissue was fixed for 30 min in 4% paraformaldehyde (by weight) and rinsed in 
phosphate-buffered saline before application of the second primary antibody. In instances of minor cross-
reactivity, nuclear versus cytoplasmic localization of fluorescence was used to distinguish between the 
two. 
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Riboprobes were generated and nonradioactive in situ hybridization was performed as previously 
described18. The Sox6 cDNA clone was a gift from V. Lefebvre(Smits et al., 2001). RT-PCR was used to 
generate the following cDNA clones: Ngn2 (NM_009718.2, BGEM), Mash1 (RP_050927_04_D07, Allen 
Brain Atlas), Olig2 (NM_016967.2, BGEM), Pax6 (RP_050927_01_H01, Allen Brain Atlas), Cux2 (ref. 
19), PlexinD1 (ref. 19), Lhx6 (MTF#274, Gudmap), and Vglut2 (nucleotides 2477–2933 of NM_080853). 
8.3c Molecular and mitotic characterization of progenitors.  
For examination of pallial progenitor phenotype, we performed immunocytochemistry for SOX5 (n = 
5 wild-type and n = 4 Sox6–/– at E13.5, n = 4 wild-type and n = 4 Sox6–/– at P0; in Figure A4) and in situ 
hybridization for Mash1 (n = 3 wild-type, n = 3 Sox6–/–, n = 1 Sox5–/–, n = 1 Sox6–/–; Sox5–/– at E13.5; n = 
2 wild-type and n = 1 Ngn2–/–; Ngn1–/– at E14.5; n = 1 wild-type and n = 1 Sox6–/– at E17.5; in Figures A5 
and A6), Sox6 (n = 2 wild-type and n = 1 Ngn2–/–; Ngn1–/– at E14.5; in Figure A5), Olig2 (n = 1 wild-type 
and n = 1 Sox6–/– at E13.5; in Figure A6) and Pax6 (n = 1 wild-type and n = 1 Sox6–/– at E13.5; in Figure 
A6). For examination of subpallial progenitor phenotype, we performed in situ hybridization for Sox6 (n 
= 3 wild-type and n = 2 Sox6–/– at E13.5; n = 3 wild-type and n = 3 Sox6–/– at P0; in Figure A4) and Ngn2 
(n = 3 wild-type, n = 2 Sox6–/–, n = 1 Sox5–/–, n = 1 Sox6–/–; Sox5–/– at E13.5; n = 1 wild-type and n = 1 
Sox6–/– at E17.5; in Figures A5 and A6). 
For BrdU birthdating and PH3 quantification, timed pregnant females received a single 
intraperitoneal injection of BrdU (50 mg per kg of body weight) at E13.5 (pallial progenitor analysis) or 
E14.5 (subpallial progenitor analysis in Figure A3). Embryos were collected 1 h later and processed for 
BrdU immunocytochemistry(Molyneaux et al., 2005). For pallial progenitor quantification, we selected 
four anatomically matched cortical sections from each mouse (n = 3 wild-type, n = 3 Sox6–/–), carried out 
BrdU and PH3 immunocytochemistry (2 h of 2N HCl treatment preceded BrdU immunocytochemistry), 
obtained fluorescent images, and selected two anatomically matched areas (130 µm × 200 µm) from each 
hemisphere of each section (one medial and one lateral) for blinded quantification of BrdU positivity 
(defined a priori as having strong and homogenous nuclear labeling) and PH3 positivity by two 
independent investigators. Normal distribution was confirmed, and the unpaired, two-tailed t test was 
used for statistical analysis. 
8.3 d. Microarray analysis.  
Each embryo from four E13.5 litters (generated by mating male and female Sox6+/– mice) was placed 
in cold Hank’s Buffered Salt Solution (HBSS), the pallium was microdissected and immediately 
preserved in RNAlater (Ambion), and the remaining embryo tissue was subsequently genotyped. RNA 
extraction, quality assessment, and amplification followed previously reported methods(Arlotta et al., 
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2005). Briefly, to ensure biological significance and reproducibility, biological replicate RNA samples 
from four wild-type and four Sox6–/– embryos were extracted using the StrataPrep Total RNA Mini Prep 
Kit (Stratagene), RNA was quantified using a NanoDrop (Thermo Fisher Scientific), and the quality was 
assessed with a Nanochip in a Bioanalyzer (Agilent Technologies). RNA was amplified via two rounds of 
in vitro transcription and biotinylated using a BioArray HighYield RNA Transcript Labeling Kit (Enzo), 
yielding approximately 20–50 µg of labeled cRNA for hybridization(Arlotta et al., 2005), and the quality 
of the amplified RNA was assessed with a Nanochip in a Bioanalyzer before hybridization on Affymetrix 
430.2 GeneChips. 
Homotypic (biological replicates) and heterotypic comparisons (wild-type versus Sox6–/–) were 
performed using Rosetta Resolver software (Rosetta Inpharmatics). Differentially expressed genes with 
an absolute fold change of more than 1.8 and a P value of less than 0.005 were selected for further 
analysis. To rigorously ensure statistical significance of identified candidate genes, we normalized the 
data via three additional independent methods (RMA (Robust Multi-Array Analysis), GCRMA (Guanine 
Cytosine Robust Multi-Array Analysis) and MAS 5.0-Affymetrix in Bioconductor and cross-referenced 
the significance of candidate genes with the Rosetta Resolver normalized dataset. Additional cross-
referencing was performed with genes identified as significant with a Significance Analysis of 
Microarrays (SAM) approach using an absolute fold change of more than 1.8 and a d value of 0.772 for 
gcRMA-normalized data and a d value of 0.35 for RMA-normalized data. The biological relevance of 
candidate genes was assessed in an integrated gene analysis platform developed in our laboratory 
(Jabaudon, D., Azim, E., Macklis, J.D., unpublished data), using online in situ hybridization, gene 
ontology, protein function, and literature databases to individually assess expression and function of each 
gene. Statistically significant genes with normally segregated pallial or subpallial expression during 
development were identified (reported in Table A1). 
8.3 e. Mis-expression of SOX6 and SOX5 via electroporation.  
For control experiments, a vector containing IRES-egfp under the control of a constitutively active 
CMV/β-actin promoter was used(Molyneaux et al., 2005) (a generous gift of C. Lois (Picower Institute)). 
Sox6 and Sox5 (ref. 22) were cloned upstream of IRES-egfp for mis-expression. We mixed 750 nl of 
purified DNA (1.0 µg/µl) with 0.005% Fast Green (for visualization), injected it in utero into the lateral 
ventricle of CD1 embryos at E12.5 under ultrasound guidance (Vevo 770, VisualSonics), and 
electroporated into the subpallial (Sox6) or pallial (Sox5) ventricular zone, as described 
previously(Molyneaux et al., 2005; Lai et al., 2008). Embryos were analyzed at E16.5 (n = 3 subpallial 
control, n = 3 subpallial Sox6, n = 3 pallial control, n = 3 pallial Sox5, multiple independent litters were 
examined in each condition). 
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8.3 f. Interneuron quantification.  
For quantification of the tangential distance between the leading edges of the marginal zone and 
intermediate zone/SVZ interneuron tangential migratory streams at E13.5, we selected anatomically 
matched sections (n = 3 Sox6+/+; GAD67-gfp+/–, n = 3 Sox6–/–; GAD67-gfp+/–; 10–12 hemispheres per 
mouse, spanning the rostro-caudal extent of the telencephalon), and carried out GFP 
immunocytochemistry. The distance was measured in micrometers between the position of the soma of 
the leading neuron of the marginal zone stream, radially projected to the pial surface, and the 
corresponding position of the soma of the leading neuron in the intermediate zone/SVZ stream, radially 
projected to the pial surface, determined by drawing imaginary lines radially from the marginal zone and 
intermediate zone/SVZ streams perpendicular to the surface of the brain (described in FigureA9). 
For quantification of interneuron number at E13.5, anatomically matched sections were selected (n = 
3 Sox6+/+; GAD67-gfp+/–, n = 3 Sox6–/–; GAD67-gfp+/–, 10–12 hemispheres per mouse spanning the rostro-
caudal extent of the telencephalon), GFP immunocytochemistry was performed, and Grid Confocal 
(Improvision) images were obtained of a single plane of GFP-positive neurons. Digital boxes of fixed 
area (marginal zone stream, 85 mm × 175 mm; intermediate zone/SVZ stream, 115 µm × 175 µm) were 
superimposed at predetermined anatomical landmarks at the base, middle, and leading edge of each 
migratory stream of each hemisphere, and GFP-positive neurons were quantified (described in Figure 
A9). 
For P0 quantification, anatomically matched sections were selected (n = 3 wild-type, n = 3 Sox6–/–; 
10–12 hemispheres per mouse spanning the rostro-caudal extent of the telencephalon), GFP 
immunocytochemistry was performed, digital boxes of fixed width were equally divided into four bins 
(see Figure A10) and superimposed on the cortices adjacent to the PSB of each hemisphere, and height 
was adjusted to extend from the bottom of layer VI to directly under the marginal zone (at P0, the 
marginal zone was still very interneuron dense and was therefore not included in the quantification). GFP-
positive neurons were quantified, and density values were calculated on the basis of the area of the box in 
each image; densities are expressed as neurons per mm2. Laminar distributions were determined by 
dividing the proportion of neurons in each bin by the total number of neurons in all bins. 
For P14 quantification, anatomically matched sections were selected (n = 3 wild-type, n = 3 Sox6–/–; 
8–12 hemispheres per mouse spanning the rostro-caudal extent of the telencephalon), and SOX6, GFP, 
PV, SST, NPY (n = 6 wild-type, n = 6 Sox6–/–), VIP (n = 4 wild-type, n = 4 Sox6–/–), calretinin, calbindin, 
and LHX6 immunocytochemistry was performed. Digital boxes of fixed width were equally divided into 
four bins (see Figure A10b), superimposed on the cortices adjacent to the PSB of each hemisphere, and 
height was adjusted to extend from the top of the white matter to the cortical surface. The percentages of 
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wild-type interneurons that express SOX6 (in Figure A12b) were calculated from the total numbers in all 
four bins. Density values and laminar distributions in wild-type and Sox6–/– were calculated as above.  
For IdU and CldU interneuron birthdating, equimolar delivery of IdU (57.5 mg per kg) at E11.5 and 
CldU (42.5 mg per kg) at E15.5 was performed(Vega and Peterson, 2005). We sacrificed and perfused 
mice at P14, genotyped, and prepared brains for immunocytochemistry. Anatomically matched sections 
were selected, and IdU, CldU, PV, SST and NPY immunocytochemistry was performed (IdU and PV, 
IdU and NPY: n = 2 wild-type, n = 3 Sox6–/–; IdU and SST, CldU and PV, CldU and SST, CldU and 
NPY: n = 2 wild-type, n = 2 Sox6–/–; 7–8 hemispheres per mouse spanning the rostro-caudal extent of the 
telencephalon). Digital boxes of fixed width were superimposed on the cortices adjacent to the PSB, and 
height was adjusted to extend from the top of the white matter to the cortical surface. Interneurons 
coexpressing SST, PV, or NPY, and either IdU or CldU (defined a priori as having strong and 
homogenous nuclear labeling) were quantified (colabeling was defined as clear nuclear label surrounded 
by cytoplasmic PV, SST, or NPY label; in Figure A13a) and density values were calculated on the basis 
of the area of the box in each image.  
All quantification was performed on 50 µm vibratome sections using well-established modified 
stereological methods, beginning at the rostral limit of the corpus callosum and continuing caudally, 
skipping four sections between samples, so that no cell could be counted twice in an adjacent section. We 
used strict a priori criteria, whereby the entire soma of a cell needed to be present to be counted, which 
was effectively accomplished by counting with high numerical aperture optics in the central 
approximately 30 µm of the thick 50 µm sections, avoiding cut neurons present in the top or bottom 
approximately 10 µm of each section. All quantifications were blinded, normal distribution was 
confirmed, and the unpaired, two-tailed t test was used for statistical analysis. Welch corrections were 
performed in the rare instances when the s.d. of the two groups varied significantly. All results are 
expressed as the mean ± s.e.m. 
8.3 g. Microscopy and image analysis.  
Tissue sections were viewed on a Nikon E1000 microscope equipped with an X-Cite 120 illuminator 
(EXFO), and images were collected and analyzed with Volocity image analysis software (Improvision, 
v4.0.1). Images were optimized for size, color, and contrast using Photoshop 7.0 (Adobe). Single plane 
fluorescence images for E13.5 interneuron quantification were obtained using the Volocity Grid Confocal 
microscopy system (Improvision). Images were collected at the approximate midpoint between the top 
and bottom planes of focus. 
 
 353 
8.4 Results 
8.4 a. SOX6 and SOX5 are mutually exclusively expressed 
To determine whether SOX6 and SOX5 have complementary or interactive roles during neocortical 
development, we characterized their expression at important stages of corticogenesis. In situ hybridization 
and immunocytochemistry revealed that SOX6 and SOX5 are expressed in complementary and almost 
entirely mutually exclusive populations of progenitors and cortical neurons: SOX6 in pallial progenitors 
and postmitotic subpallial neurons, and SOX5 in subpallial progenitors and postmitotic pallial 
corticofugal projection neurons(Lai et al., 2008) (Figure A1a–e). Early in corticogenesis, SOX6 is 
expressed in the telencephalon in a slight dorsal-high to ventral-low gradient (Figure A1b), whereas 
SOX5 is expressed in a spatially reciprocal ventral-high to dorsal-low gradient (Figure A1c). During mid- 
to late corticogenesis, SOX6 and SOX5 are mutually exclusively expressed in pallial (SOX6) and 
subpallial (SOX5) ventricular zone progenitors (Figure A1d,e and Figure A2). Their expression overlaps 
exclusively in a discrete portion of the dorsal subpallial ventricular zone at the PSB (Figure A2), a region 
that gives rise to the lateral cortical stream, populating basal telencephalic structures, including the 
amygdala and piriform cortex(Puelles et al., 2000; Carney et al., 2006). 
The postmitotic progeny of pallial and subpallial progenitors mutually exclusively express SOX6 and 
SOX5 in a reverse pattern; SOX6 is expressed in the MGE and CGE mantle zones, which contain, among 
other neuronal populations, developing cortical interneurons that maintain SOX6 expression as they 
mature in the neocortex, whereas SOX5 is expressed by corticofugal projection neurons in the cortical 
plate(Lai et al., 2008) (Figure A1d,e and Figure A2; also Fig. 6a). Notably, SOX6 is not expressed in the 
mantle zone of the lateral ganglionic eminence (LGE), where medium spiny neurons that populate the 
striatum will later mature (Figure A1d). Immunocytochemical analysis of the S-phase marker BrdU, the 
pan-mitotic marker PCNA, and the M-phase marker phospho-histone 3 (PH3) revealed that subpallial 
expression of SOX6 is overwhelmingly postmitotic (Figure A3). Taken together, these data indicate that 
SOX6 and SOX5 are expressed in spatially abutting, almost entirely non-overlapping populations of 
progenitors and postmitotic neurons, suggesting cross-repressive interactions during development. 
7.4 b. SOX6 and SOX5 progenitor expression is cross-repressive 
We hypothesized that if cross-repressive interactions exist, either direct or indirect, loss of either 
SOX6 or SOX5 would result in the corresponding ectopic expression of the other. Accordingly, loss of 
SOX6 function in Sox6–/– mice(Smits et al., 2001) results in an expansion of SOX5 expression into the 
pallial ventricular zone that normally expresses SOX6 (Figure A4a). During corticogenesis, this ectopic 
SOX5 expression in Sox6–/– pallium gradually expands from the lateral to the medial extent of the pallial 
ventricular zone, suggesting a developmental gradient of SOX5 expression. Conversely, in Sox5–/–  
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Figure A1:  SOX6 and SOX5 are expressed in complementary populations of telencephalic progenitors 
and neuronal progeny during corticogenesis. (a) Schematic illustrating the relative position of the 
neocortex, LGE, MGE, and CGE in the developing brain. A, anterior; D, dorsal; P, posterior; V, ventral. 
(b,c) Sox6 (b, black arrow) is expressed in a slight dorsal-high ventral-low gradient (analyzed by in situ 
hybridization, ISH) and SOX5 (c, black arrow) is expressed in a ventral-high dorsal-low gradient 
(analyzed by immunocytochemistry, ICC) in the telencephalon (white dotted circles) at E10.5, as 
corticogenesis is beginning. Insets show higher-magnification view of the telencephalon. (d,e) During 
corticogenesis, shown here at E13.5 and E15.5, Sox6 (d, in situ hybridization) is expressed in progenitors 
of the pallial ventricular zone (red arrows) and in postmitotic neurons in the MGE and CGE mantle zones 
(red arrowheads), but it is not expressed in subpallial ventricular zone progenitors (blue arrows). SOX5 
(e, immunocytochemistry) is expressed in subpallial ventricular zone progenitors (blue arrows) and 
postmitotic neurons in the cortical plate (blue arrowheads), but it is not expressed in pallial ventricular 
zone progenitors (red arrows). Panel a is adapted from (Corbin et al., 2001). Scale bars represent 100 µm 
and 150 µm for E.13.5 and E.15.5, respectively. 
 355 
Figure	  A1	  (Continued)	  
 356 
mice(Smits et al., 2001), SOX6 expression expands ventrally into the subpallial ventricular zone during 
neocortical development (Figure A4b). This cross-repressive interaction is restricted to progenitors and is 
not apparent in postmitotic neurons that express SOX6 or SOX5, indicating that progenitor-specific, and 
possibly indirect, interactions are occurring between these two transcription factors, most likely in 
coordination with other progenitor patterning genes. 
Notably, the dorsal subpallial ventricular zone coexpresses SOX6 and SOX5 (Figure A2), indicating 
that there is a unique relationship between the two transcription factors in this distinct developmental 
domain, and suggesting that the expression of either one alone is not sufficient to repress the expression 
of the other. To investigate whether SOX6 and SOX5 are sufficient to repress the expression of each other 
in progenitors, we mis-expressed Sox6 in the subpallial ventricular zone and Sox5 in the pallial ventricular 
zone via in utero electroporation at embryonic day 12.5 (E12.5) for analysis at E16.5. Many progenitors 
transfected with one of the genes continued to express the other gene, which is not surprising, given their 
normal coexpression in a discrete region of dorsal subpallial progenitors (Figure A2), as well as in other 
developing systems(Smits et al., 2001; Stolt et al., 2006). Taken together, these data indicate that SOX6 
and SOX5 are necessary, but not sufficient, to repress the expression of each other in forebrain 
progenitors, strongly suggesting that there are combinatorial interactions with other regional patterning 
signals during telencephalic development. 
8.4 c. SOX6 and Ngn2 cooperatively control pallial identity 
The complementary and mutually exclusive expression of SOX6 and SOX5 in forebrain progenitor 
domains is highly reminiscent of the generally non-overlapping expression of the patterning transcription 
factors Ngn2 (pallial) and Mash1 (subpallial)(Ma et al., 1997; Fode et al., 2000). Loss of Ngn2 causes 
ectopic expansion of Mash1 expression into pallial progenitors, activating downstream subpallial 
differentiation programs(Fode et al., 2000; Parras et al., 2002). Because the patterns of SOX6 and Ngn2 
expression in telencephalic progenitors are similar, we examined whether the loss of SOX6 function 
would result in a similar ventralization of the pallium. Indeed, loss of SOX6 causes a marked expansion 
of Mash1 expression into the pallial ventricular zone throughout corticogenesis (Figure A5a and Figure 
A6). Olig2, a transcription factor that is also expressed by subpallial progenitors during corticogenesis, is 
also ectopically expressed in Sox6–/– pallial ventricular zone (Figure A6). This domain-parcellating 
function is specific for SOX6, as loss of SOX5 function does not cause a reciprocal ventral expansion of 
pallium-specific Ngn2 expression, and simultaneous loss of both SOX6 and SOX5 function largely 
replicates the phenotype of Sox6–/– mice (Figure A6). These data indicate that SOX6 functions centrally in 
the molecular segregation of the pallial from the subpallial progenitor domain. 
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We next examined whether the partial ventralization of pallial progenitors in Sox6–/– mice is a result 
of the disruption of the expression of mostly pallium-restricted Pax6 or its direct downstream target Ngn2 
(ref. 41). Pax6 (Figure A6) and Ngn2 (Figure A5b) are still normally expressed in the Sox6–/– pallium, 
indicating that their expression is not centrally driven by SOX6. Because Ngn2 is known to normally 
repress Mash1 (Fode et al., 2000), and because this repression is lost in Sox6–/– pallial progenitors (where 
Ngn2 and Mash1 are abnormally coexpressed; Figure A5a, b), we hypothesized that SOX6 maintains 
pallial identity either in and transcriptionally activated by the well-described Pax6 → Ngn2  ⎯| Mash1 
pathway, mediating Ngn2 repression of Mash1, or in a previously undefined genetic cascade that does not 
require the Ngn2 pathway for transcriptional activation. To discriminate between these two possibilities, 
we examined the expression of SOX6 in the abnormally ventralized pallium of Ngn2–/–; Ngn1–/– 
mice(Fode et al., 2000), in which the repression of Mash1 by Ngn2 (supplemented by additive repression 
by Ngn1) is lost(Fode et al., 2000) (Figure A5c). Loss of SOX6 expression in the Ngn2–/–; Ngn1–/– 
pallium would suggest that SOX6 is a downstream transcriptional target of Ngn signaling, acting in this 
canonical pathway. The data exclude this alternative, as SOX6 expression is maintained in Ngn2–/–;  
Ngn1–/– pallium (Figure A5d). Just as Ngn2 is normally expressed in the pallial ventricular zone in the 
absence of SOX6, SOX6 is normally expressed in the absence of Ngn2. These data indicate that the 
cooperative convergence of both SOX6 and Ngn2 pathways is necessary to repress Mash1 and maintain 
the dorsal identity of pallial progenitors, while neither is sufficient on its own. In the absence of either of 
these critical regulators, pallial progenitors adopt a mixed dorsal-ventral identity, inappropriately 
coexpressing genes that are normally specific to one or the other developmental domain. 
Despite the partial ventralization of Sox6–/– pallial progenitors, projection neuron laminar distribution 
and subtype- and layer-specific molecular expression appear to be largely normal (Figure A7). Similarly, 
pallial progenitor proliferation is not affected by loss of SOX6 function, as assessed by BrdU uptake and 
PH3 expression (data not shown). To determine whether the expansion of Mash1 expression into the 
Sox6–/– pallium is indicative of the initiation of subpallium-specific programs of gene expression, we 
carried out comparative microarray analysis between wild-type and Sox6–/– pallium during mid-
corticogenesis at E13.5 and identified several normally subpallium-expressed genes that are ectopically 
expressed in the Sox6–/– pallium, including Dlx1, Dlx2, Dlx4, Gsh2, Isl1, Meis1 and Sox5 (Table A1). 
These data indicate that SOX6 critically maintains pallial progenitor identity by repressing subpallial 
programs of gene expression, but redundant and/or compensatory controls (for example, Ngn2 and Ngn1) 
persist that are sufficient to ensure largely appropriate pallial corticogenesis(Britz et al., 2006). We 
conclude that SOX6 acts cooperatively with Ngn2 to control the segregation of telencephalic progenitor 
domains during development. 
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Figure A2:  Sox6, expressed in pallial progenitors, and SOX5 expressed in subpallial progenitors, 
overlap in the dorsal subpallial VA, and are not sufficient to repress expression of eachother. (a) During 
corticogenesisi, shown here at E13.5, E15.5, and P0, SOX6 is expressed in progenitors of the pallial 
ventricular zonw (VZ) (white areeows), and in neurons that originate in the MGE and CGE mantle zones 
(white arrowheads). (b) SOX6 and SOX5 expression in the telencephalon is essentially nutually 
exclusive, with overlap uniquely in the dorsal subpallial VZ (white arrow). (c, d) Mis-expression of Sox6 
(IRES-EGFP) in the subpallial VZ via in utero electroporation (c) at E12.5 for analysis at E16.5 reveals 
that many transfected cells both do (white arrows) and do not (white arrowheads) express SOX5.  Mis-
expression of Sox5 (IRES-EGFP) in the pallial VZ (d) at E12.5 for analysis at E16.5, reveals extensive 
co-expression of SOX5 and SOX6 (white arrows).  Electroporation of a control EGFP vector in the pallial 
or subpoallial VZ also does not affect SOX6 or SOX5 expresion in transfected progenitors, respectively 
(data not shown).   Both the Sox6 and Sox5 constructs were immunocytochemically verified to express 
both the gene of interest as well as EGFP. (a-d) immunocytochemistry.  Ctx, cortex; LGE, lateral 
ganglionic eminence; MGE, medial ganglionic eminence; CGE, caudal ganglionic eminence; PSB, 
pallial-subpallial boundary.  Dotted lines (c,d) indicate lateral ventricle boundary.  Scale bars, (a; E13.5) 
100 µm, (a; E15.5) 150 µm, (a; P0, low magnification) 200 µm, (a; P0, high magnification) 50 µm, (b) 50 
mm, (c,d) 20 µm. 
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 Figure A3: SOX6 subpallial mantle zone expression is postmitotic. (a) At E14.5, SOX6 expression 
(white arrowheads) and BrdU label (white arros) are non-overlapping in the MGE mantle zone following 
a one hour pulse of BrdU to label cells in S-phase (as well as some cells in G2), with very rare exceptions 
(as expected in a dense transistion zone between mitotic and postmitotic cells). (b) At E15.5, SOX6 
(white arrowheads) and the pan-mitotic marker PCNA (white arrows) are not co-expressed, with very rare 
exceptions (again, as expected, with potential protein perdurance, and in a dense region of transition from 
mitotic to postmitotic state). (c) At E15.5, SOX6 (white arrowheads) and the M-phase marker PH3 (white 
arrows) are not co-expressed in the MGE mantle zone.  IN order to assess co-localization with 
surrounding mantle zone SOX6 expression, all analyses were preformed at later stages of cortico genesis 
(E14.5 and E15.5), when SVZ proliferatios predominate. (a-c) immunocytochemistry.  Ctx, cortex; LGE, 
lateral ganglionic eminence; MGE, medial ganglionic eminence.  Scale bars, (a-c; low magnification) 300 
µm, (a-c; intermediate magnification) 50 µm, (a-c; high magnification) 10 µm. 
 361 
 
 
  
Figure	  A3	  (Continued)	  
 362 
8.4 d SOX6 controls cortical interneuron subtype differentiation 
SOX6 is also expressed in postmitotic interneurons as they reside in the subpallium and populate the 
neocortex (Figures A1d, A2, and A3). We therefore examined whether the loss of SOX6 function would 
affect key sequential steps of interneuron differentiation: early postmitotic molecular identity; cortical 
laminar location and morphology; and interneuron molecular subtype differentiation. Our data indicate 
that SOX6 acts postmitotically, at all three of these stages of cortical interneuron differentiation, 
controlling their appropriate development. 
As the early molecular programs of immature postmitotic cortical interneurons in the subpallial 
mantle zones largely determine and predict their appropriate differentiation(Batista-Brito et al., 2008), we 
first examined early cortical interneuron molecular identity. We found that Sox6–/– MGE and CGE mantle 
zones abnormally express  the proneural transcription factors Mash1 and Ngn2 (Figure A5a,b). SOX6 
repression of the ectopic and persistent expression of Mash1 (normally progenitor- and subpallium-
specific) and Ngn2 (normally progenitor and pallium-specific) in subpallial mantle zones strongly 
suggests that SOX6 controls the temporal segregation of transcriptional programs between progenitors 
and postmitotic neurons. 
Because MGE and CGE Sox6–/– mantle zone cells ectopically express Ngn2, which normally 
represses subpallial and maintains pallial identity(Fode et al., 2000), we hypothesized that these cells 
might abnormally initiate pallium-like gene expression. Consistent with this hypothesis, Sox6–/– subpallial 
mantle zone cells inappropriately express Vglut2, a vesicular glutamate transporter whose expression is 
normally restricted to pallium-born excitatory projection neurons (Figure A8a). This indicates that at least 
a subpopulation of Sox6–/– subpallial immature neurons in the mantle zone are inappropriately acquiring 
pallial properties.  
To determine whether this abnormal coexpression of pallial/subpallial and progenitor/postmitotic 
molecular regulators (Mash1, Ngn2 and Vglut2) in Sox6–/– immature subpallial neurons affects their 
ability to broadly differentiate into GABAergic neurons, we examined whether they express GAD67 (also 
known as Gad1), an enzyme that is necessary for the synthesis of the inhibitory neurotransmitter GABA, 
a fundamental indicator of their identity. Using in situ hybridization for GAD67 (data not shown), and 
confirming this with GAD67-gfp (delta-neo) transgenic mice, in which green fluorescent protein (GFP) is 
expressed in the vast majority of GABA-positive neurons(Tamamaki et al., 2003; Liodis et al., 2007), we 
found that GAD67 is expressed in neurons leaving the subpallial mantle zones in Sox6–/–; GAD67-gfp 
mice (Figure A8b), suggesting appropriate GABAergic neuron specification. However, as cortical 
interneurons continue their migration tangentially in one of two streams toward the cortex (a superficial 
marginal zone stream or a deeper intermediate zone/subventricular zone (SVZ) stream), they fail to 
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migrate properly in Sox6–/– cortex, as indicated by the consistently less advanced leading edge of the 
marginal zone stream compared with the leading edge of the intermediate zone/SVZ stream (Figures A8 
b,c and A9). There is no change in the number of interneurons in either migratory stream at E13.5 
(Figures A8d and A9). From these data, we conclude that loss of SOX6 function perturbs the initial 
temporal segregation of progenitor-specific factors from postmitotic neurons, potentially causing their 
abnormal tangential migration, without affecting overall GABAergic neuron specification and abundance. 
To further investigate whether the molecular and migratory irregularities at early stages of Sox6–/– 
subpallial neuron differentiation are associated with abnormalities in subsequent stages of interneuron 
cortical invasion, we examined the laminar location and morphology of these interneurons as they 
populate the cortex. In GAD67-gfp mice at postnatal day 0 (P0; Figure A10a), just after the interneurons 
have begun their radial migration into the maturing cortex, and at P14 (Figure A10b), as they have more 
fully adopted their mature phenotypes, Sox6–/– interneurons preferentially populate deeper neocortical 
layers (Figure A10c,d), without any change in their total numbers. (Although the large majority of Sox6–/– 
mice die perinatally, small numbers survive a few weeks postnatally, which allowed us to analyze them at 
P14 (Smits et al., 2001). Sox6+/– mice survive to adulthood, with a small number exhibiting occasional 
seizure behavior.) We also examined the morphology of GAD67-GFP-positive neurons at P0 and found 
that Sox6–/– interneurons have abnormal tangential orientation, in contrast with the mostly radial 
orientation of wild-type interneurons (reflecting their transition from tangential to radial migration) 
(Figure A10a). These laminar distribution and morphological abnormalities were confirmed by analysis 
of the broad (at P0) interneuron marker calbindin (Figure A11). These data indicate that SOX6 is 
necessary for the appropriate differentiation of cortical interneurons as they integrate into the neocortical 
circuitry, manifested by their inappropriately deep laminar location and abnormal morphology in the 
absence of SOX6. 
To determine whether SOX6 differentially affects the development of distinct cortical interneuron 
subtypes, we examined interneuron subpopulations using subtype-defining molecular markers(Wonders 
and Anderson, 2006; Ascoli et al., 2008). By P14, the calcium-binding protein parvalbumin (PV) and the 
peptide hormone somatostatin (SST) are expressed by two non-overlapping subclasses of predominantly 
MGE-born interneurons, many of which are born early in corticogenesis. The peptide neurotransmitter 
neuropeptide Y (NPY) is expressed by later-born MGE and CGE-derived interneurons, many of which 
coexpress SST. The peptide hormone vasoactive intestinal peptide (VIP) is predominantly expressed by 
late-born, CGE-derived interneurons, although a subpopulation of VIP-positive interneurons coexpress 
SST and might be of MGE origin. The calcium-binding protein calretinin is predominantly expressed by 
late-born CGE interneurons, although a subpopulation also coexpresses SST and might be of MGE 
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Figure A4:  SOX6 and SOX5 are cross-repressive in pallial and subpallial telencephalic progenitor 
domains. (a) SOX5 expression (analyzed by immunocytochemistry), which normally extends to the 
ventral edge of the pallial-subpallial boundary (blue arrows in wild-type, WT) and is absent from pallial 
ventricular zone progenitors, ectopically expands into Sox6–/– pallial ventricular zone progenitors (blue 
arrows in Sox6–/–) at E13.5 and P0. This SOX5 expansion is most pronounced near the PSB at E13.5 and 
extends evenly throughout the entire pallial ventricular zone by P0. (b) Conversely, Sox6 expression 
(analyzed by in situ hybridization), which normally extends to the dorsal edge of the PSB (red arrows in 
WT) and is absent from subpallial progenitors, ectopically expands into Sox5–/– subpallial ventricular zone 
progenitors (red arrows in Sox5–/–) at E13.5 and P0. This Sox6 expansion is most pronounced near the 
PSB in the LGE at E13.5 and extends throughout the entire subpallial ventricular zone by P0. Scale bars 
represent 50 µm. 
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Figure A5: Loss of SOX6 function results in ectopic proneural gene expression in pallial progenitors and 
subpallial mantle zones. (a) Mash1, which is normally restricted to subpallial ventricular zone progenitors 
and is not expressed by pallial ventricular zone progenitors (red arrows) or by postmitotic neurons in 
subpallial mantle zones (red arrowheads), is ectopically expressed in Sox6–/– pallial ventricular zone 
progenitors and in the MGE and CGE mantle zones at E13.5. (b) Ngn2, which is normally restricted to 
pallial ventricular zone progenitors and is not expressed by postmitotic neurons in subpallial mantle zones 
(red arrowheads), is ectopically expressed in Sox6–/– MGE and CGE mantle zones at E13.5. (c) As 
previously reported4, Mash1, which is normally not strongly expressed in pallial ventricular zone 
progenitors, is ectopically expressed in progenitors of the Ngn2–/–; Ngn1–/– pallial ventricular zone at 
E14.5 (red arrows). (d) As in the wild-type, SOX6 continues to be expressed in Ngn2–/–; Ngn1–/– pallial 
ventricular zone progenitors (red arrows). SOX6 is ectopically expressed in Ngn2–/–; Ngn1–/– postmitotic 
pallium-derived neurons in the cortical plate (red arrowheads), consistent with the ectopic expression of 
subpallial postmitotic signals in pallium-born neurons in the absence of Ngn2 function, as previously 
described(Fode et al., 2000; Parras et al., 2002). All expression was analyzed by in situ hybridization. 
Scale bars represent 100 µm. 
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Figure A6: SOX6 regulates transcription factor expression during development. (a) Mash1, normally 
absent from pallial VZ progenitors (red arrow) and subpallial mantle zome (red arrowhead), is extopically 
expressed in these cells in Sox6-/- mice, shown here at E17.5.  (b) Olig2 , normally expressed in subpallial, 
but not pallial, VZ progenitors (red arrow), is ectopically expressed in Sox6-/- pallial VZ progenitors, 
shown here at E17.5.  (c) Mash1 is not expressed in pallial progenitors (red arrow) and subpallial mantle 
zones (red arrowhead) in WT and Sox5-/- brains, and is equivalently ectopically expressed in both of these 
cellular populations in Sox6-/- and Sox6-/-/ Sox5-/- brains, shown here at E13.5.  (WT and Sox6-/- panels are 
reproduced here from Figure A5 for comparison).  (d) Ngn2 is not expressed in subpallial mantle zones 
(red arrowhead) in WT and Sox5-/- brains, and is equivalently extopically expressed in these populations 
in Sox6-/- and Sox6-/-/ Sox5-/- brains, shown here at E13.5.  Additionally, Ngn2 expression expands slightly 
into the dorsal LGE in Sox6-/-/ Sox5-/- brains (red arrow).  (WT and Sox6-/- panels are reproduced here from 
Figure A5 for comparison).  (e) Pax6 retains its normal mostly pallial VZ progenitor –specific expression 
(red arrow) in Sox6-/- brains, shown here at E13.5.  (f) Ngn2 expression, normally absent from subpallial 
mantle zones (red arrowhead), is extopically expressed in these populations in Sox6-/- mice, shown here at 
E17.5. (a-f) in situ hybridization.  WT, wildtype; Ctx, cortex; LGE, lateral ganglionic eminence; MGE, 
medial ganglionic eminence.  Scale bars, (a-f) 100 µm. 
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 Figure A7: Pallium –derived cortical neuron specification and laminar location is broadly normal in  
Sox6-/- neocortex.  At P0, neurons in layer VI and V expression TBR1 (a),CTIP2 (b), and SOX5 (c); 
neurons in layers II/III expression PlexinD1 (d); neurons in layer II-IV expressing Cux2 (e); and cells in 
layer I expressing Reelin (f) have roughtly equivalent expression and laminar location ni WT and Sox6-/- 
neocortex.  (a-c, f) innunocytochemistry, (d-e) in situ hybridization.  WT, wildtype; MZ, marginal zone; 
CP, cortical plate; WM, white matter.  Dotted lines indicate pial surface.  Scale bars, (a-f) 50 µm. 
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Table A1: Loss of SOX6 function cuases a partial ventralization of the pallial VZ.  Microarray 
comparison (Affymetrix 430.2 GeneChips) between WT (n=4) and Sox6-/- (n=4) pallium at E13.5 reveals 
aberrant expression of genes normally restricted to the subpallium, and decreased expression of genes 
normally restricted to the pallium.  (in addition to its subpallial VZ progenitor expression, Sox5 is also 
expressed in the thin cortical plate at E13.5)  Fold change indicated change in expression in Sox6-/- 
pallium compared to WT.  Change in Sox6 expression is provided as a positive control.  WT, wildtype.  
 
   
Gene Fold Change p-value WT Expression Domain WT Normalized Intensity Sox6-/- Normalized Intensity 
Dlx1 27.19 5.65E-10 Subpallial 0.01543 0.53511 
Dlx2 2.41 4.86E-03 Subpallial 0.09966 0.22774 
Dlx4 (7) 6.69 1.20E-03 Subpallial 0.01105 0.07086 
Dlx6os1 3.89 6.30E-04 Subpallial 0.11904 0.49277 
Gsh2 14.80 4.00E-05 Subpallial 0.03005 0.21532 
Isl1 10.09 1.00E-05 Subpallial 0.01884 0.14475 
Meis1 1.89 1.33E-06 Subpallial 0.25469 0.48171 
Sox5 3.01 4.78E-03 Subpallial 0.06589 0.18576 
      
Boc -2.1 7.60E-04 Pallial 2.17109 1.07424 
Cdon -57.13 3.04E-11 Pallial 0.22801 0.01149 
Chrna -10.21 8.9E-04 Pallial 0.07319 0.01009 
Sox6 -15.40 1.22E-27 Pallial 3.8922 0.22086 
Table	  A1	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origin(Cavanagh and Parnavelas, 1988; Cavanagh and Parnavelas, 1990; Butt et al., 2005; Wonders and 
Anderson, 2006; Miyoshi et al., 2007). 
We found that at P14, ~65% of all GAD67-GFP-positive interneurons express SOX6, including 
essentially all of the PV-positive (86%) and SST-positive (96%) interneurons (both the calretinin-positive 
(83%) and calretinin-negative (95%) subpopulations), and over one-third of the NPY-positive 
interneurons (37%). Essentially no VIP-positive interneurons (3%) and only a small minority of 
calretinin-positive interneurons (11%) express SOX6 (Figure A12a,b). Loss of SOX6 function results in a 
marked reduction in the number of interneurons expressing PV (93% reduction, P < 0.0001) and SST 
(70% reduction, P = 0.002), including the small population of SST and calretinin double-positive 
interneurons (79% reduction, P = 0.03), and the SST-positive and calretinin-negative interneurons (70% 
reduction, P = 0.001). Conversely, there is a corresponding marked increase in the number of NPY-
positive interneurons (137% increase; P = 0.0009), and no change in the number of VIP- and calretinin-
positive interneurons (Figures A11 and A12c,d). Notably, as observed with the general interneuron 
marker GAD67, all interneuron subtypes that normally express SOX6 inappropriately redistribute to 
deeper cortical layers in Sox6–/– cortex (Figure A11). At P0, when SST expression is normally seen in 
lateral neocortex and piriform cortex, there are already markedly reduced numbers of Sox6–/– SST-
positive interneurons (Figure A11), indicating that SOX6 function is necessary at early stages of cortical 
interneuron molecular differentiation. Together, these data indicate that loss of SOX6 function causes a 
decrease in the abundance of specific molecularly-defined subtypes of cortical interneurons, many of 
which are normally MGE-derived during early corticogenesis, without affecting overall cortical 
interneuron number. 
To investigate potential temporal control by SOX6 over cortical interneuron subtype differentiation, 
particularly given its preferential effects on largely early-born PV- and SST-positive MGE-derived 
interneurons(Butt et al., 2005; Wonders and Anderson, 2006; Miyoshi et al., 2007) (Cavanagh and 
Parnavelas, 1988), we performed dual birthdating of interneuron subtypes born at E11.5 and E15.5 using 
the halogenated thymidine analogs iododeoxyuridine (IdU) and chlorodeoxyuridine (CldU), 
respectively(Vega and Peterson, 2005), for examination at P14 (Figure A13). We found that in wild-type 
cortex, NPY-positive interneurons are preferentially born during late versus early corticogenesis (about 
twice as many CldU and NPY double-positive neurons as there were IdU and NPY double-positive 
neurons, 180%, P = 0.02; Figure A13a), confirming previous reports(Cavanagh and Parnavelas, 1990). In 
addition, although the number of early- and late-born neurons are equivalent between wild-type and  
Sox6–/– cortices, far fewer Sox6–/– early- and late-born interneurons are PV- and SST-positive (early PV: 
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83% decrease, P = 0.002; early SST: 65% decrease, P = 0.009; late PV: 88% decrease, P = 0.02; late 
SST: 93% decrease, P = 0.04), while an increased number of Sox6–/– early- and late-born cortical 
interneurons are NPY positive (early NPY: 40% increase, P = 0.03; late NPY: 90% increase, P = 0.04; 
Figure A13b). These data strongly suggest that, when SOX6 function is absent, many early- and late-born 
cortical interneurons that would normally differentiate into PV- and/or SST-positive subtypes 
inappropriately express NPY, which is normally preferentially expressed by later-born subtypes. Taken 
together, these data suggest that, much like the function of SOX5 in corticofugal projection 
neurons(Kwan et al., 2008; Lai et al., 2008), SOX6 is necessary for appropriate cortical interneuron 
molecular subtype diversity, ensuring the appropriate temporal expression of subtype- and function-
defining proteins.  
Given the pronounced effects of loss of SOX6 function on the largely MGE-derived PV- and SST-
positive interneurons and the lack of an effect on overall cortical interneuron numbers, we next examined 
whether loss of SOX6 function affects the expression of LHX6, a transcription factor that is necessary for 
the appropriate development of MGE-derived cortical interneuron subtypes(Liodis et al., 2007; Zhao et 
al., 2008). In Sox6–/– mice, LXH6 is expressed in MGE-born interneurons, but these neurons are 
disorganized as they segregate into migratory streams and populate the cortex at E13.5 (Figure A14a), 
confirming the tangential migratory abnormalities that we observed in Sox6–/–; GAD67-gfp mice (Figure 
A8b,c). These data indicate that SOX6 is required for appropriate subtype-specific differentiation from 
these early stages of interneuron development. At P14, after maturing interneurons have populated the 
cortex, while there is a modest drop in the abundance of LHX6-positive neurons in Sox6–/– cortex (35% 
reduction, P = 0.04), most LHX6-positive interneurons populate the cortex (Figure A14b). LHX6 is not 
ectopically expressed in neurons born from abnormally ventralized Sox6–/– pallial progenitors (Figure 
A14a) or in Sox6–/– CGE (data not shown), indicating that, as in the normal brain, LHX6-positive neurons 
in Sox6–/– cortex are MGE-derived. 
To determine whether the abnormally abundant NPY-positive interneurons arise from the Sox6–/– MGE 
population itself (population autonomous, rather than a result of changes outside of this population), we 
investigated whether there is an increase in the number of MGE-derived LHX6-positive interneurons that 
express NPY in Sox6–/– cortex. In wild-type cortex, very few LHX6-positive neurons coexpress NPY (1% 
± 0.5% of LHX6-positive neurons), whereas the number that coexpress NPY in Sox6–/– cortex markedly 
increases (23% ± 3% of LHX6-positive neurons; ~11.5-fold increase, P = 0.004; Figure A14c,d). 
Similarly, there is a very large increase in the number of NPY-positive neurons that 
immunocytochemically colabel with LHX6 in Sox6–/– cortex (22% ± 3% of NPY-positive neurons) as 
compared with wild-type (4% ± 2% of NPY-positive neurons). In addition, the large majority of these 
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Sox6–/– LHX6 and NPY double-positive neurons are found in deep cortical layers (81% ± 5%), further 
suggesting they are of early-born MGE origin (Figure A14d). Taken together, these interneuron subtype 
analyses indicate that SOX6 functions in a population autonomous manner, controlling the appropriate 
molecular differentiation of MGE-derived cortical interneuron subtypes. 
An additional (although not mutually exclusive) potential explanation for the increase in the number 
of Sox6–/– NPY-positive interneurons is that they might be born from abnormally ventralized Sox6–/– 
pallial progenitors. However, our data indicate that Sox6–/– NPY-positive neurons are not pallium-derived: 
LHX6-positive interneurons in Sox6–/– cortex do not express TBR1 (Figure A15), a transcription factor 
that is broadly expressed by pallium-derived pyramidal neurons through P14, and all NPY-positive 
neurons in Sox6–/– cortex express GAD67-GFP (Figure A15), which is not expressed by neurons born 
from partially ventralized Sox6–/– pallial progenitors (Figure A8b). 
In sum, we found that SOX6 is largely mutually exclusively expressed and cross-repressively 
interacts with highly related SOX5 during telencephalic development, critically controlling pallial 
progenitor identity and cortical interneuron differentiation and diversity. We previously found that 
subtype differentiation in the complementary population of corticofugal projection neurons is analogously 
controlled by SOX5 (Lai et al., 2008). Taken together, these simultaneous, independent, and functionally 
parallel controls critically underlie much of the tremendous neuronal diversity in the neocortex (Figure 
A16). 
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Figure A8:  Loss of SOX6 function results in abnormal early cortical interneuron differentiation, without 
a change in interneuron number. (a) Although excitatory neuron-specific Vglut2 is not normally expressed 
in neurons born in the subpallium, it is ectopically expressed in the subpallial mantle zone in Sox6–/– mice 
at E15.5 (red arrowheads; analyzed by in situ hybridization). (b,c) GAD67-GFP-positive neurons are born 
in both wild-type and Sox6–/– MGE (white arrowheads, analyzed by immunocytochemistry). However, as 
GABAergic cortical interneurons tangentially migrate into the cortex, the leading edge of the marginal 
zone (MZ) migratory stream is consistently less advanced in the Sox6–/– cortex compared with the wild-
type cortex (white arrows; 60% reduction in distance, P = 0.03; c). Dotted lines (b) indicate lateral 
ventricle boundary. IZ, intermediate zone. (d) There is no difference between wild-type and Sox6–/– cortex 
in the number of migrating cortical interneurons in either the marginal zone or intermediate zone/SVZ 
migratory streams. Scale bars represent 150 µm (low magnification, a), 100 µm (high magnification in a 
and low magnification in b), and 50 µm (high magnification, b). Results are expressed as mean ± s.e.m. 
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Figure A9: Measurement of the tangential distance between the leading edge of the MZ and IZ/SVZ 
cortical interneuron migratory streams, and the number of interneurons migrating within each of these 
streams. (a) The distance (solid yellow line) was measured in µm between the position of the soma of the 
leading neuron of the MZ stream (white arrow), radially projected to the pial surface, and the 
correspondinf position of the soma of the leading neuron in the IZ/SVZ streasm (white arrowhead), 
radially projected to the pioal surface, determined by drawing imaginary lines (dotted white lines) radially 
from the MZ and IZ/SVZ strease perpendicular to the surface of the brain (see Methods). (b) Tangentially 
migrating cortical interneurons were quantified at three anatomically defined points in both the MZ and 
IZ/SVZ migratory streams in GAD67-GFP WT and Sox6-/- mice at E13.5 (see Methods).  (a,b) 
immunosytochemistry.  WT, wildtype; MZ, marginal zone; IZ, intermediate zone; SVZ, subventricular 
zone.  Scale bars, (a,b) 25 µm. 
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Figure A10:  Loss of SOX6 function disrupts the normal laminar position and morphology of cortical 
interneurons. (a–d) Analysis of GAD67-gfp mice revealed that, although there are equal numbers of 
cortical interneurons at P0 (a) and P14 (b) in wild-type and Sox6–/– cortex, there is a redistribution of 
interneurons toward deeper cortical layers in Sox6–/– cortex compared with wild-type (c,d). Quantification 
at P0 (c) revealed a proportional increase in interneuron density in the deepest bin, bin 1, by 13% (P = 
0.01) and bin 2 by 5% (P = 0.04), and a proportional decrease in the more superficial bin 3 by 7% (P = 
0.05) and bin 4 by 10% (P = 0.004). Quantification at P14 (d) revealed an increase in interneuron density 
in bin 1 by 10% (P = 0.001) and a decrease in the more superficially located bin 3 by 5% (P = 0.0003). 
Red lines (a,b) indicate subdivision into four bins for quantification (see Online Methods). Interneurons 
have abnormal tangential morphology in Sox6–/– cortex compared with the radially oriented interneurons 
in wild-type cortex (a, red arrowheads). (a,b) immunocytochemistry. CP, cortical plate; I-VI, cortical 
layers I-VI; WM, white matter. Dotted lines indicate pial surface. Scale bars represent 200 µm (low 
magnification, a), 50 µm (intermediate magnification, a), 25 µm (high magnification, a), 300 µm (low 
magnification, b) and 100 µm (high magnification, b). Results are expressed as mean ± s.e.m.  
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Figure A11:  SOX6 controls interneuron subtype development and laminar location. (a) At P0, Calb+ 
interneurons have abnormal laminar distribution and tangentially oriented morphology (red arrowheads) 
in Sox6-/- neocortex comparte to WT. (b) At P0, SST is predominantly expressed in neurons in the lateral 
neocortex, piriform cortex, and striatum in WT brains (white arrowheads); the number of SST+ 
interneurons is strikingly reduced in Sox6-/- brains. (c-i) The density of PV+ interneurons (c) is 
dramatically reduced in Sox6-/- cortical layers in bin 2 (p=0.02), at the expense of more superficial layer in 
bin 3(p=0.04).  The density of SST+ interneurons (d) is also reduced in Sox6-/- cortex (70% decrease; 
p=0.002), with those remaining preferentially populating the lowest cortical layers in bin1 (p=0.03), at the 
expsense of the more superficial layers in bin 2 (p=0.04) and bin 3 (p=0.01).  The density of NPY+ 
interneurons (e) is greatly increased in Sox6-/- neocortex (136% increase; p=0.0009), especially in the 
lowest cortical layers in bin 1 (p=0.006), at the expense of the most superficial layers in bin 4 (p=0.006).  
There is no change in the density of VIP+ interneurons in Sox6-/- neocortex (f).  The density of all Calret+ 
interneurons is not changed in Sox6-/- neocortex (g), but there is a laminar redistribution, whith more 
Calret+ interneurons occupying deeper cortical layers in bin 2 (p=0.01), at the expense of the most 
superficial layers in bin 4 (p=0.04), most likely representing a change in the small population of 
SST+/Calret+ interneurons (h), whose density is dramatically reduced in Sox6-/- neocortex (79% reduction; 
p=0.03), whith the reduction occurring predominantly superficially in the uppermost bin 4 (p=0.0002).  
The density of SST+/Calret- interneurons (i) is reduced in Sox6-/- neocortex (70% reduction; p=0.001), 
with those remaining preferentially population the deepest cortical layers in bin 1 (p=0.01) at the expense 
of more superficial layers in bin 3 (p=0.005). See figure A10 for bin placement.  (a,b) 
immunocytochemistry. WT, wildtype; MZ marginal zone; CP, cortical plate; WM, white matter.  Scale 
bar, (a,b; low magnification) 200 µm, (a; high magnification) 50 µm; (b; high magnification) 100 µm.  
Resuts are expessed at the mean ± SEM. 
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Figure A12:  SOX6 is necessary for cortical interneuron subtype development. (a,b) At P14, SOX6 is 
expressed in ~65% of all neocortical GAD67-GFP-positive interneurons (analyzed by 
immunocytochemistry), including essentially all PV-positive (86%), SST-positive (96%), SST and 
calretinin (Calret) double-positive (83%) (white arrowheads), and SST-positive and calretinin-negative 
(95%) interneurons. SOX6 is expressed in more than one-third of all NPY-positive interneurons (37%) 
(white arrowheads; open arrowheads indicate NPY-positive, SOX6-negative interneurons), in essentially 
no VIP-positive interneurons (3%; open arrowheads indicate VIP-positive, SOX6-negative interneurons) 
and in very few calretinin-positive interneurons (11%; open arrowheads indicate calretinin-positive, 
SOX6-negative interneurons). Red lines in a indicate approximate regions of magnification in b. (c,d) At 
P14, PV-positive cortical interneuron numbers (white arrowheads) are diminished in Sox6–/– compared 
with wild-type cortex (93% reduction, P < 0.0001), as are SST-positive cortical interneuron numbers (red 
neurons, white arrowheads; 70% reduction, P = 0.002). There is no change in the number of calretinin-
positive interneurons (green neurons, open arrowheads), although the subset of SST and calretinin 
double-positive interneurons (yellow neurons, white arrows) is reduced in number in Sox6–/– compared 
with wild-type cortex (79% reduction, P = 0.03). The subset of SST-positive, calretinin-negative 
interneurons is also reduced (70% reduction, P = 0.001). The number of NPY-positive cortical 
interneurons (white arrowheads) is increased in Sox6–/– compared with wild-type cortex (137% increase, 
P = 0.0009). There is no change in the number of VIP-positive interneurons (white arrowheads). The 
positions of the yellow boxes in the low-magnification panels (c) are representative of the neocortical 
position examined in the high-magnification panels. Quantification is represented as the percentage of 
neuron density in Sox6–/– compared with wild-type. Dotted lines indicate pial surface (a,c). Scale bars 
represent 300 µm (low magnification, a,c), 100 µm (high magnification, a,c) and 50 µm. (b). Results are 
expressed as mean ± s.e.m. 
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Figure A13:  Loss of SOX6 function produces an increased number of early- and late-born NPY-positive 
cortical interneurons. (a,b) Dual birthdating of cortical interneurons using IdU (E11.5) and CldU (E15.5) 
(analyzed by immunocytochemistry) reveals a decrease in the number of PV- and SST-positive early- and 
late-born interneurons (early PV: 83% decrease, P = 0.002; early SST: 65% decrease, P = 0.009; late PV: 
88% decrease, P = 0.02; late SST: 93% decrease, P = 0.04; b) and a large increase in the number of NPY-
positive early- (white arrowheads) and late-born (white arrows) interneurons (early NPY: 40% increase, P 
= 0.03; late NPY: 90% increase, P = 0.04; b). Colocalization was strictly assessed as homogenous, strong 
nuclear IdU or CldU label surrounded by cytoplasmic PV, SST or NPY labeling (NPY/IdU colocalization 
provided as a representative example in a, white arrowhead). Quantification is represented as the 
percentage of neuron density in Sox6–/– cortex compared with wild-type. Dotted lines in a indicate pial 
surface. Scale bars represent 100 µm (low magnification, a) and 10 µm (high magnification, a). Results 
are expressed as mean ± s.e.m. 
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Figure A14:  SOX6 control over MGE-derived cortical interneuron subtype differentiation is population 
autonomous. (a) At E13.5, during the early stages of cortical interneuron differentiation, MGE-born 
interneurons in wild-type and Sox6–/– telencephalon express Lhx6 (low magnification; red arrowheads; in 
situ hybridization), but the development of these neurons is disrupted in Sox6–/– mice. The migratory 
streams are disorganized compared with wild-type mice (high magnification, red arrowheads), and the 
leading edge of the marginal zone migratory stream compared with the intermediate zone/SVZ stream is 
consistently shorter in Sox6–/– compared with wild-type mice (red arrows). (b) By P14, a large subset of 
Lhx6-positive neurons present in the cortex of wild-type mice have populated the maturing Sox6–/– cortex 
(red arrowheads; in situ hybridization). (c,d) At P14 in wild-type cortex, the vast majority of LHX6-
positive neurons (99% ± 0.5%) do not express NPY (d, white arrowheads; immunocytochemistry), 
whereas LHX6-positive neurons increased their coexpression of NPY in Sox6–/– cortex (d, white arrows) 
(~11.5-fold increase, P = 0.004; c), especially in deeper layers (81% ± 5% of colocalization in the two 
deepest bins; see Fig. 5b for bin placement). Quantification is represented as the density of neurons per 
mm2 (c). Dotted lines in b and d indicate pial surface. Scale bars represent 100 µm (low magnification in 
a, b, and d), 50 µm (high magnification, a) and 25 µm (high magnification, d). Results are expressed as 
mean ± s.e.m. 
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Figure A15:  NPY+ neurons in Sox6-/- cortex are not pallium-born. (a) TBR1, broadly expressed by 
pallium-derived neurons through the second postnatal week, is not expressed by NPY+ neurons in WT or 
Sox6-/- cortex  (white arrowheads). (b) All NPY+ neurons in WT and Sox6-/- cortex  are GAD67+ 
interneurons (white arrowheads), as assessed in GAD67-GFP mice.  (a,b) immunocytochemistry.  WT, 
wildtype; WM, white matter.  Dotted lines indicate pial surface.  Scale bars, (a,b; low magnification) 100 
µm, (a,b; high magnification) 25 µm. 
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Figure A16:  Schematic model for cross-repressive and network interactive function of SOX6 and SOX5 
in progenitors and postmitotic cortical neurons.   SOX6 and SOX5 are cross-represseive in pallial and 
subpallial progenitors, respectively.  The purple area  at the PSB indicated a discrete region of SOX6 and 
SOX5 co-expression in the dorsal subpallium, encompassing the source of the lateral cortical streasm, 
which populates more ancient basal telencephalic structures including anygdala and piriform cortex.  
Within the pallial and subpallial domains, SOX6 and SOX5 integrate and interact with key telencephalic 
patterning molecular controls.  SOX6 and Ngn2 are both necessary, but neither is alone sufficient, to 
repress Mash1 expression and maintain dorsal identity in pallial progenitors.  Postmitotically, SOX5 
controls the subtype development of deep layer, corticofugal projection neurons(Kwan et al., 2008; Lai et 
al., 2008), while SOX6 represses the expression of progenitor-specific genes in subpallial mantle zones, 
and controls cortical interneuron subtype differentiation, potentially acting downstream of NKX2-1, and 
interacting with LHX6 (dashed lines).  These diverse functions in mutally exclusice, but complementary 
populations of cells are required for the establishment of appropriate cortical neurons diversity.  PSB, 
pallial-subpallial boundary; VZ, ventricular zone.  Adapted from(Schuurmans and Guillemot, 2002). 
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8.5 Discussion 
The cellular diversity of the CNS arises largely from the parsimonious use of a relatively small 
number of genes across distinct cell types, exemplified here by the multiple and distinct functions of 
SOX6 during neocortical development. We found that the highly related transcription factors SOX6 and 
SOX5 (which are coexpressed with largely overlapping functions in other organ systems(Smits et al., 
2001; Stolt et al., 2006)) are expressed and function in the telencephalon in a cross-repressive and 
complementary fashion. SOX6 functions cooperatively with previously described pallial/subpallial 
parcellation programs to control pallial progenitor identity, and it is critical for the subtype diversity of 
cortical interneurons, parallel to SOX5 function in pallium-derived corticofugal projection neurons(Lai et 
al., 2008). 
In the developing telencephalon, the repressive action of SOX6 and Ngn2 (Fode et al., 2000) on 
Mash1 expression is critical for maintaining pallial progenitor identity. Our data indicate that the 
expression of SOX6 and Ngn2 are independent, that these two Mash1-repressive interactions are 
cooperative, and that both are individually necessary, although neither of them is sufficient alone, for 
repressing subpallial identity. Although Pax6 directly activates Ngn2 expression in the telencephalon, 
spinal cord, and retina(Scardigli et al., 2003), it does not appear to act transcriptionally upstream or 
downstream of SOX6, as others have shown that microarray analysis of Pax6–/– pallium does not reveal a 
change in SOX6 expression(Holm et al., 2007), and we found that the Sox6–/– pallium continues to 
express Pax6. This strongly suggests that there are at least two pathways that restrict Mash1 expression to 
the subpallium: a classic Pax6-Ngn2 pathway, and a cooperative pathway in which SOX6 is expressed 
independently of Pax6 and Ngn2. 
Despite dorsal ectopic expression of Mash1, SOX5, and other subpallial ventricular zone signals in 
Sox6–/– pallial progenitors, postmitotic projection neuron progeny appear to develop normally. This 
contrasts with the apparently more severe ventralization of these neurons in Ngn2–/– mice (including 
ectopic expression of GAD67)(Fode et al., 2000; Parras et al., 2002), suggesting that, although initial 
stages of ventralization occur in Sox6–/– pallium (Table A1), dorsal identity regulators that persist in Sox6–
/– pallial progenitors, including perhaps Ngn2 and Ngn1, are sufficient to override and mask Mash1 and 
other subpallial fate programs, as has been suggested previously(Britz et al., 2006). Therefore, SOX6 
likely functions in concert with additional pallial patterning regulators to control dorsal identity. 
Notably, SOX6 and SOX5 are coexpressed in a discrete region of the dorsal subpallial ventricular 
zone near the PSB. This region encompasses a proliferative source for the lateral cortical stream, which 
populates structures of the basal limbic system, including the amygdala and piriform cortex(Puelles et al., 
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2000; Carney et al., 2006). These paleopallial structures are of older evolutionary origin than the 
neocortex of the neopallium. SOX6 and SOX5 may have been evolutionarily selected to act cooperatively 
in this unique population of progenitors, as they do in chondrocytes and spinal cord oligodendrocytes. In 
contrast, the later evolution of the neocortex may have driven the separation of these transcription factors, 
contributing to the evolution of mammalian neocortical development(Molnar and Butler, 2002). Further 
molecular phylogenetic analysis might elucidate whether SOX6 and SOX5 cooperate during paleopallium 
development, and at what point SOX6 and SOX5 function diverged into discrete telencephalic progenitor 
and neuronal populations. 
SOX6 is also necessary for successive stages of cortical interneuron postmitotic differentiation. 
Immature neurons in Sox6–/– subpallial mantle zones have mixed progenitor/postmitotic and dorsal-
ventral molecular identity, aberrantly expressing subpallial progenitor-restricted Mash1, pallial 
progenitor-restricted Ngn2 and pallial postmitotic-restricted Vglut2. As Sox6–/– cortical interneurons 
mature, they are broadly specified as GABAergic and populate the cortex in correct numbers, but finer 
molecular analysis revealed aberrant subtype differentiation, as exemplified by MGE-born cortical 
interneuron populations. In the absence of SOX6 function, there is a large increase in the abundance of 
NPY-positive interneurons at the expense of PV- and SST-positive interneurons, revealing abnormal 
subtype-defining neurotransmitter/molecular identity, one of multiple core contributing factors to the 
overall subtype identity and function of a neuron. Additional morphological and electrophysiological 
analyses might further examine whether these aberrant NPY-positive interneurons fully adopt functions 
that are normally associated with NPY expression. 
Three potential (and not mutually exclusive) processes might account for the loss of Sox6–/– cortical 
interneuron molecular subtype diversity, without an overall reduction of interneuron number. One 
possibility is that population autonomous subtype specification is primarily affected, such that MGE-
derived interneurons that would normally differentiate into subtypes that express PV and/or SST 
abnormally differentiate and express NPY. Another possibility is that MGE-born interneurons that 
normally would have been PV- and SST-positive might selectively not populate the cortex, and CGE 
progenitors might simultaneously increase their NPY-positive interneuron output. A third, similar 
possibility is that abnormally partially ventralized Sox6–/– pallial progenitors are a source of these new 
NPY-positive neurons, which populate the cortex in place of MGE-born interneurons. 
Our data very strongly favor the first interpretation of SOX6 control over population autonomous 
subtype differentiation. 1) There is a very large increase in the number of MGE-derived LHX6-positive 
interneurons that express NPY concomitant with their loss of PV and SST expression. 2) Our birthdating 
analysis revealed that, although the overall numbers of both early- and late-born neurons are unaffected 
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by the loss of SOX6 function, a large number of early-born interneurons, which tend to arise from the 
MGE rather than the CGE, do not express PV or SST, but instead inappropriately express NPY. 3) 
Abnormal molecular identity in the Sox6–/– MGE mantle zone (Ngn2, Mash1, Vglut2), observed as soon 
as the interneurons are born, strongly suggests a population autonomous effect of SOX6 function very 
early in neuronal differentiation. 4) There is no evidence of a substantial increase in the number of 
GAD67-GFP-positive migrating interneurons originating from Sox6–/– CGE, or any from the pallium, that 
would be required to compensate for the hypothetical loss of MGE-born interneurons (predicted for the 
second and third possibilities listed above). 5) Regarding the second possibility, that the NPY-positive 
neurons are all CGE-derived, it is neither likely nor supported by any of the data that Sox6–/– CGE 
progenitor populations would increase their neurogenic rate in the absence of SOX6, as SOX6 is not 
normally expressed in CGE ventricular zone progenitors. 6) Finally, regarding the third possibility, that 
the NPY-positive neurons are pallium derived, in Sox6–/– cortex, all of the NPY-positive neurons express 
GAD67, which is not ectopically expressed in Sox6–/– pallium-born neurons, and they do not express 
TBR1, which is broadly expressed by pallium-derived projection neurons, indicating that the NPY-
positive neurons are not born from pallial progenitors. Taken together, these results reinforce previous 
findings on the population autonomous functions of SOX6 both in and outside of the nervous 
system(Smits et al., 2001; Stolt et al., 2006), indicating that SOX6 functions as a critical control over the 
appropriate molecular differentiation of MGE-derived cortical interneuron subtypes. 
Additional interneuron developmental deficits might be occurring in the absence of SOX6 function. 
Although all of the LHX6-positive neurons in Sox6–/– cortex express GAD67-GFP, indicating their broad 
differentiation into GABAergic interneurons, some do not express NPY, PV, SST, or other major cortical 
interneuron subtype molecular markers. This suggests that some Sox6–/– MGE-derived interneurons might 
stall during later stages of subtype differentiation. In addition, these data do not exclude the possibility 
that SOX6 also functions in the population autonomous subtype differentiation of SOX6-positive CGE-
derived cortical interneurons, or perhaps via additional non-population autonomous pathways. 
NKX2-1 is a transcription factor that acts upstream of LHX6 (Du et al., 2008), and was recently 
shown to be critical for multiple stages of cortical interneuron development, including the temporal fate 
specification of cortical interneuron subtypes(Butt et al., 2008; Nobrega-Pereira et al., 2008) Loss of 
NKX2-1 function results in a reduction in the number of PV- and SST-positive cortical interneurons and a 
corresponding increase in the number of VIP- and calretinin-positive interneurons. Given our results, 
SOX6 might be functioning, at least partially, in the postmitotic downstream execution of NKX2-1 
signaling, potentially interacting with LHX6 (Liodis et al., 2007; Zhao et al., 2008), thereby regulating the 
temporal pacing of MGE-derived cortical interneuron fate specification and differentiation (Figure A16). 
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Additional gain- and loss-of-function analyses might reveal potential functional interactions between 
these transcription factors during interneuron subtype specification and differentiation. 
Much like pallium-born projection neuron subtypes, cortical interneuron subtype identity is largely 
determined by the time of birth. Fate-mapping experiments using H3-thymidine labeling and, more 
recently, genetic tools investigating subtype specification in MGE-born interneurons have shown that 
SST-positive interneurons, which are diminished in number in Sox6–/– cortex, are on average born at 
earlier stages of corticogenesis, whereas NPY-, VIP- and CR-positive interneurons, whose numbers are 
either increased or maintained in Sox6–/– cortex, are born later (Cavanagh and Parnavelas, 1988; 
Cavanagh and Parnavelas, 1990; Miyoshi et al., 2007; Butt et al., 2008). These data raise the hypothesis 
that, during cortical interneuron development, SOX6 participates in setting the pace for the proper timing 
of developmental transitions. In this model, loss of SOX6 might result in premature differentiation into 
neurons that are normally born at later developmental stages, at the expense of those born at earlier 
stages. Supporting this interpretation, our dual IdU/CldU birthdating analysis of the molecular 
differentiation of early- and late-born neurons in Sox6–/– cortex revealed that early-born neurons 
aberrantly differentiate and express the later-born subtype-defining protein NPY. As the lineage 
relationships of particular cortical interneuron subtypes are further clarified, it will be possible to discern 
whether loss of SOX6 function alters temporal development in a lineage (for example, those that would 
normally be SST-positive neurons aberrantly differentiate into NPY-positive neurons born later from 
potentially the same lineage) and/or whether loss of SOX6 function results in inappropriate differentiation 
across lineages (for example, those that would normally be PV-positive neurons aberrantly differentiate 
into NPY-positive neurons born later from a potentially distinct lineage). 
We recently reported that the loss of SOX5 function in pallium-derived corticofugal projection 
neurons results in the premature adoption of subcerebral projection neuron features that are characteristic 
of later stages of cortical projection neuron development(Lai et al., 2008). Therefore, it is possible that 
SOX6 and SOX5 both suppress coordinately regulated controls that promote premature transition into 
later stages of subtype differentiation. Consistent with this interpretation are the largely redundant roles of 
both SOX6 and SOX5 in chondroblasts during cartilage development and in oligodendroglial progenitors 
in the spinal cord in preventing the premature transition of these cell types to subsequent stages of 
development(Smits et al., 2001; Stolt et al., 2006). Given their analogous loss-of-function phenotypes, it 
is interesting to speculate that SOX6 and SOX5 separated in function during the evolution of the 
increasingly complex neuronal diversity of the telencephalon, and assumed complementary, but distinct, 
roles. 
 398 
Funding 
This work was partially supported by grants from the US National Institutes of Health (NS49553 and 
NS45523; additional infrastructure supported by NS41590), the Travis Roy Foundation, the Spastic 
Paraplegia Foundation, the Massachusetts Spinal Cord Injury research program, and the Harvard Stem 
Cell Institute to J.D.M., and by the Jane and Lee Seidman Fund for CNS Research, and the Emily and 
Robert Pearlstein Fund for Nervous System Repair. E.A. was partially supported by a US National 
Institutes of Health individual predoctoral National Research Service Award fellowship (F31 NS060421). 
D.J. was partially supported by fellowships from the Swiss National Science Foundation and the Holcim 
Foundation. R.F. was partially supported by a National Science Foundation Graduate Research 
Fellowship.  
 
Acknowledgements 
We thank K. Billmers, A. Palmer, L. Pasquina, K. Quinn, D. Schuback, E. Sievert, A. Wheeler, and 
T. Yamamoto for superb technical assistance; G. Fishell, R. Batista-Brito, G. Miyoshi, P. Arlotta, B. 
Molyneaux, H. Padmanabhan, F. Guillemot, Q. Ma, C. Cepko, and L. Goodrich for helpful discussions 
and input; U. Berger for technical assistance with in situ hybridization; C. Lois, R. Hevner, V. Lefebvre, 
F. Guillemot, V. Pachnis and Y. Yanagawa for generously sharing mice, antibodies and reagents; and 
current and past members of our laboratory for helpful suggestions.  
 399 
Appendix References 
 
 
Alcamo, E. A., Chirivella, L., Dautzenberg, M., Dobreva, G., Farinas, I., Grosschedl, R. and McConnell, S. 
K. (2008) Satb2 regulates callosal projection neuron identity in the developing cerebral cortex:: 
Supplemental Data, Neuron 57(3): 364-77. 
Arlotta, P., Molyneaux, B. J., Chen, J., Inoue, J., Kominami, R. and Macklis, J. D. (2005) Neuronal subtype-
specific genes that control corticospinal motor neuron development in vivo, Neuron 45(2): 207-21. 
Armijo, J. A., Valdizan, E. M., De Las Cuevas, I. and Cuadrado, A. (2002) [Advances in the 
physiopathology of epileptogenesis: molecular aspects], Rev Neurol 34(5): 409-29. 
Ascoli, G. A., Alonso-Nanclares, L., Anderson, S. A., Barrionuevo, G., Benavides-Piccione, R., Burkhalter, 
A., Buzsaki, G., Cauli, B., Defelipe, J., Fairen, A. et al. (2008) Petilla terminology: nomenclature of 
features of GABAergic interneurons of the cerebral cortex, Nat Rev Neurosci 9(7): 557-68. 
Batista-Brito, R., Machold, R., Klein, C. and Fishell, G. (2008) Gene expression in cortical interneuron 
precursors is prescient of their mature function, Cereb Cortex 18(10): 2306-17. 
Britanova, O., de Juan Romero, C., Cheung, A., Kwan, K. Y., Schwark, M., Gyorgy, A., Vogel, T., Akopov, 
S., Mitkovski, M., Agoston, D. et al. (2008) Satb2 is a postmitotic determinant for upper-layer neuron 
specification in the neocortex, Neuron 57(3): 378-92. 
Britz, O., Mattar, P., Nguyen, L., Langevin, L. M., Zimmer, C., Alam, S., Guillemot, F. and Schuurmans, C. 
(2006) A role for proneural genes in the maturation of cortical progenitor cells, Cereb Cortex 16 Suppl 1: 
i138-51. 
Butt, S. J., Fuccillo, M., Nery, S., Noctor, S., Kriegstein, A., Corbin, J. G. and Fishell, G. (2005) The 
temporal and spatial origins of cortical interneurons predict their physiological subtype, Neuron 48(4): 
591-604. 
Butt, S. J., Sousa, V. H., Fuccillo, M. V., Hjerling-Leffler, J., Miyoshi, G., Kimura, S. and Fishell, G. (2008) 
The requirement of Nkx2-1 in the temporal specification of cortical interneuron subtypes, Neuron 59(5): 
722-32. 
Carney, R. S., Alfonso, T. B., Cohen, D., Dai, H., Nery, S., Stoica, B., Slotkin, J., Bregman, B. S., Fishell, G. 
and Corbin, J. G. (2006) Cell migration along the lateral cortical stream to the developing basal 
telencephalic limbic system, J Neurosci 26(45): 11562-74. 
Cavanagh, M. E. and Parnavelas, J. G. (1988) Development of somatostatin immunoreactive neurons in the 
rat occipital cortex: a combined immunocytochemical-autoradiographic study, J Comp Neurol 268(1): 1-
12. 
Cavanagh, M. E. and Parnavelas, J. G. (1990) Development of neuropeptide Y (NPY) immunoreactive 
neurons in the rat occipital cortex: a combined immunohistochemical-autoradiographic study, J Comp 
Neurol 297(4): 553-63. 
Chen, B., Schaevitz, L. R. and McConnell, S. K. (2005a) Fezl regulates the differentiation and axon targeting 
of layer 5 subcortical projection neurons in cerebral cortex, Proc Natl Acad Sci USA 102(47): 17184-9. 
Chen, J.-G., Rasin, M.-R., Kwan, K. Y. and Sestan, N. (2005b) Zfp312 is required for subcortical axonal 
projections and dendritic morphology of deep-layer pyramidal neurons of the cerebral cortex, Proc Natl 
Acad Sci USA 102(49): 17792-7. 
 400 
Cobos, I., Calcagnotto, M. E., Vilaythong, A. J., Thwin, M. T., Noebels, J. L., Baraban, S. C. and 
Rubenstein, J. L. (2005) Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition 
and epilepsy, Nat Neurosci 8(8): 1059-68. 
Connor, F., Wright, E., Denny, P., Koopman, P. and Ashworth, A. (1995) The Sry-related HMG box-
containing gene Sox6 is expressed in the adult testis and developing nervous system of the mouse, 
Nucleic Acids Res 23(17): 3365-72. 
Corbin, J. G., Nery, S. and Fishell, G. (2001) Telencephalic cells take a tangent: non-radial migration in the 
mammalian forebrain, Nat Neurosci 4 Suppl: 1177-82. 
Du, T., Xu, Q., Ocbina, P. J. and Anderson, S. A. (2008) NKX2.1 specifies cortical interneuron fate by 
activating Lhx6, Development 135(8): 1559-67. 
Flames, N. and Marin, O. (2005) Developmental mechanisms underlying the generation of cortical 
interneuron diversity, Neuron 46(3): 377-81. 
Flames, N., Pla, R., Gelman, D. M., Rubenstein, J. L., Puelles, L. and Marin, O. (2007) Delineation of 
multiple subpallial progenitor domains by the combinatorial expression of transcriptional codes, J 
Neurosci 27(36): 9682-95. 
Fode, C., Ma, Q., Casarosa, S., Ang, S. L., Anderson, D. J. and Guillemot, F. (2000) A role for neural 
determination genes in specifying the dorsoventral identity of telencephalic neurons, Genes Dev 14(1): 
67-80. 
Fogarty, M., Grist, M., Gelman, D., Marin, O., Pachnis, V. and Kessaris, N. (2007) Spatial genetic patterning 
of the embryonic neuroepithelium generates GABAergic interneuron diversity in the adult cortex, J 
Neurosci 27(41): 10935-46. 
Holm, P. C., Mader, M. T., Haubst, N., Wizenmann, A., Sigvardsson, M. and Gotz, M. (2007) Loss- and 
gain-of-function analyses reveal targets of Pax6 in the developing mouse telencephalon, Mol Cell 
Neurosci 34(1): 99-119. 
Joshi, P. S., Molyneaux, B. J., Feng, L., Xie, X., Macklis, J. D. and Gan, L. (2008) Bhlhb5 regulates the 
postmitotic acquisition of area identities in layers II-V of the developing neocortex, Neuron 60(2): 258-
72. 
Kwan, K. Y., Lam, M. M. S., Krsnik, Z., Kawasawa, Y. I., Lefebvre, V. and Sestan, N. (2008) SOX5 
postmitotically regulates migration, postmigratory differentiation, and projections of subplate and deep-
layer neocortical neurons, Proc Natl Acad Sci USA 105(41): 16021-6. 
Lai, T., Jabaudon, D., Molyneaux, B. J., Azim, E., Arlotta, P., Menezes, J. R. and Macklis, J. D. (2008) 
SOX5 Controls the Sequential Generation of Distinct Corticofugal Neuron Subtypes, Neuron 57(2): 232-
247. 
Levitt, P., Eagleson, K. L. and Powell, E. M. (2004) Regulation of neocortical interneuron development and 
the implications for neurodevelopmental disorders, Trends Neurosci 27(7): 400-6. 
Lewis, D. A. (2000) GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia, 
Brain Res Brain Res Rev 31(2-3): 270-6. 
Liodis, P., Denaxa, M., Grigoriou, M., Akufo-Addo, C., Yanagawa, Y. and Pachnis, V. (2007) Lhx6 activity 
is required for the normal migration and specification of cortical interneuron subtypes, J Neurosci 27(12): 
3078-89. 
Ma, Q., Sommer, L., Cserjesi, P. and Anderson, D. J. (1997) Mash1 and neurogenin1 expression patterns 
define complementary domains of neuroepithelium in the developing CNS and are correlated with regions 
expressing notch ligands, J Neurosci 17(10): 3644-52. 
 401 
Miyoshi, G., Butt, S. J., Takebayashi, H. and Fishell, G. (2007) Physiologically distinct temporal cohorts of 
cortical interneurons arise from telencephalic Olig2-expressing precursors, J Neurosci 27(29): 7786-98. 
Molnar, Z. and Butler, A. B. (2002) The corticostriatal junction: a crucial region for forebrain development 
and evolution, Bioessays 24(6): 530-41. 
Molyneaux, B. J., Arlotta, P., Hirata, T., Hibi, M. and Macklis, J. D. (2005) Fezl is required for the birth and 
specification of corticospinal motor neurons, Neuron 47(6): 817-31. 
Molyneaux, B. J., Arlotta, P., Menezes, J. R. and Macklis, J. D. (2007) Neuronal subtype specification in the 
cerebral cortex, Nat Rev Neurosci 8(6): 427-37. 
Narahara, M., Yamada, A., Hamada-Kanazawa, M., Kawai, Y. and Miyake, M. (2002) cDNA cloning of the 
Sry-related gene Sox6 from rat with tissue-specific expression, Biol Pharm Bull 25(6): 705-9. 
Nobrega-Pereira, S., Kessaris, N., Du, T., Kimura, S., Anderson, S. A. and Marin, O. (2008) Postmitotic 
Nkx2-1 controls the migration of telencephalic interneurons by direct repression of guidance receptors, 
Neuron 59(5): 733-45. 
Parras, C. M., Schuurmans, C., Scardigli, R., Kim, J., Anderson, D. J. and Guillemot, F. (2002) Divergent 
functions of the proneural genes Mash1 and Ngn2 in the specification of neuronal subtype identity, Genes 
Dev 16(3): 324-38. 
Puelles, L., Kuwana, E., Puelles, E., Bulfone, A., Shimamura, K., Keleher, J., Smiga, S. and Rubenstein, J. L. 
(2000) Pallial and subpallial derivatives in the embryonic chick and mouse telencephalon, traced by the 
expression of the genes Dlx-2, Emx-1, Nkx-2.1, Pax-6, and Tbr-1, J Comp Neurol 424(3): 409-38. 
Rubenstein, J. L. and Merzenich, M. M. (2003) Model of autism: increased ratio of excitation/inhibition in 
key neural systems, Genes Brain Behav 2(5): 255-67. 
Scardigli, R., Baumer, N., Gruss, P., Guillemot, F. and Le Roux, I. (2003) Direct and concentration-
dependent regulation of the proneural gene Neurogenin2 by Pax6, Development 130(14): 3269-81. 
Schuurmans, C. and Guillemot, F. (2002) Molecular mechanisms underlying cell fate specification in the 
developing telencephalon, Curr Opin Neurobiol 12(1): 26-34. 
Smits, P., Li, P., Mandel, J., Zhang, Z., Deng, J. M., Behringer, R. R., de Crombrugghe, B. and Lefebvre, V. 
(2001) The transcription factors L-Sox5 and Sox6 are essential for cartilage formation, Dev Cell 1(2): 
277-90. 
Stolt, C. C., Schlierf, A., Lommes, P., Hillgartner, S., Werner, T., Kosian, T., Sock, E., Kessaris, N., 
Richardson, W. D., Lefebvre, V. et al. (2006) SoxD proteins influence multiple stages of oligodendrocyte 
development and modulate SoxE protein function, Dev Cell 11(5): 697-709. 
Tamamaki, N., Yanagawa, Y., Tomioka, R., Miyazaki, J., Obata, K. and Kaneko, T. (2003) Green 
fluorescent protein expression and colocalization with calretinin, parvalbumin, and somatostatin in the 
GAD67-GFP knock-in mouse, J Comp Neurol 467(1): 60-79. 
Vega, C. J. and Peterson, D. A. (2005) Stem cell proliferative history in tissue revealed by temporal 
halogenated thymidine analog discrimination, Nat Methods 2(3): 167-9. 
Wegner, M. (1999) From head to toes: the multiple facets of Sox proteins, Nucleic Acids Res 27(6): 1409-20. 
Wegner, M. and Stolt, C. C. (2005) From stem cells to neurons and glia: a Soxist's view of neural 
development, Trends Neurosci 28(11): 583-8. 
Wonders, C. P. and Anderson, S. A. (2006) The origin and specification of cortical interneurons, Nat Rev 
Neurosci 7(9): 687-96. 
 402 
Wonders, C. P., Taylor, L., Welagen, J., Mbata, I. C., Xiang, J. Z. and Anderson, S. A. (2008) A spatial bias 
for the origins of interneuron subgroups within the medial ganglionic eminence, Dev Biol 314(1): 127-36. 
Zhao, Y., Flandin, P., Long, J. E., Cuesta, M. D., Westphal, H. and Rubenstein, J. L. (2008) Distinct 
molecular pathways for development of telencephalic interneuron subtypes revealed through analysis of 
Lhx6 mutants, J Comp Neurol 510(1): 79-99. 
 
 
